1	Articles	NNPS	O	Articles	_	0	SENT_1	[p1l1910t169r2058b205],

1	Use	NN	O	use	_	0	SENT_2	[p1l8t365r112b414],
2	of	IN	O	of	prep	1	SENT_2	[p1l130t359r194b414],
3	regularly	RB	O	regularly	pcomp	2	SENT_2	[p1l209t360r469b431],
4	scheduled	VBN	O	schedule	partmod	1	SENT_2	[p1l484t360r783b414],
5	albuterol	NN	O	albuterol	nn	6	SENT_2	[p1l800t360r1066b414],
6	treatment	NN	O	treatment	dobj	4	SENT_2	[p1l1083t369r1392b414],
7	in	IN	O	in	_	0	SENT_2	[p1l1411t361r1461b413],
8	asthma	NN	O	asthma	prep_in	6	SENT_2	[p1l1480t360r1719b414],
9	:	:	O	:	_	0	SENT_2	[p1l1480t360r1719b414],
10	genotype-stratiﬁed	JJ	O	genotype-stratiﬁed	amod	14	SENT_2	[p1l6t450r609b522],
11	,	,	O	,	_	0	SENT_2	[p1l6t450r609b522],
12	randomised	JJ	O	randomised	amod	14	SENT_2	[p1l630t450r998b514],
13	,	,	O	,	_	0	SENT_2	[p1l630t450r998b514],
14	placebo-controlled	JJ	O	placebo-controlled	amod	8	SENT_2	[p1l1016t450r1579b521],

1	O	NN	O	o	_	0	SENT_3	[p1l380t542r391b553],

1	cross-over	JJ	O	cross-over	amod	2	SENT_4	[p1l6t558r312b595],
2	trial	NN	O	trial	_	0	SENT_4	[p1l325t541r442b595],

1	Elliot	NNP	PERSON	Elliot	dep	122	SENT_5	[p1l6t660r69b686],
2	lsrael	NNP	PERSON	lsrael	dep	122	SENT_5	[p1l77t660r147b691],
3	,	,	O	,	_	0	SENT_5	[p1l77t660r147b691],
4	Vernon	NNP	PERSON	Vernon	dep	122	SENT_5	[p1l156t663r244b686],
5	M	NNP	PERSON	M	dep	122	SENT_5	[p1l253t662r276b686],
6	Chinchilli	NNP	PERSON	Chinchilli	dep	122	SENT_5	[p1l285t660r407b691],
7	,	,	O	,	_	0	SENT_5	[p1l285t660r407b691],
8	Jean	NNP	PERSON	Jean	dep	122	SENT_5	[p1l411t662r468b692],
9	6	CD	NUMBER	6	dep	122	SENT_5	[p1l477t662r494b686],
10	Ford	NNP	ORGANIZATION	Ford	dep	122	SENT_5	[p1l502t660r562b691],
11	,	,	O	,	_	0	SENT_5	[p1l502t660r562b691],
12	HomerA	NNP	PERSON	HomerA	dep	122	SENT_5	[p1l572t662r680b686],
13	Boushey	NNP	PERSON	Boushey	dep	122	SENT_5	[p1l689t660r800b694],
14	,	,	O	,	_	0	SENT_5	[p1l689t660r800b694],
15	Reuben	NNP	PERSON	Reuben	dep	122	SENT_5	[p1l809t660r900b686],
16	Cherniack	NNP	PERSON	Cherniack	dep	122	SENT_5	[p1l909t660r1037b691],
17	,	,	O	,	_	0	SENT_5	[p1l909t660r1037b691],
18	Timothy	NNP	PERSON	Timothy	dep	122	SENT_5	[p1l1046t660r1154b694],
19	J	NNP	PERSON	J	dep	122	SENT_5	[p1l1156t662r1167b692],
20	Craig	NNP	PERSON	Craig	dep	122	SENT_5	[p1l1175t662r1245b694],
21	,	,	O	,	_	0	SENT_5	[p1l1175t662r1245b694],
22	Aaron	NNP	PERSON	Aaron	dep	122	SENT_5	[p1l1253t662r1329b686],
23	Deykin	NNP	PERSON	Deykin	dep	122	SENT_5	[p1l1338t660r1428b694],
24	,	,	O	,	_	0	SENT_5	[p1l1338t660r1428b694],
25	Joanne	NNP	PERSON	Joanne	dep	122	SENT_5	[p1l1433t663r1524b692],
26	K	NNP	PERSON	K	dep	122	SENT_5	[p1l1531t662r1547b686],
27	Fagan	NNP	PERSON	Fagan	dep	122	SENT_5	[p1l1553t663r1636b694],
28	,	,	O	,	_	0	SENT_5	[p1l1553t663r1636b694],
29	John	NNP	PERSON	John	dep	122	SENT_5	[p1l1641t660r1700b692],
30	VFahy	NNP	PERSON	VFahy	dep	122	SENT_5	[p1l1710t660r1799b694],
31	,	,	O	,	_	0	SENT_5	[p1l1710t660r1799b694],
32	Lancet	NNP	O	Lancet	dep	122	SENT_5	[p1l1860t668r1929b686],
33	2004	CD	DATE	2004	dep	122	SENT_5	[p1l1936t669r1997b689],
34	;	:	O	;	_	0	SENT_5	[p1l1936t669r1997b689],
35	364	CD	NUMBER	364	dep	122	SENT_5	[p1l2005t666r2052b689],
36	:	:	O	:	_	0	SENT_5	[p1l2005t666r2052b689],
37	1505-12	CD	DATE	1505-12	dep	122	SENT_5	[p1l6t715r103b735],
38	James	NNP	PERSON	James	dep	122	SENT_5	[p1l111t708r189b738],
39	Fish	NN	PERSON	fish	dep	122	SENT_5	[p1l198t706r253b736],
40	,	,	O	,	_	0	SENT_5	[p1l198t706r253b736],
41	Monica	NNP	PERSON	Monica	dep	122	SENT_5	[p1l262t707r355b732],
42	Kraft	NNP	PERSON	Kraft	dep	122	SENT_5	[p1l363t706r430b740],
43	,	,	O	,	_	0	SENT_5	[p1l363t706r430b740],
44	Susan	NNP	PERSON	Susan	dep	122	SENT_5	[p1l439t708r514b732],
45	J	NNP	PERSON	J	dep	122	SENT_5	[p1l518t708r529b738],
46	Kunselman	NNP	PERSON	Kunselman	dep	122	SENT_5	[p1l537t706r683b736],
47	,	,	O	,	_	0	SENT_5	[p1l537t706r683b736],
48	Stephen	NNP	PERSON	Stephen	dep	122	SENT_5	[p1l691t706r793b740],
49	C	NNP	PERSON	C	dep	122	SENT_5	[p1l802t708r818b732],
50	Lazarus	NNP	PERSON	Lazarus	dep	122	SENT_5	[p1l825t708r927b736],
51	,	,	O	,	_	0	SENT_5	[p1l825t708r927b736],
52	Robert	NNP	PERSON	Robert	dep	122	SENT_5	[p1l936t706r1018b732],
53	F	NN	PERSON	f	dep	122	SENT_5	[p1l1026t708r1040b732],
54	Lemanske	NN	PERSON	lemanske	dep	122	SENT_5	[p1l1046t706r1172b732],
55	Jr	NNP	PERSON	Jr	dep	122	SENT_5	[p1l1175t708r1202b738],
56	,	,	O	,	_	0	SENT_5	[p1l1175t708r1202b738],
57	Stephen	NNP	PERSON	Stephen	dep	122	SENT_5	[p1l1210t706r1312b740],
58	B	NNP	PERSON	B	dep	122	SENT_5	[p1l1321t708r1336b731],
59	Liggett	NNP	PERSON	Liggett	dep	122	SENT_5	[p1l1344t707r1437b740],
60	,	,	O	,	_	0	SENT_5	[p1l1344t707r1437b740],
61	Richard	NNP	PERSON	Richard	dep	122	SENT_5	[p1l1447t706r1540b732],
62	J	NNP	PERSON	J	dep	122	SENT_5	[p1l1543t708r1554b738],
63	Martin	NNP	PERSON	Martin	dep	122	SENT_5	[p1l1561t707r1653b736],
64	,	,	O	,	_	0	SENT_5	[p1l1561t707r1653b736],
65	Nandita	NNP	PERSON	Nandita	dep	122	SENT_5	[p1l1663t706r1765b732],
66	Mitra	NNP	PERSON	Mitra	dep	122	SENT_5	[p1l1773t707r1848b736],
67	,	,	O	,	_	0	SENT_5	[p1l1773t707r1848b736],
68	See	VB	O	see	dep	122	SENT_5	[p1l1970t716r2004b734],
69	Comment	NN	O	comment	dep	122	SENT_5	[p1l2011t716r2118b734],
70	page	NN	O	page	dep	122	SENT_5	[p1l6t766r55b786],
71	1454	CD	DATE	1454	dep	122	SENT_5	[p1l63t760r116b782],
72	Stephen	NNP	PERSON	Stephen	dep	122	SENT_5	[p1l125t751r227b785],
73	P	NN	PERSON	p	dep	122	SENT_5	[p1l236t754r251b777],
74	Peters	NNP	PERSON	Peters	dep	122	SENT_5	[p1l259t754r340b782],
75	,	,	O	,	_	0	SENT_5	[p1l259t754r340b782],
76	Eric	NNP	PERSON	Eric	dep	122	SENT_5	[p1l349t753r393b777],
77	Silverman	NNP	PERSON	Silverman	dep	122	SENT_5	[p1l399t751r531b782],
78	,	,	O	,	_	0	SENT_5	[p1l399t751r531b782],
79	Christine	NNP	PERSON	Christine	dep	122	SENT_5	[p1l540t751r652b777],
80	A	NNP	PERSON	A	dep	122	SENT_5	[p1l658t754r676b777],
81	Sorkness	NNP	PERSON	Sorkness	dep	122	SENT_5	[p1l684t751r799b782],
82	,	,	O	,	_	0	SENT_5	[p1l684t751r799b782],
83	Stanley	NNP	PERSON	Stanley	dep	122	SENT_5	[p1l808t751r902b785],
84	J	NNP	PERSON	J	dep	122	SENT_5	[p1l905t754r915b783],
85	Szefler	NNP	PERSON	Szefler	dep	122	SENT_5	[p1l922t751r1010b785],
86	,	,	O	,	_	0	SENT_5	[p1l922t751r1010b785],
87	Michael	NNP	PERSON	Michael	dep	122	SENT_5	[p1l1019t751r1118b777],
88	E	NNP	PERSON	E	dep	122	SENT_5	[p1l1125t754r1139b777],
89	Wechsler	NNP	PERSON	Wechsler	dep	122	SENT_5	[p1l1147t751r1264b782],
90	,	,	O	,	_	0	SENT_5	[p1l1147t751r1264b782],
91	Scott	NNP	PERSON	Scott	dep	122	SENT_5	[p1l1272t753r1339b777],
92	TWeiss	NNP	PERSON	TWeiss	dep	122	SENT_5	[p1l1345t753r1445b782],
93	,	,	O	,	_	0	SENT_5	[p1l1345t753r1445b782],
94	Jeffrey	NNP	PERSON	Jeffrey	dep	122	SENT_5	[p1l1450t751r1532b785],
95	M	NNP	PERSON	M	dep	122	SENT_5	[p1l1539t754r1563b777],
96	Drazen	NNP	PERSON	Drazen	dep	122	SENT_5	[p1l1572t754r1665b782],
97	,	,	O	,	_	0	SENT_5	[p1l1572t754r1665b782],
98	for	IN	O	for	dep	122	SENT_5	[p1l1674t751r1710b785],
99	the	DT	O	the	dep	122	SENT_5	[p1l1715t751r1757b777],
100	National	NNP	ORGANIZATION	National	dep	122	SENT_5	[p1l1764t751r1874b777],
101	Brigham	NNP	ORGANIZATION	Brigham	dep	122	SENT_5	[p1l1981t762r2070b788],
102	and	CC	O	and	dep	122	SENT_5	[p1l6t807r46b827],
103	women	NNS	O	woman	dep	122	SENT_5	[p1l51t808r153b827],
104	’	CD	NUMBER	’	dep	122	SENT_5	[p1l51t808r153b827],
105	;	:	O	;	_	0	SENT_5	[p1l51t808r153b827],
106	Hospirai	NNP	ORGANIZATION	Hospirai	dep	122	SENT_5	[p1l160t807r248b833],
107	Heart	NNP	ORGANIZATION	Heart	dep	122	SENT_5	[p1l257t799r331b827],
108	,	,	O	,	_	0	SENT_5	[p1l257t799r331b827],
109	Lung	NN	O	lung	dep	122	SENT_5	[p1l341t799r408b831],
110	,	,	O	,	_	0	SENT_5	[p1l341t799r408b831],
111	and	CC	O	and	dep	122	SENT_5	[p1l417t797r464b823],
112	Blood	NN	O	blood	dep	122	SENT_5	[p1l472t797r542b823],
113	lnstitute	NN	O	lnstitute	dep	122	SENT_5	[p1l550t798r676b823],
114	’s	POS	O	’s	dep	122	SENT_5	[p1l550t798r676b823],
115	Asthma	NNP	ORGANIZATION	Asthma	dep	122	SENT_5	[p1l683t797r784b823],
116	Clinical	JJ	ORGANIZATION	clinical	dep	122	SENT_5	[p1l793t797r883b823],
117	Research	NNP	ORGANIZATION	Research	dep	122	SENT_5	[p1l891t797r999b823],
118	Network	NNP	ORGANIZATION	Network	dep	122	SENT_5	[p1l1008t797r1117b823],
119	and	CC	O	and	dep	122	SENT_5	[p1l2110t799r2150b818],
120	Harvard	NNP	ORGANIZATION	Harvard	dep	122	SENT_5	[p1l6t843r90b863],
121	Medical	NNP	ORGANIZATION	Medical	dep	122	SENT_5	[p1l96t843r178b863],
122	School	NNP	ORGANIZATION	School	_	0	SENT_5	[p1l185t843r262b867],
123	,	,	O	,	_	0	SENT_5	[p1l185t843r262b867],

1	Boston	NNP	LOCATION	Boston	dep	9	SENT_6	[p1l1841t873r1923b894],
2	,	,	O	,	_	0	SENT_6	[p1l1841t873r1923b894],
3	MA	NNP	O	MA	appos	1	SENT_6	[p1l1929t873r1972b894],
4	,	,	O	,	_	0	SENT_6	[p1l1929t873r1972b894],
5	USA	NNP	LOCATION	USA	appos	1	SENT_6	[p1l1979t873r2024b891],
6	(	CD	NUMBER	(	num	7	SENT_6	[p1l2031t872r2050b896],
7	E	NN	O	e	dep	9	SENT_6	[p1l2031t872r2050b896],
8	Israel	NNP	LOCATION	Israel	nn	9	SENT_6	[p1l2057t871r2107b891],
9	MD	NNP	O	MD	dep	39	SENT_6	[p1l2115t873r2154b894],
10	,	,	O	,	_	0	SENT_6	[p1l2115t873r2154b894],
11	S	NN	O	s	nn	15	SENT_6	[p1l6t920r24b951],
12	rnm	NN	O	rnm	nn	15	SENT_6	[p1l52t928r122b950],
13	A	NN	O	a	nn	15	SENT_6	[p1l1859t909r1874b927],
14	Deykin	JJ	O	deykin	amod	15	SENT_6	[p1l1882t907r1949b933],
15	MD	NN	O	md	appos	9	SENT_6	[p1l1956t909r1996b931],
16	,	,	O	,	_	0	SENT_6	[p1l1956t909r1996b931],
17	N	NN	O	n	nn	19	SENT_6	[p1l2004t909r2018b927],
18	Mitra	NNP	O	Mitra	nn	19	SENT_6	[p1l2026t908r2079b927],
19	PhD	NNP	O	PhD	appos	9	SENT_6	[p1l2087t907r2132b930],
20	,	,	O	,	_	0	SENT_6	[p1l2087t907r2132b930],
21	U	NNP	PERSON	U	nn	25	SENT_6	[p1l28t929r48b951],
22	ary	NNP	PERSON	ary	nn	25	SENT_6	[p1l125t928r181b961],
23	E	NNP	PERSON	E	nn	25	SENT_6	[p1l1861t946r1870b964],
24	Silverman	NNP	PERSON	Silverman	nn	25	SENT_6	[p1l1877t944r1976b964],
25	MD	NNP	O	MD	appos	9	SENT_6	[p1l1984t946r2024b967],
26	,	,	O	,	_	0	SENT_6	[p1l1984t946r2024b967],
27	Background	NNP	O	Background	appos	9	SENT_6	[p1l6t969r185b1006],
28	The	DT	O	the	det	29	SENT_6	[p1l199t968r259b997],
29	issue	NN	O	issue	nsubj	39	SENT_6	[p1l277t969r357b997],
30	of	IN	O	of	_	0	SENT_6	[p1l374t968r410b997],
31	whether	IN	O	whether	amod	33	SENT_6	[p1l421t968r550b997],
32	regular	JJ	O	regular	amod	33	SENT_6	[p1l567t968r680b1006],
33	use	NN	O	use	prep_of	29	SENT_6	[p1l697t978r750b997],
34	of	IN	O	of	_	0	SENT_6	[p1l768t968r803b997],
35	an	DT	O	a	prep_of	33	SENT_6	[p1l816t978r854b997],
36	inhaled	VBN	O	inhale	partmod	35	SENT_6	[p1l871t968r988b997],
37	B,-adrenergic	JJ	O	b,-adrenergic	amod	38	SENT_6	[p1l1008t968r1215b1006],
38	agonist	NN	O	agonist	dobj	36	SENT_6	[p1l1232t969r1346b1006],
39	worsens	VBZ	O	worsen	dep	50	SENT_6	[p1l1362t978r1492b997],
40	airﬂow	NN	O	airﬂow	nn	44	SENT_6	[p1l1510t968r1619b997],
41	and	CC	O	and	_	0	SENT_6	[p1l1635t968r1694b997],
42	clinical	JJ	O	clinical	nn	44	SENT_6	[p1l1711t968r1822b997],
43	Mgwechsierr/iugrwerss	NN	O	mgwechsierr/iugrwerss	nn	44	SENT_6	[p1l1859t980r2140b1004],
44	MD	NN	O	md	dobj	39	SENT_6	[p1l6t1028r46b1050],
45	,	,	O	,	_	0	SENT_6	[p1l6t1028r46b1050],
46	outcomes	NNS	O	outcome	nsubj	50	SENT_6	[p1l55t1020r206b1043],
47	in	IN	O	in	_	0	SENT_6	[p1l217t1015r248b1042],
48	asthma	NN	O	asthma	prep_in	46	SENT_6	[p1l258t1014r373b1043],
49	is	VBZ	O	be	cop	50	SENT_6	[p1l383t1015r407b1043],
50	controversial	JJ	O	controversial	_	0	SENT_6	[p1l418t1014r627b1043],
51	.	.	O	.	_	0	SENT_6	[p1l418t1014r627b1043],

1	Retrospective	JJ	O	retrospective	amod	2	SENT_7	[p1l640t1015r849b1052],
2	studies	NNS	O	study	nsubj	4	SENT_7	[p1l860t1014r969b1043],
3	have	VBP	O	have	aux	4	SENT_7	[p1l979t1014r1051b1043],
4	suggested	VBN	O	suggest	_	0	SENT_7	[p1l1062t1014r1217b1052],
5	that	IN	O	that	complm	8	SENT_7	[p1l1226t1014r1287b1043],
6	adverse	JJ	O	adverse	amod	7	SENT_7	[p1l1296t1014r1413b1043],
7	effects	NNS	O	effect	nsubj	8	SENT_7	[p1l1423t1014r1524b1043],
8	occur	VBP	O	occur	ccomp	4	SENT_7	[p1l1534t1024r1621b1043],
9	in	IN	O	in	_	0	SENT_7	[p1l1630t1015r1661b1042],
10	patients	NNS	O	patient	prep_in	8	SENT_7	[p1l1671t1015r1795b1052],
11	with	IN	O	with	_	0	SENT_7	[p1l1804t1014r1874b1043],
12	JM	NN	PERSON	jm	nn	15	SENT_7	[p1l1908t1019r1940b1042],
13	Drazen	NN	PERSON	drazen	nn	15	SENT_7	[p1l1948t1019r2016b1037],
14	MD	NN	O	md	nn	15	SENT_7	[p1l2024t1018r2073b1042],
15	)	NN	O	)	prep_with	8	SENT_7	[p1l2024t1018r2073b1042],
16	;	:	O	;	_	0	SENT_7	[p1l2024t1018r2073b1042],
17	Pennsylvania	NNP	LOCATION	Pennsylvania	nsubj	20	SENT_7	[p1l6t1063r147b1089],
18	a	DT	O	a	det	20	SENT_7	[p1l6t1100r22b1118],
19	genetic	JJ	O	genetic	amod	20	SENT_7	[p1l40t1091r152b1128],
20	polymorphism	NN	O	polymorphism	parataxis	8	SENT_7	[p1l170t1090r402b1127],
21	that	WDT	O	that	nsubj	22	SENT_7	[p1l419t1090r480b1118],
22	results	VBZ	O	result	rcmod	20	SENT_7	[p1l497t1090r601b1118],
23	in	IN	O	in	_	0	SENT_7	[p1l619t1091r651b1118],
24	homozygosity	NN	O	homozygosity	prep_in	22	SENT_7	[p1l668t1090r887b1128],
25	for	IN	O	for	_	0	SENT_7	[p1l903t1090r949b1118],
26	arginine	NN	O	arginine	nn	29	SENT_7	[p1l965t1091r1097b1128],
27	(	CD	NUMBER	(	num	29	SENT_7	[p1l1116t1092r1277b1128],
28	Arg/Arg	NN	O	arg/arg	nn	29	SENT_7	[p1l1116t1092r1277b1128],
29	)	NN	O	)	prep_for	24	SENT_7	[p1l1116t1092r1277b1128],
30	,	,	O	,	_	0	SENT_7	[p1l1116t1092r1277b1128],
31	rather	RB	O	rather	_	0	SENT_7	[p1l1296t1090r1391b1118],
32	than	IN	O	than	_	0	SENT_7	[p1l1407t1090r1478b1118],
33	glycine	NN	O	glycine	nn	36	SENT_7	[p1l1496t1090r1606b1128],
34	(	CD	NUMBER	(	num	36	SENT_7	[p1l1626t1090r1778b1128],
35	Gly/Gly	NN	O	gly/gly	nn	36	SENT_7	[p1l1626t1090r1778b1128],
36	)	NN	O	)	prep_in	22	SENT_7	[p1l1626t1090r1778b1128],
37	,	,	O	,	_	0	SENT_7	[p1l1626t1090r1778b1128],
38	at	IN	O	at	_	0	SENT_7	[p1l1797t1095r1825b1118],
39	aminoacid	JJ	O	aminoacid	amod	40	SENT_7	[p1l6t1136r171b1164],
40	residue	NN	O	residue	prep_at	22	SENT_7	[p1l184t1136r300b1164],
41	16	CD	NUMBER	16	num	40	SENT_7	[p1l314t1138r349b1164],
42	of	IN	O	of	_	0	SENT_7	[p1l363t1136r398b1164],
43	the	DT	O	the	det	45	SENT_7	[p1l406t1136r455b1164],
44	B2-adrenergic	JJ	O	b2-adrenergic	amod	45	SENT_7	[p1l471t1136r677b1174],
45	receptor	NN	O	receptor	prep_of	40	SENT_7	[p1l691t1142r827b1173],
46	.	.	O	.	_	0	SENT_7	[p1l691t1142r827b1173],

1	However	RB	O	however	advmod	12	SENT_8	[p1l843t1139r991b1169],
2	,	,	O	,	_	0	SENT_8	[p1l843t1139r991b1169],
3	the	DT	O	the	det	4	SENT_8	[p1l1005t1136r1054b1164],
4	existence	NN	O	existence	nsubjpass	12	SENT_8	[p1l1068t1137r1211b1164],
5	of	IN	O	of	_	0	SENT_8	[p1l1224t1136r1259b1164],
6	any	DT	O	any	det	8	SENT_8	[p1l1267t1146r1323b1173],
7	genotype-dependent	JJ	O	genotype-dependent	amod	8	SENT_8	[p1l1335t1136r1654b1174],
8	difference	NN	O	difference	prep_of	4	SENT_8	[p1l1667t1136r1825b1164],
9	has	VBZ	O	have	aux	12	SENT_8	[p1l6t1182r59b1210],
10	not	RB	O	not	neg	12	SENT_8	[p1l70t1188r121b1210],
11	been	VBN	O	be	auxpass	12	SENT_8	[p1l131t1182r206b1210],
12	tested	VBN	O	test	_	0	SENT_8	[p1l216t1182r309b1210],
13	in	IN	O	in	_	0	SENT_8	[p1l319t1183r350b1210],
14	a	DT	O	a	det	17	SENT_8	[p1l361t1192r377b1210],
15	prospective	JJ	O	prospective	amod	17	SENT_8	[p1l387t1183r564b1219],
16	clinical	JJ	O	clinical	amod	17	SENT_8	[p1l575t1182r686b1210],
17	trial	NN	O	trial	prep_in	12	SENT_8	[p1l696t1182r767b1210],
18	.	.	O	.	_	0	SENT_8	[p1l696t1182r767b1210],

1	State	NNP	ORGANIZATION	State	nn	3	SENT_9	[p1l6t1264r62b1282],
2	University	NNP	ORGANIZATION	University	nn	3	SENT_9	[p1l69t1263r179b1288],
3	College	NNP	ORGANIZATION	College	_	0	SENT_9	[p1l185t1262r263b1289],
4	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l269t1262r292b1282],
5	Medicine	NNP	ORGANIZATION	Medicine	prep_of	3	SENT_9	[p1l6t1299r109b1322],
6	,	,	O	,	_	0	SENT_9	[p1l6t1299r109b1322],
7	Hershey	NNP	PERSON	Hershey	appos	5	SENT_9	[p1l116t1299r208b1325],
8	,	,	O	,	_	0	SENT_9	[p1l116t1299r208b1325],
9	PA	NN	ORGANIZATION	pa	appos	5	SENT_9	[p1l216t1301r250b1322],
10	,	,	O	,	_	0	SENT_9	[p1l216t1301r250b1322],
11	USA	NNP	LOCATION	USA	appos	5	SENT_9	[p1l258t1300r302b1319],
12	(	CD	NUMBER	(	num	11	SENT_9	[p1l7t1337r28b1361],
13	V	NNP	O	V	nn	16	SENT_9	[p1l7t1337r28b1361],
14	M	NN	O	m	nn	16	SENT_9	[p1l34t1337r53b1355],
15	Chinchilli	NNP	PERSON	Chinchilli	nn	16	SENT_9	[p1l60t1335r151b1355],
16	PhD	NNP	O	PhD	dep	3	SENT_9	[p1l159t1335r205b1359],
17	,	,	O	,	_	0	SENT_9	[p1l159t1335r205b1359],
18	TJ	NNP	PERSON	TJ	nn	20	SENT_9	[p1l211t1337r235b1360],
19	Craig	NNP	PERSON	Craig	nn	20	SENT_9	[p1l243t1336r293b1362],
20	DO	NNP	PERSON	DO	conj_and	16	SENT_9	[p1l301t1337r337b1359],
21	,	,	O	,	_	0	SENT_9	[p1l301t1337r337b1359],
22	SJ	NNP	PERSON	SJ	nn	24	SENT_9	[p1l6t1374r27b1397],
23	Kunselman	NNP	PERSON	Kunselman	nn	24	SENT_9	[p1l36t1372r147b1392],
24	MA	NNP	O	MA	conj_and	16	SENT_9	[p1l155t1373r204b1397],
25	)	NN	O	)	dep	24	SENT_9	[p1l155t1373r204b1397],
26	;	:	O	;	_	0	SENT_9	[p1l155t1373r204b1397],
27	Harlem	NNP	ORGANIZATION	Harlem	nn	29	SENT_9	[p1l212t1372r287b1392],
28	Lung	NN	ORGANIZATION	lung	nn	29	SENT_9	[p1l1870t1410r1922b1434],
29	Center	NNP	ORGANIZATION	Center	conj_and	16	SENT_9	[p1l1929t1409r2000b1428],
30	and	CC	O	and	_	0	SENT_9	[p1l2005t1408r2045b1428],
31	Columbia	NNP	LOCATION	Columbia	conj_and	16	SENT_9	[p1l2052t1408r2154b1428],

1	Methods	NNS	O	method	nn	2	SENT_10	[p1l7t1445r140b1473],
2	Patients	NNS	O	patient	nsubjpass	14	SENT_10	[p1l152t1445r276b1473],
3	with	IN	O	with	_	0	SENT_10	[p1l290t1444r359b1473],
4	mild	JJ	O	mild	amod	5	SENT_10	[p1l373t1444r446b1473],
5	asthma	NN	O	asthma	prep_with	2	SENT_10	[p1l459t1444r581b1477],
6	,	,	O	,	_	0	SENT_10	[p1l459t1444r581b1477],
7	not	RB	O	not	neg	8	SENT_10	[p1l596t1450r648b1473],
8	using	VBG	O	use	partmod	2	SENT_10	[p1l660t1445r749b1482],
9	a	DT	O	a	det	11	SENT_10	[p1l762t1454r778b1473],
10	controller	NN	O	controller	nn	11	SENT_10	[p1l792t1444r944b1473],
11	medication	NN	O	medication	dobj	8	SENT_10	[p1l957t1444r1140b1477],
12	,	,	O	,	_	0	SENT_10	[p1l957t1444r1140b1477],
13	were	VBD	O	be	auxpass	14	SENT_10	[p1l1154t1454r1229b1473],
14	enrolled	VBN	O	enrol	_	0	SENT_10	[p1l1243t1444r1372b1473],
15	in	IN	O	in	_	0	SENT_10	[p1l1385t1445r1416b1472],
16	pairs	NNS	O	pair	prep_in	14	SENT_10	[p1l1430t1445r1506b1481],
17	matched	VBN	O	match	partmod	16	SENT_10	[p1l1520t1444r1656b1473],
18	for	IN	O	for	mark	25	SENT_10	[p1l1669t1444r1714b1473],
19	forced	JJ	O	forced	amod	21	SENT_10	[p1l1726t1444r1825b1473],
20	expiratory	JJ	O	expiratory	amod	21	SENT_10	[p1l6t1491r162b1528],
21	volume	NN	O	volume	nsubj	25	SENT_10	[p1l175t1490r292b1519],
22	in	IN	O	in	_	0	SENT_10	[p1l307t1491r338b1519],
23	1	CD	NUMBER	1	num	24	SENT_10	[p1l354t1493r368b1518],
24	s	NNS	O	s	prep_in	21	SENT_10	[p1l386t1500r399b1519],
25	(	VBP	O	(	advcl	17	SENT_10	[p1l416t1492r512b1528],
26	FEV1	NN	O	fev1	dobj	25	SENT_10	[p1l416t1492r512b1528],
27	)	CD	NUMBER	)	num	26	SENT_10	[p1l416t1492r512b1528],
28	according	VBG	O	accord	_	0	SENT_10	[p1l528t1490r681b1528],
29	to	TO	O	to	prepc_according_to	25	SENT_10	[p1l695t1496r724b1519],
30	whether	IN	O	whether	complm	32	SENT_10	[p1l738t1490r868b1519],
31	they	PRP	O	they	nsubj	32	SENT_10	[p1l881t1490r948b1528],
32	had	VBD	O	have	pcomp	25	SENT_10	[p1l961t1490r1019b1519],
33	the	DT	O	the	det	36	SENT_10	[p1l1033t1490r1082b1519],
34	Arg/Arg	NN	O	arg/arg	nn	36	SENT_10	[p1l1096t1492r1228b1528],
35	(	NN	O	(	nn	36	SENT_10	[p1l1244t1492r1341b1528],
36	n	NN	O	n	dobj	32	SENT_10	[p1l1244t1492r1341b1528],
37	=	JJ	O	=	amod	36	SENT_10	[p1l1244t1492r1341b1528],
38	37	CD	NUMBER	37	tmod	37	SENT_10	[p1l1244t1492r1341b1528],
39	;	:	O	;	_	0	SENT_10	[p1l1244t1492r1341b1528],
40	four	CD	NUMBER	four	nsubj	44	SENT_10	[p1l1356t1490r1423b1519],
41	of	IN	O	of	_	0	SENT_10	[p1l1437t1490r1472b1519],
42	41	CD	NUMBER	41	num	43	SENT_10	[p1l1481t1493r1516b1519],
43	matches	NNS	O	match	prep_of	40	SENT_10	[p1l1532t1490r1662b1519],
44	withdrew	VBD	O	withdraw	parataxis	14	SENT_10	[p1l1677t1490r1825b1519],

1	University	NNP	O	University	_	0	SENT_11	[p1l6t1573r121b1598],
2	,	,	O	,	_	0	SENT_11	[p1l6t1573r121b1598],
3	New	NNP	LOCATION	New	nn	4	SENT_11	[p1l129t1574r178b1592],
4	York	NNP	LOCATION	York	appos	1	SENT_11	[p1l183t1572r239b1596],
5	,	,	O	,	_	0	SENT_11	[p1l183t1572r239b1596],
6	NY	NNP	O	NY	appos	1	SENT_11	[p1l247t1574r284b1596],
7	,	,	O	,	_	0	SENT_11	[p1l247t1574r284b1596],
8	USA	NNP	LOCATION	USA	appos	1	SENT_11	[p1l292t1574r336b1592],
9	(	CD	NUMBER	(	num	8	SENT_11	[p1l6t1610r18b1634],
10	J	NNP	O	J	nn	13	SENT_11	[p1l6t1610r18b1634],
11	6	CD	NUMBER	6	num	13	SENT_11	[p1l26t1610r39b1628],
12	Ford	NNP	ORGANIZATION	Ford	nn	13	SENT_11	[p1l47t1609r92b1628],
13	MD	NNP	O	MD	dep	8	SENT_11	[p1l99t1610r150b1633],
14	,	,	O	,	_	0	SENT_11	[p1l99t1610r150b1633],
15	J	NNP	O	J	nn	19	SENT_11	[p1l99t1610r150b1633],
16	K	NNP	O	K	nn	19	SENT_11	[p1l158t1610r170b1628],
17	Fagan	NNP	PERSON	Fagan	nn	19	SENT_11	[p1l177t1610r236b1635],
18	PhD	NN	O	phd	nn	19	SENT_11	[p1l244t1609r299b1634],
19	)	NN	O	)	appos	1	SENT_11	[p1l244t1609r299b1634],
20	;	:	O	;	_	0	SENT_11	[p1l244t1609r299b1634],
21	University	NNP	ORGANIZATION	University	dep	1	SENT_11	[p1l6t1645r116b1671],
22	of	IN	ORGANIZATION	of	_	0	SENT_11	[p1l122t1645r145b1665],
23	California	NNP	ORGANIZATION	California	prep_of	21	SENT_11	[p1l150t1645r252b1665],
24	at	IN	O	at	_	0	SENT_11	[p1l258t1648r280b1665],
25	San	NNP	O	San	amod	36	SENT_11	[p1l286t1647r323b1665],
26	before	IN	O	before	_	0	SENT_11	[p1l6t1671r105b1700],
27	randomisation	NN	O	randomisation	prep_before	25	SENT_11	[p1l120t1671r360b1709],
28	)	CD	NUMBER	)	num	27	SENT_11	[p1l120t1671r360b1709],
29	or	CC	O	or	_	0	SENT_11	[p1l377t1681r410b1700],
30	Gly/Gly	JJ	O	gly/gly	amod	32	SENT_11	[p1l425t1671r548b1709],
31	(	NN	O	(	nn	32	SENT_11	[p1l564t1673r662b1709],
32	n	NN	O	n	conj_or	27	SENT_11	[p1l564t1673r662b1709],
33	=	JJ	O	=	amod	36	SENT_11	[p1l564t1673r662b1709],
34	41	CD	NUMBER	41	number	35	SENT_11	[p1l564t1673r662b1709],
35	)	CD	NUMBER	)	num	36	SENT_11	[p1l564t1673r662b1709],
36	genotype	NN	O	genotype	prep_at	23	SENT_11	[p1l679t1677r828b1709],
37	.	.	O	.	_	0	SENT_11	[p1l679t1677r828b1709],

1	Regularly	RB	O	regularly	advmod	2	SENT_12	[p1l845t1671r994b1709],
2	scheduled	VBN	O	schedule	_	0	SENT_12	[p1l1009t1671r1167b1700],
3	treatment	NN	O	treatment	dobj	2	SENT_12	[p1l1181t1676r1335b1700],
4	with	IN	O	with	_	0	SENT_12	[p1l1349t1671r1418b1700],
5	albuterol	NN	O	albuterol	prep_with	2	SENT_12	[p1l1433t1671r1572b1700],
6	or	CC	O	or	_	0	SENT_12	[p1l1587t1681r1620b1700],
7	placebo	NN	O	placebo	conj_or	5	SENT_12	[p1l1633t1671r1752b1708],
8	was	VBD	O	be	auxpass	2	SENT_12	[p1l1766t1681r1824b1700],
9	Francisco	NNP	PERSON	Francisco	nsubjpass	2	SENT_12	[p1l1863t1682r1967b1705],
10	,	,	O	,	_	0	SENT_12	[p1l1863t1682r1967b1705],
11	San	NNP	LOCATION	San	nn	12	SENT_12	[p1l1974t1683r2011b1701],
12	Francisco	NNP	LOCATION	Francisco	appos	9	SENT_12	[p1l2019t1682r2123b1705],
13	,	,	O	,	_	0	SENT_12	[p1l2019t1682r2123b1705],
14	CA	NNP	LOCATION	CA	appos	12	SENT_12	[p1l6t1728r41b1750],
15	,	,	O	,	_	0	SENT_12	[p1l6t1728r41b1750],
16	given	VBN	O	give	prep	12	SENT_12	[p1l6t1759r90b1796],
17	in	IN	O	in	pcomp	16	SENT_12	[p1l112t1759r143b1786],
18	a	DT	O	a	det	22	SENT_12	[p1l165t1768r181b1787],
19	masked	VBN	O	mask	amod	22	SENT_12	[p1l203t1758r332b1791],
20	,	,	O	,	_	0	SENT_12	[p1l203t1758r332b1791],
21	cross-over	JJ	O	cross-over	amod	22	SENT_12	[p1l356t1768r513b1787],
22	design	NN	O	design	pobj	17	SENT_12	[p1l534t1758r646b1796],
23	,	,	O	,	_	0	SENT_12	[p1l534t1758r646b1796],
24	for	IN	O	for	_	0	SENT_12	[p1l669t1758r714b1787],
25	16-week	JJ	DURATION	16-week	amod	26	SENT_12	[p1l736t1758r863b1787],
26	periods	NNS	O	period	prep_for	22	SENT_12	[p1l884t1758r1007b1795],
27	.	.	O	.	_	0	SENT_12	[p1l884t1758r1007b1795],

1	During	IN	O	during	_	0	SENT_13	[p1l1032t1759r1145b1796],
2	the	DT	O	the	det	3	SENT_13	[p1l1166t1758r1215b1787],
3	study	NN	O	study	prep_during	9	SENT_13	[p1l1238t1758r1329b1796],
4	,	,	O	,	_	0	SENT_13	[p1l1238t1758r1329b1796],
5	as-needed	JJ	O	as-needed	amod	7	SENT_13	[p1l1352t1758r1508b1787],
6	albuterol	NN	O	albuterol	nn	7	SENT_13	[p1l1529t1758r1668b1787],
7	use	NN	O	use	nsubjpass	9	SENT_13	[p1l1690t1768r1744b1787],
8	was	VBD	O	be	auxpass	9	SENT_13	[p1l1765t1768r1823b1787],
9	discontinued	VBN	O	discontinue	_	0	SENT_13	[p1l6t1804r211b1833],
10	and	CC	O	and	_	0	SENT_13	[p1l226t1804r284b1833],
11	ipratropium	NN	O	ipratropium	nn	12	SENT_13	[p1l299t1805r490b1842],
12	bromide	NN	O	bromide	nsubjpass	14	SENT_13	[p1l505t1804r638b1833],
13	was	VBD	O	be	auxpass	14	SENT_13	[p1l653t1814r712b1833],
14	used	VBN	O	use	conj_and	9	SENT_13	[p1l728t1804r802b1833],
15	as	IN	O	as	_	0	SENT_13	[p1l817t1814r848b1833],
16	needed	VBN	O	need	prep_as	14	SENT_13	[p1l865t1804r985b1833],
17	.	.	O	.	_	0	SENT_13	[p1l865t1804r985b1833],

1	Moming	VBG	O	mome	dep	13	SENT_14	[p1l1003t1805r1142b1842],
2	peak	JJ	O	peak	amod	5	SENT_14	[p1l1157t1804r1230b1842],
3	expiratory	JJ	O	expiratory	amod	5	SENT_14	[p1l1245t1805r1402b1842],
4	ﬂow	NN	O	ﬂow	nn	5	SENT_14	[p1l1417t1804r1483b1833],
5	rate	NN	O	rate	dobj	1	SENT_14	[p1l1498t1810r1557b1833],
6	(	CD	NUMBER	(	num	8	SENT_14	[p1l1575t1806r1683b1842],
7	PEFR	NN	O	pefr	nn	8	SENT_14	[p1l1575t1806r1683b1842],
8	)	NN	O	)	nsubj	13	SENT_14	[p1l1575t1806r1683b1842],
9	was	VBD	O	be	cop	13	SENT_14	[p1l1700t1814r1758b1833],
10	the	DT	O	the	det	13	SENT_14	[p1l1775t1804r1824b1833],
11	primary	JJ	O	primary	amod	13	SENT_14	[p1l6t1851r131b1888],
12	outcome	NN	O	outcome	nn	13	SENT_14	[p1l151t1856r287b1879],
13	variable	NN	O	variable	_	0	SENT_14	[p1l307t1850r437b1879],
14	.	.	O	.	_	0	SENT_14	[p1l307t1850r437b1879],

1	The	DT	O	the	det	3	SENT_15	[p1l459t1850r519b1879],
2	primary	JJ	O	primary	amod	3	SENT_15	[p1l540t1851r666b1888],
3	comparisons	NNS	O	comparison	nsubj	4	SENT_15	[p1l686t1851r886b1887],
4	were	VBD	O	be	_	0	SENT_15	[p1l907t1860r982b1879],
5	between	IN	O	between	_	0	SENT_15	[p1l1002t1850r1132b1879],
6	treatment	NN	O	treatment	nn	7	SENT_15	[p1l1152t1856r1307b1879],
7	period	NN	O	period	prep_between	4	SENT_15	[p1l1327t1850r1427b1887],
8	for	IN	O	for	_	0	SENT_15	[p1l1447t1850r1492b1879],
9	each	DT	O	each	det	10	SENT_15	[p1l1512t1850r1583b1879],
10	genotype	NN	O	genotype	prep_for	7	SENT_15	[p1l1604t1856r1753b1888],
11	;	:	O	;	_	0	SENT_15	[p1l1604t1856r1753b1888],
12	the	DT	O	the	dep	10	SENT_15	[p1l1775t1850r1824b1879],

1	USA	NNP	LOCATION	USA	_	0	SENT_16	[p1l9t1965r54b1983],
2	(	CD	NUMBER	(	num	1	SENT_16	[p1l61t1964r82b1988],
3	H	NN	O	h	prep	1	SENT_16	[p1l61t1964r82b1988],
4	A	DT	O	a	det	6	SENT_16	[p1l90t1965r105b1983],
5	Boushey	JJ	O	boushey	amod	6	SENT_16	[p1l112t1963r199b1989],
6	MD	NN	O	md	dep	3	SENT_16	[p1l205t1965r245b1986],
7	,	,	O	,	_	0	SENT_16	[p1l205t1965r245b1986],
8	iv	NN	O	iv	nn	10	SENT_16	[p1l6t2001r34b2024],
9	Fahy	NNP	PERSON	Fahy	nn	10	SENT_16	[p1l41t1999r88b2025],
10	MD	NNP	O	MD	appos	1	SENT_16	[p1l94t2001r134b2023],
11	,	,	O	,	_	0	SENT_16	[p1l94t2001r134b2023],
12	5	CD	NUMBER	5	num	13	SENT_16	[p1l141t2001r152b2019],
13	c	NN	O	c	appos	1	SENT_16	[p1l159t2001r171b2019],
14	Lazarus	NNP	PERSON	Lazarus	nn	16	SENT_16	[p1l179t2001r253b2019],
15	MD	NNP	O	MD	nn	16	SENT_16	[p1l260t2001r309b2025],
16	)	NN	O	)	dep	13	SENT_16	[p1l260t2001r309b2025],
17	;	:	O	;	_	0	SENT_16	[p1l260t2001r309b2025],
18	National	NNP	ORGANIZATION	National	nn	20	SENT_16	[p1l9t2036r101b2056],
19	Jewish	NNP	ORGANIZATION	Jewish	nn	20	SENT_16	[p1l105t2036r176b2061],
20	Medical	NNP	ORGANIZATION	Medical	dep	1	SENT_16	[p1l183t2036r265b2056],
21	and	CC	ORGANIZATION	and	_	0	SENT_16	[p1l271t2036r311b2056],
22	Research	NNP	ORGANIZATION	Research	nn	23	SENT_16	[p1l9t2073r102b2093],
23	Center	NNP	ORGANIZATION	Center	dep	1	SENT_16	[p1l109t2074r185b2096],
24	,	,	O	,	_	0	SENT_16	[p1l109t2074r185b2096],
25	Denver	NNP	LOCATION	Denver	appos	1	SENT_16	[p1l193t2075r274b2096],
26	,	,	O	,	_	0	SENT_16	[p1l193t2075r274b2096],
27	CO	NNP	LOCATION	CO	appos	1	SENT_16	[p1l281t2074r317b2096],
28	,	,	O	,	_	0	SENT_16	[p1l281t2074r317b2096],
29	secondary	JJ	O	secondary	amod	30	SENT_16	[p1l6t2100r163b2138],
30	outcome	NN	O	outcome	nsubj	33	SENT_16	[p1l173t2106r309b2129],
31	was	VBD	O	be	cop	33	SENT_16	[p1l318t2110r376b2129],
32	a	DT	O	a	det	33	SENT_16	[p1l388t2110r404b2129],
33	treatment	NN	O	treatment	dep	1	SENT_16	[p1l414t2106r568b2129],
34	by	IN	O	by	_	0	SENT_16	[p1l577t2100r614b2138],
35	genotype	NN	O	genotype	nn	36	SENT_16	[p1l624t2106r765b2138],
36	effect	NN	O	effect	prep_by	33	SENT_16	[p1l775t2100r868b2129],
37	.	.	O	.	_	0	SENT_16	[p1l775t2100r868b2129],

1	Analyses	NNS	O	analysis	nsubj	2	SENT_17	[p1l880t2100r1018b2138],
2	were	VBD	O	be	_	0	SENT_17	[p1l1029t2110r1104b2129],
3	by	IN	O	by	_	0	SENT_17	[p1l1113t2100r1150b2138],
4	intention	NN	O	intention	prep_by	2	SENT_17	[p1l1160t2101r1304b2129],
5	to	TO	O	to	aux	6	SENT_17	[p1l1314t2106r1343b2129],
6	treat	VB	O	treat	xcomp	2	SENT_17	[p1l1353t2106r1432b2129],
7	.	.	O	.	_	0	SENT_17	[p1l1353t2106r1432b2129],

1	USA	NNP	LOCATION	USA	_	0	SENT_18	[p1l1861t2111r1905b2130],
2	(	CD	NUMBER	(	dep	1	SENT_18	[p1l1912t2111r1932b2135],
3	R	NN	O	r	dep	2	SENT_18	[p1l1912t2111r1932b2135],
4	Cherniack	NN	O	cherniack	dobj	3	SENT_18	[p1l1939t2109r2038b2130],
5	MD	NN	O	md	dep	4	SENT_18	[p1l2045t2111r2084b2133],
6	,	,	O	,	_	0	SENT_18	[p1l2045t2111r2084b2133],

1	M	NN	O	m	nn	3	SENT_19	[p1l1883t2148r1901b2166],
2	Kraft	NNP	PERSON	Kraft	nn	3	SENT_19	[p1l1909t2146r1956b2167],
3	MD	NNP	O	MD	nsubj	66	SENT_19	[p1l1963t2148r2003b2170],
4	,	,	O	,	_	0	SENT_19	[p1l1963t2148r2003b2170],
5	RJ	NN	PERSON	rj	nn	7	SENT_19	[p1l2011t2148r2033b2171],
6	Martin	NNP	PERSON	Martin	nn	7	SENT_19	[p1l2041t2147r2107b2167],
7	MD	NNP	O	MD	appos	3	SENT_19	[p1l2114t2148r2154b2170],
8	,	,	O	,	_	0	SENT_19	[p1l2114t2148r2154b2170],
9	Findings	NNS	O	finding	dep	19	SENT_19	[p1l8t2194r135b2230],
10	During	IN	O	during	dep	19	SENT_19	[p1l145t2194r258b2230],
11	the	DT	O	the	det	13	SENT_19	[p1l268t2193r317b2221],
12	run-in	JJ	O	run-in	amod	13	SENT_19	[p1l328t2194r427b2221],
13	period	NN	O	period	pobj	10	SENT_19	[p1l438t2193r546b2230],
14	,	,	O	,	_	0	SENT_19	[p1l438t2193r546b2230],
15	when	WRB	O	when	advmod	19	SENT_19	[p1l558t2193r644b2221],
16	albuterol	NN	O	albuterol	nn	17	SENT_19	[p1l655t2193r794b2221],
17	use	NN	O	use	nsubjpass	37	SENT_19	[p1l805t2203r859b2221],
18	was	VBD	O	be	auxpass	19	SENT_19	[p1l869t2203r927b2221],
19	kept	VBN	O	keep	parataxis	66	SENT_19	[p1l939t2193r1006b2230],
20	to	TO	O	to	_	0	SENT_19	[p1l1016t2198r1046b2221],
21	a	DT	O	a	det	22	SENT_19	[p1l1057t2203r1073b2221],
22	minimum	NN	O	minimum	prep_to	19	SENT_19	[p1l1084t2194r1255b2226],
23	,	,	O	,	_	0	SENT_19	[p1l1084t2194r1255b2226],
24	patients	NNS	O	patient	appos	22	SENT_19	[p1l1267t2194r1390b2230],
25	with	IN	O	with	_	0	SENT_19	[p1l1401t2193r1471b2221],
26	the	DT	O	the	det	28	SENT_19	[p1l1481t2193r1530b2221],
27	Arg/Arg	NN	O	arg/arg	nn	28	SENT_19	[p1l1540t2195r1673b2230],
28	genotype	NN	O	genotype	prep_with	24	SENT_19	[p1l1683t2198r1825b2230],
29	<	JJR	PERCENT	<	dep	30	SENT_19	[p1l1859t2183r1957b2245],
30	%	NN	PERCENT	%	amod	28	SENT_19	[p1l1859t2183r1957b2245],
31	"	''	O	"	punct	24	SENT_19	[p1l1859t2183r1957b2245],
32	+	CC	O	+	_	0	SENT_19	[p1l1859t2183r1957b2245],
33	<	JJR	PERCENT	<	amod	34	SENT_19	[p1l1964t2183r2105b2246],
34	%	NN	PERCENT	%	appos	22	SENT_19	[p1l1964t2183r2105b2246],
35	"	''	O	"	punct	19	SENT_19	[p1l1964t2183r2105b2246],
36	+	CC	O	+	_	0	SENT_19	[p1l1964t2183r2105b2246],
37	had	VBD	O	have	parataxis	66	SENT_19	[p1l6t2239r64b2267],
38	an	DT	O	a	det	39	SENT_19	[p1l73t2249r111b2267],
39	increase	NN	O	increase	dobj	37	SENT_19	[p1l120t2240r250b2267],
40	in	IN	O	in	_	0	SENT_19	[p1l259t2240r290b2267],
41	morning	NN	TIME	morning	nn	42	SENT_19	[p1l299t2240r438b2276],
42	PEFR	NN	O	pefr	prep_in	39	SENT_19	[p1l448t2240r537b2267],
43	of	IN	O	of	prep	42	SENT_19	[p1l546t2238r581b2267],
44	23	CD	NUMBER	23	num	47	SENT_19	[p1l586t2241r620b2267],
45	L/min	NN	O	l/min	nn	47	SENT_19	[p1l632t2240r731b2276],
46	(	NN	O	(	nn	47	SENT_19	[p1l742t2241r810b2276],
47	p	NN	O	p	dep	43	SENT_19	[p1l742t2241r810b2276],
48	=	JJ	O	=	amod	49	SENT_19	[p1l742t2241r810b2276],
49	o	NN	O	o	dep	47	SENT_19	[p1l742t2241r810b2276],
50	-	:	O	-	_	0	SENT_19	[p1l817t2255r822b2260],
51	0162	CD	DATE	0162	num	52	SENT_19	[p1l829t2241r923b2276],
52	)	NN	O	)	dep	47	SENT_19	[p1l829t2241r923b2276],
53	;	:	O	;	_	0	SENT_19	[p1l829t2241r923b2276],
54	the	DT	O	the	det	55	SENT_19	[p1l933t2239r982b2267],
55	change	NN	O	change	dep	52	SENT_19	[p1l991t2238r1103b2276],
56	in	IN	O	in	_	0	SENT_19	[p1l1112t2240r1144b2267],
57	patients	NNS	O	patient	prep_in	55	SENT_19	[p1l1153t2240r1276b2276],
58	with	IN	O	with	_	0	SENT_19	[p1l1286t2239r1355b2267],
59	the	DT	O	the	det	61	SENT_19	[p1l1364t2239r1413b2267],
60	Gly/Gly	NNP	O	Gly/Gly	nn	61	SENT_19	[p1l1423t2239r1547b2276],
61	genotype	NN	O	genotype	prep_with	37	SENT_19	[p1l1555t2244r1697b2276],
62	was	VBD	O	be	cop	66	SENT_19	[p1l1705t2249r1764b2267],
63	not	RB	O	not	neg	66	SENT_19	[p1l1774t2244r1825b2267],
64	Philadelphia	NNP	LOCATION	Philadelphia	nn	66	SENT_19	[p1l1862t2256r2000b2282],
65	’	CD	NUMBER	’	num	66	SENT_19	[p1l1862t2256r2000b2282],
66	PA	NN	O	pa	_	0	SENT_19	[p1l2007t2258r2042b2280],
67	,	,	O	,	_	0	SENT_19	[p1l2007t2258r2042b2280],
68	USA	NNP	LOCATION	USA	nn	70	SENT_19	[p1l2049t2258r2094b2276],
69	signiﬁcant	JJ	O	signiﬁcant	amod	70	SENT_19	[p1l6t2284r170b2322],
70	(	NN	O	(	appos	66	SENT_19	[p1l182t2287r210b2322],
71	2	CD	NUMBER	2	num	72	SENT_19	[p1l182t2287r210b2322],
72	L/min	NN	O	l/min	dep	70	SENT_19	[p1l222t2285r328b2322],
73	;	:	O	;	_	0	SENT_19	[p1l222t2285r328b2322],
74	p	NN	O	p	nn	76	SENT_19	[p1l340t2287r398b2322],
75	=	JJ	O	=	amod	76	SENT_19	[p1l340t2287r398b2322],
76	o	NN	O	o	dep	70	SENT_19	[p1l340t2287r398b2322],
77	-	:	O	-	_	0	SENT_19	[p1l406t2300r411b2306],
78	8399	CD	DATE	8399	number	79	SENT_19	[p1l418t2286r510b2322],
79	)	CD	NUMBER	)	dep	76	SENT_19	[p1l418t2286r510b2322],
80	.	.	O	.	_	0	SENT_19	[p1l418t2286r510b2322],

1	During	IN	O	during	_	0	SENT_20	[p1l524t2285r637b2322],
2	randomised	JJ	O	randomised	amod	3	SENT_20	[p1l647t2284r835b2313],
3	treatment	NN	O	treatment	prep_during	31	SENT_20	[p1l844t2290r1006b2317],
4	,	,	O	,	_	0	SENT_20	[p1l844t2290r1006b2317],
5	patients	NNS	O	patient	nsubj	31	SENT_20	[p1l1018t2285r1142b2322],
6	with	IN	O	with	_	0	SENT_20	[p1l1152t2284r1222b2313],
7	the	DT	O	the	det	9	SENT_20	[p1l1232t2284r1281b2313],
8	Gly/Gly	NNP	O	Gly/Gly	nn	9	SENT_20	[p1l1292t2284r1416b2322],
9	genotype	NN	O	genotype	prep_with	5	SENT_20	[p1l1426t2290r1567b2322],
10	had	VBD	O	have	aux	31	SENT_20	[p1l1577t2284r1635b2313],
11	an	DT	O	a	det	13	SENT_20	[p1l1645t2294r1683b2313],
12	increase	NN	O	increase	nn	13	SENT_20	[p1l1694t2285r1823b2313],
13	(	NN	O	(	dobj	31	SENT_20	[p1l1861t2293r1872b2318],
14	J	NN	O	j	nn	16	SENT_20	[p1l1861t2293r1872b2318],
15	Fish	NN	O	fish	nn	16	SENT_20	[p1l1881t2292r1919b2312],
16	MD	NN	O	md	dep	13	SENT_20	[p1l1926t2294r1966b2316],
17	,	,	O	,	_	0	SENT_20	[p1l1926t2294r1966b2316],
18	5	CD	NUMBER	5	num	19	SENT_20	[p1l1974t2294r1984b2312],
19	P	NN	O	p	appos	13	SENT_20	[p1l1992t2294r2003b2312],
20	Peters	NNP	PERSON	Peters	nn	22	SENT_20	[p1l2010t2294r2071b2312],
21	PhD	NNP	O	PhD	nn	22	SENT_20	[p1l2079t2292r2134b2317],
22	)	NN	O	)	dep	19	SENT_20	[p1l2079t2292r2134b2317],
23	;	:	O	;	_	0	SENT_20	[p1l2079t2292r2134b2317],
24	in	IN	O	in	_	0	SENT_20	[p1l6t2330r38b2357],
25	morning	NN	TIME	morning	nn	26	SENT_20	[p1l48t2330r187b2366],
26	PEFR	NN	O	pefr	prep_in	13	SENT_20	[p1l199t2331r288b2357],
27	during	IN	O	during	_	0	SENT_20	[p1l297t2329r404b2366],
28	treatment	NN	O	treatment	prep_during	31	SENT_20	[p1l413t2334r568b2357],
29	with	IN	O	with	prep	31	SENT_20	[p1l577t2329r647b2357],
30	regularly	RB	O	regularly	advmod	31	SENT_20	[p1l657t2329r797b2366],
31	scheduled	VBN	O	schedule	_	0	SENT_20	[p1l808t2329r965b2357],
32	albuterol	NN	O	albuterol	dobj	31	SENT_20	[p1l975t2329r1115b2357],
33	compared	VBN	O	compare	_	0	SENT_20	[p1l1125t2329r1281b2366],
34	with	IN	O	with	prepc_compared_with	31	SENT_20	[p1l1291t2329r1360b2357],
35	placebo	NN	O	placebo	pobj	31	SENT_20	[p1l1371t2329r1489b2366],
36	(	CD	NUMBER	(	num	35	SENT_20	[p1l1502t2331r1548b2366],
37	14	CD	NUMBER	14	num	38	SENT_20	[p1l1502t2331r1548b2366],
38	L/min	NN	O	l/min	dep	35	SENT_20	[p1l1560t2330r1659b2366],
39	[	CD	PERCENT	[	num	42	SENT_20	[p1l1671t2330r1746b2366],
40	95	CD	PERCENT	95	number	41	SENT_20	[p1l1671t2330r1746b2366],
41	%	NN	PERCENT	%	amod	42	SENT_20	[p1l1671t2330r1746b2366],
42	CI	NN	O	ci	dep	38	SENT_20	[p1l1759t2331r1795b2357],
43	3	CD	NUMBER	3	number	46	SENT_20	[p1l1807t2331r1823b2357],
44	to	TO	O	to	dep	46	SENT_20	[p1l6t2380r35b2403],
45	25	CD	NUMBER	25	number	46	SENT_20	[p1l47t2376r100b2412],
46	]	CD	NUMBER	]	num	42	SENT_20	[p1l47t2376r100b2412],
47	;	:	O	;	_	0	SENT_20	[p1l47t2376r100b2412],
48	p	NN	O	p	nn	50	SENT_20	[p1l113t2377r170b2412],
49	=	JJ	O	=	amod	50	SENT_20	[p1l113t2377r170b2412],
50	o	NN	O	o	dep	38	SENT_20	[p1l113t2377r170b2412],
51	-	:	O	-	_	0	SENT_20	[p1l178t2391r183b2396],
52	0175	CD	DATE	0175	number	53	SENT_20	[p1l190t2376r283b2412],
53	)	CD	NUMBER	)	dep	50	SENT_20	[p1l190t2376r283b2412],
54	.	.	O	.	_	0	SENT_20	[p1l190t2376r283b2412],

1	By	IN	O	by	_	0	SENT_21	[p1l297t2377r336b2412],
2	contrast	NN	O	contrast	prep_by	9	SENT_21	[p1l346t2380r479b2408],
3	,	,	O	,	_	0	SENT_21	[p1l346t2380r479b2408],
4	patients	NNS	O	patient	nsubj	9	SENT_21	[p1l492t2376r615b2412],
5	with	IN	O	with	_	0	SENT_21	[p1l626t2375r695b2403],
6	the	DT	O	the	det	8	SENT_21	[p1l706t2375r755b2403],
7	Arg/Arg	NN	O	arg/arg	nn	8	SENT_21	[p1l765t2377r898b2412],
8	genotype	NN	O	genotype	prep_with	4	SENT_21	[p1l908t2380r1049b2412],
9	had	VBD	O	have	_	0	SENT_21	[p1l1060t2375r1118b2403],
10	lower	JJR	O	lower	amod	12	SENT_21	[p1l1128t2375r1215b2403],
11	morning	NN	TIME	morning	nn	12	SENT_21	[p1l1225t2376r1364b2412],
12	PEFR	NN	O	pefr	dobj	9	SENT_21	[p1l1375t2376r1465b2403],
13	during	IN	O	during	_	0	SENT_21	[p1l1475t2375r1581b2412],
14	treatment	NN	O	treatment	prep_during	12	SENT_21	[p1l1591t2380r1745b2403],
15	with	IN	O	with	_	0	SENT_21	[p1l1755t2375r1824b2403],
16	albuterol	NN	O	albuterol	prep_with	9	SENT_21	[p1l6t2420r145b2449],
17	than	IN	O	than	dep	9	SENT_21	[p1l158t2420r229b2449],
18	during	IN	O	during	_	0	SENT_21	[p1l243t2420r349b2458],
19	the	DT	O	the	det	21	SENT_21	[p1l362t2420r411b2449],
20	placebo	NN	O	placebo	nn	21	SENT_21	[p1l424t2420r543b2458],
21	period	NN	O	period	prep_during	9	SENT_21	[p1l556t2420r664b2458],
22	,	,	O	,	_	0	SENT_21	[p1l556t2420r664b2458],
23	when	WRB	O	when	advmod	28	SENT_21	[p1l678t2420r765b2449],
24	albuterol	NN	O	albuterol	nn	25	SENT_21	[p1l779t2420r918b2449],
25	use	NN	O	use	nsubj	28	SENT_21	[p1l931t2431r984b2449],
26	was	VBD	O	be	cop	28	SENT_21	[p1l997t2431r1055b2449],
27	limited	JJ	O	limited	amod	28	SENT_21	[p1l1069t2420r1182b2449],
28	(	NN	O	(	dep	21	SENT_21	[p1l1197t2423r1261b2458],
29	-10	CD	NUMBER	-10	num	30	SENT_21	[p1l1197t2423r1261b2458],
30	L/min	NN	O	l/min	tmod	28	SENT_21	[p1l1277t2422r1375b2458],
31	[	CD	NUMBER	[	num	32	SENT_21	[p1l1390t2423r1453b2458],
32	-19	CD	NUMBER	-19	advmod	30	SENT_21	[p1l1390t2423r1453b2458],
33	to	TO	O	to	_	0	SENT_21	[p1l1467t2426r1496b2449],
34	-2	CD	NUMBER	-2	num	35	SENT_21	[p1l1509t2423r1563b2458],
35	]	CD	NUMBER	]	prep_to	32	SENT_21	[p1l1509t2423r1563b2458],
36	;	:	O	;	_	0	SENT_21	[p1l1509t2423r1563b2458],
37	p	NN	O	p	dep	28	SENT_21	[p1l1578t2423r1749b2458],
38	=	JJ	O	=	amod	40	SENT_21	[p1l1578t2423r1749b2458],
39	0-0209	CD	NUMBER	0-0209	tmod	38	SENT_21	[p1l1578t2423r1749b2458],
40	)	NN	O	)	dep	37	SENT_21	[p1l1578t2423r1749b2458],
41	.	.	O	.	_	0	SENT_21	[p1l1578t2423r1749b2458],

1	The	DT	O	the	_	0	SENT_22	[p1l1764t2420r1824b2449],

1	University	NNP	ORGANIZATION	University	nsubj	29	SENT_23	[p1l7t2533r117b2559],
2	of	IN	ORGANIZATION	of	_	0	SENT_23	[p1l122t2533r145b2553],
3	Wisconsin	NNP	ORGANIZATION	Wisconsin	nn	9	SENT_23	[p1l149t2533r265b2556],
4	,	,	O	,	_	0	SENT_23	[p1l149t2533r265b2556],
5	Madison	NNP	PERSON	Madison	appos	9	SENT_23	[p1l6t2570r104b2593],
6	,	,	O	,	_	0	SENT_23	[p1l6t2570r104b2593],
7	WI	NNP	O	WI	appos	9	SENT_23	[p1l110t2571r145b2593],
8	,	,	O	,	_	0	SENT_23	[p1l110t2571r145b2593],
9	USA	NNP	LOCATION	USA	prep_of	1	SENT_23	[p1l153t2571r197b2590],
10	(	CD	NUMBER	(	num	9	SENT_23	[p1l7t2607r27b2631],
11	R	NN	O	r	nn	14	SENT_23	[p1l7t2607r27b2631],
12	F	NN	O	f	nn	14	SENT_23	[p1l34t2608r44b2626],
13	Lemanskejr	NN	O	lemanskejr	nn	14	SENT_23	[p1l51t2606r172b2631],
14	MD	NN	O	md	dep	9	SENT_23	[p1l178t2608r218b2630],
15	,	,	O	,	_	0	SENT_23	[p1l178t2608r218b2630],
16	C	NN	O	c	nn	20	SENT_23	[p1l6t2644r18b2663],
17	A	NN	O	a	nn	20	SENT_23	[p1l25t2644r39b2663],
18	Sorkness	NN	O	sorkness	nn	20	SENT_23	[p1l46t2643r135b2663],
19	PharmD	NN	O	pharmd	nn	20	SENT_23	[p1l143t2643r239b2668],
20	)	NN	O	)	dep	9	SENT_23	[p1l143t2643r239b2668],
21	;	:	O	;	_	0	SENT_23	[p1l143t2643r239b2668],
22	and	CC	O	and	_	0	SENT_23	[p1l245t2643r285b2663],
23	genotype-attributable	JJ	O	genotype-attributable	amod	25	SENT_23	[p1l6t2672r338b2710],
24	treatment	NN	O	treatment	nn	25	SENT_23	[p1l354t2677r508b2701],
25	difference	NN	O	difference	conj_and	14	SENT_23	[p1l524t2672r682b2701],
26	was	VBD	O	be	cop	29	SENT_23	[p1l697t2682r755b2701],
27	therefore	RB	O	therefore	advmod	29	SENT_23	[p1l772t2672r915b2701],
28	-24	CD	NUMBER	-24	num	29	SENT_23	[p1l930t2674r987b2700],
29	L/min	NN	O	l/min	_	0	SENT_23	[p1l1004t2673r1102b2709],
30	(	CD	NUMBER	(	num	31	SENT_23	[p1l1120t2673r1185b2710],
31	-37	CD	NUMBER	-37	dep	29	SENT_23	[p1l1120t2673r1185b2710],
32	to	TO	O	to	_	0	SENT_23	[p1l1201t2678r1230b2701],
33	-12	CD	NUMBER	-12	prep_to	31	SENT_23	[p1l1246t2674r1310b2705],
34	;	:	O	;	_	0	SENT_23	[p1l1246t2674r1310b2705],
35	p	NN	O	p	dep	29	SENT_23	[p1l1327t2674r1498b2710],
36	=	JJ	O	=	advmod	40	SENT_23	[p1l1327t2674r1498b2710],
37	0	CD	NUMBER	0	dep	36	SENT_23	[p1l1327t2674r1498b2710],
38	~	CD	NUMBER	~	number	39	SENT_23	[p1l1327t2674r1498b2710],
39	0003	CD	DATE	0003	num	40	SENT_23	[p1l1327t2674r1498b2710],
40	)	NN	O	)	rcmod	35	SENT_23	[p1l1327t2674r1498b2710],
41	.	.	O	.	_	0	SENT_23	[p1l1327t2674r1498b2710],

1	There	EX	O	there	expl	2	SENT_24	[p1l1515t2672r1607b2701],
2	were	VBD	O	be	_	0	SENT_24	[p1l1622t2682r1697b2701],
3	similar	JJ	O	similar	amod	8	SENT_24	[p1l1714t2672r1824b2701],
4	University	NNP	O	University	nn	8	SENT_24	[p1l1861t2679r1971b2705],
5	ofCincinnati	NNP	O	ofCincinnati	nn	8	SENT_24	[p1l1977t2679r2112b2699],
6	College	NNP	O	College	nn	8	SENT_24	[p1l6t2722r84b2749],
7	genotype-speciﬁc	JJ	O	genotype-speciﬁc	amod	8	SENT_24	[p1l106t2715r375b2753],
8	effects	NNS	O	effect	nsubj	2	SENT_24	[p1l386t2715r486b2744],
9	in	IN	O	in	_	0	SENT_24	[p1l497t2716r529b2744],
10	FEV1	NN	O	fev1	prep_in	8	SENT_24	[p1l540t2717r623b2751],
11	,	,	O	,	_	0	SENT_24	[p1l540t2717r623b2751],
12	symptoms	NNS	O	symptom	conj_and	10	SENT_24	[p1l636t2721r807b2753],
13	,	,	O	,	_	0	SENT_24	[p1l636t2721r807b2753],
14	and	CC	O	and	_	0	SENT_24	[p1l819t2715r877b2744],
15	use	NN	O	use	prep_in	8	SENT_24	[p1l886t2725r940b2744],
16	of	IN	O	of	_	0	SENT_24	[p1l951t2715r986b2744],
17	supplementary	JJ	O	supplementary	amod	19	SENT_24	[p1l992t2715r1227b2753],
18	reliever	NN	O	reliever	nn	19	SENT_24	[p1l1237t2715r1354b2744],
19	medication	NN	O	medication	prep_of	15	SENT_24	[p1l1364t2715r1547b2744],
20	.	.	O	.	_	0	SENT_24	[p1l1364t2715r1547b2744],

1	of	IN	O	of	_	0	SENT_25	[p1l6t2785r29b2805],
2	Medicine	NNP	MISC	Medicine	nn	4	SENT_25	[p1l34t2785r137b2809],
3	,	,	O	,	_	0	SENT_25	[p1l34t2785r137b2809],
4	Cincinnati	NNP	LOCATION	Cincinnati	prep_of	26	SENT_25	[p1l144t2786r258b2809],
5	,	,	O	,	_	0	SENT_25	[p1l144t2786r258b2809],
6	OH	NN	O	oh	nn	8	SENT_25	[p1l265t2787r304b2809],
7	,	,	O	,	_	0	SENT_25	[p1l265t2787r304b2809],
8	USA	NNP	LOCATION	USA	nsubj	26	SENT_25	[p1l7t2823r51b2842],
9	(	CD	NUMBER	(	num	8	SENT_25	[p1l58t2823r77b2847],
10	S	NN	O	s	nn	11	SENT_25	[p1l58t2823r77b2847],
11	B	NN	O	b	dep	8	SENT_25	[p1l84t2824r96b2841],
12	Liggett	NNP	ORGANIZATION	Liggett	nn	16	SENT_25	[p1l104t2823r176b2848],
13	MD	NNP	O	MD	nn	16	SENT_25	[p1l182t2823r224b2847],
14	)	NNP	O	)	nn	16	SENT_25	[p1l182t2823r224b2847],
15	Interpretation	NNP	O	Interpretation	nn	16	SENT_25	[p1l8t2872r220b2906],
16	Genotype	NN	O	genotype	dep	8	SENT_25	[p1l232t2872r381b2907],
17	at	IN	O	at	_	0	SENT_25	[p1l390t2875r418b2898],
18	the	DT	O	the	det	21	SENT_25	[p1l426t2870r475b2898],
19	16th	JJ	ORDINAL	16th	amod	21	SENT_25	[p1l486t2870r554b2898],
20	aminoacid	JJ	O	aminoacid	amod	21	SENT_25	[p1l563t2870r727b2898],
21	residue	NN	O	residue	prep_at	16	SENT_25	[p1l736t2870r852b2898],
22	of	IN	O	of	_	0	SENT_25	[p1l861t2870r896b2898],
23	the	DT	O	the	det	25	SENT_25	[p1l899t2870r949b2898],
24	B,-adrenergic	JJ	O	b,-adrenergic	amod	25	SENT_25	[p1l960t2870r1167b2907],
25	receptor	NN	O	receptor	prep_of	21	SENT_25	[p1l1176t2875r1305b2907],
26	affects	VBZ	O	affect	_	0	SENT_25	[p1l1313t2870r1414b2898],
27	the	DT	O	the	det	29	SENT_25	[p1l1423t2870r1472b2898],
28	long-term	JJ	O	long-term	amod	29	SENT_25	[p1l1481t2870r1636b2907],
29	response	NN	O	response	dobj	26	SENT_25	[p1l1645t2880r1786b2907],
30	to	TO	O	to	_	0	SENT_25	[p1l1794t2875r1824b2898],
31	albuterol	NN	O	albuterol	nn	32	SENT_25	[p1l6t2916r145b2944],
32	use	NN	O	use	prep_to	26	SENT_25	[p1l163t2926r224b2944],
33	.	.	O	.	_	0	SENT_25	[p1l163t2926r224b2944],

1	Bronchodilator	NN	O	bronchodilator	nn	2	SENT_26	[p1l245t2916r481b2944],
2	treatments	NNS	O	treatment	nsubj	7	SENT_26	[p1l498t2921r667b2944],
3	avoiding	VBG	O	avoid	partmod	2	SENT_26	[p1l686t2916r821b2953],
4	albuterol	NN	O	albuterol	dobj	3	SENT_26	[p1l838t2916r977b2944],
5	may	MD	O	may	aux	7	SENT_26	[p1l996t2926r1062b2953],
6	be	VB	O	be	cop	7	SENT_26	[p1l1079t2916r1116b2944],
7	appropriate	JJ	O	appropriate	_	0	SENT_26	[p1l1134t2917r1315b2953],
8	for	IN	O	for	_	0	SENT_26	[p1l1333t2916r1378b2944],
9	patients	NNS	O	patient	prep_for	7	SENT_26	[p1l1396t2917r1519b2953],
10	with	IN	O	with	_	0	SENT_26	[p1l1538t2916r1607b2944],
11	the	DT	O	the	det	13	SENT_26	[p1l1625t2916r1674b2944],
12	Arg/Arg	NN	O	arg/arg	nn	13	SENT_26	[p1l1692t2918r1824b2953],
13	Correspondence	NN	O	correspondence	prep_with	9	SENT_26	[p1l8t2953r405b3016],
14	to	TO	O	to	_	0	SENT_26	[p1l419t2962r485b3001],
15	:	:	O	:	_	0	SENT_26	[p1l419t2962r485b3001],
16	Dr	NNP	O	Dr	nn	17	SENT_26	[p1l10t3046r63b3088],
17	Elliot	NNP	PERSON	Elliot	prep_to	7	SENT_26	[p1l79t3041r199b3089],
18	lsrael	NN	PERSON	lsrael	dep	17	SENT_26	[p1l217t3041r352b3097],
19	,	,	O	,	_	0	SENT_26	[p1l217t3041r352b3097],
20	Brigham	NNP	ORGANIZATION	Brigham	poss	24	SENT_26	[p1l372t3041r575b3104],
21	and	CC	ORGANIZATION	and	_	0	SENT_26	[p1l593t3041r682b3089],
22	Women	NNP	ORGANIZATION	Women	poss	24	SENT_26	[p1l6t3132r239b3177],
23	's	POS	ORGANIZATION	's	_	0	SENT_26	[p1l6t3132r239b3177],
24	Hospital	NNP	ORGANIZATION	Hospital	appos	17	SENT_26	[p1l258t3129r470b3191],
25	,	,	O	,	_	0	SENT_26	[p1l258t3129r470b3191],
26	75	CD	NUMBER	75	num	28	SENT_26	[p1l488t3136r549b3184],
27	Francis	NNP	PERSON	Francis	nn	28	SENT_26	[p1l569t3132r734b3177],
28	genotype	NN	O	genotype	appos	24	SENT_26	[p1l8t3211r367b3287],
29	.	.	O	.	_	0	SENT_26	[p1l8t3211r367b3287],

1	Introduction	NN	O	introduction	_	0	SENT_27	[p1l14t3406r564b3486],

1	Inhalation	NN	O	inhalation	nsubj	18	SENT_28	[p1l12t3527r400b3595],
2	of	IN	O	of	_	0	SENT_28	[p1l438t3527r522b3595],
3	a	DT	O	a	det	6	SENT_28	[p1l548t3552r585b3595],
4	selective	JJ	O	selective	amod	5	SENT_28	[p1l625t3527r937b3595],
5	B2-adrenergic	JJ	O	b2-adrenergic	amod	6	SENT_28	[p1l981t3527r1479b3617],
6	agonist	NN	O	agonist	prep_of	1	SENT_28	[p1l1518t3532r1808b3617],
7	,	,	O	,	_	0	SENT_28	[p1l1518t3532r1808b3617],
8	such	JJ	O	such	_	0	SENT_28	[p1l1852t3527r2026b3595],
9	as	IN	O	as	_	0	SENT_28	[p1l2065t3551r2137b3595],
10	albuterol	NN	O	albuterol	prep_such_as	1	SENT_28	[p2l9t17r361b95],
11	,	,	O	,	_	0	SENT_28	[p2l9t17r361b95],
12	is	VBZ	O	be	cop	18	SENT_28	[p2l388t21r446b85],
13	the	DT	O	the	det	18	SENT_28	[p2l471t17r588b85],
14	most	RBS	O	most	advmod	16	SENT_28	[p2l612t30r801b85],
15	commonly	RB	O	commonly	advmod	16	SENT_28	[p2l824t17r1228b106],
16	used	VBN	O	use	amod	18	SENT_28	[p2l1248t17r1427b85],
17	asthma	NN	O	asthma	nn	18	SENT_28	[p2l1450t17r1725b85],
18	treatment	NN	O	treatment	_	0	SENT_28	[p2l1747t30r2135b85],
19	.	.	O	.	_	0	SENT_28	[p2l1747t30r2135b85],

1	Albuterol	NNP	O	Albuterol	nsubj	2	SENT_29	[p2l7t125r361b194],
2	stimulates	VBZ	O	stimulate	_	0	SENT_29	[p2l391t125r777b194],
3	the	DT	O	the	det	5	SENT_29	[p2l806t125r923b194],
4	B,-adrenergic	JJ	O	b,-adrenergic	amod	5	SENT_29	[p2l956t125r1454b215],
5	receptor	NN	O	receptor	dobj	2	SENT_29	[p2l1480t139r1808b214],
6	,	,	O	,	_	0	SENT_29	[p2l1480t139r1808b214],
7	relaxing	VBG	O	relax	dep	2	SENT_29	[p2l1838t126r2140b215],
8	smooth	JJ	O	smooth	amod	9	SENT_29	[p2l11t234r293b302],
9	muscle	NN	O	muscle	dobj	7	SENT_29	[p2l315t234r585b302],
10	and	CC	O	and	_	0	SENT_29	[p2l609t234r748b302],
11	thereby	RB	O	thereby	advmod	12	SENT_29	[p2l768t234r1052b324],
12	relieving	VBG	O	relieve	dep	2	SENT_29	[p2l1072t234r1400b324],
13	airway	NN	O	airway	nn	14	SENT_29	[p2l1423t239r1666b324],
14	obstruction	NN	O	obstruction	dobj	12	SENT_29	[p2l1688t234r2136b312],
15	;	:	O	;	_	0	SENT_29	[p2l1688t234r2136b312],
16	its	PRP$	O	its	poss	17	SENT_29	[p2l8t349r93b413],
17	duration	NN	O	duration	nsubj	22	SENT_29	[p2l148t345r470b413],
18	of	IN	O	of	_	0	SENT_29	[p2l521t345r605b413],
19	action	NN	O	action	prep_of	17	SENT_29	[p2l644t349r871b413],
20	is	VBZ	O	be	cop	22	SENT_29	[p2l922t349r980b413],
21	4-6	CD	NUMBER	4-6	num	22	SENT_29	[p2l1033t351r1165b413],
22	hf	NN	O	hf	parataxis	2	SENT_29	[p2l1217t345r1309b413],
23	Many	JJ	O	many	amod	24	SENT_29	[p2l1365t351r1576b434],
24	patients	NNS	O	patient	nsubjpass	29	SENT_29	[p2l1625t349r1921b434],
25	with	IN	O	with	_	0	SENT_29	[p2l1973t345r2140b413],
26	intermittent	JJ	O	intermittent	amod	27	SENT_29	[p2l8t458r468b522],
27	asthma	NN	O	asthma	prep_with	24	SENT_29	[p2l538t454r813b522],
28	are	VBP	O	be	auxpass	29	SENT_29	[p2l884t478r996b522],
29	instructed	VBN	O	instruct	rcmod	22	SENT_29	[p2l1068t454r1450b522],
30	to	TO	O	to	aux	31	SENT_29	[p2l1518t467r1588b522],
31	use	VB	O	use	xcomp	29	SENT_29	[p2l1659t478r1787b522],
32	inhaled	VBN	O	inhale	dep	31	SENT_29	[p2l1859t453r2141b522],

1	B2	NN	O	b2	nn	2	SENT_30	[p2l13t569r82b649],
2	agonists	NNS	O	agonist	_	0	SENT_30	[p2l132t568r439b653],
3	as	IN	O	as	_	0	SENT_30	[p2l490t587r563b631],
4	their	PRP$	O	they	poss	7	SENT_30	[p2l612t563r791b631],
5	only	JJ	O	only	amod	7	SENT_30	[p2l838t563r998b653],
6	asthma	NN	O	asthma	nn	7	SENT_30	[p2l1045t563r1320b631],
7	treatment	NN	O	treatment	prep_as	2	SENT_30	[p2l1366t568r1828b631],
8	.	.	O	.	_	0	SENT_30	[p2l1366t568r1828b631],

1	“	NN	O	“	dep	20	SENT_31	[p2l1366t568r1828b631],
2	Over	IN	O	over	dep	1	SENT_31	[p2l1877t569r2056b631],
3	a	DT	DATE	a	det	4	SENT_31	[p2l2102t588r2140b631],
4	decade	NN	DATE	decade	npadvmod	5	SENT_31	[p2l9t673r264b741],
5	ago	RB	DATE	ago	pcomp	2	SENT_31	[p2l302t697r449b763],
6	,	,	O	,	_	0	SENT_31	[p2l302t697r449b763],
7	concern	NN	O	concern	nsubjpass	9	SENT_31	[p2l490t697r791b741],
8	was	VBD	O	be	auxpass	9	SENT_31	[p2l825t697r964b741],
9	raised	VBN	O	raise	parataxis	20	SENT_31	[p2l1003t673r1230b741],
10	that	IN	O	that	complm	15	SENT_31	[p2l1264t673r1410b740],
11	the	DT	O	the	det	13	SENT_31	[p2l1443t673r1561b740],
12	regular	JJ	O	regular	amod	13	SENT_31	[p2l1598t673r1869b763],
13	use	NN	O	use	nsubj	15	SENT_31	[p2l1902t697r2031b741],
14	of	IN	O	of	prep	13	SENT_31	[p2l2069t673r2153b740],
15	inhaled	VBN	O	inhale	ccomp	9	SENT_31	[p2l8t781r290b850],
16	[	NN	O	[	dobj	15	SENT_31	[p2l333t787r402b867],
17	3	CD	NUMBER	3	num	16	SENT_31	[p2l333t787r402b867],
18	,	,	O	,	_	0	SENT_31	[p2l333t787r402b867],
19	agonists	NNS	O	agonist	nsubj	20	SENT_31	[p2l442t786r749b871],
20	had	VBD	O	have	_	0	SENT_31	[p2l789t781r929b850],
21	a	DT	O	a	det	23	SENT_31	[p2l967t806r1004b850],
22	detrimental	JJ	O	detrimental	amod	23	SENT_31	[p2l1044t782r1482b850],
23	effect	NN	O	effect	dobj	20	SENT_31	[p2l1521t781r1727b850],
24	on	IN	O	on	_	0	SENT_31	[p2l1765t806r1859b850],
25	airway	NN	O	airway	nn	26	SENT_31	[p2l1898t786r2141b871],
26	diameter	NN	O	diameter	prep_on	20	SENT_31	[p2l9t890r346b959],
27	and	CC	O	and	_	0	SENT_31	[p2l398t890r537b959],
28	asthma	NN	O	asthma	nn	29	SENT_31	[p2l590t890r865b959],
29	control	NN	O	control	prep_on	20	SENT_31	[p2l919t890r1274b959],
30	.	.	O	.	_	0	SENT_31	[p2l919t890r1274b959],

1	”	NN	O	”	nn	3	SENT_32	[p2l919t890r1274b959],
2	Such	JJ	O	such	amod	3	SENT_32	[p2l1332t890r1516b959],
3	concerns	NNS	O	concern	nsubjpass	5	SENT_32	[p2l1571t914r1906b959],
4	were	VBD	O	be	auxpass	5	SENT_32	[p2l1960t915r2139b959],
5	alleviated	VBN	O	alleviate	_	0	SENT_32	[p2l9t1002r361b1070],
6	by	IN	O	by	_	0	SENT_32	[p2l385t1002r473b1091],
7	placebo-controlled	JJ	O	placebo-controlled	amod	8	SENT_32	[p2l497t1002r1190b1091],
8	trials	NNS	O	trial	agent	5	SENT_32	[p2l1214t1002r1400b1070],
9	which	WDT	O	which	nsubj	10	SENT_32	[p2l1427t1002r1657b1070],
10	showed	VBD	O	show	rcmod	8	SENT_32	[p2l1687t1002r1970b1070],
11	that	IN	O	that	complm	13	SENT_32	[p2l1995t1002r2141b1070],
12	regularly	RB	O	regularly	advmod	13	SENT_32	[p2l8t1110r343b1200],
13	scheduled	VBN	O	schedule	ccomp	10	SENT_32	[p2l380t1110r759b1179],
14	use	NN	O	use	dobj	13	SENT_32	[p2l791t1135r920b1179],
15	of	IN	O	of	_	0	SENT_32	[p2l958t1110r1041b1179],
16	inhaled	VBN	O	inhale	prepc_of	14	SENT_32	[p2l1063t1110r1346b1179],
17	albuterol	NN	O	albuterol	dobj	16	SENT_32	[p2l1382t1110r1714b1179],
18	(	CD	NUMBER	(	num	17	SENT_32	[p2l1755t1117r1910b1200],
19	two	CD	NUMBER	two	num	20	SENT_32	[p2l1755t1117r1910b1200],
20	puffs	NNS	O	puff	amod	17	SENT_32	[p2l1946t1110r2137b1199],
21	four	CD	NUMBER	four	num	22	SENT_32	[p2l8t1219r167b1287],
22	times	NNS	O	time	dep	20	SENT_32	[p2l227t1224r434b1287],
23	daily	JJ	SET	daily	amod	24	SENT_32	[p2l501t1219r697b1309],
24	)	NN	O	)	nsubj	25	SENT_32	[p2l501t1219r697b1309],
25	had	VBD	O	have	rcmod	17	SENT_32	[p2l765t1219r904b1287],
26	no	DT	O	no	det	29	SENT_32	[p2l966t1244r1059b1287],
27	overall	JJ	O	overall	amod	29	SENT_32	[p2l1124t1219r1371b1287],
28	adverse	JJ	O	adverse	amod	29	SENT_32	[p2l1435t1219r1715b1287],
29	effect	NN	O	effect	dobj	25	SENT_32	[p2l1779t1219r1984b1287],
30	on	IN	O	on	_	0	SENT_32	[p2l2046t1244r2140b1287],
31	expiratory	JJ	O	expiratory	amod	32	SENT_32	[p2l9t1334r384b1419],
32	airﬂow	NN	O	airﬂow	prep_on	29	SENT_32	[p2l409t1330r670b1398],
33	or	CC	O	or	_	0	SENT_32	[p2l695t1354r771b1398],
34	asthma	NN	O	asthma	nn	35	SENT_32	[p2l797t1330r1072b1398],
35	control	NN	O	control	prep_on	29	SENT_32	[p2l1098t1330r1441b1398],
36	.	.	O	.	_	0	SENT_32	[p2l1098t1330r1441b1398],

1	”	NN	O	”	_	0	SENT_33	[p2l1098t1330r1441b1398],

1	The	DT	O	the	nsubj	15	SENT_34	[p2l78t1439r223b1507],
2	ﬁnding	VBG	O	ﬁnding	amod	1	SENT_34	[p2l301t1438r576b1528],
3	that	IN	O	that	complm	5	SENT_34	[p2l653t1438r799b1507],
4	there	EX	O	there	expl	5	SENT_34	[p2l874t1439r1067b1507],
5	are	VBP	O	be	dep	1	SENT_34	[p2l1147t1463r1259b1507],
6	common	JJ	O	common	amod	9	SENT_34	[p2l1338t1463r1677b1507],
7	functional	JJ	O	functional	amod	8	SENT_34	[p2l1755t1438r2140b1507],
8	polymorphic	JJ	O	polymorphic	amod	9	SENT_34	[p2l8t1547r488b1637],
9	variants	NNS	O	variant	nsubj	5	SENT_34	[p2l519t1552r814b1615],
10	of	IN	O	of	_	0	SENT_34	[p2l851t1547r935b1615],
11	the	DT	O	the	det	14	SENT_34	[p2l954t1547r1071b1615],
12	B2-adrenergic	JJ	O	b2-adrenergic	amod	14	SENT_34	[p2l1111t1547r1609b1637],
13	receptor	NN	O	receptor	nn	14	SENT_34	[p2l1642t1552r1997b1636],
14	”	NN	O	”	prep_of	9	SENT_34	[p2l1642t1552r1997b1636],
15	led	VBD	O	lead	_	0	SENT_34	[p2l2028t1547r2141b1615],
16	to	TO	O	to	_	0	SENT_34	[p2l7t1670r76b1724],
17	the	DT	O	the	det	18	SENT_34	[p2l119t1657r236b1725],
18	suggestion	NN	O	suggestion	prep_to	15	SENT_34	[p2l282t1661r687b1747],
19	that	WDT	O	that	dep	20	SENT_34	[p2l728t1657r874b1725],
20	patients	NNS	O	patient	rcmod	18	SENT_34	[p2l914t1661r1211b1746],
21	with	IN	O	with	_	0	SENT_34	[p2l1254t1657r1420b1725],
22	certain	JJ	O	certain	amod	24	SENT_34	[p2l1463t1661r1720b1725],
23	genotypes	NNS	O	genotype	nn	24	SENT_34	[p2l1763t1670r2137b1747],
24	wvvw	NN	O	wvvw	prep_with	20	SENT_34	[p2l7t1928r542b1979],
25	.	.	O	.	_	0	SENT_34	[p2l7t1928r542b1979],

1	the	DT	O	the	det	2	SENT_35	[p2l7t1928r542b1979],
2	|	NN	O	|	_	0	SENT_35	[p2l7t1928r542b1979],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_35	[p2l7t1928r542b1979],
4	Vol	NNP	O	Vol	dep	2	SENT_35	[p2l585t1928r675b1979],
5	364	CD	NUMBER	364	num	4	SENT_35	[p2l696t1928r805b1987],
6	October	NNP	DATE	October	tmod	4	SENT_35	[p2l850t1928r1074b1979],
7	23	CD	DATE	23	num	6	SENT_35	[p2l1092t1935r1177b1988],
8	,	,	DATE	,	_	0	SENT_35	[p2l1092t1935r1177b1988],
9	2004	CD	DATE	2004	num	6	SENT_35	[p2l1199t1935r1344b1986],

1	Street	NNP	O	Street	nn	5	SENT_36	[p2l1574t2115r1685b2152],
2	,	,	O	,	_	0	SENT_36	[p2l1574t2115r1685b2152],
3	Boston	NNP	LOCATION	Boston	appos	5	SENT_36	[p2l1700t2116r1830b2152],
4	,	,	O	,	_	0	SENT_36	[p2l1700t2116r1830b2152],
5	MA	NNP	O	MA	nsubj	13	SENT_36	[p2l1843t2115r1901b2146],
6	02115	CD	DATE	02115	num	5	SENT_36	[p2l1912t2117r2036b2152],
7	,	,	O	,	_	0	SENT_36	[p2l1912t2117r2036b2152],
8	USA	NNP	LOCATION	USA	appos	5	SENT_36	[p2l2050t2115r2122b2147],
9	eisrae	FW	O	eisrae	nn	11	SENT_36	[p2l1574t2154r2027b2198],
10	|	FW	O	|	nn	11	SENT_36	[p2l1574t2154r2027b2198],
11	asst@partners.org	NN	O	asst@partners.org	dep	8	SENT_36	[p2l1574t2154r2027b2198],
12	might	MD	O	might	aux	13	SENT_36	[p2l8t2233r169b2297],
13	experience	VB	O	experience	_	0	SENT_36	[p2l187t2236r469b2296],
14	adverse	JJ	O	adverse	amod	15	SENT_36	[p2l489t2233r686b2282],
15	effects	NNS	O	effect	dobj	13	SENT_36	[p2l706t2233r875b2282],
16	when	WRB	O	when	advmod	20	SENT_36	[p2l893t2233r1041b2282],
17	inhaled	VBN	O	inhale	csubjpass	20	SENT_36	[p2l1059t2233r1258b2282],
18	albuterol	NN	O	albuterol	dobj	17	SENT_36	[p2l1277t2233r1511b2282],
19	was	VBD	O	be	auxpass	20	SENT_36	[p2l7t2328r105b2360],
20	used	VBN	O	use	advcl	13	SENT_36	[p2l153t2311r279b2360],
21	regularly	RB	O	regularly	advmod	20	SENT_36	[p2l326t2311r574b2375],
22	.	.	O	.	_	0	SENT_36	[p2l326t2311r574b2375],

1	Indeed	RB	O	indeed	advmod	26	SENT_37	[p2l627t2311r823b2367],
2	,	,	O	,	_	0	SENT_37	[p2l627t2311r823b2367],
3	analyses	NNS	O	analysis	nsubj	26	SENT_37	[p2l873t2311r1092b2375],
4	of	IN	O	of	_	0	SENT_37	[p2l1142t2311r1201b2360],
5	previously	RB	DATE	previously	advmod	6	SENT_37	[p2l1239t2311r1513b2375],
6	published	VBN	O	publish	amod	8	SENT_37	[p2l8t2390r272b2453],
7	clinical	JJ	O	clinical	amod	8	SENT_37	[p2l324t2390r512b2438],
8	trials	NNS	O	trial	prep_of	3	SENT_37	[p2l564t2390r695b2438],
9	on	IN	O	on	_	0	SENT_37	[p2l750t2407r816b2438],
10	the	DT	O	the	det	12	SENT_37	[p2l868t2390r950b2438],
11	long-term	JJ	O	long-term	amod	12	SENT_37	[p2l1002t2390r1266b2454],
12	use	NN	O	use	prep_on	8	SENT_37	[p2l1317t2407r1408b2438],
13	of	IN	O	of	_	0	SENT_37	[p2l1462t2390r1521b2438],
14	albuterol	NN	O	albuterol	prep_of	12	SENT_37	[p2l9t2467r257b2523],
15	,	,	O	,	_	0	SENT_37	[p2l9t2467r257b2523],
16	when	WRB	O	when	advmod	18	SENT_37	[p2l282t2467r429b2516],
17	retrospectively	RB	O	retrospectively	advmod	18	SENT_37	[p2l452t2467r838b2531],
18	stratified	VBN	O	stratify	dep	3	SENT_37	[p2l862t2467r1096b2516],
19	by	IN	O	by	_	0	SENT_37	[p2l1118t2467r1179b2531],
20	genotype	NN	O	genotype	prep_by	18	SENT_37	[p2l1203t2477r1441b2531],
21	at	IN	O	at	_	0	SENT_37	[p2l1466t2477r1512b2516],
22	the	DT	O	the	det	24	SENT_37	[p2l7t2545r90b2594],
23	B2-adrenergic	JJ	O	b2-adrenergic	amod	24	SENT_37	[p2l119t2545r470b2609],
24	receptor	NN	O	receptor	prep_at	18	SENT_37	[p2l494t2555r725b2608],
25	,	,	O	,	_	0	SENT_37	[p2l494t2555r725b2608],
26	showed	VBD	O	show	_	0	SENT_37	[p2l754t2545r954b2594],
27	that	IN	O	that	complm	31	SENT_37	[p2l977t2545r1081b2594],
28	this	DT	O	this	det	29	SENT_37	[p2l1103t2545r1200b2594],
29	hypothesis	NN	O	hypothesis	nsubj	31	SENT_37	[p2l1225t2545r1510b2609],
30	was	VBD	O	be	cop	31	SENT_37	[p2l7t2641r105b2672],
31	correct	JJ	O	correct	ccomp	26	SENT_37	[p2l144t2633r325b2672],
32	for	IN	O	for	_	0	SENT_37	[p2l360t2624r436b2672],
33	individuals	NNS	O	individual	prep_for	31	SENT_37	[p2l471t2624r763b2672],
34	homozygous	JJ	O	homozygous	amod	33	SENT_37	[p2l801t2624r1140b2688],
35	for	IN	O	for	_	0	SENT_37	[p2l1178t2624r1254b2672],
36	arginine	NN	O	arginine	nn	40	SENT_37	[p2l1289t2627r1511b2688],
37	(	CD	NUMBER	(	num	40	SENT_37	[p2l12t2705r250b2765],
38	Arg/Arg	NN	O	arg/arg	nn	40	SENT_37	[p2l12t2705r250b2765],
39	genotype	NN	O	genotype	nn	40	SENT_37	[p2l267t2706r521b2765],
40	)	NN	O	)	prep_for	34	SENT_37	[p2l267t2706r521b2765],
41	at	IN	O	at	_	0	SENT_37	[p2l542t2711r589b2750],
42	the	DT	O	the	det	45	SENT_37	[p2l603t2701r686b2750],
43	16th	JJ	ORDINAL	16th	amod	45	SENT_37	[p2l706t2701r820b2750],
44	aminoacid	JJ	O	aminoacid	amod	45	SENT_37	[p2l836t2701r1115b2750],
45	position	NN	O	position	prep_at	31	SENT_37	[p2l1130t2704r1346b2764],
46	of	IN	O	of	_	0	SENT_37	[p2l1363t2701r1422b2750],
47	the	DT	O	the	det	49	SENT_37	[p2l1428t2701r1511b2750],
48	B-adrenergic	JJ	MISC	b-adrenergic	amod	49	SENT_37	[p2l12t2779r347b2843],
49	receptor	NN	O	receptor	prep_of	45	SENT_37	[p2l373t2782r678b2842],
50	.	.	O	.	_	0	SENT_37	[p2l373t2782r678b2842],

1	““	NN	O	““	npadvmod	23	SENT_38	[p2l373t2782r678b2842],
2	In	IN	O	in	_	0	SENT_38	[p2l707t2784r763b2827],
3	these	DT	O	these	det	4	SENT_38	[p2l788t2779r927b2828],
4	analyses	NNS	O	analysis	prep_in	23	SENT_38	[p2l955t2779r1188b2843],
5	,	,	O	,	_	0	SENT_38	[p2l955t2779r1188b2843],
6	individuals	NNS	O	individual	nsubj	23	SENT_38	[p2l1217t2779r1510b2828],
7	with	IN	O	with	_	0	SENT_38	[p2l7t2858r124b2906],
8	the	DT	O	the	det	10	SENT_38	[p2l157t2858r240b2906],
9	Arg/Arg	NN	O	arg/arg	nn	10	SENT_38	[p2l274t2861r498b2922],
10	genotype	NN	O	genotype	prep_with	6	SENT_38	[p2l533t2867r785b2922],
11	,	,	O	,	_	0	SENT_38	[p2l533t2867r785b2922],
12	about	IN	O	about	_	0	SENT_38	[p2l823t2858r971b2906],
13	a	DT	O	a	det	14	SENT_38	[p2l1005t2875r1031b2906],
14	sixth	NN	ORDINAL	sixth	prep_about	6	SENT_38	[p2l1068t2858r1192b2906],
15	of	IN	O	of	_	0	SENT_38	[p2l1227t2858r1286b2906],
16	the	DT	O	the	det	18	SENT_38	[p2l1310t2858r1393b2906],
17	US	NNP	LOCATION	US	nn	18	SENT_38	[p2l1431t2861r1508b2906],
18	population	NN	O	population	prep_of	14	SENT_38	[p2l8t2934r309b2997],
19	,	,	O	,	_	0	SENT_38	[p2l8t2934r309b2997],
20	for	IN	O	for	_	0	SENT_38	[p2l347t2934r423b2983],
21	example	NN	O	example	prep_for	14	SENT_38	[p2l459t2934r693b2997],
22	,	,	O	,	_	0	SENT_38	[p2l459t2934r693b2997],
23	had	VBD	O	have	_	0	SENT_38	[p2l730t2934r829b2983],
24	declines	NNS	O	decline	dobj	23	SENT_38	[p2l865t2934r1079b2983],
25	in	IN	O	in	_	0	SENT_38	[p2l1117t2937r1170b2982],
26	airﬂow	NN	O	airﬂow	prep_in	24	SENT_38	[p2l1207t2934r1420b2983],
27	“	CD	NUMBER	“	num	26	SENT_38	[p2l1207t2934r1420b2983],
28	or	CC	O	or	_	0	SENT_38	[p2l1458t2952r1512b2983],
29	asthma	NN	O	asthma	nn	30	SENT_38	[p2l9t3012r203b3061],
30	control	NN	O	control	dobj	23	SENT_38	[p2l237t3012r454b3061],
31	”	CD	NUMBER	”	dep	30	SENT_38	[p2l237t3012r454b3061],
32	in	IN	O	in	_	0	SENT_38	[p2l489t3015r542b3060],
33	association	NN	O	association	prep_in	23	SENT_38	[p2l576t3015r869b3061],
34	with	IN	O	with	_	0	SENT_38	[p2l901t3012r1018b3061],
35	regular	JJ	O	regular	amod	37	SENT_38	[p2l1052t3012r1243b3076],
36	albuterol	NN	O	albuterol	nn	37	SENT_38	[p2l1277t3012r1511b3061],
37	use	NN	O	use	prep_with	33	SENT_38	[p2l7t3108r111b3139],
38	.	.	O	.	_	0	SENT_38	[p2l7t3108r111b3139],

1	However	RB	O	however	advmod	6	SENT_39	[p2l148t3096r398b3147],
2	,	,	O	,	_	0	SENT_39	[p2l148t3096r398b3147],
3	these	DT	O	these	det	4	SENT_39	[p2l430t3091r569b3139],
4	investigations	NNS	O	investigation	nsubj	6	SENT_39	[p2l601t3094r967b3155],
5	were	VBD	O	be	cop	6	SENT_39	[p2l999t3108r1125b3139],
6	retrospective	JJ	O	retrospective	_	0	SENT_39	[p2l1157t3094r1509b3154],
7	.	.	O	.	_	0	SENT_39	[p2l1157t3094r1509b3154],

1	To	TO	O	to	aux	2	SENT_40	[p2l7t3171r75b3217],
2	establish	VB	O	establish	purpcl	29	SENT_40	[p2l101t3168r334b3217],
3	unequivocally	RB	O	unequivocally	advmod	2	SENT_40	[p2l358t3168r728b3232],
4	a	DT	O	a	det	6	SENT_40	[p2l751t3186r778b3217],
5	genotype-dependent	JJ	O	genotype-dependent	amod	6	SENT_40	[p2l803t3168r1344b3232],
6	effect	NN	O	effect	dobj	2	SENT_40	[p2l1368t3168r1512b3217],
7	of	IN	O	of	prep	6	SENT_40	[p2l9t3246r68b3295],
8	regularly	RB	O	regularly	pcomp	7	SENT_40	[p2l79t3246r316b3310],
9	scheduled	VBN	O	schedule	partmod	6	SENT_40	[p2l337t3246r604b3295],
10	albuterol	NN	O	albuterol	nn	11	SENT_40	[p2l624t3246r859b3295],
11	use	NN	O	use	dobj	9	SENT_40	[p2l879t3263r969b3295],
12	on	IN	O	on	_	0	SENT_40	[p2l991t3263r1058b3295],
13	airway	NN	O	airway	nn	14	SENT_40	[p2l1079t3249r1251b3310],
14	function	NN	O	function	prep_on	9	SENT_40	[p2l1270t3246r1509b3302],
15	,	,	O	,	_	0	SENT_40	[p2l1270t3246r1509b3302],
16	a	DT	O	a	det	18	SENT_40	[p2l9t3341r35b3372],
17	prospective	JJ	O	prospective	amod	18	SENT_40	[p2l63t3327r364b3387],
18	trial	NN	O	trial	nsubj	29	SENT_40	[p2l392t3324r511b3379],
19	,	,	O	,	_	0	SENT_40	[p2l392t3324r511b3379],
20	in	IN	O	in	_	0	SENT_40	[p2l542t3327r595b3371],
21	which	WDT	O	which	rel	24	SENT_40	[p2l622t3324r784b3372],
22	patients	NNS	O	patient	nsubjpass	24	SENT_40	[p2l812t3327r1021b3387],
23	were	VBD	O	be	auxpass	24	SENT_40	[p2l1050t3341r1177b3372],
24	enrolled	VBN	O	enrol	rcmod	18	SENT_40	[p2l1206t3324r1424b3372],
25	by	IN	O	by	_	0	SENT_40	[p2l1451t3324r1513b3387],
26	genotype	NN	O	genotype	agent	24	SENT_40	[p2l9t3411r261b3465],
27	,	,	O	,	_	0	SENT_40	[p2l9t3411r261b3465],
28	was	VBD	O	be	cop	29	SENT_40	[p2l280t3418r379b3450],
29	necessary	JJ	O	necessary	_	0	SENT_40	[p2l399t3418r668b3465],
30	.	.	O	.	_	0	SENT_40	[p2l399t3418r668b3465],

1	We	PRP	O	we	nsubj	2	SENT_41	[p2l57t3483r145b3527],
2	report	VBP	O	report	_	0	SENT_41	[p2l177t3488r339b3541],
3	the	DT	O	the	det	4	SENT_41	[p2l368t3478r451b3526],
4	results	NNS	O	result	dobj	2	SENT_41	[p2l483t3478r658b3527],
5	of	IN	O	of	_	0	SENT_41	[p2l692t3478r751b3526],
6	such	PDT	O	such	predet	9	SENT_41	[p2l775t3478r898b3527],
7	a	DT	O	a	det	9	SENT_41	[p2l930t3495r956b3526],
8	clinical	JJ	O	clinical	amod	9	SENT_41	[p2l988t3478r1176b3526],
9	trial	NN	O	trial	prep_of	4	SENT_41	[p2l1207t3478r1326b3534],
10	,	,	O	,	_	0	SENT_41	[p2l1207t3478r1326b3534],
11	called	VBN	O	call	partmod	9	SENT_41	[p2l1360t3478r1512b3527],
12	BARGE	NNP	O	BARGE	nn	14	SENT_41	[p2l11t3560r213b3605],
13	(	CD	NUMBER	(	num	14	SENT_41	[p2l260t3557r708b3621],
14	Beta-Adrenergic	NNP	O	Beta-Adrenergic	nsubj	15	SENT_41	[p2l260t3557r708b3621],
15	Response	NN	O	response	ccomp	11	SENT_41	[p2l751t3562r1003b3620],
16	by	IN	O	by	_	0	SENT_41	[p2l1044t3557r1106b3620],
17	Genotype	NN	O	genotype	nn	18	SENT_41	[p2l1147t3560r1416b3621],
18	)	NN	O	)	prep_by	15	SENT_41	[p2l1147t3560r1416b3621],
19	of	IN	O	of	prep	18	SENT_41	[p2l1462t3557r1521b3605],

1	Articles	NNPS	O	Articles	_	0	SENT_42	[p3l101t221r249b257],

1	Randomise	NNP	O	Randomise	nn	2	SENT_43	[p3l391t502r504b522],
2	Screen	NNP	O	Screen	_	0	SENT_43	[p3l64t693r129b712],
3	and	CC	O	and	_	0	SENT_43	[p3l136t692r174b712],
4	genotype	NN	O	genotype	conj_and	2	SENT_43	[p3l64t727r161b749],

1	6	CD	DURATION	6	num	2	SENT_44	[p3l242t692r254b712],
2	weeks	NNS	DURATION	week	_	0	SENT_44	[p3l260t692r323b712],
3	run-in	NN	O	run-in	dep	2	SENT_44	[p3l330t693r397b715],
4	;	:	O	;	_	0	SENT_44	[p3l330t693r397b715],
5	all	DT	O	all	dep	2	SENT_44	[p3l242t723r263b743],
6	on	IN	O	on	_	0	SENT_44	[p3l270t730r295b743],
7	placebo	NN	O	placebo	nn	9	SENT_44	[p3l302t723r381b749],
8	'	''	O	'	_	0	SENT_44	[p3l446t725r448b734],
9	orplacebo	NN	O	orplacebo	prep_on	5	SENT_44	[p3l476t723r581b749],

1	.	.	O	.	_	0	SENT_45	[p3l446t741r448b748],

1	l	NN	O	l	nn	2	SENT_46	[p3l220t741r222b772],
2	I	NN	O	i	_	0	SENT_46	[p3l446t753r448b772],

1	E	NN	O	e	nn	2	SENT_47	[p3l220t975r222b1015],
2	S	NN	O	s	_	0	SENT_47	[p3l317t977r320b1018],
3	5	CD	NUMBER	5	dep	2	SENT_47	[p3l446t976r448b1016],

1	Baseline	NN	O	baseline	nn	3	SENT_48	[p3l193t1108r275b1128],
2	Pretreatment	NN	O	pretreatment	nn	3	SENT_48	[p3l424t1110r558b1128],
3	Weeks	NNS	DURATION	week	_	0	SENT_48	[p3l192t1139r257b1159],
4	0-2	CD	NUMBER	0-2	num	5	SENT_48	[p3l263t1142r302b1159],
5	Baseline	NN	O	baseline	dep	3	SENT_48	[p3l424t1139r506b1159],
6	1	CD	NUMBER	1	dep	3	SENT_48	[p3l513t1142r524b1159],

1	.	.	O	.	_	0	SENT_49	[p3l446t675r448b684],

1	I	PRP	O	I	_	0	SENT_50	[p3l446t691r448b717],
2	16	CD	DURATION	16	num	3	SENT_50	[p3l477t692r502b712],
3	weeks	NNS	NUMBER	week	dep	1	SENT_50	[p3l508t692r570b712],
4	active	JJ	O	active	amod	5	SENT_50	[p3l577t693r636b712],
5	treatment	NN	O	treatment	dep	1	SENT_50	[p3l641t695r746b712],

1	.	.	O	.	_	0	SENT_51	[p3l1155t675r1158b684],

1	:	:	O	:	_	0	SENT_52	[p3l1155t691r1158b717],
2	16	CD	DURATION	16	num	3	SENT_52	[p3l1179t692r1204b712],
3	weeks	NNS	NUMBER	week	_	0	SENT_52	[p3l1210t692r1273b712],
4	placebo	NN	O	placebo	dep	3	SENT_52	[p3l1279t692r1357b718],
5	or	CC	O	or	_	0	SENT_52	[p3l1364t698r1385b712],
6	1	CD	NUMBER	1	num	8	SENT_52	[p3l1155t725r1158b748],
7	active	JJ	O	active	amod	8	SENT_52	[p3l1178t724r1237b743],
8	treatment	NN	O	treatment	dep	3	SENT_52	[p3l1242t727r1347b743],

1	8	CD	DURATION	8	num	2	SENT_53	[p3l1477t692r1489b712],
2	weeks	NNS	DURATION	week	_	0	SENT_53	[p3l1495t692r1557b712],
3	run-out	NN	O	run-out	dep	2	SENT_53	[p3l1565t695r1649b715],
4	;	:	O	;	_	0	SENT_53	[p3l1565t695r1649b715],
5	all	DT	O	all	dep	2	SENT_53	[p3l1477t723r1498b743],
6	on	IN	O	on	_	0	SENT_53	[p3l1505t730r1530b743],
7	placebo	NN	O	placebo	prep_on	5	SENT_53	[p3l1537t723r1616b749],

1	8	CD	DURATION	8	num	2	SENT_54	[p3l892t692r903b712],
2	weeks	NNS	DURATION	week	_	0	SENT_54	[p3l909t692r972b712],
3	run-out	NN	O	run-out	dep	2	SENT_54	[p3l979t695r1064b715],
4	;	:	O	;	_	0	SENT_54	[p3l979t695r1064b715],
5	all	DT	O	all	dep	2	SENT_54	[p3l891t723r912b743],
6	on	IN	O	on	_	0	SENT_54	[p3l920t730r945b743],
7	placebo	NN	O	placebo	prep_on	5	SENT_54	[p3l952t723r1030b749],

1	22	CD	NUMBER	22	num	2	SENT_55	[p3l854t883r878b900],
2	kMи	NN	O	kmи	_	0	SENT_55	[p3l1027t867r1029b907],
3	*	CD	NUMBER	*	number	4	SENT_55	[p3l1027t867r1029b907],
4	30	CD	NUMBER	30	dep	2	SENT_55	[p3l1145t883r1171b903],
5	46	CD	NUMBER	46	num	6	SENT_55	[p3l1432t880r1458b903],
6	54	CD	NUMBER	54	dep	4	SENT_55	[p3l1754t883r1780b903],

1	pgLи	NN	O	pglи	nn	4	SENT_56	[p3l1027t976r1158b1098],
2	*	CD	NUMBER	*	num	4	SENT_56	[p3l1027t976r1158b1098],
3	Pretreatment	NN	O	pretreatment	nn	4	SENT_56	[p3l1007t1110r1142b1128],
4	Baseline	NN	O	baseline	_	0	SENT_56	[p3l1007t1139r1089b1159],
5	2	CD	NUMBER	2	dep	4	SENT_56	[p3l1096t1142r1107b1159],

1	Weeks	NNS	DURATION	week	dep	6	SENT_57	[p3l753t1170r818b1190],
2	3	CD	NUMBER	3	num	3	SENT_57	[p3l825t1170r864b1193],
3	—	NN	O	—	dep	1	SENT_57	[p3l825t1170r864b1193],
4	6	CD	DURATION	6	num	5	SENT_57	[p3l825t1170r864b1193],
5	Weeks	NNS	DURATION	week	dep	6	SENT_57	[p3l1336t1170r1401b1190],
6	27-30	CD	NUMBER	27-30	_	0	SENT_57	[p3l1409t1173r1475b1193],
7	I	PRP	O	I	dep	6	SENT_57	[p3l2153t1159r2154b1218],

1	Figure	NNP	O	Figure	_	0	SENT_58	[p3l6t1246r73b1273],
2	1	CD	NUMBER	1	num	1	SENT_58	[p3l80t1248r99b1266],
3	:	:	O	:	_	0	SENT_58	[p3l80t1248r99b1266],
4	Schematic	JJ	O	schematic	amod	5	SENT_58	[p3l105t1245r225b1266],
5	diagram	NN	O	diagram	dep	1	SENT_58	[p3l231t1245r326b1273],
6	of	IN	O	of	_	0	SENT_58	[p3l334t1245r359b1266],
7	the	DT	O	the	det	9	SENT_58	[p3l363t1245r402b1266],
8	trial	NN	O	trial	nn	9	SENT_58	[p3l408t1245r453b1266],
9	protocol	NN	O	protocol	prep_of	5	SENT_58	[p3l461t1245r558b1273],
10	regularly	RB	O	regularly	advmod	11	SENT_58	[p3l646t1369r883b1433],
11	scheduled	VBN	O	schedule	partmod	9	SENT_58	[p3l911t1369r1179b1417],
12	albuterol	NN	O	albuterol	nn	13	SENT_58	[p3l1207t1369r1442b1417],
13	treatment	NN	O	treatment	dobj	11	SENT_58	[p3l1469t1378r1743b1417],
14	.	.	O	.	_	0	SENT_58	[p3l1469t1378r1743b1417],

1	In	IN	O	in	_	0	SENT_59	[p3l1777t1374r1833b1416],
2	this	DT	O	this	det	3	SENT_59	[p3l1860t1369r1957b1417],
3	study	NN	O	study	prep_in	10	SENT_59	[p3l1988t1369r2142b1432],
4	,	,	O	,	_	0	SENT_59	[p3l1988t1369r2142b1432],
5	patients	NNS	O	patient	nsubjpass	10	SENT_59	[p3l646t1449r855b1508],
6	with	IN	O	with	_	0	SENT_59	[p3l875t1445r993b1494],
7	mild	JJ	O	mild	amod	8	SENT_59	[p3l1012t1445r1136b1494],
8	asthma	NN	O	asthma	prep_with	5	SENT_59	[p3l1156t1445r1350b1494],
9	were	VBD	O	be	auxpass	10	SENT_59	[p3l1368t1463r1495b1494],
10	enrolled	VBN	O	enrol	_	0	SENT_59	[p3l1516t1445r1734b1494],
11	on	IN	O	on	_	0	SENT_59	[p3l1754t1463r1820b1494],
12	the	DT	O	the	det	13	SENT_59	[p3l1839t1445r1922b1494],
13	basis	NN	O	basis	prep_on	10	SENT_59	[p3l1941t1445r2073b1494],
14	of	IN	O	of	_	0	SENT_59	[p3l2095t1445r2154b1494],
15	clinical	JJ	O	clinical	amod	16	SENT_59	[p3l647t1523r835b1572],
16	criteria	NNS	O	criterion	prep_of	13	SENT_59	[p3l896t1526r1083b1572],
17	and	CC	O	and	_	0	SENT_59	[p3l1144t1523r1242b1572],
18	their	PRP$	O	they	poss	21	SENT_59	[p3l1301t1523r1428b1572],
19	genotype	NN	O	genotype	nn	21	SENT_59	[p3l1488t1533r1727b1587],
20	(	CD	NUMBER	(	num	21	SENT_59	[p3l1792t1526r2030b1587],
21	Arg/Arg	NN	O	arg/arg	prep_of	13	SENT_59	[p3l1792t1526r2030b1587],
22	or	CC	O	or	_	0	SENT_59	[p3l2092t1541r2146b1572],
23	homozygous	JJ	O	homozygous	amod	29	SENT_59	[p3l645t1602r985b1666],
24	for	IN	O	for	_	0	SENT_59	[p3l1004t1602r1080b1650],
25	glycine	NN	O	glycine	nn	27	SENT_59	[p3l1098t1602r1283b1666],
26	[	CD	NUMBER	[	num	27	SENT_59	[p3l1305t1602r1558b1666],
27	Gly/Gly	NN	O	gly/gly	prep_for	23	SENT_59	[p3l1305t1602r1558b1666],
28	]	CD	NUMBER	]	num	27	SENT_59	[p3l1305t1602r1558b1666],
29	)	NN	O	)	conj_or	13	SENT_59	[p3l1305t1602r1558b1666],
30	at	IN	O	at	_	0	SENT_59	[p3l1581t1611r1627b1650],
31	the	DT	O	the	det	32	SENT_59	[p3l1643t1602r1726b1650],
32	locus	NN	O	locus	prep_at	10	SENT_59	[p3l1743t1602r1880b1650],
33	encoding	VBG	O	encode	partmod	32	SENT_59	[p3l1901t1602r2145b1666],
34	the	DT	O	the	det	36	SENT_59	[p3l645t1679r728b1728],
35	16th	JJ	ORDINAL	16th	amod	36	SENT_59	[p3l750t1679r864b1728],
36	aminoacid	JJ	O	aminoacid	dobj	33	SENT_59	[p3l882t1679r1161b1728],
37	of	IN	O	of	_	0	SENT_59	[p3l1179t1679r1238b1728],
38	the	DT	O	the	det	40	SENT_59	[p3l1247t1679r1329b1728],
39	B,-adrenergic	JJ	O	b,-adrenergic	amod	40	SENT_59	[p3l1352t1679r1703b1743],
40	receptor	NN	O	receptor	prep_of	36	SENT_59	[p3l1721t1689r1952b1743],
41	.	.	O	.	_	0	SENT_59	[p3l1721t1689r1952b1743],

1	Methods	NNS	O	method	nn	2	SENT_60	[p3l648t1827r921b1883],
2	Patients	NNS	O	patient	nsubjpass	73	SENT_60	[p3l649t1913r867b1961],
3	We	PRP	O	we	nsubj	10	SENT_60	[p3l645t1994r733b2038],
4	recruited	VBD	O	recruit	parataxis	73	SENT_60	[p3l761t1989r1001b2038],
5	patients	NNS	O	patient	dobj	4	SENT_60	[p3l1028t1992r1237b2052],
6	with	IN	O	with	_	0	SENT_60	[p3l1265t1989r1383b2038],
7	mild	JJ	O	mild	amod	8	SENT_60	[p3l1411t1989r1535b2037],
8	asthma	NN	O	asthma	prep_with	4	SENT_60	[p3l1562t1989r1756b2038],
9	and	CC	O	and	_	0	SENT_60	[p3l1785t1989r1883b2037],
10	screened	VBD	O	screen	parataxis	73	SENT_60	[p3l1912t1989r2146b2038],
11	them	PRP	O	they	dobj	10	SENT_60	[p3l645t2067r785b2115],
12	by	IN	O	by	_	0	SENT_60	[p3l804t2067r866b2130],
13	methods	NNS	O	method	prep_by	10	SENT_60	[p3l885t2067r1115b2115],
14	and	CC	O	and	_	0	SENT_60	[p3l1138t2067r1236b2115],
15	equipment	NN	O	equipment	prep_by	10	SENT_60	[p3l1256t2070r1547b2130],
16	previously	RB	DATE	previously	advmod	10	SENT_60	[p3l1566t2067r1840b2130],
17	describedf	JJ	O	describedf	amod	19	SENT_60	[p3l1860t2067r2145b2115],
18	‘	NN	O	‘	nn	19	SENT_60	[p3l1860t2067r2145b2115],
19	Men	NN	O	man	dobj	4	SENT_60	[p3l648t2149r768b2193],
20	and	CC	O	and	_	0	SENT_60	[p3l799t2144r897b2193],
21	women	NNS	O	woman	dobj	4	SENT_60	[p3l925t2162r1125b2193],
22	aged	JJ	O	aged	amod	19	SENT_60	[p3l1156t2144r1278b2208],
23	18-55	CD	NUMBER	18-55	num	24	SENT_60	[p3l1312t2147r1462b2193],
24	years	NNS	NUMBER	year	tmod	22	SENT_60	[p3l1494t2162r1644b2208],
25	,	,	O	,	_	0	SENT_60	[p3l1494t2162r1644b2208],
26	with	IN	O	with	dobj	4	SENT_60	[p3l1676t2144r1794b2193],
27	a	DT	O	a	det	28	SENT_60	[p3l1825t2162r1851b2193],
28	history	NN	O	history	pobj	26	SENT_60	[p3l1881t2144r2065b2208],
29	of	IN	O	of	_	0	SENT_60	[p3l2095t2144r2154b2193],
30	physician-diagnosed	JJ	O	physician-diagnosed	amod	31	SENT_60	[p3l646t2222r1190b2286],
31	asthma	NN	O	asthma	prep_of	28	SENT_60	[p3l1223t2222r1430b2278],
32	,	,	O	,	_	0	SENT_60	[p3l1223t2222r1430b2278],
33	who	WP	O	who	nsubj	34	SENT_60	[p3l1464t2222r1576b2271],
34	reported	VBD	O	report	rcmod	31	SENT_60	[p3l1610t2222r1835b2285],
35	use	NN	O	use	dobj	34	SENT_60	[p3l1866t2239r1956b2271],
36	of	IN	O	of	_	0	SENT_60	[p3l1991t2222r2050b2271],
37	asneeded	JJ	O	asneeded	prep_of	35	SENT_60	[p3l2074t2239r2143b2271, p3l646t2301r838b2349],
38	inhaled	VBN	O	inhale	partmod	37	SENT_60	[p3l855t2301r1054b2349],
39	B2	NN	O	b2	nn	40	SENT_60	[p3l1075t2305r1124b2362],
40	agonist	NN	O	agonist	dobj	38	SENT_60	[p3l1143t2304r1335b2365],
41	of	IN	O	of	_	0	SENT_60	[p3l1353t2301r1412b2349],
42	less	JJR	O	less	mwe	43	SENT_60	[p3l1419t2301r1517b2349],
43	than	IN	O	than	quantmod	44	SENT_60	[p3l1536t2301r1656b2349],
44	56	CD	NUMBER	56	num	45	SENT_60	[p3l1676t2304r1734b2349],
45	puffs	NNS	O	puff	prep_of	40	SENT_60	[p3l1753t2301r1887b2364],
46	per	IN	O	per	_	0	SENT_60	[p3l1907t2318r1994b2364],
47	week	NN	DURATION	week	prep_per	45	SENT_60	[p3l2009t2301r2146b2349],
48	as	IN	O	as	_	0	SENT_60	[p3l647t2396r698b2427],
49	their	PRP$	O	they	poss	52	SENT_60	[p3l743t2378r869b2427],
50	only	JJ	O	only	amod	52	SENT_60	[p3l913t2378r1026b2442],
51	asthma	NN	O	asthma	nn	52	SENT_60	[p3l1069t2378r1263b2427],
52	treatment	NN	O	treatment	prep_as	38	SENT_60	[p3l1306t2388r1580b2434],
53	,	,	O	,	_	0	SENT_60	[p3l1306t2388r1580b2434],
54	and	CC	O	and	_	0	SENT_60	[p3l1627t2378r1725b2427],
55	whose	WP$	O	whose	dep	70	SENT_60	[p3l1767t2378r1935b2427],
56	forced	VBN	O	force	amod	58	SENT_60	[p3l1980t2378r2146b2427],
57	expiratory	JJ	O	expiratory	amod	58	SENT_60	[p3l647t2459r912b2520],
58	volume	NN	O	volume	nsubjpass	70	SENT_60	[p3l945t2456r1143b2505],
59	in	IN	O	in	_	0	SENT_60	[p3l1181t2459r1234b2504],
60	1s	NNS	O	1	prep_in	58	SENT_60	[p3l1274t2461r1325b2505],
61	(	CD	NUMBER	(	num	63	SENT_60	[p3l1367t2459r1528b2520],
62	FEV1	NN	O	fev1	nn	63	SENT_60	[p3l1367t2459r1528b2520],
63	)	NN	O	)	dep	60	SENT_60	[p3l1367t2459r1528b2520],
64	was	VBD	O	be	auxpass	70	SENT_60	[p3l1567t2473r1665b2505],
65	at	IN	O	at	quantmod	67	SENT_60	[p3l1704t2466r1751b2505],
66	least	JJS	O	least	mwe	65	SENT_60	[p3l1785t2456r1907b2505],
67	70	CD	PERCENT	70	num	68	SENT_60	[p3l1944t2459r2057b2507],
68	%	NN	PERCENT	%	npadvmod	69	SENT_60	[p3l1944t2459r2057b2507],
69	of	IN	O	of	advmod	70	SENT_60	[p3l2095t2456r2154b2505],
70	predicted	VBN	O	predict	conj_and	19	SENT_60	[p3l646t2534r907b2597],
71	,	,	O	,	_	0	SENT_60	[p3l646t2534r907b2597],
72	were	VBD	O	be	auxpass	73	SENT_60	[p3l963t2551r1089b2582],
73	recruited	VBN	O	recruit	_	0	SENT_60	[p3l1145t2534r1385b2582],
74	at	IN	O	at	_	0	SENT_60	[p3l1440t2543r1486b2582],
75	the	DT	O	the	det	79	SENT_60	[p3l1539t2534r1622b2582],
76	Asthma	NNP	ORGANIZATION	Asthma	nn	79	SENT_60	[p3l1677t2534r1886b2582],
77	Clinical	JJ	ORGANIZATION	clinical	amod	79	SENT_60	[p3l1943t2534r2145b2582],
78	Research	NNP	ORGANIZATION	Research	nn	79	SENT_60	[p3l649t2610r888b2659],
79	Network	NNP	ORGANIZATION	Network	prep_at	73	SENT_60	[p3l918t2610r1145b2659],
80	outpatient	NN	O	outpatient	nn	81	SENT_60	[p3l1173t2613r1444b2673],
81	sites	NNS	O	site	dobj	73	SENT_60	[p3l1473t2613r1603b2659],
82	.	.	O	.	_	0	SENT_60	[p3l1473t2613r1603b2659],

1	Asthma	NN	O	asthma	nsubj	18	SENT_61	[p3l1633t2610r1842b2659],
2	that	WDT	O	that	nsubjpass	6	SENT_61	[p3l1869t2610r1973b2659],
3	could	MD	O	could	aux	6	SENT_61	[p3l2001t2610r2146b2659],
4	be	VB	O	be	auxpass	6	SENT_61	[p3l645t2688r706b2737],
5	safely	RB	O	safely	advmod	6	SENT_61	[p3l767t2688r916b2752],
6	managed	VBN	O	manage	rcmod	1	SENT_61	[p3l972t2688r1218b2752],
7	through	IN	O	through	_	0	SENT_61	[p3l1275t2688r1490b2752],
8	the	DT	O	the	det	9	SENT_61	[p3l1547t2688r1630b2737],
9	use	NN	O	use	prep_through	6	SENT_61	[p3l1688t2705r1779b2737],
10	of	IN	O	of	_	0	SENT_61	[p3l1838t2688r1897b2737],
11	inhaled	VBN	O	inhale	prepc_of	9	SENT_61	[p3l1946t2688r2146b2737],
12	bronchodilator	NN	O	bronchodilator	nn	13	SENT_61	[p3l645t2767r1041b2815],
13	medications	NNS	O	medication	dobj	11	SENT_61	[p3l1085t2767r1409b2815],
14	alone	RB	O	alone	advmod	18	SENT_61	[p3l1457t2767r1598b2815],
15	was	VBD	O	be	cop	18	SENT_61	[p3l1642t2784r1741b2815],
16	an	DT	O	a	det	18	SENT_61	[p3l1789t2784r1852b2815],
17	inclusion	NN	O	inclusion	nn	18	SENT_61	[p3l1897t2767r2145b2815],
18	criterion	NN	O	criterion	_	0	SENT_61	[p3l647t2846r886b2899],
19	;	:	O	;	_	0	SENT_61	[p3l647t2846r886b2899],
20	other	JJ	O	other	amod	21	SENT_61	[p3l912t2843r1051b2891],
21	inclusion	NN	O	inclusion	nsubj	27	SENT_61	[p3l1072t2843r1320b2891],
22	and	CC	O	and	_	0	SENT_61	[p3l1343t2843r1441b2891],
23	exclusion	NN	O	exclusion	nn	24	SENT_61	[p3l1463t2843r1712b2891],
24	criteria	NNS	O	criterion	conj_and	21	SENT_61	[p3l1735t2846r1921b2891],
25	were	VBD	O	be	cop	27	SENT_61	[p3l1942t2861r2068b2892],
26	as	RB	O	as	advmod	27	SENT_61	[p3l2092t2860r2143b2891],
27	reported	VBN	O	report	parataxis	18	SENT_61	[p3l646t2921r871b2984],
28	previouslyf	NN	O	previouslyf	dep	27	SENT_61	[p3l923t2921r1228b2985],
29	‘	CD	NUMBER	‘	num	28	SENT_61	[p3l923t2921r1228b2985],
30	All	DT	O	all	det	31	SENT_61	[p3l1279t2921r1355b2969],
31	patients	NNS	O	patient	nsubj	32	SENT_61	[p3l1407t2924r1616b2984],
32	provided	VBD	O	provide	rcmod	28	SENT_61	[p3l1671t2921r1903b2984],
33	Written	VBN	O	write	dep	32	SENT_61	[p3l1954t2924r2145b2970],
34	informed	VBN	O	inform	amod	35	SENT_61	[p3l646t2999r896b3047],
35	consent	NN	O	consent	dobj	33	SENT_61	[p3l912t3008r1120b3047],
36	as	IN	O	as	mark	37	SENT_61	[p3l1136t3016r1187b3047],
37	approved	VBN	O	approve	dep	35	SENT_61	[p3l1206t2999r1449b3062],
38	by	IN	O	by	_	0	SENT_61	[p3l1464t2999r1526b3062],
39	the	DT	O	the	det	41	SENT_61	[p3l1540t2999r1623b3047],
40	local	JJ	O	local	amod	41	SENT_61	[p3l1639t2999r1760b3047],
41	committee	NN	O	committee	prep_by	37	SENT_61	[p3l1777t3002r2061b3047],
42	on	IN	O	on	_	0	SENT_61	[p3l2078t3016r2145b3047],
43	human	JJ	O	human	amod	44	SENT_61	[p3l645t3075r839b3123],
44	research	NN	O	research	prep_on	41	SENT_61	[p3l857t3075r1094b3123],
45	.	.	O	.	_	0	SENT_61	[p3l857t3075r1094b3123],

1	Design	NN	O	design	nn	4	SENT_62	[p4l649t61r826b124],
2	and	CC	O	and	_	0	SENT_62	[p4l843t60r942b109],
3	procedures	NNS	O	procedure	conj_and	1	SENT_62	[p4l957t60r1252b124],
4	Patients	NNS	O	patient	nsubj	9	SENT_62	[p4l649t141r859b186],
5	who	WP	O	who	nsubj	6	SENT_62	[p4l877t137r988b186],
6	met	VBD	O	meet	rcmod	4	SENT_62	[p4l1006t147r1110b186],
7	these	DT	O	these	det	8	SENT_62	[p4l1125t137r1264b186],
8	criteria	NNS	O	criterion	dobj	6	SENT_62	[p4l1283t141r1469b186],
9	had	VBD	O	have	_	0	SENT_62	[p4l1486t137r1585b186],
10	blood	NN	O	blood	nn	11	SENT_62	[p4l1600t137r1749b186],
11	samples	NNS	O	sample	dobj	9	SENT_62	[p4l1767t137r1981b200],
12	taken	VBN	O	take	partmod	11	SENT_62	[p4l1999t137r2145b186],
13	so	RB	O	so	advmod	32	SENT_62	[p4l648t232r702b264],
14	that	IN	O	that	dep	32	SENT_62	[p4l736t215r839b264],
15	the	DT	O	the	det	16	SENT_62	[p4l872t215r954b264],
16	genotype	NN	O	genotype	nsubjpass	32	SENT_62	[p4l990t225r1228b279],
17	at	IN	O	at	_	0	SENT_62	[p4l1264t225r1310b264],
18	the	DT	O	the	det	19	SENT_62	[p4l1343t215r1425b264],
19	locus	NN	O	locus	prep_at	16	SENT_62	[p4l1459t215r1596b264],
20	encoding	VBG	O	encode	partmod	19	SENT_62	[p4l1633t215r1877b279],
21	the	DT	O	the	det	24	SENT_62	[p4l1911t215r1993b264],
22	16th	JJ	ORDINAL	16th	amod	24	SENT_62	[p4l2032t215r2145b264],
23	aminoacid	JJ	O	aminoacid	amod	24	SENT_62	[p4l647t294r926b342],
24	residue	NN	O	residue	dobj	20	SENT_62	[p4l941t294r1136b342],
25	of	IN	O	of	_	0	SENT_62	[p4l1154t294r1213b342],
26	the	DT	O	the	det	29	SENT_62	[p4l1219t294r1302b342],
27	[	CD	NUMBER	[	num	29	SENT_62	[p4l1322t294r1674b358],
28	32-adrenergic	JJ	O	32-adrenergic	amod	29	SENT_62	[p4l1322t294r1674b358],
29	receptor	NN	O	receptor	prep_of	24	SENT_62	[p4l1690t303r1908b357],
30	could	MD	O	could	aux	32	SENT_62	[p4l1924t294r2069b342],
31	be	VB	O	be	auxpass	32	SENT_62	[p4l2083t294r2144b342],
32	identiﬁed	VBN	O	identiﬁed	advcl	12	SENT_62	[p4l646t371r913b420],
33	.	.	O	.	_	0	SENT_62	[p4l646t371r913b420],

1	If	IN	O	if	mark	3	SENT_63	[p4l938t371r986b419],
2	they	PRP	O	they	nsubj	3	SENT_63	[p4l996t371r1109b435],
3	had	VBD	O	have	advcl	17	SENT_63	[p4l1126t371r1225b420],
4	either	CC	O	either	preconj	6	SENT_63	[p4l1244t371r1398b420],
5	the	DT	O	the	det	6	SENT_63	[p4l1416t371r1498b420],
6	Arg/Arg	NN	O	arg/arg	dobj	3	SENT_63	[p4l1517t375r1741b435],
7	or	CC	O	or	_	0	SENT_63	[p4l1761t389r1815b420],
8	the	DT	O	the	det	10	SENT_63	[p4l1833t371r1915b420],
9	Gly/Gly	NNP	O	Gly/Gly	nn	10	SENT_63	[p4l1937t371r2146b435],
10	genotype	NN	O	genotype	dobj	3	SENT_63	[p4l647t459r885b513],
11	at	IN	O	at	_	0	SENT_63	[p4l911t459r957b498],
12	this	DT	O	this	det	13	SENT_63	[p4l979t449r1076b498],
13	locus	NN	O	locus	prep_at	3	SENT_63	[p4l1101t449r1253b505],
14	,	,	O	,	_	0	SENT_63	[p4l1101t449r1253b505],
15	they	PRP	O	they	nsubjpass	17	SENT_63	[p4l1278t449r1391b513],
16	were	VBD	O	be	auxpass	17	SENT_63	[p4l1413t466r1539b498],
17	classed	VBN	O	class	_	0	SENT_63	[p4l1564t449r1753b498],
18	as	IN	O	as	_	0	SENT_63	[p4l1777t466r1828b498],
19	eligible	JJ	O	eligible	prep_as	17	SENT_63	[p4l1855t449r2046b513],
20	for	IN	O	for	_	0	SENT_63	[p4l2070t449r2146b498],
21	the	DT	O	the	det	22	SENT_63	[p4l645t528r728b576],
22	study	NN	O	study	prep_for	17	SENT_63	[p4l748t528r901b591],
23	.	.	O	.	_	0	SENT_63	[p4l748t528r901b591],

1	For	IN	O	for	_	0	SENT_64	[p4l925t531r1014b576],
2	each	DT	O	each	det	3	SENT_64	[p4l1031t528r1151b576],
3	patient	NN	O	patient	prep_for	16	SENT_64	[p4l1168t531r1353b591],
4	with	IN	O	with	_	0	SENT_64	[p4l1369t528r1486b576],
5	the	DT	O	the	det	7	SENT_64	[p4l1503t528r1586b576],
6	Arg/Arg	NN	O	arg/arg	nn	7	SENT_64	[p4l1604t531r1827b592],
7	genotype	NN	O	genotype	prep_with	3	SENT_64	[p4l1845t537r2097b592],
8	,	,	O	,	_	0	SENT_64	[p4l1845t537r2097b592],
9	a	DT	O	a	det	10	SENT_64	[p4l2118t545r2145b576],
10	patient	NN	O	patient	nsubjpass	16	SENT_64	[p4l646t608r831b668],
11	with	IN	O	with	_	0	SENT_64	[p4l847t605r965b654],
12	the	DT	O	the	det	14	SENT_64	[p4l982t605r1065b654],
13	Gly/Gly	NNP	O	Gly/Gly	nn	14	SENT_64	[p4l1087t605r1296b669],
14	genotype	NN	O	genotype	prep_with	10	SENT_64	[p4l1314t615r1552b669],
15	was	VBD	O	be	auxpass	16	SENT_64	[p4l1570t622r1668b654],
16	matched	VBN	O	match	_	0	SENT_64	[p4l1689t605r1919b654],
17	by	IN	O	by	_	0	SENT_64	[p4l1936t605r1998b669],
18	FEV	NN	O	fev	agent	16	SENT_64	[p4l2018t608r2143b666],
19	,	,	O	,	_	0	SENT_64	[p4l2018t608r2143b666],
20	(	NN	O	(	appos	18	SENT_64	[p4l650t683r837b747],
21	within	IN	O	within	_	0	SENT_64	[p4l650t683r837b747],
22	10	CD	PERCENT	10	num	23	SENT_64	[p4l861t686r972b734],
23	%	NN	PERCENT	%	prep_within	16	SENT_64	[p4l861t686r972b734],
24	of	IN	O	of	_	0	SENT_64	[p4l993t683r1052b732],
25	predicted	VBN	O	predict	amod	26	SENT_64	[p4l1062t683r1325b747],
26	)	NN	O	)	prep_of	23	SENT_64	[p4l1062t683r1325b747],
27	and	CC	O	and	_	0	SENT_64	[p4l1350t683r1448b732],
28	study	NN	O	study	nn	29	SENT_64	[p4l1469t683r1611b747],
29	centre	NN	O	centre	prep_of	23	SENT_64	[p4l1630t693r1806b732],
30	.	.	O	.	_	0	SENT_64	[p4l1630t693r1806b732],

1	If	IN	O	if	mark	8	SENT_65	[p4l1832t683r1880b731],
2	a	DT	O	a	det	4	SENT_65	[p4l1892t700r1918b732],
3	suitable	JJ	O	suitable	amod	4	SENT_65	[p4l1940t683r2144b732],
4	match	NN	O	match	nsubjpass	8	SENT_65	[p4l646t762r812b810],
5	could	MD	O	could	aux	8	SENT_65	[p4l834t762r979b810],
6	not	RB	O	not	neg	8	SENT_65	[p4l999t771r1086b810],
7	be	VB	O	be	auxpass	8	SENT_65	[p4l1106t762r1167b810],
8	found	VBN	O	find	advcl	28	SENT_65	[p4l1189t762r1347b810],
9	at	IN	O	at	_	0	SENT_65	[p4l1369t771r1415b810],
10	a	DT	O	a	det	11	SENT_65	[p4l1436t779r1462b810],
11	centre	NN	O	centre	prep_at	8	SENT_65	[p4l1484t771r1647b810],
12	within	IN	O	within	_	0	SENT_65	[p4l1667t762r1840b810],
13	4	CD	DURATION	4	num	14	SENT_65	[p4l1861t766r1891b810],
14	weeks	NNS	NUMBER	week	prep_within	11	SENT_65	[p4l1911t762r2071b810],
15	of	IN	O	of	_	0	SENT_65	[p4l2095t762r2154b810],
16	establishment	NN	O	establishment	prep_of	14	SENT_65	[p4l647t839r1023b888],
17	of	IN	O	of	_	0	SENT_65	[p4l1074t839r1133b888],
18	genotypic	JJ	O	genotypic	amod	19	SENT_65	[p4l1176t842r1431b903],
19	eligibility	NN	O	eligibility	prep_of	16	SENT_65	[p4l1483t839r1742b903],
20	,	,	O	,	_	0	SENT_65	[p4l1483t839r1742b903],
21	the	DT	O	the	det	22	SENT_65	[p4l1795t839r1877b888],
22	pool	NN	O	pool	nsubjpass	28	SENT_65	[p4l1929t839r2043b902],
23	of	IN	O	of	_	0	SENT_65	[p4l2095t839r2154b888],
24	potential	JJ	O	potential	amod	26	SENT_65	[p4l646t917r879b980],
25	matching	NN	O	matching	nn	26	SENT_65	[p4l905t917r1158b981],
26	patients	NNS	O	patient	prep_of	22	SENT_65	[p4l1183t920r1392b980],
27	was	VBD	O	be	auxpass	28	SENT_65	[p4l1418t934r1517b966],
28	extended	VBN	O	extend	_	0	SENT_65	[p4l1545t917r1783b966],
29	to	TO	O	to	_	0	SENT_65	[p4l1807t927r1856b966],
30	the	DT	O	the	det	32	SENT_65	[p4l1881t917r1964b966],
31	entire	JJ	O	entire	amod	32	SENT_65	[p4l1991t920r2144b966],
32	network	NN	O	network	prep_to	28	SENT_65	[p4l646t996r876b1044],
33	.	.	O	.	_	0	SENT_65	[p4l646t996r876b1044],

1	Pairs	NNS	O	pair	dep	10	SENT_66	[p4l83t1399r267b1463],
2	of	IN	O	of	_	0	SENT_66	[p4l301t1395r385b1463],
3	patients	NNS	O	patient	prep_of	1	SENT_66	[p4l402t1399r720b1485],
4	,	,	O	,	_	0	SENT_66	[p4l402t1399r720b1485],
5	matched	VBN	O	match	partmod	3	SENT_66	[p4l754t1395r1081b1463],
6	by	IN	O	by	_	0	SENT_66	[p4l1109t1395r1197b1485],
7	genotype	NN	O	genotype	agent	5	SENT_66	[p4l1227t1408r1585b1486],
8	,	,	O	,	_	0	SENT_66	[p4l1227t1408r1585b1486],
9	were	VBD	O	be	auxpass	10	SENT_66	[p4l1618t1419r1797b1463],
10	enrolled	VBN	O	enrol	_	0	SENT_66	[p4l1829t1395r2139b1463],
11	in	IN	O	in	_	0	SENT_66	[p4l7t1510r83b1573],
12	the	DT	O	the	det	14	SENT_66	[p4l110t1505r227b1574],
13	treatment	NN	O	treatment	nn	14	SENT_66	[p4l256t1519r628b1574],
14	protocol	NN	O	protocol	prep_in	10	SENT_66	[p4l655t1505r963b1595],
15	(	CD	NUMBER	(	num	18	SENT_66	[p4l997t1505r1242b1596],
16	ﬁgure	NN	O	ﬁgure	nn	18	SENT_66	[p4l997t1505r1242b1596],
17	1	CD	NUMBER	1	num	18	SENT_66	[p4l1277t1512r1360b1596],
18	)	NN	O	)	nsubjpass	10	SENT_66	[p4l1277t1512r1360b1596],
19	.	.	O	.	_	0	SENT_66	[p4l1277t1512r1360b1596],

1	There	EX	O	there	expl	2	SENT_67	[p4l1391t1505r1612b1574],
2	was	VBD	O	be	_	0	SENT_67	[p4l1639t1530r1779b1574],
3	a	DT	O	a	det	7	SENT_67	[p4l1812t1530r1849b1574],
4	6-week	JJ	DURATION	6-week	amod	7	SENT_67	[p4l1880t1505r2140b1574],
5	single-blind	JJ	O	single-blind	amod	7	SENT_67	[p4l10t1616r457b1707],
6	run-in	NN	O	run-in	nn	7	SENT_67	[p4l511t1621r750b1685],
7	period	NN	O	period	nsubj	2	SENT_67	[p4l805t1616r1048b1706],
8	during	IN	O	during	_	0	SENT_67	[p4l1103t1616r1357b1707],
9	which	WDT	O	which	rel	13	SENT_67	[p4l1411t1616r1641b1685],
10	all	DT	O	all	det	11	SENT_67	[p4l1697t1616r1783b1685],
11	patients	NNS	O	patient	nsubjpass	20	SENT_67	[p4l1838t1621r2135b1706],
12	were	VBD	O	be	auxpass	13	SENT_67	[p4l6t1752r185b1796],
13	given	VBN	O	give	rcmod	7	SENT_67	[p4l227t1732r429b1819],
14	a	DT	O	a	det	16	SENT_67	[p4l470t1752r508b1796],
15	metered-dose	JJ	O	metered-dose	amod	16	SENT_67	[p4l548t1728r1057b1796],
16	inhaler	NN	O	inhaler	dobj	13	SENT_67	[p4l1099t1728r1368b1796],
17	containing	VBG	O	contain	xcomp	13	SENT_67	[p4l1408t1732r1812b1819],
18	placebo	NN	O	placebo	dobj	17	SENT_67	[p4l1852t1728r2136b1818],
19	and	CC	O	and	_	0	SENT_67	[p4l9t1838r148b1907],
20	asked	VBD	O	ask	rcmod	7	SENT_67	[p4l174t1838r387b1907],
21	to	TO	O	to	aux	22	SENT_67	[p4l410t1852r480b1907],
22	take	VB	O	take	xcomp	20	SENT_67	[p4l506t1838r660b1907],
23	two	CD	NUMBER	two	num	24	SENT_67	[p4l685t1852r819b1907],
24	puffs	NNS	O	puff	dobj	22	SENT_67	[p4l846t1838r1038b1928],
25	four	CD	NUMBER	four	number	26	SENT_67	[p4l1066t1838r1226b1907],
26	times	NNS	O	time	num	24	SENT_67	[p4l1249t1843r1457b1907],
27	a	DT	DURATION	a	det	28	SENT_67	[p4l1487t1863r1524b1907],
28	day	NN	DURATION	day	tmod	22	SENT_67	[p4l1551t1838r1695b1929],
29	;	:	O	;	_	0	SENT_67	[p4l1551t1838r1695b1929],
30	all	DT	O	all	det	31	SENT_67	[p4l1726t1838r1812b1907],
31	patients	NNS	O	patient	nsubjpass	33	SENT_67	[p4l1838t1843r2135b1928],
32	were	VBD	O	be	auxpass	33	SENT_67	[p4l6t1974r185b2018],
33	given	VBN	O	give	parataxis	2	SENT_67	[p4l282t1954r484b2040],
34	open-label	JJ	O	open-label	amod	36	SENT_67	[p4l579t1949r968b2039],
35	ipratropium	NN	O	ipratropium	nn	36	SENT_67	[p4l1063t1954r1522b2039],
36	bromide	NN	O	bromide	dobj	33	SENT_67	[p4l1615t1949r1936b2018],
37	for	IN	O	for	_	0	SENT_67	[p4l2032t1949r2140b2018],
38	inhalation	NN	O	inhalation	prep_for	33	SENT_67	[p4l7t2061r393b2129],
39	to	TO	O	to	aux	41	SENT_67	[p4l446t2074r515b2129],
40	be	VB	O	be	auxpass	41	SENT_67	[p4l570t2061r656b2129],
41	used	VBN	O	use	xcomp	33	SENT_67	[p4l711t2061r890b2129],
42	as	IN	O	as	_	0	SENT_67	[p4l945t2085r1017b2129],
43	“	NN	O	“	nn	46	SENT_67	[p4l1078t2067r1354b2129],
44	rescue	NN	O	rescue	nn	46	SENT_67	[p4l1078t2067r1354b2129],
45	medication	NN	O	medication	nn	46	SENT_67	[p4l1410t2061r1889b2129],
46	”	NN	O	”	prep_as	41	SENT_67	[p4l1410t2061r1889b2129],
47	.	.	O	.	_	0	SENT_67	[p4l1410t2061r1889b2129],

1	After	IN	O	after	mark	12	SENT_68	[p4l1946t2061r2139b2129],
2	baseline	NN	O	baseline	nsubjpass	12	SENT_68	[p4l6t2171r317b2240],
3	clinical	JJ	O	clinical	amod	2	SENT_68	[p4l351t2171r637b2251],
4	,	,	O	,	_	0	SENT_68	[p4l351t2171r637b2251],
5	physiological	JJ	O	physiological	amod	9	SENT_68	[p4l673t2171r1185b2262],
6	,	,	O	,	_	0	SENT_68	[p4l673t2171r1185b2262],
7	and	CC	O	and	_	0	SENT_68	[p4l1222t2171r1361b2240],
8	genotypic	JJ	O	genotypic	amod	9	SENT_68	[p4l1393t2176r1756b2262],
9	eligibility	NN	O	eligibility	appos	2	SENT_68	[p4l1789t2171r2140b2262],
10	had	VBD	O	have	aux	12	SENT_68	[p4l6t2282r146b2351],
11	been	VBN	O	be	auxpass	12	SENT_68	[p4l228t2282r411b2351],
12	established	VBN	O	establish	advcl	19	SENT_68	[p4l496t2282r936b2360],
13	,	,	O	,	_	0	SENT_68	[p4l496t2282r936b2360],
14	the	DT	O	the	det	15	SENT_68	[p4l1023t2282r1141b2351],
15	pair	NN	O	pair	nsubjpass	19	SENT_68	[p4l1226t2287r1375b2371],
16	of	IN	O	of	_	0	SENT_68	[p4l1458t2282r1542b2351],
17	patients	NNS	O	patient	prep_of	15	SENT_68	[p4l1613t2287r1910b2371],
18	was	VBD	O	be	auxpass	19	SENT_68	[p4l1996t2306r2135b2351],
19	randomised	VBN	O	randomise	_	0	SENT_68	[p4l7t2393r462b2461],
20	to	TO	O	to	_	0	SENT_68	[p4l490t2406r560b2461],
21	the	DT	O	the	det	25	SENT_68	[p4l592t2393r709b2461],
22	same	JJ	O	same	amod	25	SENT_68	[p4l744t2417r939b2461],
23	cross-over	JJ	O	cross-over	amod	25	SENT_68	[p4l971t2417r1351b2461],
24	sequence	NN	O	sequence	nn	25	SENT_68	[p4l1383t2397r2036b2482],
25	—	NN	O	—	prep_to	19	SENT_68	[p4l1383t2397r2036b2482],
26	active	JJ	O	active	amod	25	SENT_68	[p4l1383t2397r2036b2482],
27	to	TO	O	to	_	0	SENT_68	[p4l2067t2406r2137b2461],
28	placebo	NN	O	placebo	prep_to	26	SENT_68	[p4l7t2502r312b2591],
29	,	,	O	,	_	0	SENT_68	[p4l7t2502r312b2591],
30	or	CC	O	or	_	0	SENT_68	[p4l393t2527r470b2571],
31	placebo	NN	O	placebo	conj_or	28	SENT_68	[p4l544t2502r829b2591],
32	to	TO	O	to	_	0	SENT_68	[p4l905t2516r974b2571],
33	active	JJ	O	active	prep_to	26	SENT_68	[p4l1053t2507r1282b2571],
34	.	.	O	.	_	0	SENT_68	[p4l1053t2507r1282b2571],

1	In	IN	O	in	_	0	SENT_69	[p4l1366t2509r1445b2570],
2	each	DT	O	each	det	4	SENT_69	[p4l1522t2502r1692b2571],
3	treatment	NN	O	treatment	nn	4	SENT_69	[p4l1767t2516r2140b2571],
4	sequence	NN	O	sequence	prep_in	7	SENT_69	[p4l10t2636r377b2701],
5	,	,	O	,	_	0	SENT_69	[p4l10t2636r377b2701],
6	there	EX	O	there	expl	7	SENT_69	[p4l418t2612r612b2681],
7	was	VBD	O	be	_	0	SENT_69	[p4l649t2636r789b2681],
8	a	DT	O	a	det	12	SENT_69	[p4l831t2637r868b2681],
9	16-week	JJ	DURATION	16-week	amod	12	SENT_69	[p4l912t2612r1214b2681],
10	double-blind	JJ	O	double-blind	amod	12	SENT_69	[p4l1251t2612r1730b2681],
11	treatment	NN	O	treatment	nn	12	SENT_69	[p4l1767t2626r2140b2681],
12	phase	NN	O	phase	nsubj	7	SENT_69	[p4l7t2723r225b2812],
13	in	IN	O	in	_	0	SENT_69	[p4l270t2727r345b2790],
14	which	WDT	O	which	rel	16	SENT_69	[p4l387t2723r617b2791],
15	patients	NNS	O	patient	nsubj	16	SENT_69	[p4l660t2727r957b2812],
16	received	VBD	O	receive	rcmod	12	SENT_69	[p4l1004t2723r1314b2791],
17	inhaled	VBN	O	inhale	dep	16	SENT_69	[p4l1357t2723r1640b2791],
18	albuterol	NN	O	albuterol	dobj	17	SENT_69	[p4l1683t2723r2018b2791],
19	or	CC	O	or	_	0	SENT_69	[p4l2062t2747r2139b2791],
20	placebo	NN	O	placebo	conj_or	18	SENT_69	[p4l7t2832r312b2922],
21	,	,	O	,	_	0	SENT_69	[p4l7t2832r312b2922],
22	two	CD	NUMBER	two	num	23	SENT_69	[p4l343t2846r476b2901],
23	puffs	NNS	O	puff	appos	18	SENT_69	[p4l506t2832r720b2922],
24	,	,	O	,	_	0	SENT_69	[p4l506t2832r720b2922],
25	90	CD	NUMBER	90	num	26	SENT_69	[p4l754t2838r839b2901],
26	pug	NN	O	pug	appos	18	SENT_69	[p4l874t2857r972b2923],
27	per	IN	O	per	_	0	SENT_69	[p4l1000t2857r1124b2922],
28	puff	NN	O	puff	prep_per	26	SENT_69	[p4l1150t2832r1326b2922],
29	,	,	O	,	_	0	SENT_69	[p4l1150t2832r1326b2922],
30	four	CD	NUMBER	four	num	31	SENT_69	[p4l1383t2832r1543b2901],
31	times	NNS	O	time	appos	18	SENT_69	[p4l1569t2837r1776b2901],
32	a	DT	DURATION	a	det	33	SENT_69	[p4l1809t2857r1846b2901],
33	day	NN	DURATION	day	dep	31	SENT_69	[p4l1876t2832r2020b2923],
34	.	.	O	.	_	0	SENT_69	[p4l1876t2832r2020b2923],

1	At	IN	O	at	_	0	SENT_70	[p4l2051t2838r2140b2901],
2	the	DT	O	the	det	3	SENT_70	[p4l6t2943r124b3012],
3	end	NN	O	end	prep_at	13	SENT_70	[p4l168t2943r307b3012],
4	of	IN	O	of	_	0	SENT_70	[p4l349t2943r433b3012],
5	the	DT	O	the	det	9	SENT_70	[p4l461t2943r579b3012],
6	ﬁrst	JJ	O	ﬁrst	amod	9	SENT_70	[p4l621t2943r772b3012],
7	double-blind	JJ	O	double-blind	amod	9	SENT_70	[p4l813t2943r1293b3012],
8	treatment	NN	O	treatment	nn	9	SENT_70	[p4l1332t2957r1705b3012],
9	period	NN	O	period	prep_of	3	SENT_70	[p4l1745t2943r2006b3032],
10	,	,	O	,	_	0	SENT_70	[p4l1745t2943r2006b3032],
11	all	DT	O	all	det	12	SENT_70	[p4l2052t2943r2138b3012],
12	participants	NNS	O	participant	nsubj	13	SENT_70	[p4l7t3058r451b3144],
13	resumed	VBD	O	resume	_	0	SENT_70	[p4l478t3054r812b3122],
14	single-blind	JJ	O	single-blind	amod	16	SENT_70	[p4l838t3054r1285b3145],
15	regular	JJ	O	regular	amod	16	SENT_70	[p4l1308t3054r1580b3145],
16	use	NN	O	use	dobj	13	SENT_70	[p4l1602t3078r1730b3122],
17	of	IN	O	of	_	0	SENT_70	[p4l1757t3054r1841b3122],
18	placebo	NN	O	placebo	nn	19	SENT_70	[p4l1852t3054r2136b3144],
19	inhaler	NN	O	inhaler	prep_of	16	SENT_70	[p4l7t3164r295b3244],
20	,	,	O	,	_	0	SENT_70	[p4l7t3164r295b3244],
21	two	CD	NUMBER	two	num	22	SENT_70	[p4l331t3178r464b3233],
22	puffs	NNS	O	puff	appos	19	SENT_70	[p4l499t3164r691b3254],
23	four	CD	NUMBER	four	num	24	SENT_70	[p4l728t3164r887b3233],
24	times	NNS	O	time	tmod	22	SENT_70	[p4l918t3169r1126b3233],
25	a	DT	DURATION	a	det	26	SENT_70	[p4l1164t3189r1201b3233],
26	day	NN	DURATION	day	tmod	13	SENT_70	[p4l1236t3164r1381b3255],
27	,	,	O	,	_	0	SENT_70	[p4l1236t3164r1381b3255],
28	for	IN	O	for	_	0	SENT_70	[p4l1418t3164r1526b3233],
29	an	DT	O	a	det	32	SENT_70	[p4l1559t3189r1649b3233],
30	8-week	JJ	DURATION	8-week	amod	32	SENT_70	[p4l1684t3164r1945b3233],
31	runout	NN	O	runout	nn	32	SENT_70	[p4l1978t3189r2136b3233, p4l8t3289r131b3344],
32	period	NN	O	period	prep_for	13	SENT_70	[p4l188t3275r447b3364],
33	.	.	O	.	_	0	SENT_70	[p4l188t3275r447b3364],

1	At	IN	O	at	_	0	SENT_71	[p4l510t3280r597b3343],
2	the	DT	DATE	the	det	3	SENT_71	[p4l654t3275r771b3344],
3	end	NN	DATE	end	prep_at	13	SENT_71	[p4l832t3275r972b3344],
4	of	IN	DATE	of	_	0	SENT_71	[p4l1031t3275r1114b3344],
5	the	DT	DATE	the	det	9	SENT_71	[p4l1160t3275r1277b3344],
6	second	JJ	DATE	second	amod	9	SENT_71	[p4l1340t3275r1601b3344],
7	double-blind	JJ	O	double-blind	amod	9	SENT_71	[p4l1660t3275r2139b3344],
8	treatment	NN	O	treatment	nn	9	SENT_71	[p4l6t3399r379b3454],
9	period	NN	O	period	prep_of	3	SENT_71	[p4l414t3386r674b3476],
10	,	,	O	,	_	0	SENT_71	[p4l414t3386r674b3476],
11	all	DT	O	all	det	12	SENT_71	[p4l715t3386r801b3454],
12	participants	NNS	O	participant	nsubj	13	SENT_71	[p4l837t3390r1281b3476],
13	resumed	VBD	O	resume	_	0	SENT_71	[p4l1320t3386r1654b3454],
14	single-blind	JJ	O	single-blind	amod	16	SENT_71	[p4l1692t3386r2139b3477],
15	regular	JJ	O	regular	amod	16	SENT_71	[p4l7t3496r279b3587],
16	use	NN	O	use	dobj	13	SENT_71	[p4l308t3521r436b3565],
17	of	IN	O	of	_	0	SENT_71	[p4l470t3496r554b3565],
18	a	DT	O	a	det	20	SENT_71	[p4l573t3521r610b3565],
19	placebo	NN	O	placebo	nn	20	SENT_71	[p4l641t3496r926b3586],
20	inhaler	NN	O	inhaler	prep_of	16	SENT_71	[p4l958t3496r1245b3575],
21	,	,	O	,	_	0	SENT_71	[p4l958t3496r1245b3575],
22	two	CD	NUMBER	two	num	23	SENT_71	[p4l1279t3510r1412b3565],
23	puffs	NNS	O	puff	appos	20	SENT_71	[p4l1445t3496r1636b3586],
24	four	CD	NUMBER	four	num	25	SENT_71	[p4l1670t3496r1829b3565],
25	times	NNS	O	time	tmod	23	SENT_71	[p4l1858t3501r2066b3565],
26	a	DT	DURATION	a	det	27	SENT_71	[p4l2101t3521r2138b3565],
27	day	NN	DURATION	day	tmod	13	SENT_71	[p4l8t3607r153b3698],
28	,	,	O	,	_	0	SENT_71	[p4l8t3607r153b3698],
29	for	IN	O	for	_	0	SENT_71	[p4l182t3607r290b3676],
30	an	DT	O	a	det	33	SENT_71	[p4l315t3632r405b3676],
31	8-week	JJ	DURATION	8-week	amod	33	SENT_71	[p4l432t3607r694b3676],
32	run-out	NN	O	run-out	nn	33	SENT_71	[p4l717t3621r1004b3676],
33	period	NN	O	period	prep_for	13	SENT_71	[p4l1028t3607r1288b3697],
34	.	.	O	.	_	0	SENT_71	[p4l1028t3607r1288b3697],

1	The	DT	O	the	det	2	SENT_72	[p4l77t3719r222b3787],
2	Asthma	NNP	ORGANIZATION	Asthma	nsubj	9	SENT_72	[p4l324t3719r621b3787],
3	Clinical	JJ	ORGANIZATION	clinical	amod	6	SENT_72	[p4l725t3719r1012b3787],
4	Research	NNP	ORGANIZATION	Research	nn	6	SENT_72	[p4l1117t3719r1457b3787],
5	Network	NNP	ORGANIZATION	Network	nn	6	SENT_72	[p4l1562t3719r1884b3787],
6	data	NNS	O	datum	dep	2	SENT_72	[p4l1984t3719r2138b3787],
7	coordinating	VBG	O	coordinate	partmod	2	SENT_72	[p5l8t28r488b119],
8	centre	NN	O	centre	dobj	7	SENT_72	[p5l531t42r762b97],
9	used	VBD	O	use	_	0	SENT_72	[p5l803t28r982b97],
10	a	DT	O	a	det	12	SENT_72	[p5l1024t53r1061b97],
11	random-number	NN	O	random-number	nn	12	SENT_72	[p5l1103t28r1736b97],
12	generator	NN	O	generator	dobj	9	SENT_72	[p5l1778t42r2140b119],
13	in	IN	O	in	_	0	SENT_72	[p5l7t144r83b207],
14	SAS	NNP	O	SAS	prep_in	9	SENT_72	[p5l142t144r291b208],
15	8.2	CD	NUMBER	8.2	num	14	SENT_72	[p5l351t145r457b208],
16	to	TO	O	to	aux	17	SENT_72	[p5l512t153r582b208],
17	generate	VB	O	generate	xcomp	9	SENT_72	[p5l639t153r959b230],
18	the	DT	O	the	det	20	SENT_72	[p5l1013t139r1131b208],
19	randomisation	NN	O	randomisation	nn	20	SENT_72	[p5l1185t139r1740b208],
20	codes	NNS	O	code	dobj	17	SENT_72	[p5l1795t139r2022b208],
21	.	.	O	.	_	0	SENT_72	[p5l1795t139r2022b208],

1	A	DT	O	a	det	4	SENT_73	[p5l2079t144r2139b207],
2	separate	JJ	O	separate	amod	4	SENT_73	[p5l10t264r318b340],
3	randomisation	NN	O	randomisation	nn	4	SENT_73	[p5l359t251r915b319],
4	plan	NN	O	plan	nsubjpass	12	SENT_73	[p5l954t251r1119b340],
5	was	VBD	O	be	auxpass	6	SENT_73	[p5l1157t275r1297b319],
6	constructed	VBN	O	construct	_	0	SENT_73	[p5l1341t251r1782b319],
7	for	IN	O	for	_	0	SENT_73	[p5l1821t251r1928b319],
8	each	DT	O	each	det	10	SENT_73	[p5l1968t251r2138b319],
9	clinical	JJ	O	clinical	amod	10	SENT_73	[p5l8t360r276b429],
10	centre	NN	O	centre	prep_for	6	SENT_73	[p5l351t374r583b429],
11	and	CC	O	and	_	0	SENT_73	[p5l659t360r798b429],
12	implemented	VBD	O	implement	conj_and	6	SENT_73	[p5l871t360r1381b449],
13	via	IN	O	via	_	0	SENT_73	[p5l1452t365r1559b429],
14	a	DT	O	a	det	17	SENT_73	[p5l1634t385r1671b429],
15	web-based	JJ	O	web-based	amod	17	SENT_73	[p5l1743t360r2139b429],
16	randomisation	NN	O	randomisation	nn	17	SENT_73	[p5l8t470r563b539],
17	process	NN	O	process	prep_via	12	SENT_73	[p5l598t494r877b560],
18	that	WDT	O	that	nsubj	19	SENT_73	[p5l914t470r1061b539],
19	provided	VBD	O	provide	rcmod	17	SENT_73	[p5l1093t470r1424b560],
20	the	DT	O	the	det	21	SENT_73	[p5l1457t470r1574b539],
21	codes	NNS	O	code	dobj	19	SENT_73	[p5l1611t470r1817b539],
22	of	IN	O	of	_	0	SENT_73	[p5l1856t470r1939b539],
23	drug	NN	O	drug	nn	24	SENT_73	[p5l1962t470r2138b561],
24	packets	NNS	O	packet	prep_of	21	SENT_73	[p5l7t582r284b672],
25	containing	VBG	O	contain	partmod	24	SENT_73	[p5l336t586r740b673],
26	masked	VBN	O	mask	dep	25	SENT_73	[p5l788t582r1081b650],
27	drugs	NNS	O	drug	dobj	26	SENT_73	[p5l1128t582r1340b673],
28	to	TO	O	to	aux	30	SENT_73	[p5l1389t595r1459b650],
29	be	VB	O	be	auxpass	30	SENT_73	[p5l1507t582r1594b650],
30	used	VBN	O	use	xcomp	26	SENT_73	[p5l1641t582r1820b650],
31	for	IN	O	for	_	0	SENT_73	[p5l1867t582r1974b650],
32	the	DT	O	the	det	34	SENT_73	[p5l2020t582r2137b650],
33	speciﬁc	JJ	O	speciﬁc	amod	34	SENT_73	[p5l10t692r290b782],
34	patient	NN	O	patient	prep_for	30	SENT_73	[p5l344t697r625b782],
35	.	.	O	.	_	0	SENT_73	[p5l344t697r625b782],

1	To	TO	O	to	aux	2	SENT_74	[p5l683t697r780b761],
2	assess	VB	O	assess	purpcl	19	SENT_74	[p5l838t717r1067b761],
3	the	DT	O	the	det	4	SENT_74	[p5l1124t692r1241b761],
4	success	NN	O	success	dobj	2	SENT_74	[p5l1300t717r1578b761],
5	of	IN	O	of	_	0	SENT_74	[p5l1637t692r1721b761],
6	the	DT	O	the	det	8	SENT_74	[p5l1762t692r1880b761],
7	drugmasking	NN	O	drugmasking	nn	8	SENT_74	[p5l1937t692r2136b783, p5l7t803r334b894],
8	process	NN	O	process	prep_of	4	SENT_74	[p5l385t827r687b893],
9	,	,	O	,	_	0	SENT_74	[p5l385t827r687b893],
10	when	WRB	O	when	advmod	13	SENT_74	[p5l740t803r949b872],
11	an	DT	O	a	det	12	SENT_74	[p5l1001t828r1091b872],
12	individual	JJ	O	individual	nsubj	13	SENT_74	[p5l1143t803r1522b872],
13	left	VBD	O	leave	dep	8	SENT_74	[p5l1573t803r1695b872],
14	the	DT	O	the	det	15	SENT_74	[p5l1743t803r1861b872],
15	study	NN	O	study	dobj	13	SENT_74	[p5l1916t803r2134b894],
16	,	,	O	,	_	0	SENT_74	[p5l1916t803r2134b894],
17	clinic	NN	O	clinic	nn	18	SENT_74	[p5l8t915r211b983],
18	coordinators	NNS	O	coordinator	nsubj	19	SENT_74	[p5l264t915r735b983],
19	had	VBD	O	have	_	0	SENT_74	[p5l789t915r929b983],
20	to	TO	O	to	aux	21	SENT_74	[p5l980t928r1050b983],
21	complete	VB	O	complete	xcomp	19	SENT_74	[p5l1105t915r1448b1004],
22	a	DT	O	a	det	24	SENT_74	[p5l1503t939r1540b983],
23	data-collection	JJ	O	data-collection	amod	24	SENT_74	[p5l1594t915r2138b983],
24	form	NN	O	form	dobj	21	SENT_74	[p5l7t1024r194b1093],
25	saying	VBG	O	say	xcomp	19	SENT_74	[p5l227t1029r465b1115],
26	which	WDT	O	which	det	28	SENT_74	[p5l494t1024r724b1093],
27	treatment	NN	O	treatment	nn	28	SENT_74	[p5l754t1038r1126b1093],
28	regimen	NN	O	regimen	dep	30	SENT_74	[p5l1155t1029r1474b1115],
29	they	PRP	O	they	nsubj	30	SENT_74	[p5l1503t1024r1664b1115],
30	thought	VBD	O	think	ccomp	25	SENT_74	[p5l1691t1024r1991b1115],
31	the	DT	O	the	det	32	SENT_74	[p5l2019t1024r2136b1093],
32	patient	NN	O	patient	nsubj	34	SENT_74	[p5l7t1140r271b1224],
33	had	VBD	O	have	aux	34	SENT_74	[p5l304t1135r445b1204],
34	had	VBN	O	have	ccomp	30	SENT_74	[p5l479t1135r619b1204],
35	on	IN	O	on	_	0	SENT_74	[p5l656t1160r750b1204],
36	the	DT	O	the	det	37	SENT_74	[p5l785t1135r903b1204],
37	basis	NN	O	basis	prep_on	34	SENT_74	[p5l939t1135r1126b1204],
38	of	IN	O	of	_	0	SENT_74	[p5l1166t1135r1250b1204],
39	their	PRP$	O	they	poss	40	SENT_74	[p5l1272t1135r1452b1204],
40	observations	NNS	O	observation	prep_of	37	SENT_74	[p5l1488t1135r1960b1204],
41	and	CC	O	and	_	0	SENT_74	[p5l2000t1135r2139b1204],
42	those	DT	O	those	conj_and	37	SENT_74	[p5l6t1246r208b1314],
43	of	IN	O	of	_	0	SENT_74	[p5l245t1246r329b1314],
44	the	DT	O	the	det	45	SENT_74	[p5l350t1246r468b1314],
45	patient	NN	O	patient	prep_of	42	SENT_74	[p5l504t1250r784b1336],
46	.	.	O	.	_	0	SENT_74	[p5l504t1250r784b1336],

1	The	DT	O	the	det	2	SENT_75	[p5l823t1246r968b1314],
2	proportion	NN	O	proportion	nsubj	8	SENT_75	[p5l1004t1250r1409b1336],
3	of	IN	O	of	_	0	SENT_75	[p5l1446t1246r1530b1314],
4	correct	JJ	O	correct	amod	5	SENT_75	[p5l1553t1259r1811b1314],
5	guesses	NNS	O	guess	prep_of	2	SENT_75	[p5l1846t1270r2135b1337],
6	was	VBD	O	be	cop	8	SENT_75	[p5l6t1381r145b1425],
7	50-0	CD	PERCENT	50-0	num	8	SENT_75	[p5l183t1361r432b1427],
8	%	NN	PERCENT	%	_	0	SENT_75	[p5l183t1361r432b1427],
9	for	IN	O	for	_	0	SENT_75	[p5l466t1356r574b1425],
10	placebo	NN	O	placebo	prep_for	8	SENT_75	[p5l605t1356r889b1445],
11	and	CC	O	and	_	0	SENT_75	[p5l924t1356r1063b1425],
12	58-3	CD	PERCENT	58-3	num	13	SENT_75	[p5l1098t1361r1347b1427],
13	%	NN	PERCENT	%	conj_and	8	SENT_75	[p5l1098t1361r1347b1427],
14	for	IN	O	for	_	0	SENT_75	[p5l1381t1356r1488b1425],
15	albuterol	NN	O	albuterol	prep_for	13	SENT_75	[p5l1520t1356r1873b1435],
16	,	,	O	,	_	0	SENT_75	[p5l1520t1356r1873b1435],
17	which	WDT	O	which	nsubj	18	SENT_75	[p5l1908t1356r2138b1425],
18	suggests	VBZ	O	suggest	rcmod	15	SENT_75	[p5l10t1480r329b1557],
19	that	IN	O	that	complm	25	SENT_75	[p5l414t1466r561b1535],
20	adequate	JJ	O	adequate	amod	22	SENT_75	[p5l644t1466r980b1556],
21	drug	NN	O	drug	nn	22	SENT_75	[p5l1065t1466r1241b1557],
22	masking	NN	O	masking	nsubjpass	25	SENT_75	[p5l1325t1466r1652b1557],
23	had	VBD	O	have	aux	25	SENT_75	[p5l1734t1466r1874b1535],
24	been	VBN	O	be	auxpass	25	SENT_75	[p5l1956t1466r2138b1535],
25	maintained	VBN	O	maintain	ccomp	18	SENT_75	[p5l8t1578r459b1646],
26	.	.	O	.	_	0	SENT_75	[p5l8t1578r459b1646],

1	Articles	NNPS	O	Articles	_	0	SENT_76	[p5l6t2127r154b2163],
2	I	PRP	O	I	dep	1	SENT_76	[p5l202t1964r250b2162],

1	wvvw	NN	O	wvvw	_	0	SENT_77	[p5l813t1828r1350b1879],
2	.	.	O	.	_	0	SENT_77	[p5l813t1828r1350b1879],

1	the	DT	O	the	det	2	SENT_78	[p5l813t1828r1350b1879],
2	|	NN	O	|	_	0	SENT_78	[p5l813t1828r1350b1879],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_78	[p5l813t1828r1350b1879],
4	Vol	NNP	O	Vol	dep	2	SENT_78	[p5l1393t1828r1482b1879],
5	364	CD	NUMBER	364	num	4	SENT_78	[p5l1503t1827r1613b1887],
6	October	NNP	DATE	October	tmod	4	SENT_78	[p5l1658t1828r1883b1879],
7	23	CD	DATE	23	num	6	SENT_78	[p5l1901t1835r1986b1889],
8	,	,	DATE	,	_	0	SENT_78	[p5l1901t1835r1986b1889],
9	2004	CD	DATE	2004	num	6	SENT_78	[p5l2008t1835r2153b1886],

1	338	CD	NUMBER	338	num	2	SENT_79	[p6l874t112r913b134],
2	patients	NNS	O	patient	nsubj	3	SENT_79	[p6l920t113r1001b137],
3	screened	VBN	O	screen	_	0	SENT_79	[p6l1007t112r1094b131],

1	158	CD	NUMBER	158	num	3	SENT_80	[p6l875t266r913b289],
2	ineligible	JJ	O	ineligible	amod	3	SENT_80	[p6l920t266r1009b292],
3	genotype	NN	O	genotype	_	0	SENT_80	[p6l1015t270r1110b292],
4	125	CD	NUMBER	125	num	6	SENT_80	[p6l1391t269r1428b289],
5	Gly/Gly	NNP	O	Gly/Gly	nn	6	SENT_80	[p6l1436t266r1507b292],
6	genotype	NN	O	genotype	dep	3	SENT_80	[p6l1513t270r1608b292],

1	55	CD	NUMBER	55	num	2	SENT_81	[p6l347t269r371b289],
2	Arg/Arg	NN	O	arg/arg	_	0	SENT_81	[p6l378t267r457b292],
3	genotype	NN	O	genotype	dep	2	SENT_81	[p6l464t270r559b292],

1	73	CD	NUMBER	73	nsubj	5	SENT_82	[p6l1220t345r1244b365],
2	withdrawn	VBN	O	withdraw	partmod	1	SENT_82	[p6l1251t343r1358b362],
3	41	CD	NUMBER	41	num	4	SENT_82	[p6l1254t377r1279b397],
4	study	NN	O	study	dobj	2	SENT_82	[p6l1286t375r1342b400],
5	ended	VBD	O	end	_	0	SENT_82	[p6l1348t375r1414b398],
6	;	:	O	;	_	0	SENT_82	[p6l1348t375r1414b398],
7	no	DT	O	no	det	8	SENT_82	[p6l1270t413r1295b426],
8	match	NN	O	match	nsubj	10	SENT_82	[p6l1302t407r1363b426],
9	21	CD	NUMBER	21	dep	8	SENT_82	[p6l1255t442r1279b458],
10	withdrew	VBD	O	withdraw	parataxis	5	SENT_82	[p6l1286t439r1382b458],
11	consent	NN	O	consent	nsubj	13	SENT_82	[p6l1387t442r1466b458],
12	6	CD	NUMBER	6	num	11	SENT_82	[p6l1270t471r1281b490],
13	lost	VBD	O	lose	ccomp	10	SENT_82	[p6l1289t471r1324b490],
14	to	TO	O	to	_	0	SENT_82	[p6l1329t475r1351b490],
15	follow-up	JJ	O	follow-up	prep_to	13	SENT_82	[p6l1356t471r1455b496],
16	3	CD	NUMBER	3	tmod	15	SENT_82	[p6l1270t506r1281b525],
17	ineligible	JJ	O	ineligible	amod	15	SENT_82	[p6l1289t503r1377b529],
18	2	CD	NUMBER	2	number	19	SENT_82	[p6l1270t538r1281b554],
19	pregnant	JJ	O	pregnant	amod	15	SENT_82	[p6l1288t539r1379b561],

1	16	CD	NUMBER	16	_	0	SENT_83	[p6l62t2047r86b2067],
2	completed	VBN	O	complete	dep	1	SENT_83	[p6l93t2047r199b2073],

1	Figure	NN	O	figure	_	0	SENT_84	[p6l7t2171r72b2198],
2	2	CD	NUMBER	2	num	1	SENT_84	[p6l78t2173r98b2191],
3	:	:	O	:	_	0	SENT_84	[p6l78t2173r98b2191],
4	Trial	NN	O	trial	nn	5	SENT_84	[p6l103t2170r152b2191],
5	proﬁle	NN	O	proﬁle	dep	1	SENT_84	[p6l159t2170r232b2198],

1	The	DT	O	the	det	3	SENT_85	[p6l78t2336r224b2405],
2	primary	JJ	O	primary	amod	3	SENT_85	[p6l347t2341r651b2427],
3	outcome	NN	O	outcome	nsubj	6	SENT_85	[p6l773t2350r1099b2405],
4	was	VBD	O	be	cop	6	SENT_85	[p6l1221t2360r1361b2405],
5	asthma	NN	O	asthma	nn	6	SENT_85	[p6l1487t2336r1763b2405],
6	control	NN	O	control	_	0	SENT_85	[p6l1886t2336r2152b2405],
7	characterised	VBN	O	characterise	partmod	6	SENT_85	[p6l9t2448r511b2516],
8	by	IN	O	by	_	0	SENT_85	[p6l580t2448r669b2538],
9	peak	JJ	O	peak	amod	15	SENT_85	[p6l738t2448r916b2538],
10	expiratory	JJ	O	expiratory	amod	15	SENT_85	[p6l987t2452r1364b2538],
11	ﬂow	NN	O	ﬂow	nn	15	SENT_85	[p6l1434t2448r1596b2516],
12	rate	NN	O	rate	nn	15	SENT_85	[p6l1666t2461r1807b2516],
13	(	CD	NUMBER	(	num	15	SENT_85	[p6l1886t2452r2146b2539],
14	PEFR	NN	O	pefr	nn	15	SENT_85	[p6l1886t2452r2146b2539],
15	)	NN	O	)	agent	7	SENT_85	[p6l1886t2452r2146b2539],
16	measured	VBN	O	measure	partmod	15	SENT_85	[p6l8t2558r384b2627],
17	in	IN	O	in	_	0	SENT_85	[p6l453t2563r528b2626],
18	the	DT	O	the	det	19	SENT_85	[p6l596t2558r714b2627],
19	morning	NN	TIME	morning	prep_in	16	SENT_85	[p6l784t2563r1118b2649],
20	before	IN	TIME	before	_	0	SENT_85	[p6l1186t2558r1425b2627],
21	the	DT	O	the	det	22	SENT_85	[p6l1493t2558r1611b2627],
22	use	NN	O	use	prep_before	16	SENT_85	[p6l1680t2583r1809b2627],
23	of	IN	O	of	_	0	SENT_85	[p6l1880t2558r1964b2627],
24	any	DT	O	any	det	25	SENT_85	[p6l2021t2583r2153b2649],
25	bronchodilator	NN	O	bronchodilator	prep_of	22	SENT_85	[p6l7t2669r588b2738],
26	.	.	O	.	_	0	SENT_85	[p6l7t2669r588b2738],

1	Prespeciﬁed	JJ	O	prespeciﬁed	amod	3	SENT_86	[p6l639t2669r1100b2759],
2	secondary	JJ	O	secondary	amod	3	SENT_86	[p6l1144t2669r1523b2760],
3	outcomes	NNS	O	outcome	nsubj	6	SENT_86	[p6l1564t2683r1928b2738],
4	were	VBD	O	be	cop	6	SENT_86	[p6l1971t2694r2151b2738],
5	spirometric	JJ	O	spirometric	amod	6	SENT_86	[p6l11t2785r447b2871],
6	values	NNS	O	value	_	0	SENT_86	[p6l504t2781r760b2860],
7	,	,	O	,	_	0	SENT_86	[p6l504t2781r760b2860],
8	evening	NN	TIME	evening	nn	9	SENT_86	[p6l824t2785r1122b2872],
9	PEFR	NN	O	pefr	appos	6	SENT_86	[p6l1185t2785r1415b2860],
10	,	,	O	,	_	0	SENT_86	[p6l1185t2785r1415b2860],
11	morning/evening	VBG	O	morning/evening	partmod	6	SENT_86	[p6l1479t2785r2152b2872],
12	PEFR	NN	O	pefr	nn	13	SENT_86	[p6l12t2896r225b2959],
13	variability	NN	O	variability	nsubj	16	SENT_86	[p6l259t2891r633b2982],
14	(	CD	TIME	(	num	16	SENT_86	[p6l673t2896r994b2982],
15	evening	NN	TIME	evening	nn	16	SENT_86	[p6l673t2896r994b2982],
16	PEFR	NN	TIME	pefr	xcomp	11	SENT_86	[p6l1034t2896r1247b2959],
17	minus	CC	TIME	minus	prep	16	SENT_86	[p6l1283t2896r1526b2960],
18	morning	NN	TIME	morning	nn	19	SENT_86	[p6l1565t2896r1900b2982],
19	PEFR	NN	O	pefr	dep	17	SENT_86	[p6l1941t2896r2153b2959],
20	as	IN	O	as	_	0	SENT_86	[p6l9t3027r82b3072],
21	a	DT	O	a	det	22	SENT_86	[p6l129t3028r167b3072],
22	percentage	NN	O	percentage	prep_as	19	SENT_86	[p6l210t3017r622b3094],
23	of	IN	O	of	_	0	SENT_86	[p6l668t3003r752b3072],
24	evening	NN	TIME	evening	nn	26	SENT_86	[p6l784t3008r1081b3094],
25	PEFR	NN	O	pefr	nn	26	SENT_86	[p6l1129t3008r1387b3094],
26	)	NN	O	)	prep_of	22	SENT_86	[p6l1129t3008r1387b3094],
27	,	,	O	,	_	0	SENT_86	[p6l1129t3008r1387b3094],
28	asthma	NN	O	asthma	nn	29	SENT_86	[p6l1436t3003r1712b3072],
29	symptoms	NNS	O	symptom	appos	16	SENT_86	[p6l1758t3017r2149b3094],
30	(	JJ	O	(	amod	32	SENT_86	[p6l14t3121r249b3206],
31	range	NN	O	range	nn	32	SENT_86	[p6l14t3121r249b3206],
32	o	NN	O	o	dep	29	SENT_86	[p6l275t3121r335b3194],
33	,	,	O	,	_	0	SENT_86	[p6l275t3121r335b3194],
34	absent	JJ	O	absent	amod	29	SENT_86	[p6l364t3115r628b3194],
35	,	,	O	,	_	0	SENT_86	[p6l364t3115r628b3194],
36	to	TO	O	to	_	0	SENT_86	[p6l655t3128r725b3183],
37	3	CD	NUMBER	3	prep_to	29	SENT_86	[p6l753t3121r811b3194],
38	,	,	O	,	_	0	SENT_86	[p6l753t3121r811b3194],
39	severe	JJ	O	severe	amod	40	SENT_86	[p6l842t3121r1121b3206],
40	)	NN	O	)	appos	16	SENT_86	[p6l842t3121r1121b3206],
41	,	,	O	,	_	0	SENT_86	[p6l842t3121r1121b3206],
42	use	NN	O	use	appos	16	SENT_86	[p6l1148t3139r1277b3183],
43	of	IN	O	of	_	0	SENT_86	[p6l1303t3115r1387b3183],
44	rescue	NN	O	rescue	nn	45	SENT_86	[p6l1398t3139r1641b3183],
45	medications	NNS	O	medication	prep_of	42	SENT_86	[p6l1666t3115r2148b3194],
46	,	,	O	,	_	0	SENT_86	[p6l1666t3115r2148b3194],

1	wvv	NN	O	wvv	nn	3	SENT_87	[p6l7t3389r545b3440],
2	\	CD	NUMBER	\	num	3	SENT_87	[p6l7t3389r545b3440],
3	N.	NNP	O	N.	_	0	SENT_87	[p6l7t3389r545b3440],
4	the	DT	O	the	det	5	SENT_87	[p6l7t3389r545b3440],
5	|	NN	O	|	dep	3	SENT_87	[p6l7t3389r545b3440],
6	ancet.com	NNP	O	ancet.com	nn	7	SENT_87	[p6l7t3389r545b3440],
7	Vol	NNP	O	Vol	dep	5	SENT_87	[p6l589t3389r678b3440],
8	364	CD	NUMBER	364	num	7	SENT_87	[p6l700t3388r809b3448],
9	October	NNP	DATE	October	tmod	5	SENT_87	[p6l855t3389r1080b3440],
10	23	CD	DATE	23	num	9	SENT_87	[p6l1098t3396r1184b3450],
11	,	,	DATE	,	_	0	SENT_87	[p6l1098t3396r1184b3450],
12	2004	CD	DATE	2004	num	9	SENT_87	[p6l1205t3396r1352b3447],

1	and	CC	O	and	dep	2	SENT_88	[p7l9t70r107b119],
2	episodes	NNS	O	episode	_	0	SENT_88	[p7l128t70r354b133],
3	of	IN	O	of	_	0	SENT_88	[p7l378t70r437b119],
4	adverse	JJ	O	adverse	amod	6	SENT_88	[p7l450t70r647b119],
5	asthma	NN	O	asthma	nn	6	SENT_88	[p7l670t70r864b119],
6	control	NN	O	control	prep_of	2	SENT_88	[p7l886t70r1085b119],
7	.	.	O	.	_	0	SENT_88	[p7l886t70r1085b119],

1	Quality	JJ	O	quality	amod	2	SENT_89	[p7l1111t70r1305b134],
2	control	NN	O	control	nsubjpass	12	SENT_89	[p7l1325t70r1512b119],
3	and	CC	O	and	_	0	SENT_89	[p7l9t149r107b197],
4	training	NN	O	training	nn	5	SENT_89	[p7l129t152r343b213],
5	measures	NNS	O	measure	nsubjpass	12	SENT_89	[p7l367t166r621b197],
6	and	CC	O	and	_	0	SENT_89	[p7l648t149r746b197],
7	deﬁnitions	NNS	O	deﬁnitions	nsubjpass	12	SENT_89	[p7l770t149r1054b197],
8	for	IN	O	for	_	0	SENT_89	[p7l1080t149r1156b197],
9	assessments	NNS	O	assessment	prep_for	7	SENT_89	[p7l1180t158r1510b197],
10	have	VBP	O	have	aux	12	SENT_89	[p7l7t226r128b275],
11	been	VBN	O	be	auxpass	12	SENT_89	[p7l146t226r274b275],
12	described	VBN	O	describe	_	0	SENT_89	[p7l293t226r547b275],
13	previously	RB	DATE	previously	advmod	12	SENT_89	[p7l564t226r883b290],
14	.	.	O	.	_	0	SENT_89	[p7l564t226r883b290],

1	”	NN	O	”	_	0	SENT_90	[p7l564t226r883b290],

1	During	IN	O	during	_	0	SENT_91	[p7l61t307r251b368],
2	the	DT	O	the	det	4	SENT_91	[p7l274t304r357b353],
3	entire	JJ	O	entire	amod	4	SENT_91	[p7l382t307r535b353],
4	study	NN	O	study	prep_during	8	SENT_91	[p7l562t304r715b368],
5	,	,	O	,	_	0	SENT_91	[p7l562t304r715b368],
6	all	DT	O	all	det	7	SENT_91	[p7l743t304r803b353],
7	participants	NNS	O	participant	nsubj	8	SENT_91	[p7l826t307r1139b367],
8	used	VBD	O	use	_	0	SENT_91	[p7l1164t304r1290b353],
9	inhaled	VBN	O	inhale	csubj	33	SENT_91	[p7l1313t304r1512b353],
10	ipratropium	NN	O	ipratropium	nn	11	SENT_91	[p7l8t385r331b445],
11	bromide	NN	O	bromide	nsubj	17	SENT_91	[p7l353t382r579b430],
12	as	IN	O	as	_	0	SENT_91	[p7l603t399r654b430],
13	the	DT	O	the	det	15	SENT_91	[p7l678t382r761b430],
14	rescue	NN	O	rescue	nn	15	SENT_91	[p7l785t399r956b430],
15	medication	NN	O	medication	prep_as	11	SENT_91	[p7l979t382r1277b430],
16	to	TO	O	to	aux	17	SENT_91	[p7l1299t391r1348b430],
17	avoid	VB	O	avoid	xcomp	9	SENT_91	[p7l1373t382r1512b430],
18	the	DT	O	the	det	20	SENT_91	[p7l7t459r90b508],
19	confounding	JJ	O	confounding	amod	20	SENT_91	[p7l130t459r472b523],
20	effects	NNS	O	effect	dobj	17	SENT_91	[p7l512t459r680b508],
21	of	IN	O	of	_	0	SENT_91	[p7l722t459r781b508],
22	B2-adrenergic	JJ	O	b2-adrenergic	amod	23	SENT_91	[p7l814t459r1166b523],
23	stimulation	NN	O	stimulation	prep_of	20	SENT_91	[p7l1207t459r1512b508],
24	from	IN	O	from	_	0	SENT_91	[p7l8t536r139b584],
25	use	NN	O	use	prep_from	17	SENT_91	[p7l170t553r261b584],
26	of	IN	O	of	_	0	SENT_91	[p7l295t536r354b584],
27	rescue	NN	O	rescue	nn	28	SENT_91	[p7l377t553r547b584],
28	inhaler	NN	O	inhaler	prep_of	25	SENT_91	[p7l581t536r770b584],
29	on	IN	O	on	_	0	SENT_91	[p7l802t553r868b584],
30	the	DT	O	the	det	32	SENT_91	[p7l900t536r983b584],
31	outcome	NN	O	outcome	nn	32	SENT_91	[p7l1016t546r1245b584],
32	variables	NNS	O	variable	prep_on	17	SENT_91	[p7l1277t536r1510b584],
33	monitored	VBD	O	monitor	ccomp	8	SENT_91	[p7l8t613r301b661],
34	.	.	O	.	_	0	SENT_91	[p7l8t613r301b661],

1	However	RB	O	however	_	0	SENT_92	[p7l339t618r589b668],
2	,	,	O	,	_	0	SENT_92	[p7l339t618r589b668],
3	in	IN	O	in	dep	1	SENT_92	[p7l624t616r677b660],
4	the	DT	O	the	det	5	SENT_92	[p7l708t613r791b661],
5	event	NN	O	event	pobj	3	SENT_92	[p7l824t622r966b661],
6	that	IN	O	that	_	0	SENT_92	[p7l996t613r1099b661],
7	an	DT	O	a	det	8	SENT_92	[p7l1131t630r1194b661],
8	episode	NN	O	episode	prep_that	5	SENT_92	[p7l1228t613r1428b676],
9	of	IN	O	of	prep	8	SENT_92	[p7l1462t613r1521b661],

1	I	PRP	O	I	_	0	SENT_93	[p7l6t916r53b1114],
2	Articles	NNPS	O	Articles	dep	1	SENT_93	[p7l101t1079r249b1115],

1	Arg/Arg	NN	O	arg/arg	nn	3	SENT_94	[p7l890t1400r1098b1461],
2	(	CD	NUMBER	(	num	3	SENT_94	[p7l1115t1400r1288b1458],
3	n	NN	O	n	_	0	SENT_94	[p7l1115t1400r1288b1458],
4	=	JJ	O	=	amod	3	SENT_94	[p7l1115t1400r1288b1458],
5	37	CD	NUMBER	37	tmod	4	SENT_94	[p7l1115t1400r1288b1458],
6	)	CD	NUMBER	)	num	9	SENT_94	[p7l1115t1400r1288b1458],
7	Gly/Gly	NN	O	gly/gly	nn	9	SENT_94	[p7l1499t1398r1688b1460],
8	(	NN	O	(	nn	9	SENT_94	[p7l1702t1400r1875b1458],
9	n	NN	O	n	dep	3	SENT_94	[p7l1702t1400r1875b1458],
10	=	JJ	O	=	amod	12	SENT_94	[p7l1702t1400r1875b1458],
11	41	CD	NUMBER	41	tmod	10	SENT_94	[p7l1702t1400r1875b1458],
12	)	NN	O	)	dep	9	SENT_94	[p7l1702t1400r1875b1458],

1	Demography	NN	MISC	demography	dep	154	SENT_95	[p7l113t1514r450b1577],
2	Male/female	NN	O	male/female	dep	154	SENT_95	[p7l112t1601r415b1656],
3	10	CD	PERCENT	10	dep	154	SENT_95	[p7l921t1609r981b1650],
4	(	CD	PERCENT	(	dep	154	SENT_95	[p7l1000t1604r1233b1662],
5	27	CD	PERCENT	27	dep	154	SENT_95	[p7l1000t1604r1233b1662],
6	%	NN	PERCENT	%	dep	154	SENT_95	[p7l1000t1604r1233b1662],
7	)	CD	NUMBER	)	dep	154	SENT_95	[p7l1000t1604r1233b1662],
8	/	:	O	/	dep	154	SENT_95	[p7l1000t1604r1233b1662],
9	27	CD	PERCENT	27	dep	154	SENT_95	[p7l1000t1604r1233b1662],
10	(	CD	PERCENT	(	dep	154	SENT_95	[p7l1251t1605r1395b1662],
11	73	CD	PERCENT	73	dep	154	SENT_95	[p7l1251t1605r1395b1662],
12	%	NN	PERCENT	%	dep	154	SENT_95	[p7l1251t1605r1395b1662],
13	)	CD	NUMBER	)	dep	154	SENT_95	[p7l1251t1605r1395b1662],
14	15	CD	NUMBER	15	dep	154	SENT_95	[p7l1522t1609r1581b1657],
15	(	NN	O	(	dep	154	SENT_95	[p7l1600t1601r1834b1662],
16	37	CD	PERCENT	37	dep	154	SENT_95	[p7l1600t1601r1834b1662],
17	%	NN	PERCENT	%	dep	154	SENT_95	[p7l1600t1601r1834b1662],
18	)	CD	NUMBER	)	dep	154	SENT_95	[p7l1600t1601r1834b1662],
19	/	:	O	/	dep	154	SENT_95	[p7l1600t1601r1834b1662],
20	26	CD	PERCENT	26	dep	154	SENT_95	[p7l1600t1601r1834b1662],
21	(	CD	PERCENT	(	dep	154	SENT_95	[p7l1852t1601r1997b1662],
22	63	CD	PERCENT	63	dep	154	SENT_95	[p7l1852t1601r1997b1662],
23	%	NN	PERCENT	%	dep	154	SENT_95	[p7l1852t1601r1997b1662],
24	)	CD	NUMBER	)	dep	154	SENT_95	[p7l1852t1601r1997b1662],
25	White	NNP	O	White	dep	154	SENT_95	[p7l109t1690r256b1738],
26	20	CD	PERCENT	20	dep	154	SENT_95	[p7l921t1697r981b1738],
27	(	CD	PERCENT	(	dep	154	SENT_95	[p7l1000t1693r1144b1750],
28	54	CD	PERCENT	54	dep	154	SENT_95	[p7l1000t1693r1144b1750],
29	%	NN	PERCENT	%	dep	154	SENT_95	[p7l1000t1693r1144b1750],
30	)	CD	NUMBER	)	dep	154	SENT_95	[p7l1000t1693r1144b1750],
31	26	CD	NUMBER	26	dep	154	SENT_95	[p7l1521t1689r1582b1738],
32	(	NN	O	(	dep	154	SENT_95	[p7l1600t1689r1745b1750],
33	63	CD	PERCENT	63	dep	154	SENT_95	[p7l1600t1689r1745b1750],
34	%	NN	PERCENT	%	dep	154	SENT_95	[p7l1600t1689r1745b1750],
35	)	CD	NUMBER	)	dep	154	SENT_95	[p7l1600t1689r1745b1750],
36	Black	JJ	O	black	dep	154	SENT_95	[p7l114t1777r237b1825],
37	8	CD	PERCENT	8	dep	154	SENT_95	[p7l953t1777r981b1825],
38	(	CD	PERCENT	(	dep	154	SENT_95	[p7l1000t1780r1144b1838],
39	22	CD	PERCENT	22	dep	154	SENT_95	[p7l1000t1780r1144b1838],
40	%	NN	PERCENT	%	dep	154	SENT_95	[p7l1000t1780r1144b1838],
41	)	CD	NUMBER	)	dep	154	SENT_95	[p7l1000t1780r1144b1838],
42	7	CD	NUMBER	7	dep	154	SENT_95	[p7l1554t1785r1582b1831],
43	(	NN	O	(	dep	154	SENT_95	[p7l1600t1781r1745b1838],
44	17	CD	PERCENT	17	dep	154	SENT_95	[p7l1600t1781r1745b1838],
45	%	NN	PERCENT	%	dep	154	SENT_95	[p7l1600t1781r1745b1838],
46	)	CD	NUMBER	)	dep	154	SENT_95	[p7l1600t1781r1745b1838],
47	Hispanic	JJ	O	hispanic	dep	154	SENT_95	[p7l114t1868r317b1927],
48	2	CD	PERCENT	2	dep	154	SENT_95	[p7l954t1872r980b1913],
49	(	CD	PERCENT	(	dep	154	SENT_95	[p7l1000t1868r1111b1926],
50	5	CD	PERCENT	5	dep	154	SENT_95	[p7l1000t1868r1111b1926],
51	%	NN	PERCENT	%	dep	154	SENT_95	[p7l1000t1868r1111b1926],
52	)	CD	NUMBER	)	dep	154	SENT_95	[p7l1000t1868r1111b1926],
53	4	CD	NUMBER	4	dep	154	SENT_95	[p7l1552t1872r1584b1920],
54	(	NN	O	(	dep	154	SENT_95	[p7l1600t1869r1745b1926],
55	10	CD	PERCENT	10	dep	154	SENT_95	[p7l1600t1869r1745b1926],
56	%	NN	PERCENT	%	dep	154	SENT_95	[p7l1600t1869r1745b1926],
57	)	CD	NUMBER	)	dep	154	SENT_95	[p7l1600t1869r1745b1926],
58	Other	JJ	O	other	dep	154	SENT_95	[p7l112t1953r251b2001],
59	7	CD	PERCENT	7	dep	154	SENT_95	[p7l953t1961r981b2008],
60	(	CD	PERCENT	(	dep	154	SENT_95	[p7l1000t1956r1144b2014],
61	19	CD	PERCENT	19	dep	154	SENT_95	[p7l1000t1956r1144b2014],
62	%	NN	PERCENT	%	dep	154	SENT_95	[p7l1000t1956r1144b2014],
63	)	CD	NUMBER	)	dep	154	SENT_95	[p7l1000t1956r1144b2014],
64	4	CD	NUMBER	4	dep	154	SENT_95	[p7l1552t1960r1584b2008],
65	(	NN	O	(	dep	154	SENT_95	[p7l1600t1957r1745b2014],
66	10	CD	PERCENT	10	dep	154	SENT_95	[p7l1600t1957r1745b2014],
67	%	NN	PERCENT	%	dep	154	SENT_95	[p7l1600t1957r1745b2014],
68	)	CD	NUMBER	)	dep	154	SENT_95	[p7l1600t1957r1745b2014],
69	Age	NNP	O	Age	dep	154	SENT_95	[p7l111t2045r219b2104],
70	,	,	O	,	_	0	SENT_95	[p7l111t2045r219b2104],
71	years	NNS	DURATION	year	dep	154	SENT_95	[p7l235t2044r385b2103],
72	*	VBP	O	*	dep	154	SENT_95	[p7l235t2044r385b2103],
73	31-0	CD	NUMBER	31-0	dep	154	SENT_95	[p7l920t2048r1029b2096],
74	(	CD	NUMBER	(	dep	154	SENT_95	[p7l1047t2041r1161b2102],
75	8-7	CD	NUMBER	8-7	dep	154	SENT_95	[p7l1047t2041r1161b2102],
76	)	NN	O	)	dep	154	SENT_95	[p7l1047t2041r1161b2102],
77	31-0	CD	NUMBER	31-0	dep	154	SENT_95	[p7l1520t2048r1629b2096],
78	(	CD	NUMBER	(	dep	154	SENT_95	[p7l1648t2041r1762b2102],
79	8-8	CD	NUMBER	8-8	dep	154	SENT_95	[p7l1648t2041r1762b2102],
80	)	NN	O	)	dep	154	SENT_95	[p7l1648t2041r1762b2102],
81	Spirometry	NN	O	spirometry	dep	154	SENT_95	[p7l111t2130r426b2191],
82	*	CD	NUMBER	*	dep	154	SENT_95	[p7l111t2130r426b2191],
83	FEV1	NN	O	fev1	dep	154	SENT_95	[p7l113t2222r230b2277],
84	,	,	O	,	_	0	SENT_95	[p7l113t2222r230b2277],
85	LT	NN	O	lt	dep	154	SENT_95	[p7l251t2221r300b2268],
86	3-02	CD	NUMBER	3-02	dep	154	SENT_95	[p7l953t2223r1060b2272],
87	(	CD	NUMBER	(	dep	154	SENT_95	[p7l1080t2220r1228b2277],
88	0-93	CD	NUMBER	0-93	dep	154	SENT_95	[p7l1080t2220r1228b2277],
89	)	NN	O	)	dep	154	SENT_95	[p7l1080t2220r1228b2277],
90	3-14	CD	NUMBER	3-14	dep	154	SENT_95	[p7l1554t2223r1665b2272],
91	(	CD	NUMBER	(	dep	154	SENT_95	[p7l1682t2220r1829b2277],
92	0-77	CD	NUMBER	0-77	dep	154	SENT_95	[p7l1682t2220r1829b2277],
93	)	NN	O	)	dep	154	SENT_95	[p7l1682t2220r1829b2277],
94	FEV1	NN	O	fev1	dep	154	SENT_95	[p7l113t2310r231b2365],
95	,	,	O	,	_	0	SENT_95	[p7l113t2310r231b2365],
96	%	NN	O	%	dep	154	SENT_95	[p7l249t2314r288b2352],
97	predictedt	NN	O	predictedt	dep	154	SENT_95	[p7l305t2305r563b2367],
98	89-9	CD	NUMBER	89-9	dep	154	SENT_95	[p7l919t2304r1028b2360],
99	(	CD	NUMBER	(	dep	154	SENT_95	[p7l1047t2308r1195b2365],
100	13-1	CD	NUMBER	13-1	dep	154	SENT_95	[p7l1047t2308r1195b2365],
101	)	NN	O	)	dep	154	SENT_95	[p7l1047t2308r1195b2365],
102	89-8	CD	NUMBER	89-8	dep	154	SENT_95	[p7l1520t2304r1629b2360],
103	(	CD	NUMBER	(	dep	154	SENT_95	[p7l1648t2305r1795b2365],
104	11-6	CD	NUMBER	11-6	dep	154	SENT_95	[p7l1648t2305r1795b2365],
105	)	NN	O	)	dep	154	SENT_95	[p7l1648t2305r1795b2365],
106	FVC	NN	O	fvc	dep	154	SENT_95	[p7l113t2397r218b2449],
107	,	,	O	,	_	0	SENT_95	[p7l113t2397r218b2449],
108	Lt	NN	O	lt	dep	154	SENT_95	[p7l238t2397r287b2444],
109	4-11	CD	NUMBER	4-11	dep	154	SENT_95	[p7l951t2392r1228b2453],
110	(	CD	NUMBER	(	dep	154	SENT_95	[p7l951t2392r1228b2453],
111	1-18	CD	NUMBER	1-18	dep	154	SENT_95	[p7l951t2392r1228b2453],
112	)	NN	O	)	dep	154	SENT_95	[p7l951t2392r1228b2453],
113	4-16	CD	NUMBER	4-16	dep	154	SENT_95	[p7l1552t2392r1663b2447],
114	(	CD	NUMBER	(	dep	154	SENT_95	[p7l1681t2392r1829b2453],
115	1-08	CD	NUMBER	1-08	dep	154	SENT_95	[p7l1681t2392r1829b2453],
116	)	CD	NUMBER	)	dep	154	SENT_95	[p7l1681t2392r1829b2453],
117	Morning	NN	TIME	morning	dep	154	SENT_95	[p7l112t2483r317b2543],
118	PEFR	NN	O	pefr	dep	154	SENT_95	[p7l338t2485r468b2537],
119	,	,	O	,	_	0	SENT_95	[p7l338t2485r468b2537],
120	L/mini	NN	O	l/mini	dep	154	SENT_95	[p7l489t2482r656b2535],
121	450	CD	NUMBER	450	dep	154	SENT_95	[p7l884t2487r981b2535],
122	(	NN	O	(	dep	154	SENT_95	[p7l1000t2483r1133b2541],
123	127	CD	NUMBER	127	dep	154	SENT_95	[p7l1000t2483r1133b2541],
124	)	NN	O	)	dep	154	SENT_95	[p7l1000t2483r1133b2541],
125	479	CD	NUMBER	479	dep	154	SENT_95	[p7l1485t2487r1581b2535],
126	(	NN	O	(	dep	154	SENT_95	[p7l1600t2483r1734b2541],
127	139	CD	NUMBER	139	dep	154	SENT_95	[p7l1600t2483r1734b2541],
128	)	CD	NUMBER	)	dep	154	SENT_95	[p7l1600t2483r1734b2541],
129	Evening	NN	TIME	evening	dep	154	SENT_95	[p7l113t2571r304b2631],
130	PEFR	NN	O	pefr	dep	154	SENT_95	[p7l325t2573r455b2625],
131	,	,	O	,	_	0	SENT_95	[p7l325t2573r455b2625],
132	L/mini	NN	O	l/mini	dep	154	SENT_95	[p7l475t2570r642b2622],
133	463	CD	NUMBER	463	dep	154	SENT_95	[p7l884t2568r980b2623],
134	(	NN	O	(	dep	154	SENT_95	[p7l1000t2571r1133b2629],
135	122	CD	NUMBER	122	dep	154	SENT_95	[p7l1000t2571r1133b2629],
136	)	NN	O	)	dep	154	SENT_95	[p7l1000t2571r1133b2629],
137	497	CD	NUMBER	497	dep	154	SENT_95	[p7l1485t2575r1582b2623],
138	(	NN	O	(	dep	154	SENT_95	[p7l1600t2571r1734b2629],
139	135	CD	NUMBER	135	dep	154	SENT_95	[p7l1600t2571r1734b2629],
140	)	CD	NUMBER	)	dep	154	SENT_95	[p7l1600t2571r1734b2629],
141	PEFR	NN	O	pefr	dep	154	SENT_95	[p7l113t2661r231b2704],
142	variability	NN	O	variability	dep	154	SENT_95	[p7l245t2656r497b2719],
143	,	,	O	,	_	0	SENT_95	[p7l245t2656r497b2719],
144	%	NN	O	%	dep	154	SENT_95	[p7l515t2660r583b2708],
145	at	IN	O	at	dep	154	SENT_95	[p7l515t2660r583b2708],
146	2-1	CD	NUMBER	2-1	dep	154	SENT_95	[p7l954t2663r1028b2703],
147	(	CD	NUMBER	(	dep	154	SENT_95	[p7l1047t2656r1161b2716],
148	5-6	CD	NUMBER	5-6	dep	154	SENT_95	[p7l1047t2656r1161b2716],
149	)	NN	O	)	dep	154	SENT_95	[p7l1047t2656r1161b2716],
150	3-5	CD	NUMBER	3-5	dep	154	SENT_95	[p7l1554t2663r1628b2711],
151	(	CD	NUMBER	(	dep	154	SENT_95	[p7l1648t2659r1762b2717],
152	4-9	CD	NUMBER	4-9	dep	154	SENT_95	[p7l1648t2659r1762b2717],
153	)	CD	NUMBER	)	dep	154	SENT_95	[p7l1648t2659r1762b2717],
154	Clinical	JJ	O	clinical	_	0	SENT_95	[p7l111t2744r290b2792],

1	Morning	NN	TIME	morning	_	0	SENT_96	[p7l112t2834r317b2895],
2	symptom	NN	O	symptom	nn	3	SENT_96	[p7l335t2841r569b2895],
3	score	NN	NUMBER	score	nsubj	6	SENT_96	[p7l588t2834r768b2883],
4	*	CD	NUMBER	*	dep	3	SENT_96	[p7l588t2834r768b2883],
5	:	:	O	:	_	0	SENT_96	[p7l588t2834r768b2883],
6	lE	VB	O	le	rcmod	1	SENT_96	[p7l588t2834r768b2883],
7	0-2	CD	NUMBER	0-2	num	8	SENT_96	[p7l953t2839r1027b2880],
8	(	CD	NUMBER	(	dobj	6	SENT_96	[p7l1047t2835r1161b2892],
9	0-2	CD	NUMBER	0-2	num	10	SENT_96	[p7l1047t2835r1161b2892],
10	)	NN	O	)	dep	15	SENT_96	[p7l1047t2835r1161b2892],
11	0-2	CD	NUMBER	0-2	num	12	SENT_96	[p7l1553t2839r1628b2880],
12	(	CD	NUMBER	(	dep	10	SENT_96	[p7l1648t2834r1762b2892],
13	0-4	CD	NUMBER	0-4	num	14	SENT_96	[p7l1648t2834r1762b2892],
14	)	NN	O	)	dep	15	SENT_96	[p7l1648t2834r1762b2892],
15	PC20	NN	O	pc20	dep	24	SENT_96	[p7l114t2924r219b2980],
16	,	,	O	,	_	0	SENT_96	[p7l114t2924r219b2980],
17	g/L	NN	O	g/l	appos	15	SENT_96	[p7l237t2922r326b2983],
18	,	,	O	,	_	0	SENT_96	[p7l237t2922r326b2983],
19	at	IN	O	at	_	0	SENT_96	[p7l343t2929r390b2968],
20	week	NN	DURATION	week	nn	22	SENT_96	[p7l404t2920r533b2968],
21	OS	NN	O	os	nn	22	SENT_96	[p7l548t2923r603b2976],
22	O-94	NN	O	o-94	prep_at	15	SENT_96	[p7l953t2927r1064b2974],
23	(	CD	NUMBER	(	num	24	SENT_96	[p7l1080t2920r1375b2980],
24	O-60-3-37	NN	O	o-60-3-37	dep	26	SENT_96	[p7l1080t2920r1375b2980],
25	)	CD	NUMBER	)	num	26	SENT_96	[p7l1080t2920r1375b2980],
26	1-O5	NN	O	1-o5	dep	28	SENT_96	[p7l1555t2927r1661b2974],
27	(	CD	NUMBER	(	num	28	SENT_96	[p7l1681t2923r1976b2980],
28	O-52-3-91	NN	O	o-52-3-91	dep	30	SENT_96	[p7l1681t2923r1976b2980],
29	)	CD	NUMBER	)	num	30	SENT_96	[p7l1681t2923r1976b2980],
30	Pre	NN	O	pre	dep	1	SENT_96	[p7l114t3008r469b3056],
31	—	CD	NUMBER	—	num	34	SENT_96	[p7l114t3008r469b3056],
32	enro	NN	O	enro	nn	34	SENT_96	[p7l114t3008r469b3056],
33	|	NN	O	|	nn	34	SENT_96	[p7l114t3008r469b3056],
34	ment	NN	O	ment	nsubj	35	SENT_96	[p7l114t3008r469b3056],
35	reported	VBD	O	report	rcmod	30	SENT_96	[p7l486t3008r695b3070],
36	use	NN	O	use	dep	43	SENT_96	[p7l713t3024r792b3056],
37	of	IN	O	of	_	0	SENT_96	[p7l808t3008r861b3056],
38	1-0	CD	NUMBER	1-0	num	39	SENT_96	[p7l955t3015r1029b3056],
39	(	CD	NUMBER	(	prep_of	36	SENT_96	[p7l1047t3011r1161b3068],
40	1-2	CD	NUMBER	1-2	num	41	SENT_96	[p7l1047t3011r1161b3068],
41	)	NN	O	)	dep	43	SENT_96	[p7l1047t3011r1161b3068],
42	1-1	CD	NUMBER	1-1	num	43	SENT_96	[p7l1555t3015r1628b3055],
43	(	CD	NUMBER	(	dep	35	SENT_96	[p7l1648t3010r1762b3068],
44	1-5	CD	NUMBER	1-5	num	46	SENT_96	[p7l1648t3010r1762b3068],
45	)	NN	O	)	nn	46	SENT_96	[p7l1648t3010r1762b3068],
46	fS2	NN	O	fs2	dep	43	SENT_96	[p7l109t3096r399b3159],
47	—	CD	NUMBER	—	num	48	SENT_96	[p7l109t3096r399b3159],
48	agonist	NN	O	agonist	dobj	35	SENT_96	[p7l109t3096r399b3159],
49	,	,	O	,	_	0	SENT_96	[p7l109t3096r399b3159],
50	puffs	NNS	O	puff	appos	48	SENT_96	[p7l416t3096r541b3158],
51	per	IN	O	per	_	0	SENT_96	[p7l556t3111r634b3158],
52	day	NN	DURATION	day	prep_per	50	SENT_96	[p7l648t3096r735b3158],

1	FVC	NN	O	fvc	_	0	SENT_97	[p7l85t3229r344b3274],
2	=	JJ	O	=	amod	5	SENT_97	[p7l85t3229r344b3274],
3	forced	JJ	O	forced	amod	5	SENT_97	[p7l85t3229r344b3274],
4	vital	JJ	O	vital	amod	5	SENT_97	[p7l357t3230r451b3274],
5	capacity	NN	O	capacity	dep	1	SENT_97	[p7l468t3232r663b3288],
6	.	.	O	.	_	0	SENT_97	[p7l468t3232r663b3288],

1	Data	NNS	O	datum	nsubj	3	SENT_98	[p7l681t3234r783b3274],
2	are	VBP	O	be	cop	3	SENT_98	[p7l797t3245r864b3274],
3	number	NN	O	number	_	0	SENT_98	[p7l881t3230r1058b3274],
4	of	IN	O	of	_	0	SENT_98	[p7l1072t3229r1121b3274],
5	participants	NNS	O	participant	prep_of	3	SENT_98	[p7l1131t3232r1398b3288],
6	unless	IN	O	unless	mark	8	SENT_98	[p7l1414t3230r1552b3274],
7	otherwise	RB	O	otherwise	advmod	8	SENT_98	[p7l1567t3230r1789b3274],
8	indicated	VBN	O	indicate	dep	5	SENT_98	[p7l1806t3230r2023b3274],
9	.	.	O	.	_	0	SENT_98	[p7l1806t3230r2023b3274],

1	*	NN	O	*	nn	2	SENT_99	[p7l83t3320r230b3362],
2	Mean	NN	O	mean	_	0	SENT_99	[p7l83t3320r230b3362],
3	(	CD	NUMBER	(	num	5	SENT_99	[p7l248t3320r355b3373],
4	SD	NN	O	sd	nn	5	SENT_99	[p7l248t3320r355b3373],
5	)	NN	O	)	dep	2	SENT_99	[p7l248t3320r355b3373],
6	.	.	O	.	_	0	SENT_99	[p7l248t3320r355b3373],

1	TAverage	NN	O	taverage	_	0	SENT_100	[p7l373t3321r583b3376],
2	of	IN	O	of	_	0	SENT_100	[p7l597t3317r646b3362],
3	measurement	NN	O	measurement	prep_of	1	SENT_100	[p7l659t3326r973b3362],
4	at	IN	O	at	_	0	SENT_100	[p7l987t3326r1030b3362],
5	weeks	NNS	DURATION	week	nn	6	SENT_100	[p7l1043t3317r1182b3362],
6	o	NN	O	o	prep_at	1	SENT_100	[p7l1197t3324r1224b3362],
7	and	CC	O	and	_	0	SENT_100	[p7l1239t3317r1323b3362],
8	2	CD	NUMBER	2	prep_at	1	SENT_100	[p7l1339t3323r1376b3361],
9	.	.	O	.	_	0	SENT_100	[p7l1339t3323r1376b3361],

1	iAverage	NN	O	iaverage	_	0	SENT_101	[p7l1394t3321r1604b3376],
2	of	IN	O	of	_	0	SENT_101	[p7l1618t3317r1667b3362],
3	weeks	NNS	DURATION	week	prep_of	1	SENT_101	[p7l1676t3317r1816b3362],
4	1	CD	NUMBER	1	num	3	SENT_101	[p7l1832t3324r1856b3361],
5	and	CC	O	and	_	0	SENT_101	[p7l1872t3317r1956b3362],
6	2	CD	NUMBER	2	prep_of	1	SENT_101	[p7l1972t3323r2009b3361],
7	.	.	O	.	_	0	SENT_101	[p7l1972t3323r2009b3361],

1	§	NN	O	§	nsubj	11	SENT_102	[p7l84t3405r272b3457],
2	Median	JJ	MISC	median	amod	5	SENT_102	[p7l84t3405r272b3457],
3	(	NN	O	(	nn	5	SENT_102	[p7l291t3408r418b3461],
4	IQR	NN	O	iqr	nn	5	SENT_102	[p7l291t3408r418b3461],
5	)	NN	O	)	dep	1	SENT_102	[p7l291t3408r418b3461],
6	;	:	O	;	_	0	SENT_102	[p7l291t3408r418b3461],
7	imputed	JJ	O	imputed	dep	1	SENT_102	[p7l435t3405r627b3463],
8	for	IN	O	for	_	0	SENT_102	[p7l639t3405r705b3450],
9	right	JJ	O	right	amod	10	SENT_102	[p7l720t3405r1051b3464],
10	—	NN	O	—	prep_for	7	SENT_102	[p7l720t3405r1051b3464],
11	censored	VBD	O	censor	_	0	SENT_102	[p7l720t3405r1051b3464],
12	observations	NNS	O	observation	dobj	11	SENT_102	[p7l1065t3405r1366b3450],
13	.	.	O	.	_	0	SENT_102	[p7l1065t3405r1366b3450],

1	Table	NNP	O	Table	_	0	SENT_103	[p7l82t3557r226b3609],
2	1	CD	NUMBER	1	num	1	SENT_103	[p7l242t3565r288b3608],
3	:	:	O	:	_	0	SENT_103	[p7l242t3565r288b3608],
4	Baseline	NN	O	baseline	nn	5	SENT_103	[p7l306t3557r530b3609],
5	characteristics	NNS	O	characteristic	nsubj	11	SENT_103	[p7l547t3557r945b3609],
6	of	IN	O	of	_	0	SENT_103	[p7l961t3557r1021b3609],
7	participants	NNS	O	participant	nn	10	SENT_103	[p7l1033t3559r1369b3624],
8	adverse	JJ	O	adverse	amod	10	SENT_103	[p8l9t84r289b152],
9	asthma	NN	O	asthma	nn	10	SENT_103	[p8l363t84r637b152],
10	control	NN	O	control	prep_of	5	SENT_103	[p8l710t84r974b152],
11	responded	VBD	O	respond	ccomp	18	SENT_103	[p8l1045t84r1442b173],
12	incompletely	RB	O	incompletely	advmod	11	SENT_103	[p8l1512t84r2000b174],
13	to	TO	O	to	_	0	SENT_103	[p8l2070t98r2139b152],
14	ipratropium	NN	O	ipratropium	prep_to	11	SENT_103	[p8l8t198r486b283],
15	,	,	O	,	_	0	SENT_103	[p8l8t198r486b283],
16	patients	NNS	O	patient	nsubjpass	18	SENT_103	[p8l535t198r830b283],
17	were	VBD	O	be	auxpass	18	SENT_103	[p8l877t218r1056b262],
18	permitted	VBN	O	permit	dep	1	SENT_103	[p8l1102t194r1474b283],
19	to	TO	O	to	aux	20	SENT_103	[p8l1517t207r1586b262],
20	use	VB	O	use	xcomp	18	SENT_103	[p8l1631t218r1759b262],
21	albuterol	NN	O	albuterol	nn	22	SENT_103	[p8l1807t194r2140b262],
22	(	NN	O	(	nsubj	25	SENT_103	[p8l14t308r123b392],
23	90	CD	NUMBER	90	num	25	SENT_103	[p8l14t308r123b392],
24	pug/puff	NN	O	pug/puff	nn	25	SENT_103	[p8l155t302r470b392],
25	)	NN	O	)	xcomp	20	SENT_103	[p8l155t302r470b392],
26	as	IN	O	as	_	0	SENT_103	[p8l502t327r575b371],
27	a	DT	O	a	det	30	SENT_103	[p8l604t327r641b371],
28	superseding	VBG	O	supersede	amod	30	SENT_103	[p8l670t302r1130b392],
29	rescue	NN	O	rescue	nn	30	SENT_103	[p8l1155t327r1397b371],
30	medication	NN	O	medication	prep_as	25	SENT_103	[p8l1424t302r1865b371],
31	.	.	O	.	_	0	SENT_103	[p8l1424t302r1865b371],

1	DNA	NN	O	dna	nsubjpass	3	SENT_104	[p8l84t416r272b479],
2	was	VBD	O	be	auxpass	3	SENT_104	[p8l308t435r448b480],
3	extracted	VBN	O	extract	_	0	SENT_104	[p8l491t411r828b479],
4	from	IN	O	from	_	0	SENT_104	[p8l866t411r1052b479],
5	peripheral-blood	JJ	O	peripheral-blood	amod	6	SENT_104	[p8l1091t411r1717b500],
6	leucocytes	NNS	O	leucocyte	prep_from	3	SENT_104	[p8l1754t411r2137b500],
7	of	IN	O	of	_	0	SENT_104	[p8l9t521r93b588],
8	participating	VBG	O	participate	prepc_of	6	SENT_104	[p8l167t525r646b611],
9	patients	NNS	O	patient	dobj	8	SENT_104	[p8l732t525r1029b610],
10	by	IN	O	by	_	0	SENT_104	[p8l1118t521r1205b610],
11	standard	JJ	O	standard	amod	12	SENT_104	[p8l1294t521r1619b588],
12	techniques	NNS	O	technique	prep_by	8	SENT_104	[p8l1704t521r2135b610],
13	.	.	O	.	_	0	SENT_104	[p8l1704t521r2135b610],

1	Genotype	NN	O	genotype	nsubjpass	17	SENT_105	[p8l11t635r369b719],
2	at	IN	O	at	_	0	SENT_105	[p8l437t643r502b698],
3	the	DT	O	the	det	4	SENT_105	[p8l565t629r682b698],
4	codon	NN	O	codon	prep_at	1	SENT_105	[p8l750t629r977b698],
5	corresponding	VBG	O	correspond	partmod	4	SENT_105	[p8l1043t629r1591b719],
6	to	TO	O	to	_	0	SENT_105	[p8l1655t643r1724b698],
7	the	DT	O	the	det	10	SENT_105	[p8l1790t629r1907b698],
8	16th	JJ	ORDINAL	16th	amod	10	SENT_105	[p8l1980t629r2140b698],
9	aminoacid	JJ	O	aminoacid	amod	10	SENT_105	[p8l9t738r405b806],
10	residue	NN	O	residue	prep_to	5	SENT_105	[p8l457t738r734b806],
11	of	IN	O	of	_	0	SENT_105	[p8l789t738r872b806],
12	the	DT	O	the	det	15	SENT_105	[p8l911t738r1028b806],
13	[	CD	NUMBER	[	num	15	SENT_105	[p8l1088t738r1586b828],
14	32-adrenergic	JJ	O	32-adrenergic	amod	15	SENT_105	[p8l1088t738r1586b828],
15	receptor	NN	O	receptor	prep_of	10	SENT_105	[p8l1638t752r1948b827],
16	was	VBD	O	be	auxpass	17	SENT_105	[p8l1998t762r2137b806],
17	assessed	VBN	O	assess	_	0	SENT_105	[p8l9t849r331b917],
18	twice	RB	O	twice	advmod	17	SENT_105	[p8l430t853r624b917],
19	by	IN	O	by	_	0	SENT_105	[p8l724t849r812b938],
20	two	CD	NUMBER	two	num	22	SENT_105	[p8l909t862r1042b917],
21	different	JJ	O	different	amod	22	SENT_105	[p8l1146t849r1472b917],
22	methods	NNS	O	method	agent	17	SENT_105	[p8l1571t849r1918b927],
23	;	:	O	;	_	0	SENT_105	[p8l1571t849r1918b927],
24	the	DT	O	the	det	27	SENT_105	[p8l2022t849r2139b917],
25	ampliﬁcation	NN	O	ampliﬁcation	nn	27	SENT_105	[p8l9t957r508b1046],
26	refractory	JJ	O	refractory	amod	27	SENT_105	[p8l596t957r960b1047],
27	mutation	NN	O	mutation	dep	28	SENT_105	[p8l1046t962r1393b1026],
28	system	NN	O	system	parataxis	17	SENT_105	[p8l1484t963r1786b1047],
29	“	CD	NUMBER	“	num	28	SENT_105	[p8l1484t963r1786b1047],
30	and	CC	O	and	_	0	SENT_105	[p8l1877t958r2015b1026],
31	a	DT	O	a	det	34	SENT_105	[p8l2103t982r2140b1026],
32	restriction	NN	O	restriction	nn	34	SENT_105	[p8l8t1071r395b1134],
33	fragment	NN	O	fragment	nn	34	SENT_105	[p8l418t1066r768b1156],
34	method	NN	O	method	conj_and	28	SENT_105	[p8l789t1066r1149b1134],
35	.	.	O	.	_	0	SENT_105	[p8l789t1066r1149b1134],

1	”	NN	O	”	nsubjpass	6	SENT_106	[p8l789t1066r1149b1134],
2	The	DT	O	the	det	4	SENT_106	[p8l1170t1066r1314b1134],
3	genotype	NN	O	genotype	nn	4	SENT_106	[p8l1339t1080r1677b1156],
4	assignment	NN	O	assignment	dep	1	SENT_106	[p8l1702t1071r2141b1156],
5	was	VBD	O	be	auxpass	6	SENT_106	[p8l7t1200r146b1243],
6	made	VBN	O	make	_	0	SENT_106	[p8l180t1176r387b1243],
7	when	WRB	O	when	advmod	11	SENT_106	[p8l418t1176r627b1243],
8	the	DT	O	the	det	10	SENT_106	[p8l657t1176r774b1243],
9	two	CD	NUMBER	two	num	10	SENT_106	[p8l806t1189r939b1244],
10	methods	NNS	O	method	nsubj	11	SENT_106	[p8l972t1176r1298b1243],
11	agreed	VBD	O	agree	advcl	6	SENT_106	[p8l1334t1176r1600b1266],
12	.	.	O	.	_	0	SENT_106	[p8l1334t1176r1600b1266],

1	Genotypes	NNS	O	genotype	nsubjpass	7	SENT_107	[p8l1640t1181r2034b1265],
2	of	IN	O	of	_	0	SENT_107	[p8l2070t1176r2153b1243],
3	enrolled	VBN	O	enrol	amod	4	SENT_107	[p8l9t1284r318b1353],
4	patients	NNS	O	patient	prep_of	1	SENT_107	[p8l379t1289r676b1373],
5	were	VBD	O	be	auxpass	7	SENT_107	[p8l739t1309r918b1353],
6	also	RB	O	also	advmod	7	SENT_107	[p8l983t1284r1127b1353],
7	assessed	VBN	O	assess	_	0	SENT_107	[p8l1191t1284r1513b1353],
8	by	IN	O	by	_	0	SENT_107	[p8l1573t1284r1661b1374],
9	single-base	JJ	O	single-base	amod	10	SENT_107	[p8l1725t1284r2139b1374],
10	extension	NN	O	extension	agent	7	SENT_107	[p8l9t1398r369b1461],
11	followed	VBN	O	follow	partmod	10	SENT_107	[p8l408t1393r728b1462],
12	by	IN	O	by	_	0	SENT_107	[p8l765t1393r853b1483],
13	MALDI-TOF	NN	O	maldi-tof	nn	14	SENT_107	[p8l892t1398r1371b1461],
14	mass	NN	O	mass	agent	11	SENT_107	[p8l1413t1417r1605b1461],
15	spectrometry	NN	O	spectrometry	nn	17	SENT_107	[p8l1649t1407r2142b1483],
16	(	CD	NUMBER	(	num	17	SENT_107	[p8l14t1508r463b1593],
17	Sequenom	NNP	ORGANIZATION	Sequenom	tmod	11	SENT_107	[p8l14t1508r463b1593],
18	,	,	O	,	_	0	SENT_107	[p8l14t1508r463b1593],
19	San	NNP	LOCATION	San	nn	20	SENT_107	[p8l496t1508r631b1570],
20	Diego	NNP	LOCATION	Diego	appos	17	SENT_107	[p8l659t1507r896b1593],
21	,	,	O	,	_	0	SENT_107	[p8l659t1507r896b1593],
22	CA	NNP	LOCATION	CA	appos	20	SENT_107	[p8l926t1508r1060b1581],
23	,	,	O	,	_	0	SENT_107	[p8l926t1508r1060b1581],
24	USA	NNP	LOCATION	USA	appos	20	SENT_107	[p8l1092t1506r1361b1593],
25	)	CD	NUMBER	)	number	26	SENT_107	[p8l1092t1506r1361b1593],
26	”	CD	NUMBER	”	num	28	SENT_107	[p8l1092t1506r1361b1593],
27	Neither	DT	O	neither	det	28	SENT_107	[p8l1389t1503r1672b1570],
28	participants	NNS	O	participant	dep	24	SENT_107	[p8l1695t1507r2137b1592],
29	nor	CC	O	nor	_	0	SENT_107	[p8l8t1637r139b1681],
30	study	NN	O	study	nn	31	SENT_107	[p8l220t1613r420b1702],
31	personnel	NNS	O	personnel	appos	20	SENT_107	[p8l497t1613r874b1701],
32	interacting	VBG	O	interact	partmod	31	SENT_107	[p8l953t1617r1362b1702],
33	with	IN	O	with	mark	36	SENT_107	[p8l1440t1613r1606b1681],
34	them	PRP	O	they	nsubjpass	36	SENT_107	[p8l1684t1613r1882b1681],
35	were	VBD	O	be	auxpass	36	SENT_107	[p8l1960t1637r2139b1681],
36	informed	VBN	O	inform	advcl	32	SENT_107	[p8l8t1721r363b1789],
37	of	IN	O	of	_	0	SENT_107	[p8l389t1721r472b1789],
38	their	PRP$	O	they	poss	39	SENT_107	[p8l484t1721r663b1789],
39	genotype	NN	O	genotype	prep_of	36	SENT_107	[p8l689t1735r1045b1811],
40	.	.	O	.	_	0	SENT_107	[p8l689t1735r1045b1811],

1	Statistics	NNS	O	statistics	_	0	SENT_108	[p8l10t1942r356b2009],

1	We	PRP	O	we	nsubj	2	SENT_109	[p8l7t2057r131b2119],
2	used	VBD	O	use	_	0	SENT_109	[p8l180t2050r359b2118],
3	the	DT	O	the	det	4	SENT_109	[p8l406t2050r523b2118],
4	change	NN	O	change	dobj	2	SENT_109	[p8l574t2050r841b2140],
5	in	IN	O	in	_	0	SENT_109	[p8l891t2055r966b2117],
6	morning	NN	TIME	morning	nn	7	SENT_109	[p8l1015t2055r1348b2140],
7	PEFR	NN	O	pefr	prep_in	2	SENT_109	[p8l1401t2055r1612b2117],
8	between	IN	O	between	_	0	SENT_109	[p8l1660t2050r1974b2118],
9	the	DT	O	the	det	10	SENT_109	[p8l2022t2050r2139b2118],
10	beginning	NN	O	beginning	prep_between	7	SENT_109	[p8l7t2159r395b2249],
11	and	CC	O	and	_	0	SENT_109	[p8l426t2159r565b2226],
12	the	DT	O	the	det	13	SENT_109	[p8l594t2159r711b2226],
13	end	NN	O	end	conj_and	7	SENT_109	[p8l744t2159r883b2226],
14	of	IN	O	of	_	0	SENT_109	[p8l914t2159r998b2226],
15	the	DT	O	the	det	18	SENT_109	[p8l1014t2159r1131b2226],
16	16-week	JJ	DURATION	16-week	amod	18	SENT_109	[p8l1169t2159r1471b2226],
17	treatment	NN	O	treatment	nn	18	SENT_109	[p8l1498t2172r1870b2226],
18	period	NN	O	period	prep_of	13	SENT_109	[p8l1899t2159r2141b2248],
19	as	IN	O	as	_	0	SENT_109	[p8l9t2292r82b2336],
20	the	DT	O	the	det	23	SENT_109	[p8l161t2268r278b2336],
21	primary	JJ	O	primary	amod	23	SENT_109	[p8l355t2272r658b2357],
22	response	NN	O	response	nn	23	SENT_109	[p8l733t2292r1070b2356],
23	Variable	NNP	O	Variable	prep_as	2	SENT_109	[p8l1145t2268r1458b2336],
24	.	.	O	.	_	0	SENT_109	[p8l1145t2268r1458b2336],

1	The	DT	O	the	det	2	SENT_110	[p8l1538t2268r1683b2336],
2	difference	NN	O	difference	nsubj	13	SENT_110	[p8l1762t2267r2139b2336],
3	between	IN	O	between	_	0	SENT_110	[p8l7t2377r321b2446],
4	albuterol	NN	O	albuterol	nn	7	SENT_110	[p8l389t2377r722b2446],
5	and	CC	O	and	_	0	SENT_110	[p8l789t2377r928b2446],
6	placebo	NN	O	placebo	nn	7	SENT_110	[p8l992t2377r1276b2466],
7	treatments	NNS	O	treatment	prep_between	2	SENT_110	[p8l1342t2391r1748b2446],
8	was	VBD	O	be	cop	11	SENT_110	[p8l1815t2401r1954b2446],
9	the	DT	O	the	det	11	SENT_110	[p8l2022t2377r2139b2446],
10	primary	JJ	O	primary	amod	11	SENT_110	[p8l8t2492r311b2577],
11	outcome	NN	O	outcome	_	0	SENT_110	[p8l353t2501r677b2556],
12	and	CC	O	and	_	0	SENT_110	[p8l723t2488r861b2556],
13	assessed	VBN	O	assess	conj_and	11	SENT_110	[p8l904t2488r1225b2556],
14	separately	RB	O	separately	advmod	13	SENT_110	[p8l1270t2488r1644b2577],
15	within	IN	O	within	_	0	SENT_110	[p8l1683t2488r1928b2556],
16	each	DT	O	each	det	17	SENT_110	[p8l1971t2488r2140b2556],
17	genotype	NN	O	genotype	prep_within	13	SENT_110	[p8l10t2610r347b2686],
18	(	CD	NUMBER	(	num	21	SENT_110	[p8l468t2596r1099b2686],
19	within-genotype	NN	O	within-genotype	nn	21	SENT_110	[p8l468t2596r1099b2686],
20	difference	NN	O	difference	nn	21	SENT_110	[p8l1214t2596r1639b2686],
21	)	NN	O	)	dep	17	SENT_110	[p8l1214t2596r1639b2686],
22	.	.	O	.	_	0	SENT_110	[p8l1214t2596r1639b2686],

1	We	PRP	O	we	nsubj	3	SENT_111	[p8l1756t2603r1880b2665],
2	also	RB	O	also	advmod	3	SENT_111	[p8l1995t2596r2139b2665],
3	compared	VBD	O	compare	_	0	SENT_111	[p8l9t2706r384b2795],
4	the	DT	O	the	det	5	SENT_111	[p8l407t2706r524b2775],
5	difference	NN	O	difference	dobj	3	SENT_111	[p8l550t2706r928b2775],
6	in	IN	O	in	_	0	SENT_111	[p8l953t2711r1028b2773],
7	the	DT	O	the	det	8	SENT_111	[p8l1052t2706r1169b2775],
8	response	NN	O	response	prep_in	3	SENT_111	[p8l1194t2730r1530b2795],
9	of	IN	O	of	_	0	SENT_111	[p8l1557t2706r1641b2775],
10	patients	NNS	O	patient	prep_of	8	SENT_111	[p8l1652t2711r1948b2795],
11	with	IN	O	with	_	0	SENT_111	[p8l1973t2706r2140b2775],
12	each	DT	O	each	prep_with	10	SENT_111	[p8l9t2816r178b2883],
13	of	IN	O	of	_	0	SENT_111	[p8l213t2816r296b2883],
14	the	DT	O	the	det	15	SENT_111	[p8l314t2816r431b2883],
15	genotypes	NNS	O	genotype	prep_of	12	SENT_111	[p8l466t2829r840b2906],
16	in	IN	O	in	_	0	SENT_111	[p8l876t2820r951b2882],
17	terms	NNS	O	term	prep_in	15	SENT_111	[p8l982t2829r1198b2883],
18	of	IN	O	of	_	0	SENT_111	[p8l1235t2816r1318b2883],
19	their	PRP$	O	they	poss	20	SENT_111	[p8l1336t2816r1516b2883],
20	changes	NNS	O	change	prep_of	17	SENT_111	[p8l1548t2816r1851b2906],
21	during	IN	O	during	_	0	SENT_111	[p8l1887t2816r2140b2906],
22	the	DT	O	the	det	23	SENT_111	[p8l7t2924r124b2993],
23	albuterol	NN	O	albuterol	prep_during	3	SENT_111	[p8l151t2924r484b2993],
24	and	CC	O	and	_	0	SENT_111	[p8l509t2924r648b2993],
25	placebo	NN	O	placebo	nn	27	SENT_111	[p8l671t2924r955b3013],
26	treatment	NN	O	treatment	nn	27	SENT_111	[p8l979t2938r1351b2993],
27	periods	NNS	O	period	prep_during	3	SENT_111	[p8l1374t2924r1650b3013],
28	for	IN	O	for	_	0	SENT_111	[p8l1677t2924r1784b2993],
29	morning	NN	TIME	morning	nn	30	SENT_111	[p8l1807t2929r2140b3014],
30	PEFR	NN	O	pefr	prep_for	3	SENT_111	[p8l13t3038r224b3100],
31	(	CD	NUMBER	(	num	34	SENT_111	[p8l257t3033r959b3123],
32	between-genotype	NN	O	between-genotype	nn	34	SENT_111	[p8l257t3033r959b3123],
33	difference	NN	O	difference	nn	34	SENT_111	[p8l989t3033r1414b3123],
34	)	NN	O	)	dep	30	SENT_111	[p8l989t3033r1414b3123],
35	.	.	O	.	_	0	SENT_111	[p8l989t3033r1414b3123],

1	We	PRP	O	we	nsubj	3	SENT_112	[p8l1445t3040r1569b3102],
2	also	RB	O	also	advmod	3	SENT_112	[p8l1600t3033r1744b3101],
3	examined	VBD	O	examine	_	0	SENT_112	[p8l1774t3033r2141b3101],
4	the	DT	O	the	det	5	SENT_112	[p8l7t3143r124b3210],
5	within-genotype	NN	O	within-genotype	dobj	3	SENT_112	[p8l166t3143r777b3233],
6	and	CC	O	and	_	0	SENT_112	[p8l820t3143r959b3210],
7	between-genotype	JJ	O	between-genotype	amod	8	SENT_112	[p8l999t3143r1680b3233],
8	differences	NNS	O	difference	dobj	3	SENT_112	[p8l1724t3143r2138b3210],
9	for	IN	O	for	_	0	SENT_112	[p8l8t3251r116b3320],
10	secondary	JJ	O	secondary	amod	12	SENT_112	[p8l143t3251r519b3341],
11	outcome	NN	O	outcome	nn	12	SENT_112	[p8l544t3265r869b3320],
12	Variables	NNS	O	variable	prep_for	3	SENT_112	[p8l894t3251r1244b3320],
13	.	.	O	.	_	0	SENT_112	[p8l894t3251r1244b3320],

1	The	DT	O	the	det	4	SENT_113	[p8l78t3360r223b3428],
2	target	NN	O	target	nn	4	SENT_113	[p8l262t3374r478b3450],
3	sample	NN	O	sample	nn	4	SENT_113	[p8l519t3360r786b3449],
4	size	NN	O	size	nsubj	7	SENT_113	[p8l829t3365r970b3428],
5	was	VBD	O	be	cop	7	SENT_113	[p8l1008t3384r1147b3428],
6	72	CD	NUMBER	72	num	7	SENT_113	[p8l1192t3365r1273b3431],
7	participants	NNS	O	participant	dep	8	SENT_113	[p8l1315t3365r1758b3449],
8	(	VBP	O	(	_	0	SENT_113	[p8l1806t3366r1914b3450],
9	36	CD	NUMBER	36	dobj	8	SENT_113	[p8l1806t3366r1914b3450],
10	from	IN	O	from	_	0	SENT_113	[p8l1954t3360r2140b3428],
11	each	DT	O	each	prep_from	8	SENT_113	[p8l9t3470r178b3537],
12	of	IN	O	of	_	0	SENT_113	[p8l206t3470r289b3537],
13	the	DT	O	the	det	15	SENT_113	[p8l301t3470r418b3537],
14	two	CD	NUMBER	two	num	15	SENT_113	[p8l443t3483r577b3537],
15	genotypes	NNS	O	genotype	prep_of	11	SENT_113	[p8l605t3476r1028b3560],
16	)	CD	NUMBER	)	nsubj	8	SENT_113	[p8l605t3476r1028b3560],
17	.	.	O	.	_	0	SENT_113	[p8l605t3476r1028b3560],

1	From	IN	O	from	_	0	SENT_114	[p8l1062t3474r1266b3537],
2	our	PRP$	O	we	poss	3	SENT_114	[p8l1293t3494r1421b3537],
3	estimates	NNS	O	estimate	prep_from	12	SENT_114	[p8l1447t3474r1800b3537],
4	of	IN	O	of	_	0	SENT_114	[p8l1830t3470r1913b3537],
5	PEFR	NN	O	pefr	nn	6	SENT_114	[p8l1930t3474r2141b3536],
6	Variability	NN	O	variability	prep_of	3	SENT_114	[p8l7t3578r396b3668],
7	,	,	O	,	_	0	SENT_114	[p8l7t3578r396b3668],
8	this	DT	O	this	det	10	SENT_114	[p8l421t3578r559b3647],
9	sample	NN	O	sample	nn	10	SENT_114	[p8l588t3578r854b3667],
10	size	NN	O	size	nsubj	12	SENT_114	[p8l881t3583r1022b3647],
11	would	MD	O	would	aux	12	SENT_114	[p8l1044t3578r1277b3647],
12	provide	VB	O	provide	_	0	SENT_114	[p8l1298t3578r1578b3667],
13	90	CD	PERCENT	90	number	14	SENT_114	[p8l1604t3583r1765b3649],
14	%	NN	PERCENT	%	amod	16	SENT_114	[p8l1604t3583r1765b3649],
15	statistical	JJ	O	statistical	amod	16	SENT_114	[p8l1792t3578r2140b3647],
16	power	NN	O	power	dobj	12	SENT_114	[p8l8t3712r241b3776],
17	for	IN	O	for	_	0	SENT_114	[p8l286t3687r394b3755],
18	a	DT	O	a	det	24	SENT_114	[p8l442t3712r478b3755],
19	two-sided	JJ	O	two-sided	amod	24	SENT_114	[p8l525t3687r905b3765],
20	,	,	O	,	_	0	SENT_114	[p8l525t3687r905b3765],
21	O-O5	NN	O	o-o5	dep	24	SENT_114	[p8l957t3692r1126b3755],
22	signiﬁcance	NN	O	signiﬁcance	nn	24	SENT_114	[p8l1181t3687r1628b3777],
23	level	NN	O	level	nn	24	SENT_114	[p8l1675t3687r1845b3755],
24	test	NN	O	test	prep_for	16	SENT_114	[p8l1891t3701r2024b3755],
25	to	TO	O	to	aux	26	SENT_114	[p8l2070t3701r2139b3755],
26	detect	VB	O	detect	xcomp	12	SENT_114	[p9l10t17r232b84],
27	an	DT	O	a	det	29	SENT_114	[p9l282t41r370b84],
28	effect	NN	O	effect	nn	29	SENT_114	[p9l421t17r626b84],
29	size	NN	O	size	dobj	26	SENT_114	[p9l678t21r818b84],
30	of	IN	O	of	_	0	SENT_114	[p9l871t17r953b84],
31	25	CD	NUMBER	25	num	32	SENT_114	[p9l993t21r1073b84],
32	L/min	NN	O	l/min	prep_of	29	SENT_114	[p9l1131t21r1367b106],
33	in	IN	O	in	_	0	SENT_114	[p9l1417t21r1492b83],
34	morning	NN	TIME	morning	nn	35	SENT_114	[p9l1542t21r1874b107],
35	PEFR	NN	O	pefr	prep_in	32	SENT_114	[p9l1928t21r2139b83],
36	within	IN	O	within	_	0	SENT_114	[p9l8t125r252b194],
37	genotype	NN	O	genotype	prep_within	26	SENT_114	[p9l296t139r633b215],
38	while	IN	O	while	mark	39	SENT_114	[p9l675t125r879b194],
39	allowing	VBG	O	allow	advcl	26	SENT_114	[p9l924t125r1242b215],
40	for	IN	O	for	_	0	SENT_114	[p9l1285t125r1392b194],
41	a	DT	O	a	det	45	SENT_114	[p9l1435t150r1471b194],
42	20	CD	PERCENT	20	number	43	SENT_114	[p9l1517t130r1676b196],
43	%	NN	PERCENT	%	amod	45	SENT_114	[p9l1517t130r1676b196],
44	withdrawal	NN	O	withdrawal	nn	45	SENT_114	[p9l1719t125r2138b194],
45	rate	NN	O	rate	prep_for	39	SENT_114	[p9l9t248r168b303],
46	.	.	O	.	_	0	SENT_114	[p9l9t248r168b303],

1	An	DT	O	a	det	2	SENT_115	[p9l231t239r341b301],
2	SD	NN	O	sd	nsubjpass	11	SENT_115	[p9l406t239r512b303],
3	of	IN	O	of	_	0	SENT_115	[p9l575t234r659b303],
4	42	CD	NUMBER	42	num	5	SENT_115	[p9l704t241r789b301],
5	L/min	NN	O	l/min	prep_of	2	SENT_115	[p9l855t239r1090b323],
6	for	IN	O	for	_	0	SENT_115	[p9l1149t234r1256b303],
7	the	DT	O	the	det	9	SENT_115	[p9l1312t234r1429b303],
8	within-individual	JJ	O	within-individual	amod	9	SENT_115	[p9l1488t234r2138b303],
9	comparison	NN	O	comparison	prep_for	5	SENT_115	[p9l10t349r455b434],
10	was	VBD	O	be	auxpass	11	SENT_115	[p9l502t369r641b413],
11	estimated	VBN	O	estimate	_	0	SENT_115	[p9l694t345r1059b413],
12	from	IN	O	from	_	0	SENT_115	[p9l1107t345r1292b413],
13	the	DT	O	the	det	19	SENT_115	[p9l1340t345r1457b413],
14	Asthma	NNP	ORGANIZATION	Asthma	nn	19	SENT_115	[p9l1505t345r1801b413],
15	Clinical	JJ	ORGANIZATION	clinical	amod	19	SENT_115	[p9l1852t345r2138b413],
16	Research	NN	ORGANIZATION	research	nn	19	SENT_115	[p9l14t454r352b523],
17	Network	NNP	ORGANIZATION	Network	nn	19	SENT_115	[p9l420t454r741b523],
18	BAGS	NNP	ORGANIZATION	BAGS	nn	19	SENT_115	[p9l809t460r1033b523],
19	trial	NN	O	trial	prep_from	11	SENT_115	[p9l1102t454r1253b523],
20	for	IN	O	for	_	0	SENT_115	[p9l1319t454r1427b523],
21	this	DT	O	this	det	23	SENT_115	[p9l1490t454r1626b523],
22	sample-size	JJ	O	sample-size	amod	23	SENT_115	[p9l1698t454r2137b543],
23	calculations	NNS	O	calculation	prep_for	11	SENT_115	[p9l10t563r461b631],
24	The	DT	O	the	det	26	SENT_115	[p9l488t563r633b631],
25	actual	JJ	O	actual	amod	26	SENT_115	[p9l662t563r882b631],
26	variability	NN	O	variability	nsubj	33	SENT_115	[p9l908t563r1280b653],
27	observed	VBN	O	observe	partmod	26	SENT_115	[p9l1307t563r1640b631],
28	in	IN	O	in	_	0	SENT_115	[p9l1667t568r1742b630],
29	this	DT	O	this	det	30	SENT_115	[p9l1769t563r1906b631],
30	study	NN	O	study	prep_in	27	SENT_115	[p9l1939t563r2140b653],
31	was	VBD	O	be	cop	33	SENT_115	[p9l8t698r147b742],
32	28	CD	NUMBER	28	num	33	SENT_115	[p9l199t680r283b742],
33	L/min	NN	O	l/min	ccomp	11	SENT_115	[p9l335t678r589b763],
34	;	:	O	;	_	0	SENT_115	[p9l335t678r589b763],
35	thus	RB	O	thus	advmod	48	SENT_115	[p9l639t674r802b742],
36	the	DT	O	the	det	37	SENT_115	[p9l851t674r967b742],
37	power	NN	O	power	nsubj	48	SENT_115	[p9l1015t698r1248b763],
38	to	TO	O	to	aux	39	SENT_115	[p9l1293t687r1362b742],
39	detect	VB	O	detect	infmod	37	SENT_115	[p9l1412t674r1632b742],
40	a	DT	O	a	det	43	SENT_115	[p9l1680t698r1716b742],
41	25	CD	NUMBER	25	num	43	SENT_115	[p9l1766t678r1846b742],
42	L/min	NN	O	l/min	nn	43	SENT_115	[p9l1903t678r2138b763],
43	difference	NN	O	difference	dobj	39	SENT_115	[p9l10t782r387b851],
44	within	IN	O	within	_	0	SENT_115	[p9l425t782r669b851],
45	genotype	NN	O	genotype	prep_within	43	SENT_115	[p9l709t796r1046b872],
46	was	VBD	O	be	cop	48	SENT_115	[p9l1083t807r1223b851],
47	99	CD	PERCENT	99	num	48	SENT_115	[p9l1265t787r1427b853],
48	%	NN	PERCENT	%	parataxis	33	SENT_115	[p9l1265t787r1427b853],
49	and	CC	O	and	_	0	SENT_115	[p9l1467t782r1605b851],
50	that	IN	O	that	complm	55	SENT_115	[p9l1642t782r1788b851],
51	between	IN	O	between	_	0	SENT_115	[p9l1824t782r2138b851],
52	genotypes	NNS	O	genotype	prep_between	55	SENT_115	[p9l11t904r384b981],
53	was	VBD	O	be	cop	55	SENT_115	[p9l410t914r549b959],
54	92	CD	PERCENT	92	num	55	SENT_115	[p9l579t895r760b962],
55	%	NN	PERCENT	%	ccomp	11	SENT_115	[p9l579t895r760b962],
56	.	.	O	.	_	0	SENT_115	[p9l579t895r760b962],

1	Because	IN	O	because	mark	25	SENT_116	[p9l85t1008r386b1070],
2	of	IN	O	of	_	0	SENT_116	[p9l415t1002r499b1070],
3	the	DT	O	the	det	5	SENT_116	[p9l512t1002r629b1070],
4	repeated	VBN	O	repeat	amod	5	SENT_116	[p9l657t1002r978b1091],
5	measurements	NNS	O	measurement	prep_of	25	SENT_116	[p9l1005t1015r1565b1070],
6	of	IN	O	of	_	0	SENT_116	[p9l1596t1002r1679b1070],
7	the	DT	O	the	dep	8	SENT_116	[p9l1693t1002r1810b1070],
8	primary	JJ	O	primary	prep_of	5	SENT_116	[p9l1837t1006r2140b1091],
9	and	CC	O	and	_	0	SENT_116	[p9l10t1110r149b1179],
10	secondary	JJ	O	secondary	amod	12	SENT_116	[p9l186t1110r561b1200],
11	response	NN	O	response	nn	12	SENT_116	[p9l595t1135r930b1199],
12	variables	NNS	O	variable	prep_of	5	SENT_116	[p9l964t1110r1294b1179],
13	within	IN	O	within	_	0	SENT_116	[p9l1330t1110r1573b1179],
14	each	DT	O	each	det	15	SENT_116	[p9l1610t1110r1779b1179],
15	phase	NN	O	phase	prep_within	5	SENT_116	[p9l1813t1110r2031b1199],
16	of	IN	O	of	_	0	SENT_116	[p9l2068t1110r2151b1179],
17	the	DT	O	the	det	19	SENT_116	[p9l8t1219r125b1287],
18	cross-over	JJ	O	cross-over	amod	19	SENT_116	[p9l179t1243r557b1287],
19	design	NN	O	design	prep_of	15	SENT_116	[p9l608t1219r875b1309],
20	,	,	O	,	_	0	SENT_116	[p9l608t1219r875b1309],
21	longitudinal	JJ	O	longitudinal	amod	23	SENT_116	[p9l929t1219r1390b1309],
22	data	NN	O	datum	nn	23	SENT_116	[p9l1443t1219r1596b1287],
23	analysis	NN	O	analysis	nsubjpass	25	SENT_116	[p9l1650t1219r1943b1309],
24	was	VBD	O	be	auxpass	25	SENT_116	[p9l1996t1243r2135b1288],
25	applied	VBN	O	apply	advcl	41	SENT_116	[p9l10t1330r285b1419],
26	within	IN	O	within	_	0	SENT_116	[p9l348t1330r593b1398],
27	the	DT	O	the	det	28	SENT_116	[p9l658t1330r775b1398],
28	context	NN	O	context	prep_within	25	SENT_116	[p9l843t1343r1112b1398],
29	of	IN	O	of	_	0	SENT_116	[p9l1178t1330r1262b1398],
30	the	DT	O	the	det	32	SENT_116	[p9l1314t1330r1432b1398],
31	intention-to-treat	NN	O	intention-to-treat	nn	32	SENT_116	[p9l1499t1334r2139b1398],
32	principle	NN	O	principle	prep_of	28	SENT_116	[p9l9t1438r344b1527],
33	(	CD	NUMBER	(	num	36	SENT_116	[p9l376t1438r484b1528],
34	all	DT	O	all	dep	35	SENT_116	[p9l376t1438r484b1528],
35	available	JJ	O	available	amod	36	SENT_116	[p9l510t1438r831b1507],
36	data	NNS	O	datum	nsubjpass	41	SENT_116	[p9l858t1438r1011b1507],
37	from	IN	O	from	_	0	SENT_116	[p9l1035t1438r1221b1507],
38	randomised	JJ	O	randomised	amod	39	SENT_116	[p9l1246t1438r1697b1507],
39	individuals	NNS	O	individual	prep_from	36	SENT_116	[p9l1721t1438r2136b1507],
40	were	VBD	O	be	auxpass	41	SENT_116	[p9l8t1571r187b1614],
41	included	VBN	O	include	_	0	SENT_116	[p9l286t1546r613b1614],
42	in	IN	O	in	_	0	SENT_116	[p9l711t1551r786b1613],
43	the	DT	O	the	det	45	SENT_116	[p9l883t1546r999b1614],
44	analysis	NN	O	analysis	nn	45	SENT_116	[p9l1100t1546r1443b1636],
45	)	NN	O	)	prep_in	41	SENT_116	[p9l1100t1546r1443b1636],
46	.	.	O	.	_	0	SENT_116	[p9l1100t1546r1443b1636],

1	Four	CD	NUMBER	four	num	3	SENT_117	[p9l1549t1551r1726b1614],
2	Arg/Arg	NN	O	arg/arg	nn	3	SENT_117	[p9l1822t1551r2138b1636],
3	participants	NNS	O	participant	nsubj	4	SENT_117	[p9l9t1661r451b1746],
4	withdrew	VBD	O	withdraw	_	0	SENT_117	[p9l501t1657r857b1725],
5	before	IN	O	before	_	0	SENT_117	[p9l903t1657r1140b1725],
6	randomisation	NN	O	randomisation	prep_before	4	SENT_117	[p9l1190t1657r1762b1735],
7	,	,	O	,	_	0	SENT_117	[p9l1190t1657r1762b1735],
8	so	RB	O	so	advmod	4	SENT_117	[p9l1818t1681r1895b1725],
9	there	EX	O	there	expl	10	SENT_117	[p9l1945t1657r2137b1725],
10	were	VBD	O	be	ccomp	4	SENT_117	[p9l8t1790r187b1834],
11	four	CD	NUMBER	four	num	13	SENT_117	[p9l213t1765r371b1834],
12	Gly/Gly	JJ	O	gly/gly	amod	13	SENT_117	[p9l398t1765r694b1855],
13	individuals	NNS	O	individual	nsubj	10	SENT_117	[p9l718t1765r1131b1834],
14	without	IN	O	without	_	0	SENT_117	[p9l1158t1765r1450b1834],
15	matched	VBN	O	match	amod	16	SENT_117	[p9l1475t1765r1799b1834],
16	partners	NNS	O	partner	prep_without	10	SENT_117	[p9l1823t1779r2136b1854],
17	during	IN	O	during	_	0	SENT_117	[p9l10t1874r264b1964],
18	the	DT	O	the	det	20	SENT_117	[p9l307t1874r424b1942],
19	randomised	JJ	O	randomised	amod	20	SENT_117	[p9l471t1874r924b1942],
20	part	NN	O	part	prep_during	16	SENT_117	[p9l967t1888r1117b1963],
21	of	IN	O	of	_	0	SENT_117	[p9l1162t1874r1246b1942],
22	the	DT	O	the	det	23	SENT_117	[p9l1277t1874r1395b1942],
23	trial	NN	O	trial	prep_of	20	SENT_117	[p9l1440t1874r1608b1942],
24	.	.	O	.	_	0	SENT_117	[p9l1440t1874r1608b1942],

1	A	DT	O	a	det	3	SENT_118	[p9l1657t1879r1716b1941],
2	secondary	JJ	O	secondary	amod	3	SENT_118	[p9l1764t1874r2140b1964],
3	analysis	NN	O	analysis	nsubj	10	SENT_118	[p9l10t1985r305b2074],
4	that	IN	O	that	nsubj	5	SENT_118	[p9l332t1985r478b2053],
5	excluded	VBN	O	exclude	rcmod	3	SENT_118	[p9l504t1985r835b2053],
6	these	DT	O	these	det	9	SENT_118	[p9l859t1985r1055b2053],
7	four	CD	NUMBER	four	num	9	SENT_118	[p9l1083t1985r1241b2053],
8	unmatched	JJ	O	unmatched	amod	9	SENT_118	[p9l1265t1985r1696b2053],
9	individuals	NNS	O	individual	dobj	5	SENT_118	[p9l1721t1985r2135b2053],
10	gave	VBD	O	give	_	0	SENT_118	[p9l11t2118r174b2183],
11	results	NNS	O	result	iobj	10	SENT_118	[p9l204t2093r452b2162],
12	nearly	RB	O	nearly	advmod	13	SENT_118	[p9l484t2093r717b2183],
13	identical	JJ	O	identical	amod	19	SENT_118	[p9l744t2093r1064b2162],
14	to	TO	O	to	_	0	SENT_118	[p9l1093t2107r1162b2162],
15	those	DT	O	those	prep_to	13	SENT_118	[p9l1191t2093r1392b2162],
16	of	IN	O	of	_	0	SENT_118	[p9l1424t2093r1508b2162],
17	the	DT	O	the	det	18	SENT_118	[p9l1523t2093r1639b2162],
18	intentiontotreat	NN	O	intentiontotreat	prep_of	15	SENT_118	[p9l1669t2098r2137b2162, p9l8t2215r179b2269],
19	analysis	NN	O	analysis	dobj	10	SENT_118	[p9l204t2201r519b2291],
20	,	,	O	,	_	0	SENT_118	[p9l204t2201r519b2291],
21	so	RB	O	so	advmod	22	SENT_118	[p9l551t2225r628b2269],
22	only	RB	O	only	advmod	10	SENT_118	[p9l655t2201r816b2291],
23	the	DT	O	the	det	24	SENT_118	[p9l838t2201r954b2269],
24	latter	JJ	O	latter	nsubjpass	26	SENT_118	[p9l979t2201r1175b2269],
25	is	VBZ	O	be	auxpass	26	SENT_118	[p9l1199t2206r1257b2269],
26	presented	VBN	O	present	dep	22	SENT_118	[p9l1284t2201r1673b2290],
27	.	.	O	.	_	0	SENT_118	[p9l1284t2201r1673b2290],

1	The	DT	O	the	det	2	SENT_119	[p9l79t2311r224b2378],
2	data	NNS	O	datum	nsubjpass	12	SENT_119	[p9l279t2311r431b2378],
3	on	IN	O	on	_	0	SENT_119	[p9l486t2335r580b2378],
4	change	NN	O	change	prep_on	2	SENT_119	[p9l634t2311r900b2401],
5	from	IN	O	from	_	0	SENT_119	[p9l953t2311r1139b2378],
6	baseline	NN	O	baseline	prep_from	4	SENT_119	[p9l1191t2311r1500b2378],
7	for	IN	O	for	_	0	SENT_119	[p9l1553t2311r1661b2378],
8	continuous	JJ	O	continuous	amod	10	SENT_119	[p9l1713t2315r2136b2378],
9	outcome	NN	O	outcome	nn	10	SENT_119	[p9l10t2434r335b2489],
10	variables	NNS	O	variable	prep_for	6	SENT_119	[p9l370t2420r700b2489],
11	were	VBD	O	be	auxpass	12	SENT_119	[p9l737t2445r916b2489],
12	modelled	VBN	O	model	_	0	SENT_119	[p9l952t2420r1304b2489],
13	in	IN	O	in	_	0	SENT_119	[p9l1338t2425r1414b2488],
14	a	DT	O	a	det	17	SENT_119	[p9l1451t2445r1488b2489],
15	piecewise	JJ	O	piecewise	amod	17	SENT_119	[p9l1524t2425r1885b2509],
16	linear	JJ	O	linear	amod	17	SENT_119	[p9l1921t2420r2140b2489],
17	fashion	NN	O	fashion	prep_in	12	SENT_119	[p9l9t2529r290b2597],
18	with	IN	O	with	_	0	SENT_119	[p9l316t2529r483b2597],
19	one	CD	NUMBER	one	num	20	SENT_119	[p9l513t2554r648b2597],
20	slope	NN	O	slope	prep_with	17	SENT_119	[p9l681t2529r872b2618],
21	during	IN	O	during	_	0	SENT_119	[p9l904t2529r1157b2619],
22	each	DT	O	each	det	24	SENT_119	[p9l1187t2529r1356b2597],
23	washout	NN	O	washout	nn	24	SENT_119	[p9l1383t2529r1701b2598],
24	period	NN	O	period	prep_during	20	SENT_119	[p9l1729t2529r1971b2618],
25	and	CC	O	and	_	0	SENT_119	[p9l2000t2529r2139b2597],
26	two	CD	NUMBER	two	num	27	SENT_119	[p9l8t2652r142b2707],
27	slopes	NNS	O	slope	conj_and	20	SENT_119	[p9l192t2639r419b2728],
28	during	IN	O	during	_	0	SENT_119	[p9l469t2639r723b2729],
29	each	DT	O	each	det	32	SENT_119	[p9l770t2639r939b2706],
30	randomised	JJ	O	randomised	amod	32	SENT_119	[p9l985t2639r1438b2706],
31	treatment	NN	O	treatment	nn	32	SENT_119	[p9l1482t2652r1852b2706],
32	period	NN	O	period	prep_during	27	SENT_119	[p9l1898t2639r2139b2728],
33	(	CD	NUMBER	(	number	34	SENT_119	[p9l15t2754r173b2837],
34	one	CD	NUMBER	one	num	35	SENT_119	[p9l15t2754r173b2837],
35	slope	NN	O	slope	tmod	12	SENT_119	[p9l203t2747r393b2836],
36	for	IN	O	for	_	0	SENT_119	[p9l420t2747r527b2816],
37	the	DT	DURATION	the	det	40	SENT_119	[p9l550t2747r667b2816],
38	first	JJ	DURATION	first	amod	40	SENT_119	[p9l694t2747r844b2816],
39	5	CD	DURATION	5	num	40	SENT_119	[p9l871t2752r906b2815],
40	weeks	NNS	NUMBER	week	prep_for	35	SENT_119	[p9l933t2747r1161b2816],
41	and	CC	O	and	_	0	SENT_119	[p9l1190t2747r1329b2816],
42	another	DT	O	another	det	43	SENT_119	[p9l1354t2747r1645b2816],
43	slope	NN	O	slope	conj_and	35	SENT_119	[p9l1671t2747r1863b2836],
44	for	IN	O	for	_	0	SENT_119	[p9l1889t2747r1997b2816],
45	the	DT	O	the	det	48	SENT_119	[p9l2020t2747r2137b2816],
46	remaining	VBG	O	remain	amod	48	SENT_119	[p9l9t2860r404b2945],
47	11	CD	DURATION	11	num	48	SENT_119	[p9l470t2861r546b2922],
48	weeks	NNS	NUMBER	week	prep_for	43	SENT_119	[p9l610t2855r887b2945],
49	)	CD	NUMBER	)	dep	35	SENT_119	[p9l610t2855r887b2945],
50	.	.	O	.	_	0	SENT_119	[p9l610t2855r887b2945],

1	The	DT	O	the	det	2	SENT_120	[p9l949t2855r1094b2923],
2	rationale	NN	O	rationale	nsubj	11	SENT_120	[p9l1155t2855r1484b2923],
3	for	IN	O	for	_	0	SENT_120	[p9l1545t2855r1652b2923],
4	two	CD	NUMBER	two	num	5	SENT_120	[p9l1710t2869r1843b2924],
5	slopes	NNS	O	slope	prep_for	2	SENT_120	[p9l1908t2855r2136b2944],
6	during	IN	O	during	_	0	SENT_120	[p9l10t2965r264b3055],
7	the	DT	O	the	det	10	SENT_120	[p9l285t2965r401b3032],
8	randomised	JJ	O	randomised	amod	10	SENT_120	[p9l425t2965r878b3032],
9	treatment	NN	O	treatment	nn	10	SENT_120	[p9l898t2978r1269b3032],
10	periods	NNS	O	period	prep_during	5	SENT_120	[p9l1290t2965r1565b3054],
11	was	VBD	O	be	_	0	SENT_120	[p9l1588t2989r1728b3033],
12	to	TO	O	to	aux	13	SENT_120	[p9l1752t2978r1821b3032],
13	account	VB	O	account	xcomp	11	SENT_120	[p9l1847t2978r2139b3032],

1	Mean	NN	O	mean	dep	7	SENT_121	[p9l465t3102r523b3120],
2	(	CD	NUMBER	(	num	3	SENT_121	[p9l530t3101r575b3125],
3	SD	NN	O	sd	dep	1	SENT_121	[p9l530t3101r575b3125],
4	)	CD	NUMBER	)	num	5	SENT_121	[p9l530t3101r575b3125],
5	Arg/Arg	NN	O	arg/arg	dep	7	SENT_121	[p9l464t3149r550b3174],
6	Gly/Gly	NNP	O	Gly/Gly	nn	7	SENT_121	[p9l1160t3148r1239b3174],
7	Start	NNP	O	Start	_	0	SENT_121	[p9l465t3198r513b3217],
8	of	IN	O	of	_	0	SENT_121	[p9l520t3196r542b3217],
9	albuterol	NN	O	albuterol	nn	11	SENT_121	[p9l546t3197r637b3217],
10	(	CD	NUMBER	(	num	11	SENT_121	[p9l645t3196r713b3222],
11	n	NN	O	n	prep_of	7	SENT_121	[p9l645t3196r713b3222],
12	=	JJ	O	=	amod	38	SENT_121	[p9l645t3196r713b3222],
13	36	CD	NUMBER	36	number	14	SENT_121	[p9l645t3196r713b3222],
14	)	CD	NUMBER	)	num	15	SENT_121	[p9l645t3196r713b3222],
15	Start	NNP	O	Start	dep	12	SENT_121	[p9l835t3198r883b3217],
16	of	IN	O	of	_	0	SENT_121	[p9l889t3196r912b3217],
17	placebo	NN	O	placebo	nn	19	SENT_121	[p9l916t3197r994b3222],
18	(	CD	NUMBER	(	num	19	SENT_121	[p9l1001t3196r1070b3222],
19	n	NN	O	n	prep_of	15	SENT_121	[p9l1001t3196r1070b3222],
20	=	JJ	O	=	amod	38	SENT_121	[p9l1001t3196r1070b3222],
21	36	CD	NUMBER	36	number	22	SENT_121	[p9l1001t3196r1070b3222],
22	)	CD	NUMBER	)	num	38	SENT_121	[p9l1001t3196r1070b3222],
23	Start	NNP	O	Start	dep	38	SENT_121	[p9l1161t3198r1209b3217],
24	of	IN	O	of	_	0	SENT_121	[p9l1215t3196r1237b3217],
25	albuterol	NN	O	albuterol	nn	27	SENT_121	[p9l1242t3197r1332b3217],
26	(	CD	NUMBER	(	num	27	SENT_121	[p9l1340t3196r1409b3222],
27	n	NN	O	n	prep_of	23	SENT_121	[p9l1340t3196r1409b3222],
28	=	JJ	O	=	amod	38	SENT_121	[p9l1340t3196r1409b3222],
29	38	CD	NUMBER	38	number	30	SENT_121	[p9l1340t3196r1409b3222],
30	)	CD	NUMBER	)	num	38	SENT_121	[p9l1340t3196r1409b3222],
31	Start	NNP	O	Start	dep	38	SENT_121	[p9l1507t3198r1554b3217],
32	of	IN	O	of	_	0	SENT_121	[p9l1561t3196r1583b3216],
33	placebo	NN	O	placebo	nn	35	SENT_121	[p9l1587t3197r1666b3222],
34	(	CD	NUMBER	(	num	35	SENT_121	[p9l1673t3198r1742b3222],
35	n	NN	O	n	prep_of	31	SENT_121	[p9l1673t3198r1742b3222],
36	=	JJ	O	=	amod	38	SENT_121	[p9l1673t3198r1742b3222],
37	39	CD	NUMBER	39	num	38	SENT_121	[p9l1673t3198r1742b3222],
38	)	NN	O	)	rcmod	11	SENT_121	[p9l1673t3198r1742b3222],

1	Morning	NN	TIME	morning	_	0	SENT_122	[p9l50t3246r136b3271],
2	PEFR	NN	O	pefr	dep	1	SENT_122	[p9l144t3247r199b3268],
3	.	.	O	.	_	0	SENT_122	[p9l144t3247r199b3268],

1	L/min	JJ	O	l/min	dep	208	SENT_123	[p9l207t3246r275b3267],
2	*	NN	O	*	dep	208	SENT_123	[p9l207t3246r275b3267],
3	469	CD	NUMBER	469	dep	208	SENT_123	[p9l462t3245r502b3268],
4	(	NN	O	(	dep	208	SENT_123	[p9l509t3246r565b3270],
5	131	CD	NUMBER	131	dep	208	SENT_123	[p9l509t3246r565b3270],
6	)	NN	O	)	dep	208	SENT_123	[p9l509t3246r565b3270],
7	470	CD	NUMBER	470	dep	208	SENT_123	[p9l840t3248r880b3267],
8	(	NN	O	(	dep	208	SENT_123	[p9l887t3246r942b3270],
9	139	CD	NUMBER	139	dep	208	SENT_123	[p9l887t3246r942b3270],
10	)	NN	O	)	dep	208	SENT_123	[p9l887t3246r942b3270],
11	476	CD	NUMBER	476	dep	208	SENT_123	[p9l1162t3245r1203b3267],
12	(	NN	O	(	dep	208	SENT_123	[p9l1210t3246r1266b3270],
13	149	CD	NUMBER	149	dep	208	SENT_123	[p9l1210t3246r1266b3270],
14	)	NN	O	)	dep	208	SENT_123	[p9l1210t3246r1266b3270],
15	469	CD	NUMBER	469	dep	208	SENT_123	[p9l1509t3245r1549b3268],
16	(	NN	O	(	dep	208	SENT_123	[p9l1556t3246r1612b3270],
17	124	CD	NUMBER	124	dep	208	SENT_123	[p9l1556t3246r1612b3270],
18	)	CD	NUMBER	)	dep	208	SENT_123	[p9l1556t3246r1612b3270],
19	Evening	NN	TIME	evening	dep	208	SENT_123	[p9l51t3282r130b3307],
20	PEFR	NN	O	pefr	dep	208	SENT_123	[p9l139t3283r193b3305],
21	,	,	O	,	_	0	SENT_123	[p9l139t3283r193b3305],
22	L/min	NN	O	l/min	dep	208	SENT_123	[p9l201t3282r270b3304],
23	*	NN	O	*	dep	208	SENT_123	[p9l201t3282r270b3304],
24	467	CD	NUMBER	467	dep	208	SENT_123	[p9l462t3281r502b3304],
25	(	NN	O	(	dep	208	SENT_123	[p9l509t3282r565b3306],
26	122	CD	NUMBER	122	dep	208	SENT_123	[p9l509t3282r565b3306],
27	)	NN	O	)	dep	208	SENT_123	[p9l509t3282r565b3306],
28	481	CD	NUMBER	481	dep	208	SENT_123	[p9l840t3281r879b3304],
29	(	NN	O	(	dep	208	SENT_123	[p9l887t3282r942b3306],
30	131	CD	NUMBER	131	dep	208	SENT_123	[p9l887t3282r942b3306],
31	)	NN	O	)	dep	208	SENT_123	[p9l887t3282r942b3306],
32	490	CD	NUMBER	490	dep	208	SENT_123	[p9l1162t3284r1203b3304],
33	(	NN	O	(	dep	208	SENT_123	[p9l1210t3281r1266b3306],
34	146	CD	NUMBER	146	dep	208	SENT_123	[p9l1210t3281r1266b3306],
35	)	NN	O	)	dep	208	SENT_123	[p9l1210t3281r1266b3306],
36	481	CD	NUMBER	481	dep	208	SENT_123	[p9l1509t3281r1548b3304],
37	(	NN	O	(	dep	208	SENT_123	[p9l1556t3282r1612b3306],
38	125	CD	NUMBER	125	dep	208	SENT_123	[p9l1556t3282r1612b3306],
39	)	CD	NUMBER	)	dep	208	SENT_123	[p9l1556t3282r1612b3306],
40	PEFR	NN	O	pefr	dep	208	SENT_123	[p9l51t3320r100b3338],
41	variability	NN	O	variability	dep	208	SENT_123	[p9l106t3318r210b3344],
42	,	,	O	,	_	0	SENT_123	[p9l106t3318r210b3344],
43	%	NN	O	%	dep	208	SENT_123	[p9l218t3319r245b3338],
44	*	CD	NUMBER	*	dep	208	SENT_123	[p9l218t3319r245b3338],
45	o41	NN	O	o41	dep	208	SENT_123	[p9l490t3319r577b3343],
46	(	CD	NUMBER	(	dep	208	SENT_123	[p9l490t3319r577b3343],
47	4-7	CD	NUMBER	4-7	dep	208	SENT_123	[p9l490t3319r577b3343],
48	)	NN	O	)	dep	208	SENT_123	[p9l490t3319r577b3343],
49	o	NN	O	o	dep	208	SENT_123	[p9l868t3320r885b3338],
50	-	:	O	-	_	0	SENT_123	[p9l868t3320r885b3338],
51	5	CD	NUMBER	5	dep	208	SENT_123	[p9l888t3321r899b3341],
52	(	NN	O	(	dep	208	SENT_123	[p9l907t3319r954b3343],
53	749	CD	NUMBER	749	dep	208	SENT_123	[p9l907t3319r954b3343],
54	)	CD	NUMBER	)	dep	208	SENT_123	[p9l907t3319r954b3343],
55	1.7	CD	NUMBER	1.7	dep	208	SENT_123	[p9l1191t3321r1222b3340],
56	(	NN	O	(	dep	208	SENT_123	[p9l1230t3319r1277b3343],
57	4.9	CD	NUMBER	4.9	dep	208	SENT_123	[p9l1230t3319r1277b3343],
58	)	CD	NUMBER	)	dep	208	SENT_123	[p9l1230t3319r1277b3343],
59	1-6	CD	NUMBER	1-6	dep	208	SENT_123	[p9l1539t3318r1569b3338],
60	(	NN	O	(	dep	208	SENT_123	[p9l1576t3318r1624b3343],
61	6-1	CD	NUMBER	6-1	dep	208	SENT_123	[p9l1576t3318r1624b3343],
62	)	CD	NUMBER	)	dep	208	SENT_123	[p9l1576t3318r1624b3343],
63	FEV	NN	O	fev	dep	208	SENT_123	[p9l51t3356r100b3379],
64	,	,	O	,	_	0	SENT_123	[p9l51t3356r100b3379],
65	,	,	O	,	_	0	SENT_123	[p9l51t3356r100b3379],
66	LT	JJ	O	lt	dep	208	SENT_123	[p9l108t3356r129b3375],
67	307	CD	NUMBER	307	dep	208	SENT_123	[p9l490t3357r536b3377],
68	(	NN	O	(	dep	208	SENT_123	[p9l543t3355r605b3379],
69	097	CD	NUMBER	097	dep	208	SENT_123	[p9l543t3355r605b3379],
70	)	NN	O	)	dep	208	SENT_123	[p9l543t3355r605b3379],
71	299	CD	NUMBER	299	dep	208	SENT_123	[p9l869t3357r913b3377],
72	(	NN	O	(	dep	208	SENT_123	[p9l921t3354r982b3379],
73	098	CD	NUMBER	098	dep	208	SENT_123	[p9l921t3354r982b3379],
74	)	NN	O	)	dep	208	SENT_123	[p9l921t3354r982b3379],
75	3-08	CD	NUMBER	3-08	dep	208	SENT_123	[p9l1191t3354r1236b3377],
76	(	CD	NUMBER	(	dep	208	SENT_123	[p9l1244t3354r1305b3379],
77	0-81	CD	NUMBER	0-81	dep	208	SENT_123	[p9l1244t3354r1305b3379],
78	)	NN	O	)	dep	208	SENT_123	[p9l1244t3354r1305b3379],
79	3	CD	NUMBER	3	dep	208	SENT_123	[p9l1538t3355r1651b3379],
80	‘	NN	O	‘	dep	208	SENT_123	[p9l1538t3355r1651b3379],
81	11	CD	NUMBER	11	dep	208	SENT_123	[p9l1538t3355r1651b3379],
82	(	CD	NUMBER	(	dep	208	SENT_123	[p9l1538t3355r1651b3379],
83	O	NN	O	o	dep	208	SENT_123	[p9l1538t3355r1651b3379],
84	«	CD	NUMBER	«	dep	208	SENT_123	[p9l1538t3355r1651b3379],
85	72	CD	NUMBER	72	dep	208	SENT_123	[p9l1538t3355r1651b3379],
86	)	CD	NUMBER	)	dep	208	SENT_123	[p9l1538t3355r1651b3379],
87	FEV	NN	O	fev	dep	208	SENT_123	[p9l51t3392r100b3416],
88	,	,	O	,	_	0	SENT_123	[p9l51t3392r100b3416],
89	,	,	O	,	_	0	SENT_123	[p9l51t3392r100b3416],
90	%	NN	O	%	dep	208	SENT_123	[p9l107t3394r124b3411],
91	predictedt	NN	O	predictedt	dep	208	SENT_123	[p9l131t3391r238b3417],
92	902	CD	NUMBER	902	dep	208	SENT_123	[p9l476t3393r521b3413],
93	(	NN	O	(	dep	208	SENT_123	[p9l529t3390r591b3416],
94	138	CD	NUMBER	138	dep	208	SENT_123	[p9l529t3390r591b3416],
95	)	CD	NUMBER	)	dep	208	SENT_123	[p9l529t3390r591b3416],
96	88-5	CD	NUMBER	88-5	dep	208	SENT_123	[p9l854t3390r899b3413],
97	(	NN	O	(	dep	208	SENT_123	[p9l907t3392r968b3416],
98	15-7	CD	NUMBER	15-7	dep	208	SENT_123	[p9l907t3392r968b3416],
99	)	CD	NUMBER	)	dep	208	SENT_123	[p9l907t3392r968b3416],
100	87-4	CD	NUMBER	87-4	dep	208	SENT_123	[p9l1177t3390r1223b3413],
101	(	NN	O	(	dep	208	SENT_123	[p9l1230t3391r1291b3416],
102	116	CD	NUMBER	116	dep	208	SENT_123	[p9l1230t3391r1291b3416],
103	)	CD	NUMBER	)	dep	208	SENT_123	[p9l1230t3391r1291b3416],
104	90-4	CD	NUMBER	90-4	dep	208	SENT_123	[p9l1524t3393r1570b3413],
105	(	NN	O	(	dep	208	SENT_123	[p9l1576t3392r1624b3416],
106	9-3	CD	NUMBER	9-3	dep	208	SENT_123	[p9l1576t3392r1624b3416],
107	)	CD	NUMBER	)	dep	208	SENT_123	[p9l1576t3392r1624b3416],
108	FVC	NN	O	fvc	dep	208	SENT_123	[p9l51t3429r94b3451],
109	,	,	O	,	_	0	SENT_123	[p9l51t3429r94b3451],
110	L'	NN	O	l'	dep	208	SENT_123	[p9l103t3429r123b3449],
111	l'	NN	O	l'	dep	208	SENT_123	[p9l103t3429r123b3449],
112	4	CD	NUMBER	4	dep	208	SENT_123	[p9l489t3428r604b3452],
113	~	NN	O	~	dep	208	SENT_123	[p9l489t3428r604b3452],
114	14	CD	NUMBER	14	dep	208	SENT_123	[p9l489t3428r604b3452],
115	(	NN	O	(	dep	208	SENT_123	[p9l489t3428r604b3452],
116	1	CD	NUMBER	1	dep	208	SENT_123	[p9l489t3428r604b3452],
117	«	CD	NUMBER	«	dep	208	SENT_123	[p9l489t3428r604b3452],
118	20	CD	NUMBER	20	dep	208	SENT_123	[p9l489t3428r604b3452],
119	)	NN	O	)	dep	208	SENT_123	[p9l489t3428r604b3452],
120	4	CD	NUMBER	4	dep	208	SENT_123	[p9l867t3427r981b3452],
121	‘	CD	NUMBER	‘	dep	208	SENT_123	[p9l867t3427r981b3452],
122	08	CD	NUMBER	08	dep	208	SENT_123	[p9l867t3427r981b3452],
123	(	NN	O	(	dep	208	SENT_123	[p9l867t3427r981b3452],
124	1	CD	NUMBER	1	dep	208	SENT_123	[p9l867t3427r981b3452],
125	«	CD	NUMBER	«	dep	208	SENT_123	[p9l867t3427r981b3452],
126	23	CD	NUMBER	23	dep	208	SENT_123	[p9l867t3427r981b3452],
127	)	NN	O	)	dep	208	SENT_123	[p9l867t3427r981b3452],
128	4-08	CD	NUMBER	4-08	dep	208	SENT_123	[p9l1190t3427r1236b3450],
129	(	CD	NUMBER	(	dep	208	SENT_123	[p9l1244t3428r1305b3452],
130	1-12	CD	NUMBER	1-12	dep	208	SENT_123	[p9l1244t3428r1305b3452],
131	)	NN	O	)	dep	208	SENT_123	[p9l1244t3428r1305b3452],
132	4-05	CD	NUMBER	4-05	dep	208	SENT_123	[p9l1537t3430r1582b3450],
133	(	CD	NUMBER	(	dep	208	SENT_123	[p9l1590t3428r1651b3452],
134	1-03	CD	NUMBER	1-03	dep	208	SENT_123	[p9l1590t3428r1651b3452],
135	)	CD	NUMBER	)	dep	208	SENT_123	[p9l1590t3428r1651b3452],
136	Morning	NN	TIME	morning	dep	208	SENT_123	[p9l50t3465r136b3490],
137	symptom	NN	O	symptom	dep	208	SENT_123	[p9l143t3467r240b3489],
138	score	NN	NUMBER	score	dep	208	SENT_123	[p9l248t3464r309b3484],
139	’	CD	NUMBER	’	dep	208	SENT_123	[p9l248t3464r309b3484],
140	0-1	CD	NUMBER	0-1	dep	208	SENT_123	[p9l490t3466r521b3483],
141	(	NN	O	(	dep	208	SENT_123	[p9l529t3465r577b3489],
142	0-2	CD	NUMBER	0-2	dep	208	SENT_123	[p9l529t3465r577b3489],
143	)	CD	NUMBER	)	dep	208	SENT_123	[p9l529t3465r577b3489],
144	0-2	CD	NUMBER	0-2	dep	208	SENT_123	[p9l868t3466r899b3483],
145	(	NN	O	(	dep	208	SENT_123	[p9l907t3465r954b3489],
146	0-2	CD	NUMBER	0-2	dep	208	SENT_123	[p9l907t3465r954b3489],
147	)	CD	NUMBER	)	dep	208	SENT_123	[p9l907t3465r954b3489],
148	0-2	CD	NUMBER	0-2	dep	208	SENT_123	[p9l1191t3466r1222b3484],
149	(	NN	O	(	dep	208	SENT_123	[p9l1230t3465r1277b3489],
150	0-4	CD	NUMBER	0-4	dep	208	SENT_123	[p9l1230t3465r1277b3489],
151	)	CD	NUMBER	)	dep	208	SENT_123	[p9l1230t3465r1277b3489],
152	0-2	CD	NUMBER	0-2	dep	208	SENT_123	[p9l1538t3466r1568b3484],
153	(	NN	O	(	dep	208	SENT_123	[p9l1576t3465r1624b3489],
154	0-4	CD	NUMBER	0-4	dep	208	SENT_123	[p9l1576t3465r1624b3489],
155	)	CD	NUMBER	)	dep	208	SENT_123	[p9l1576t3465r1624b3489],
156	Rescue	NN	O	rescue	dep	208	SENT_123	[p9l51t3502r120b3519],
157	ipratropium	NN	O	ipratropium	dep	208	SENT_123	[p9l127t3501r254b3525],
158	,	,	O	,	_	0	SENT_123	[p9l127t3501r254b3525],
159	puffs	NNS	O	puff	dep	208	SENT_123	[p9l261t3500r311b3525],
160	per	IN	O	per	dep	208	SENT_123	[p9l318t3507r350b3525],
161	day	NN	DURATION	day	dep	208	SENT_123	[p9l356t3500r402b3525],
162	*	CD	NUMBER	*	dep	208	SENT_123	[p9l356t3500r402b3525],
163	06	CD	NUMBER	06	dep	208	SENT_123	[p9l490t3500r522b3519],
164	(	NN	O	(	dep	208	SENT_123	[p9l529t3501r577b3524],
165	1-4	CD	NUMBER	1-4	dep	208	SENT_123	[p9l529t3501r577b3524],
166	)	CD	NUMBER	)	dep	208	SENT_123	[p9l529t3501r577b3524],
167	06	CD	NUMBER	06	dep	208	SENT_123	[p9l868t3500r900b3519],
168	(	NN	O	(	dep	208	SENT_123	[p9l907t3501r954b3524],
169	0-9	CD	NUMBER	0-9	dep	208	SENT_123	[p9l907t3501r954b3524],
170	)	CD	NUMBER	)	dep	208	SENT_123	[p9l907t3501r954b3524],
171	0-8	CD	NUMBER	0-8	dep	208	SENT_123	[p9l1191t3500r1222b3519],
172	(	NN	O	(	dep	208	SENT_123	[p9l1230t3501r1277b3524],
173	1-3	CD	NUMBER	1-3	dep	208	SENT_123	[p9l1230t3501r1277b3524],
174	)	CD	NUMBER	)	dep	208	SENT_123	[p9l1230t3501r1277b3524],
175	0-7	CD	NUMBER	0-7	dep	208	SENT_123	[p9l1538t3503r1569b3522],
176	(	NN	O	(	dep	208	SENT_123	[p9l1576t3501r1624b3524],
177	1-5	CD	NUMBER	1-5	dep	208	SENT_123	[p9l1576t3501r1624b3524],
178	)	CD	NUMBER	)	dep	208	SENT_123	[p9l1576t3501r1624b3524],
179	Rescue	NN	O	rescue	dep	208	SENT_123	[p9l51t3537r120b3555],
180	albuterol	NN	O	albuterol	dep	208	SENT_123	[p9l126t3535r222b3559],
181	,	,	O	,	_	0	SENT_123	[p9l126t3535r222b3559],
182	puffs	NNS	O	puff	dep	208	SENT_123	[p9l230t3535r281b3561],
183	per	IN	O	per	dep	208	SENT_123	[p9l288t3542r319b3561],
184	day	NN	DURATION	day	dep	208	SENT_123	[p9l325t3535r371b3561],
185	*	CD	NUMBER	*	dep	208	SENT_123	[p9l325t3535r371b3561],
186	0	CD	NUMBER	0	dep	208	SENT_123	[p9l490t3537r577b3561],
187	~	NN	O	~	dep	208	SENT_123	[p9l490t3537r577b3561],
188	1	CD	NUMBER	1	dep	208	SENT_123	[p9l490t3537r577b3561],
189	(	CD	NUMBER	(	dep	208	SENT_123	[p9l490t3537r577b3561],
190	0-3	CD	NUMBER	0-3	dep	208	SENT_123	[p9l490t3537r577b3561],
191	)	NN	O	)	dep	208	SENT_123	[p9l490t3537r577b3561],
192	0-3	CD	NUMBER	0-3	dep	208	SENT_123	[p9l868t3538r899b3558],
193	(	CD	NUMBER	(	dep	208	SENT_123	[p9l907t3537r954b3561],
194	0-9	CD	NUMBER	0-9	dep	208	SENT_123	[p9l907t3537r954b3561],
195	)	NN	O	)	dep	208	SENT_123	[p9l907t3537r954b3561],
196	0-2	CD	NUMBER	0-2	dep	208	SENT_123	[p9l1191t3538r1222b3555],
197	(	CD	NUMBER	(	dep	208	SENT_123	[p9l1230t3537r1277b3561],
198	0-5	CD	NUMBER	0-5	dep	208	SENT_123	[p9l1230t3537r1277b3561],
199	)	NN	O	)	dep	208	SENT_123	[p9l1230t3537r1277b3561],
200	0-3	CD	NUMBER	0-3	dep	208	SENT_123	[p9l1538t3538r1568b3558],
201	(	CD	NUMBER	(	dep	208	SENT_123	[p9l1576t3537r1624b3561],
202	L1	NN	O	l1	dep	208	SENT_123	[p9l1576t3537r1624b3561],
203	)	CD	NUMBER	)	dep	208	SENT_123	[p9l1576t3537r1624b3561],
204	FVC	NN	O	fvc	dep	208	SENT_123	[p9l39t3591r147b3610],
205	=	JJ	O	=	dep	208	SENT_123	[p9l39t3591r147b3610],
206	forced	JJ	O	forced	dep	208	SENT_123	[p9l39t3591r147b3610],
207	vital	JJ	O	vital	dep	208	SENT_123	[p9l152t3591r191b3610],
208	capacity	NN	O	capacity	_	0	SENT_123	[p9l198t3592r279b3615],
209	.	.	O	.	_	0	SENT_123	[p9l198t3592r279b3615],

1	*	NN	O	*	nn	2	SENT_124	[p9l286t3592r372b3615],
2	Average	NN	O	average	_	0	SENT_124	[p9l286t3592r372b3615],
3	of	IN	O	of	_	0	SENT_124	[p9l378t3591r398b3610],
4	the	DT	DURATION	the	det	6	SENT_124	[p9l402t3591r433b3610],
5	4	CD	DURATION	4	num	6	SENT_124	[p9l438t3594r451b3612],
6	weeks	NNS	NUMBER	week	prep_of	2	SENT_124	[p9l456t3591r514b3610],
7	preceding	VBG	O	precede	partmod	2	SENT_124	[p9l520t3591r611b3615],
8	the	DT	O	the	det	9	SENT_124	[p9l617t3591r648b3610],
9	phase	NN	O	phase	dobj	7	SENT_124	[p9l654t3591r709b3615],
10	during	IN	O	during	_	0	SENT_124	[p9l715t3591r775b3615],
11	the	DT	O	the	det	14	SENT_124	[p9l781t3591r813b3610],
12	run	NN	O	run	nn	14	SENT_124	[p9l819t3591r979b3612],
13	—	CD	NUMBER	—	num	14	SENT_124	[p9l819t3591r979b3612],
14	in/wash-out	NN	O	in/wash-out	prep_during	7	SENT_124	[p9l819t3591r979b3612],
15	.	.	O	.	_	0	SENT_124	[p9l819t3591r979b3612],

1	tAverage	NN	O	taverage	_	0	SENT_125	[p9l986t3592r1073b3615],
2	of	IN	O	of	_	0	SENT_125	[p9l1079t3591r1100b3610],
3	measurement	NN	O	measurement	prep_of	1	SENT_125	[p9l1105t3595r1235b3610],
4	on	IN	O	on	_	0	SENT_125	[p9l1241t3597r1264b3610],
5	the	DT	DATE	the	det	6	SENT_125	[p9l1270t3591r1301b3610],
6	day	NN	DATE	day	prep_on	3	SENT_125	[p9l1307t3591r1340b3615],
7	of	IN	O	of	_	0	SENT_125	[p9l1346t3591r1366b3610],
8	the	DT	O	the	det	9	SENT_125	[p9l1370t3591r1401b3610],
9	start	NN	O	start	prep_of	6	SENT_125	[p9l1407t3594r1450b3610],
10	of	IN	O	of	_	0	SENT_125	[p9l1455t3591r1476b3610],
11	the	DT	O	the	det	12	SENT_125	[p9l1479t3591r1511b3610],
12	phase	NN	O	phase	prep_of	9	SENT_125	[p9l1517t3591r1570b3615],
13	and	CC	O	and	_	0	SENT_125	[p9l1576t3591r1610b3610],
14	the	DT	O	the	det	15	SENT_125	[p9l1616t3591r1647b3610],
15	visit	NN	O	visit	conj_and	12	SENT_125	[p9l1652t3592r1691b3610],
16	immediately	RB	O	immediately	advmod	1	SENT_125	[p9l39t3628r156b3652],
17	before	IN	O	before	_	0	SENT_125	[p9l162t3627r222b3646],
18	that	DT	O	that	det	19	SENT_125	[p9l227t3628r267b3646],
19	visit	NN	O	visit	prep_before	16	SENT_125	[p9l272t3628r314b3646],
20	.	.	O	.	_	0	SENT_125	[p9l272t3628r314b3646],

1	Table	NNP	O	Table	_	0	SENT_126	[p9l38t3690r98b3712],
2	2	CD	NUMBER	2	num	1	SENT_126	[p9l103t3694r124b3712],
3	:	:	O	:	_	0	SENT_126	[p9l103t3694r124b3712],
4	Characteristics	NNS	O	characteristic	dep	1	SENT_126	[p9l130t3691r299b3712],
5	of	IN	O	of	_	0	SENT_126	[p9l305t3691r329b3712],
6	patients	NNS	O	patient	prep_of	4	SENT_126	[p9l334t3691r430b3719],
7	at	IN	O	at	_	0	SENT_126	[p9l437t3694r460b3712],
8	the	DT	O	the	det	9	SENT_126	[p9l466t3691r505b3712],
9	beginning	NN	O	beginning	prep_at	6	SENT_126	[p9l512t3691r628b3719],
10	of	IN	O	of	_	0	SENT_126	[p9l636t3691r661b3712],
11	each	DT	O	each	det	13	SENT_126	[p9l666t3691r717b3712],
12	treatment	NN	O	treatment	nn	13	SENT_126	[p9l724t3694r844b3712],
13	period	NN	O	period	prep_of	9	SENT_126	[p9l851t3691r924b3719],

1	1508	CD	DATE	1508	_	0	SENT_127	[p9l7t3808r66b3833],
2	www	NN	O	www	dep	1	SENT_127	[p9l1644t3808r1867b3830],
3	.	.	O	.	_	0	SENT_127	[p9l1644t3808r1867b3830],

1	the	DT	O	the	det	2	SENT_128	[p9l1644t3808r1867b3830],
2	|	NN	O	|	_	0	SENT_128	[p9l1644t3808r1867b3830],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_128	[p9l1644t3808r1867b3830],
4	Vol	NNP	O	Vol	dep	2	SENT_128	[p9l1884t3808r1921b3830],
5	364	CD	NUMBER	364	nn	6	SENT_128	[p9l1930t3808r1975b3833],
6	October	NNP	DATE	October	rcmod	4	SENT_128	[p9l1994t3808r2087b3830],
7	23	CD	DATE	23	dep	6	SENT_128	[p9l2095t3811r2130b3834],
8	,	,	O	,	_	0	SENT_128	[p9l2095t3811r2130b3834],

1	Treatment	NN	O	treatment	nn	4	SENT_129	[p10l744t743r1007b786],
2	Washout	NN	O	washout	nn	4	SENT_129	[p10l1691t739r1915b786],
3	j	NN	O	j	nn	4	SENT_129	[p10l336t2134r482b2145],
4	Albuterol	NNP	O	Albuterol	nsubj	5	SENT_129	[p10l505t2112r732b2160],
5	modelled	VBD	O	model	_	0	SENT_129	[p10l752t2112r979b2160],
6	Albuterol	NNP	O	Albuterol	nn	8	SENT_129	[p10l505t2179r732b2227],
7	raw	JJ	O	raw	amod	8	SENT_129	[p10l752t2195r840b2227],
8	means	NNS	O	means	dobj	5	SENT_129	[p10l855t2195r1014b2227],

1	Placebo	NN	O	placebo	dep	2	SENT_130	[p10l508t2246r694b2294],
2	modelled	VBD	O	model	_	0	SENT_130	[p10l712t2246r939b2294],
3	Placebo	NNP	O	Placebo	nn	5	SENT_130	[p10l507t2313r694b2361],
4	raw	JJ	O	raw	amod	5	SENT_130	[p10l712t2329r799b2361],
5	means	NNS	O	means	nsubj	2	SENT_130	[p10l815t2329r974b2361],

1	10	CD	NUMBER	10	num	2	SENT_131	[p10l155t2357r216b2398],
2	Morning	NN	TIME	morning	_	0	SENT_131	[p10l37t2724r98b2930],
3	PEFR	NN	O	pefr	nn	6	SENT_131	[p10l40t2586r83b2704],
4	(	CD	NUMBER	(	num	6	SENT_131	[p10l37t2389r96b2568],
5	L/min	NN	O	l/min	nn	6	SENT_131	[p10l37t2389r96b2568],
6	)	NN	O	)	dep	2	SENT_131	[p10l37t2389r96b2568],
7	.	.	O	.	_	0	SENT_131	[p10l122t2889r181b2929],

1	L	NN	O	l	_	0	SENT_132	[p10l122t2889r181b2929],
2	o	NN	O	o	nn	3	SENT_132	[p10l187t2888r216b2930],
3	o	NN	O	o	dep	1	SENT_132	[p10l187t2623r216b2664],

1	O	NN	O	o	_	0	SENT_133	[p10l257t3233r286b3274],
2	5	CD	NUMBER	5	number	3	SENT_133	[p10l633t3234r659b3281],
3	10	CD	NUMBER	10	dep	1	SENT_133	[p10l996t3233r1056b3274],
4	15	CD	NUMBER	15	num	5	SENT_133	[p10l1372t3234r1430b3281],
5	20	CD	NUMBER	20	dep	3	SENT_133	[p10l1754t3233r1814b3274],

1	Time	NNP	O	Time	_	0	SENT_134	[p10l1017t3319r1141b3364],
2	(	JJ	O	(	amod	3	SENT_134	[p10l1159t3317r1346b3377],
3	weeks	NNS	DURATION	week	dep	1	SENT_134	[p10l1159t3317r1346b3377],
4	)	IN	O	)	amod	3	SENT_134	[p10l1159t3317r1346b3377],

1	Figure	NNP	O	Figure	nsubj	34	SENT_135	[p11l13t37r175b104],
2	3	CD	NUMBER	3	num	1	SENT_135	[p11l187t43r237b95],
3	:	:	O	:	_	0	SENT_135	[p11l187t43r237b95],
4	Change	NNP	O	Change	dep	1	SENT_135	[p11l253t36r460b103],
5	in	IN	O	in	_	0	SENT_135	[p11l478t37r525b86],
6	morning	NN	TIME	morning	nn	7	SENT_135	[p11l546t37r782b103],
7	PEFR	NN	O	pefr	prep_in	4	SENT_135	[p11l802t41r937b87],
8	during	IN	O	during	_	0	SENT_135	[p11l953t36r1134b103],
9	the	DT	O	the	det	10	SENT_135	[p11l1150t36r1244b87],
10	16-week	JJ	DURATION	16-week	prep_during	7	SENT_135	[p11l1264t35r1506b87],
11	masked	VBN	O	mask	partmod	10	SENT_135	[p11l1523t36r1737b87],
12	treatment	NN	O	treatment	nn	13	SENT_135	[p11l1751t45r2041b87],
13	period	NN	O	period	dep	23	SENT_135	[p11l12t124r192b190],
14	and	CC	O	and	_	0	SENT_135	[p11l207t124r311b175],
15	8-week	JJ	DURATION	8-week	amod	16	SENT_135	[p11l327t123r534b175],
16	washout	NN	O	washout	dep	23	SENT_135	[p11l548t124r795b175],
17	within	IN	O	within	_	0	SENT_135	[p11l809t124r991b175],
18	each	DT	O	each	det	19	SENT_135	[p11l1009t124r1133b175],
19	genotype	NN	O	genotype	prep_within	13	SENT_135	[p11l1151t132r1418b190],
20	The	DT	O	the	det	22	SENT_135	[p11l11t209r110b261],
21	smoothed	VBN	O	smooth	amod	22	SENT_135	[p11l127t209r399b261],
22	lines	NNS	O	line	nsubj	23	SENT_135	[p11l418t209r533b261],
23	represent	VBP	O	represent	ccomp	11	SENT_135	[p11l553t219r798b276],
24	the	DT	O	the	det	25	SENT_135	[p11l812t209r900b260],
25	means	NNS	O	means	nsubj	31	SENT_135	[p11l919t227r1090b261],
26	derived	VBN	O	derive	partmod	25	SENT_135	[p11l1107t209r1300b261],
27	from	IN	O	from	_	0	SENT_135	[p11l1315t209r1443b260],
28	the	DT	O	the	det	30	SENT_135	[p11l1460t209r1547b260],
29	statistical	JJ	O	statistical	amod	30	SENT_135	[p11l1565t209r1811b261],
30	models	NNS	O	model	prep_from	26	SENT_135	[p11l1833t209r2023b261],
31	(	VBP	O	(	ccomp	23	SENT_135	[p11l14t295r295b360],
32	modelled	VBN	O	model	dep	31	SENT_135	[p11l14t295r295b360],
33	;	:	O	;	_	0	SENT_135	[p11l14t295r295b360],
34	see	VB	O	see	_	0	SENT_135	[p11l314t313r396b347],
35	table	NN	O	table	nn	37	SENT_135	[p11l412t295r543b346],
36	3	CD	NUMBER	3	num	37	SENT_135	[p11l562t298r612b360],
37	)	NN	O	)	dobj	34	SENT_135	[p11l562t298r612b360],
38	and	CC	O	and	_	0	SENT_135	[p11l631t295r728b346],
39	thejagged	JJ	O	thejagged	amod	40	SENT_135	[p11l743t295r1024b362],
40	lines	NNS	O	line	dobj	34	SENT_135	[p11l1043t295r1158b347],
41	the	DT	O	the	det	43	SENT_135	[p11l1173t295r1260b347],
42	unadjusted	JJ	O	unadjusted	amod	43	SENT_135	[p11l1280t295r1575b362],
43	mean	NN	O	mean	dep	40	SENT_135	[p11l1594t313r1737b346],
44	weekly	JJ	SET	weekly	amod	45	SENT_135	[p11l1754t295r1938b362],
45	data	NNS	O	datum	dep	40	SENT_135	[p11l1953t295r2082b347],
46	.	.	O	.	_	0	SENT_135	[p11l1953t295r2082b347],

1	For	IN	O	for	_	0	SENT_136	[p11l16t386r98b432],
2	patients	NNS	O	patient	prep_for	19	SENT_136	[p11l112t383r328b447],
3	with	IN	O	with	_	0	SENT_136	[p11l342t381r459b432],
4	the	DT	O	the	det	6	SENT_136	[p11l477t381r564b432],
5	Gly/Gly	NNP	O	Gly/Gly	nn	6	SENT_136	[p11l582t381r771b447],
6	genotype	NN	O	genotype	prep_with	2	SENT_136	[p11l787t390r1051b448],
7	,	,	O	,	_	0	SENT_136	[p11l787t390r1051b448],
8	at	IN	O	at	_	0	SENT_136	[p11l1070t390r1121b432],
9	completion	NN	O	completion	prep_at	2	SENT_136	[p11l1137t381r1437b447],
10	of	IN	O	of	_	0	SENT_136	[p11l1457t381r1514b432],
11	the	DT	O	the	det	12	SENT_136	[p11l1524t381r1612b432],
12	16-week	JJ	DURATION	16-week	prep_of	9	SENT_136	[p11l1632t381r1860b432],
13	masked	VBN	O	mask	partmod	12	SENT_136	[p11l1878t381r2079b432],
14	treatment	NN	O	treatment	nn	15	SENT_136	[p11l11t476r282b518],
15	periods	NNS	O	period	dobj	13	SENT_136	[p11l298t467r491b533],
16	the	DT	O	the	det	17	SENT_136	[p11l506t467r593b518],
17	PEFR	NN	ORGANIZATION	pefr	nsubj	19	SENT_136	[p11l613t472r741b518],
18	had	VBD	O	have	aux	19	SENT_136	[p11l760t467r854b518],
19	improved	VBN	O	improve	_	0	SENT_136	[p11l873t467r1124b533],
20	signiﬁcantly	RB	O	signiﬁcantly	advmod	21	SENT_136	[p11l1141t467r1459b534],
21	more	RBR	O	more	dep	19	SENT_136	[p11l1477t484r1612b518],
22	in	IN	O	in	_	0	SENT_136	[p11l1631t469r1674b517],
23	the	DT	O	the	det	26	SENT_136	[p11l1691t467r1778b518],
24	regular	JJ	O	regular	amod	26	SENT_136	[p11l1798t467r1980b534],
25	albuterol	NN	O	albuterol	nn	26	SENT_136	[p11l13t554r246b605],
26	phase	NN	O	phase	prep_in	19	SENT_136	[p11l265t554r418b620],
27	than	IN	O	than	_	0	SENT_136	[p11l433t554r554b605],
28	the	DT	O	the	det	30	SENT_136	[p11l571t554r658b605],
29	placebo	NN	O	placebo	nn	30	SENT_136	[p11l675t554r879b620],
30	phase	NN	O	phase	prep_than	26	SENT_136	[p11l896t554r1049b620],
31	(	CD	NUMBER	(	number	32	SENT_136	[p11l1068t557r1158b618],
32	14	CD	NUMBER	14	num	34	SENT_136	[p11l1068t557r1158b618],
33	L/min	NN	O	l/min	nn	34	SENT_136	[p11l1176t556r1362b618],
34	)	NN	O	)	dep	30	SENT_136	[p11l1176t556r1362b618],
35	;	:	O	;	_	0	SENT_136	[p11l1176t556r1362b618],
36	*	CD	NUMBER	*	num	37	SENT_136	[p11l1382t556r1685b620],
37	p	NN	O	p	dep	30	SENT_136	[p11l1382t556r1685b620],
38	=	JJ	O	=	amod	39	SENT_136	[p11l1382t556r1685b620],
39	O-0175	NN	O	o-0175	dep	37	SENT_136	[p11l1382t556r1685b620],
40	.	.	O	.	_	0	SENT_136	[p11l1382t556r1685b620],

1	For	IN	O	for	_	0	SENT_137	[p11l1707t559r1788b605],
2	the	DT	O	the	det	3	SENT_137	[p11l1801t554r1889b605],
3	patients	NNS	O	patient	prep_for	20	SENT_137	[p11l1906t556r2121b620],
4	with	IN	O	with	_	0	SENT_137	[p11l11t640r128b690],
5	the	DT	O	the	det	7	SENT_137	[p11l145t640r232b691],
6	Arg/Arg	NN	O	arg/arg	nn	7	SENT_137	[p11l249t642r458b707],
7	genotype	NN	O	genotype	prep_with	3	SENT_137	[p11l477t649r742b707],
8	,	,	O	,	_	0	SENT_137	[p11l477t649r742b707],
9	at	IN	O	at	_	0	SENT_137	[p11l760t649r811b691],
10	completion	NN	O	completion	prep_at	3	SENT_137	[p11l828t640r1128b706],
11	of	IN	O	of	_	0	SENT_137	[p11l1147t640r1204b691],
12	the	DT	O	the	det	13	SENT_137	[p11l1214t640r1302b691],
13	16-week	JJ	DURATION	16-week	prep_of	10	SENT_137	[p11l1323t640r1551b691],
14	masked	VBN	O	mask	partmod	13	SENT_137	[p11l1569t640r1770b691],
15	treatment	NN	O	treatment	nn	16	SENT_137	[p11l1784t649r2056b691],
16	periods	NNS	O	period	dobj	14	SENT_137	[p11l12t726r206b792],
17	the	DT	O	the	det	18	SENT_137	[p11l220t726r308b777],
18	PEFR	NN	ORGANIZATION	pefr	nsubj	20	SENT_137	[p11l329t731r455b776],
19	had	VBD	O	have	aux	20	SENT_137	[p11l474t726r569b777],
20	improved	VBN	O	improve	_	0	SENT_137	[p11l588t726r839b792],
21	signiﬁcantly	RB	O	signiﬁcantly	advmod	22	SENT_137	[p11l856t726r1174b793],
22	more	RBR	O	more	dep	20	SENT_137	[p11l1191t743r1327b777],
23	in	IN	O	in	_	0	SENT_137	[p11l1346t728r1388b776],
24	the	DT	O	the	det	26	SENT_137	[p11l1406t726r1493b777],
25	placebo	NN	O	placebo	nn	26	SENT_137	[p11l1510t726r1713b792],
26	phase	NN	O	phase	prep_in	20	SENT_137	[p11l1730t726r1883b792],
27	than	IN	O	than	_	0	SENT_137	[p11l1899t726r2019b777],
28	the	DT	O	the	det	30	SENT_137	[p11l2036t726r2123b777],
29	albuterol	NN	O	albuterol	nn	30	SENT_137	[p11l13t812r246b863],
30	phase	NN	O	phase	prep_than	26	SENT_137	[p11l265t812r418b879],
31	(	CD	NUMBER	(	number	32	SENT_137	[p11l437t815r524b877],
32	10	CD	NUMBER	10	num	34	SENT_137	[p11l437t815r524b877],
33	L/min	NN	O	l/min	nn	34	SENT_137	[p11l546t814r731b877],
34	)	NN	O	)	dep	30	SENT_137	[p11l546t814r731b877],
35	;	:	O	;	_	0	SENT_137	[p11l546t814r731b877],
36	Tp	NN	O	tp	nn	38	SENT_137	[p11l752t816r1056b879],
37	=	JJ	O	=	amod	38	SENT_137	[p11l752t816r1056b879],
38	O-0209	NN	O	o-0209	dep	30	SENT_137	[p11l752t816r1056b879],
39	.	.	O	.	_	0	SENT_137	[p11l752t816r1056b879],

1	There	EX	O	there	expl	2	SENT_138	[p11l1072t812r1223b863],
2	was	VBD	O	be	_	0	SENT_138	[p11l1238t829r1340b863],
3	no	DT	O	no	det	5	SENT_138	[p11l1359t829r1424b863],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_138	[p11l1441t811r1713b880],
5	change	NN	O	change	nsubj	2	SENT_138	[p11l1730t812r1919b880],
6	in	IN	O	in	_	0	SENT_138	[p11l1938t814r1981b863],
7	PEFR	NN	ORGANIZATION	pefr	prep_in	5	SENT_138	[p11l2003t817r2130b863],
8	in	IN	O	in	_	0	SENT_138	[p11l14t901r57b950],
9	the	DT	O	the	det	11	SENT_138	[p11l74t899r162b950],
10	washout	NN	O	washout	nn	11	SENT_138	[p11l177t899r409b950],
11	periods	NNS	O	period	prep_in	7	SENT_138	[p11l425t899r618b966],
12	for	IN	O	for	_	0	SENT_138	[p11l633t898r710b950],
13	either	CC	O	either	dep	14	SENT_138	[p11l725t899r878b950],
14	genotype	NN	O	genotype	prep_for	11	SENT_138	[p11l894t909r1144b967],
15	compared	VBN	O	compare	_	0	SENT_138	[p11l1161t899r1426b966],
16	with	IN	O	with	prepc_compared_with	14	SENT_138	[p11l1441t899r1558b950],
17	the	DT	O	the	det	19	SENT_138	[p11l1575t899r1663b950],
18	last	JJ	O	last	amod	19	SENT_138	[p11l1682t899r1770b950],
19	measurement	NN	O	measurement	pobj	14	SENT_138	[p11l15t997r382b1039],
20	in	IN	O	in	_	0	SENT_138	[p11l400t990r442b1038],
21	the	DT	O	the	det	23	SENT_138	[p11l459t988r547b1039],
22	treatment	NN	O	treatment	nn	23	SENT_138	[p11l562t997r833b1039],
23	period	NN	O	period	prep_in	19	SENT_138	[p11l849t988r1030b1054],
24	.	.	O	.	_	0	SENT_138	[p11l849t988r1030b1054],

1	for	IN	O	for	_	0	SENT_139	[p11l8t1216r116b1284],
2	short-term	JJ	O	short-term	amod	5	SENT_139	[p11l176t1216r574b1284],
3	and	CC	O	and	_	0	SENT_139	[p11l634t1216r772b1284],
4	long-term	JJ	O	long-term	amod	5	SENT_139	[p11l829t1216r1203b1306],
5	effects	NNS	O	effect	pobj	1	SENT_139	[p11l1263t1216r1523b1284],
6	.	.	O	.	_	0	SENT_139	[p11l1263t1216r1523b1284],

1	The	DT	O	the	det	3	SENT_140	[p11l1585t1216r1729b1284],
2	statistical	JJ	O	statistical	amod	3	SENT_140	[p11l1792t1216r2140b1284],
3	model	NN	O	model	nsubj	4	SENT_140	[p11l8t1326r245b1394],
4	included	VBD	O	include	_	0	SENT_140	[p11l325t1326r653b1394],
5	correction	NN	O	correction	nn	6	SENT_140	[p11l735t1330r1114b1394],
6	terms	NNS	O	term	dobj	4	SENT_140	[p11l1194t1339r1410b1394],
7	for	IN	O	for	_	0	SENT_140	[p11l1493t1326r1600b1394],
8	period	NN	O	period	nn	11	SENT_140	[p11l1679t1326r1922b1415],
9	and	CC	O	and	_	0	SENT_140	[p11l2002t1326r2141b1394],
10	sequence	NN	O	sequence	nn	11	SENT_140	[p11l11t1459r357b1523],
11	effects	NNS	O	effect	prep_for	4	SENT_140	[p11l384t1434r623b1503],
12	in	IN	O	in	_	0	SENT_140	[p11l652t1439r726b1501],
13	the	DT	O	the	det	15	SENT_140	[p11l750t1434r868b1503],
14	cross-over	JJ	O	cross-over	amod	15	SENT_140	[p11l895t1459r1273b1503],
15	design	NN	O	design	prep_in	4	SENT_140	[p11l1298t1434r1564b1524],
16	.	.	O	.	_	0	SENT_140	[p11l1298t1434r1564b1524],

1	Because	IN	O	because	_	0	SENT_141	[p11l1597t1441r1899b1503],
2	of	IN	O	of	_	0	SENT_141	[p11l1927t1434r2011b1503],
3	the	DT	O	the	det	5	SENT_141	[p11l2022t1434r2139b1503],
4	one-to-one	JJ	O	one-to-one	amod	5	SENT_141	[p11l9t1557r406b1611],
5	matching	NN	O	matching	prep_because_of	38	SENT_141	[p11l518t1543r876b1633],
6	of	IN	O	of	_	0	SENT_141	[p11l988t1543r1071b1611],
7	Arg/Arg	NN	O	arg/arg	nn	10	SENT_141	[p11l1167t1548r1484b1633],
8	and	CC	O	and	_	0	SENT_141	[p11l1595t1543r1734b1611],
9	Gly/Gly	NN	O	gly/gly	nn	10	SENT_141	[p11l1846t1543r2141b1633],
10	participants	NNS	O	participant	prep_of	5	SENT_141	[p11l8t1658r451b1743],
11	before	IN	O	before	_	0	SENT_141	[p11l517t1654r753b1722],
12	randomisation	NN	O	randomisation	prep_before	10	SENT_141	[p11l819t1654r1392b1732],
13	,	,	O	,	_	0	SENT_141	[p11l819t1654r1392b1732],
14	the	DT	O	the	det	16	SENT_141	[p11l1458t1654r1575b1722],
15	four	CD	NUMBER	four	num	16	SENT_141	[p11l1641t1654r1799b1722],
16	sets	NNS	O	set	appos	12	SENT_141	[p11l1865t1667r2001b1722],
17	of	IN	O	of	_	0	SENT_141	[p11l2069t1654r2153b1722],
18	repeated	VBN	O	repeat	amod	19	SENT_141	[p11l8t1762r330b1851],
19	measurements	NNS	O	measurement	prep_of	16	SENT_141	[p11l377t1776r939b1831],
20	for	IN	O	for	_	0	SENT_141	[p11l989t1762r1097b1831],
21	a	DT	O	a	det	23	SENT_141	[p11l1144t1787r1182b1831],
22	matched	VBN	O	match	amod	23	SENT_141	[p11l1230t1762r1555b1831],
23	pair	NN	O	pair	prep_for	19	SENT_141	[p11l1602t1767r1750b1851],
24	(	CD	NUMBER	(	num	26	SENT_141	[p11l1802t1768r2140b1852],
25	Arg/Arg	NN	O	arg/arg	nn	26	SENT_141	[p11l1802t1768r2140b1852],
26	albuterol	NN	O	albuterol	nsubjpass	38	SENT_141	[p11l9t1871r361b1949],
27	,	,	O	,	_	0	SENT_141	[p11l9t1871r361b1949],
28	Arg/Arg	NN	O	arg/arg	nn	29	SENT_141	[p11l404t1876r721b1961],
29	placebo	NN	O	placebo	appos	26	SENT_141	[p11l760t1871r1064b1960],
30	,	,	O	,	_	0	SENT_141	[p11l760t1871r1064b1960],
31	Gly/Gly	JJ	O	gly/gly	amod	32	SENT_141	[p11l1111t1871r1407b1961],
32	albuterol	NN	O	albuterol	appos	26	SENT_141	[p11l1447t1871r1799b1949],
33	,	,	O	,	_	0	SENT_141	[p11l1447t1871r1799b1949],
34	Gly/Gly	JJ	O	gly/gly	amod	36	SENT_141	[p11l1846t1871r2141b1961],
35	placebo	NN	O	placebo	nn	36	SENT_141	[p11l8t1981r315b2071],
36	)	NN	O	)	appos	26	SENT_141	[p11l8t1981r315b2071],
37	were	VBD	O	be	auxpass	38	SENT_141	[p11l348t2005r527b2049],
38	assumed	VBN	O	assume	_	0	SENT_141	[p11l558t1981r893b2049],
39	to	TO	O	to	aux	41	SENT_141	[p11l920t1994r989b2049],
40	be	VB	O	be	auxpass	41	SENT_141	[p11l1018t1981r1105b2049],
41	correlated	VBN	O	correlate	xcomp	38	SENT_141	[p11l1136t1981r1527b2049],
42	.	.	O	.	_	0	SENT_141	[p11l1136t1981r1527b2049],

1	The	DT	O	the	det	3	SENT_142	[p11l1559t1981r1703b2048],
2	correlation	NN	O	correlation	nn	3	SENT_142	[p11l1734t1981r2140b2049],
3	matrix	NN	O	matrix	nsubjpass	5	SENT_142	[p11l8t2095r254b2159],
4	was	VBD	O	be	auxpass	5	SENT_142	[p11l278t2115r418b2159],
5	modelled	VBN	O	model	_	0	SENT_142	[p11l448t2090r799b2159],
6	as	IN	O	as	_	0	SENT_142	[p11l827t2115r900b2159],
7	the	DT	O	the	det	9	SENT_142	[p11l929t2090r1046b2159],
8	Kronecker	NNP	O	Kronecker	nn	9	SENT_142	[p11l1079t2090r1467b2159],
9	product	NN	O	product	prep_as	5	SENT_142	[p11l1493t2090r1786b2179],
10	of	IN	O	of	_	0	SENT_142	[p11l1813t2090r1896b2159],
11	a	DT	O	a	quantmod	12	SENT_142	[p11l1912t2115r1950b2159],
12	4	CD	NUMBER	4	num	13	SENT_142	[p11l1977t2097r2140b2158],
13	>	JJR	O	>	npadvmod	14	SENT_142	[p11l1977t2097r2140b2158],
14	<	JJR	O	<	amod	17	SENT_142	[p11l1977t2097r2140b2158],
15	4	CD	NUMBER	4	number	16	SENT_142	[p11l1977t2097r2140b2158],
16	unstructured	JJ	O	unstructured	amod	17	SENT_142	[p11l7t2200r502b2269],
17	matrix	NN	O	matrix	prep_of	9	SENT_142	[p11l555t2205r801b2269],
18	for	IN	O	for	_	0	SENT_142	[p11l853t2200r960b2269],
19	the	DT	O	the	det	21	SENT_142	[p11l1011t2200r1128b2269],
20	four	CD	NUMBER	four	num	21	SENT_142	[p11l1183t2200r1342b2269],
21	sets	NNS	O	set	prep_for	5	SENT_142	[p11l1397t2214r1533b2269],
22	with	IN	O	with	_	0	SENT_142	[p11l1588t2200r1754b2269],
23	an	DT	O	a	det	25	SENT_142	[p11l1809t2225r1899b2269],
24	equicorrelation	NN	O	equicorrelation	nn	25	SENT_142	[p11l1953t2205r2138b2289, p11l9t2311r416b2379],
25	matrix	NN	O	matrix	prep_with	21	SENT_142	[p11l438t2315r684b2379],
26	for	IN	O	for	_	0	SENT_142	[p11l706t2311r812b2379],
27	repeated	VBN	O	repeat	amod	28	SENT_142	[p11l835t2311r1157b2400],
28	measurements	NNS	O	measurement	prep_for	25	SENT_142	[p11l1178t2324r1740b2379],
29	over	IN	O	over	_	0	SENT_142	[p11l1766t2335r1925b2379],
30	time	NN	O	time	prep_over	28	SENT_142	[p11l1945t2315r2136b2379],
31	.	.	O	.	_	0	SENT_142	[p11l1945t2315r2136b2379],

1	Although	IN	O	although	mark	7	SENT_143	[p11l7t2419r363b2509],
2	this	DT	O	this	nsubj	7	SENT_143	[p11l396t2419r534b2488],
3	is	VBZ	O	be	cop	7	SENT_143	[p11l571t2424r629b2488],
4	a	DT	O	a	det	7	SENT_143	[p11l668t2444r705b2488],
5	complex	JJ	O	complex	amod	7	SENT_143	[p11l741t2419r1057b2508],
6	correlational	JJ	O	correlational	amod	7	SENT_143	[p11l1090t2419r1562b2488],
7	structure	NN	O	structure	advcl	11	SENT_143	[p11l1600t2433r1957b2498],
8	,	,	O	,	_	0	SENT_143	[p11l1600t2433r1957b2498],
9	it	PRP	O	it	nsubj	11	SENT_143	[p11l1995t2424r2046b2487],
10	is	VBZ	O	be	cop	11	SENT_143	[p11l2079t2424r2137b2488],
11	necessary	JJ	O	necessary	_	0	SENT_143	[p11l8t2552r374b2618],
12	because	IN	O	because	mark	29	SENT_143	[p11l443t2528r741b2596],
13	a	DT	O	a	det	15	SENT_143	[p11l817t2553r853b2596],
14	simpler	JJR	O	simpler	amod	15	SENT_143	[p11l929t2528r1217b2617],
15	model	NN	O	model	nsubj	29	SENT_143	[p11l1289t2528r1525b2596],
16	that	WDT	O	that	nsubj	17	SENT_143	[p11l1597t2528r1743b2596],
17	assumes	VBZ	O	assume	rcmod	15	SENT_143	[p11l1816t2552r2137b2596],
18	independence	NN	O	independence	dobj	17	SENT_143	[p11l8t2639r538b2728],
19	of	IN	O	of	_	0	SENT_143	[p11l572t2639r655b2707],
20	all	PDT	O	all	predet	22	SENT_143	[p11l676t2639r761b2707],
21	the	DT	O	the	det	22	SENT_143	[p11l792t2639r909b2707],
22	observations	NNS	O	observation	prep_of	18	SENT_143	[p11l943t2639r1413b2707],
23	from	IN	O	from	_	0	SENT_143	[p11l1448t2639r1634b2707],
24	the	DT	O	the	det	26	SENT_143	[p11l1665t2639r1782b2707],
25	matched	VBN	O	match	amod	26	SENT_143	[p11l1815t2639r2141b2707],
26	pair	NN	O	pair	prep_from	22	SENT_143	[p11l8t2752r156b2836],
27	is	VBZ	O	be	cop	29	SENT_143	[p11l187t2752r245b2816],
28	not	RB	O	not	neg	29	SENT_143	[p11l279t2761r402b2816],
29	valid	JJ	O	valid	advcl	11	SENT_143	[p11l431t2747r627b2816],
30	.	.	O	.	_	0	SENT_143	[p11l431t2747r627b2816],

1	The	DT	O	the	det	5	SENT_144	[p11l662t2747r806b2816],
2	primary	JJ	O	primary	amod	5	SENT_144	[p11l839t2752r1141b2837],
3	and	CC	O	and	_	0	SENT_144	[p11l1172t2747r1311b2816],
4	secondary	JJ	O	secondary	conj_and	2	SENT_144	[p11l1344t2747r1721b2837],
5	results	NNS	O	result	nsubjpass	16	SENT_144	[p11l1751t2747r2000b2816],
6	for	IN	O	for	_	0	SENT_144	[p11l2034t2747r2141b2816],
7	comparing	VBG	O	compare	prepc_for	5	SENT_144	[p11l9t2861r417b2946],
8	changes	NNS	O	change	dobj	7	SENT_144	[p11l466t2856r769b2946],
9	during	IN	O	during	_	0	SENT_144	[p11l820t2856r1074b2946],
10	the	DT	O	the	det	14	SENT_144	[p11l1120t2856r1238b2924],
11	albuterol	NN	O	albuterol	nn	14	SENT_144	[p11l1288t2856r1621b2924],
12	and	CC	O	and	_	0	SENT_144	[p11l1670t2856r1808b2924],
13	placebo	NN	O	placebo	conj_and	11	SENT_144	[p11l1855t2856r2139b2945],
14	periods	NNS	O	period	prep_during	7	SENT_144	[p11l8t2967r284b3056],
15	are	VBP	O	be	auxpass	16	SENT_144	[p11l329t2991r441b3035],
16	derived	VBN	O	derive	_	0	SENT_144	[p11l484t2967r760b3035],
17	from	IN	O	from	_	0	SENT_144	[p11l800t2967r986b3035],
18	the	DT	O	the	det	20	SENT_144	[p11l1026t2967r1143b3035],
19	model-based	JJ	O	model-based	amod	20	SENT_144	[p11l1185t2967r1664b3035],
20	means	NNS	O	means	prep_from	16	SENT_144	[p11l1704t2991r1973b3045],
21	,	,	O	,	_	0	SENT_144	[p11l1704t2991r1973b3045],
22	not	RB	O	not	neg	20	SENT_144	[p11l2018t2980r2141b3035],
23	the	DT	O	the	det	25	SENT_144	[p11l7t3075r124b3144],
24	raw	JJ	O	raw	amod	25	SENT_144	[p11l171t3100r309b3144],
25	means	NNS	O	means	dep	20	SENT_144	[p11l353t3100r622b3144],
26	.	.	O	.	_	0	SENT_144	[p11l353t3100r622b3144],

1	This	DT	O	this	det	3	SENT_145	[p11l671t3075r835b3144],
2	repeated-measurements	JJ	O	repeated-measurements	amod	3	SENT_145	[p11l883t3075r1794b3164],
3	analysis	NN	O	analysis	nsubjpass	5	SENT_145	[p11l1843t3075r2137b3165],
4	was	VBD	O	be	auxpass	5	SENT_145	[p11l6t3208r146b3252],
5	done	VBN	O	do	_	0	SENT_145	[p11l218t3184r400b3252],
6	by	IN	O	by	_	0	SENT_145	[p11l468t3184r556b3274],
7	PROC	NNP	O	PROC	nn	8	SENT_145	[p11l626t3189r857b3252],
8	MIXED	NNP	O	MIXED	agent	5	SENT_145	[p11l930t3189r1216b3251],
9	of	IN	O	of	_	0	SENT_145	[p11l1288t3184r1371b3252],
10	SAS	NNP	ORGANIZATION	SAS	prep_of	8	SENT_145	[p11l1432t3189r1604b3252],
11	.	.	O	.	_	0	SENT_145	[p11l1432t3189r1604b3252],

1	Finally	RB	O	finally	_	0	SENT_146	[p11l1680t3184r1951b3274],
2	,	,	O	,	_	0	SENT_146	[p11l1680t3184r1951b3274],
3	the	DT	O	the	det	4	SENT_146	[p11l2022t3184r2139b3252],
4	occurrences	NNS	O	occurrence	dep	5	SENT_146	[p11l9t3319r458b3363],
5	of	IN	O	of	dep	1	SENT_146	[p11l494t3295r577b3363],
6	binary	JJ	O	binary	amod	7	SENT_146	[p11l594t3295r835b3384],
7	events	NNS	O	event	pobj	5	SENT_146	[p11l866t3308r1122b3373],
8	,	,	O	,	_	0	SENT_146	[p11l866t3308r1122b3373],
9	such	JJ	O	such	_	0	SENT_146	[p11l1159t3295r1334b3363],
10	as	IN	O	as	_	0	SENT_146	[p11l1366t3319r1439b3363],
11	treatment	NN	O	treatment	nn	12	SENT_146	[p11l1471t3308r1843b3363],
12	failure	NN	O	failure	prep_such_as	7	SENT_146	[p11l1873t3295r2136b3373],
13	,	,	O	,	_	0	SENT_146	[p11l1873t3295r2136b3373],

1	wvvw	NN	O	wvvw	_	0	SENT_147	[p11l7t3566r542b3617],
2	.	.	O	.	_	0	SENT_147	[p11l7t3566r542b3617],

1	the	DT	O	the	det	2	SENT_148	[p11l7t3566r542b3617],
2	|	NN	O	|	_	0	SENT_148	[p11l7t3566r542b3617],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_148	[p11l7t3566r542b3617],
4	Vol	NNP	O	Vol	dep	2	SENT_148	[p11l585t3566r675b3617],
5	364	CD	NUMBER	364	num	6	SENT_148	[p11l696t3565r805b3624],
6	October	NNP	DATE	October	dep	2	SENT_148	[p11l850t3566r1074b3617],
7	23,2004	CD	DATE	23,2004	num	6	SENT_148	[p11l1092t3572r1345b3626],

1	exacerbation	NN	O	exacerbation	nsubjpass	11	SENT_149	[p12l9t70r355b126],
2	,	,	O	,	_	0	SENT_149	[p12l9t70r355b126],
3	or	CC	O	or	_	0	SENT_149	[p12l382t88r436b119],
4	failure	NN	O	failure	nsubjpass	11	SENT_149	[p12l459t70r630b119],
5	of	IN	O	of	_	0	SENT_149	[p12l655t70r714b119],
6	ipratropium	NN	O	ipratropium	nn	8	SENT_149	[p12l729t73r1052b133],
7	bromide	NN	O	bromide	nn	8	SENT_149	[p12l1075t70r1300b119],
8	rescue	NN	O	rescue	prep_of	4	SENT_149	[p12l1324t87r1509b126],
9	,	,	O	,	_	0	SENT_149	[p12l1324t87r1509b126],
10	were	VBD	O	be	auxpass	11	SENT_149	[p12l7t166r133b197],
11	analysed	VBN	O	analyse	_	0	SENT_149	[p12l152t148r381b212],
12	with	IN	O	with	_	0	SENT_149	[p12l397t148r514b197],
13	McNemar	NN	O	mcnemar	poss	15	SENT_149	[p12l535t152r842b197],
14	’s	POS	O	’s	_	0	SENT_149	[p12l535t152r842b197],
15	test	NN	O	test	prep_with	11	SENT_149	[p12l861t158r967b197],
16	.	.	O	.	_	0	SENT_149	[p12l861t158r967b197],

1	Role	NN	O	role	nsubjpass	9	SENT_150	[p12l11t303r122b352],
2	of	IN	O	of	_	0	SENT_150	[p12l138t302r196b352],
3	the	DT	O	the	det	5	SENT_150	[p12l206t303r295b352],
4	funding	NN	O	funding	nn	5	SENT_150	[p12l309t302r521b367],
5	sources	NNS	O	source	prep_of	1	SENT_150	[p12l539t318r736b352],
6	The	DT	O	the	det	7	SENT_150	[p12l7t381r109b430],
7	study	NN	O	study	dep	5	SENT_150	[p12l150t381r292b445],
8	was	VBD	O	be	auxpass	9	SENT_150	[p12l329t398r427b430],
9	funded	VBN	O	fund	_	0	SENT_150	[p12l468t381r658b430],
10	by	IN	O	by	_	0	SENT_150	[p12l695t381r757b445],
11	the	DT	O	the	det	14	SENT_150	[p12l794t381r877b430],
12	National	NNP	ORGANIZATION	National	nn	14	SENT_150	[p12l919t381r1143b430],
13	Heart	NNP	ORGANIZATION	Heart	nn	14	SENT_150	[p12l1185t386r1336b430],
14	Lung	NN	ORGANIZATION	lung	agent	9	SENT_150	[p12l1377t386r1512b445],
15	and	CC	O	and	_	0	SENT_150	[p12l9t460r107b508],
16	Blood	NN	ORGANIZATION	blood	nn	17	SENT_150	[p12l158t460r310b508],
17	Institute	NNP	ORGANIZATION	Institute	agent	9	SENT_150	[p12l361t463r584b508],
18	(	CD	NUMBER	(	num	20	SENT_150	[p12l639t465r866b524],
19	NI-ILBI	NN	O	ni-ilbus	nn	20	SENT_150	[p12l639t465r866b524],
20	)	NN	O	)	dobj	9	SENT_150	[p12l639t465r866b524],
21	of	IN	O	of	_	0	SENT_150	[p12l921t460r980b508],
22	the	DT	O	the	det	25	SENT_150	[p12l1019t460r1102b508],
23	US	NNP	ORGANIZATION	US	nn	25	SENT_150	[p12l1155t463r1232b508],
24	National	NNP	ORGANIZATION	National	nn	25	SENT_150	[p12l1287t460r1512b508],
25	Institutes	NNPS	ORGANIZATION	Institutes	prep_of	20	SENT_150	[p12l11t539r259b585],
26	of	IN	ORGANIZATION	of	_	0	SENT_150	[p12l307t536r366b585],
27	Health	NNP	ORGANIZATION	Health	prep_of	25	SENT_150	[p12l405t536r597b585],
28	.	.	O	.	_	0	SENT_150	[p12l405t536r597b585],

1	An	DT	O	a	det	5	SENT_151	[p12l645t540r724b584],
2	NHLBI-appointed	JJ	O	nhlbi-appointed	amod	5	SENT_151	[p12l771t536r1251b599],
3	protocol	NN	O	protocol	nn	5	SENT_151	[p12l1295t536r1512b599],
4	review	NN	O	review	nn	5	SENT_151	[p12l8t617r181b663],
5	committee	NN	O	committee	nsubj	6	SENT_151	[p12l203t617r487b663],
6	approved	VBD	O	approve	_	0	SENT_151	[p12l512t614r755b677],
7	the	DT	O	the	det	9	SENT_151	[p12l776t614r859b663],
8	study	NN	O	study	nn	9	SENT_151	[p12l885t614r1026b678],
9	design	NN	O	design	dobj	6	SENT_151	[p12l1049t614r1236b678],
10	.	.	O	.	_	0	SENT_151	[p12l1049t614r1236b678],

1	Albuterol	NNP	O	Albuterol	nsubjpass	9	SENT_152	[p12l1261t614r1512b663],
2	and	CC	O	and	_	0	SENT_152	[p12l9t693r107b741],
3	matching	VBG	O	match	amod	4	SENT_152	[p12l123t693r376b757],
4	placebo	NN	O	placebo	nsubjpass	9	SENT_152	[p12l393t693r594b756],
5	in	IN	O	in	_	0	SENT_152	[p12l611t696r664b740],
6	masked	VBN	O	mask	amod	7	SENT_152	[p12l681t693r888b741],
7	inhalers	NNS	O	inhaler	prep_in	1	SENT_152	[p12l904t693r1118b741],
8	were	VBD	O	be	auxpass	9	SENT_152	[p12l1135t710r1262b741],
9	provided	VBN	O	provide	_	0	SENT_152	[p12l1280t693r1512b756],
10	by	IN	O	by	_	0	SENT_152	[p12l7t770r69b834],
11	Glaxo-SmithKline	NNP	O	Glaxo-SmithKline	agent	9	SENT_152	[p12l98t770r586b819],
12	.	.	O	.	_	0	SENT_152	[p12l98t770r586b819],

1	Open-label	JJ	O	open-label	amod	3	SENT_153	[p12l619t770r907b833],
2	ipratropium	NN	O	ipratropium	nn	3	SENT_153	[p12l935t773r1258b833],
3	bromide	NN	O	bromide	nsubjpass	5	SENT_153	[p12l1285t770r1511b819],
4	was	VBD	O	be	auxpass	5	SENT_153	[p12l7t865r105b897],
5	provided	VBN	O	provide	_	0	SENT_153	[p12l168t848r401b911],
6	by	IN	O	by	_	0	SENT_153	[p12l460t848r522b912],
7	Boehringer	NNP	ORGANIZATION	Boehringer	nn	9	SENT_153	[p12l585t848r884b912],
8	Ingelheim	NNP	ORGANIZATION	Ingelheim	nn	9	SENT_153	[p12l947t848r1222b912],
9	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	agent	5	SENT_153	[p12l1286t848r1510b897, p12l9t926r250b981],
10	,	,	ORGANIZATION	,	_	0	SENT_153	[p12l1286t848r1510b897, p12l9t926r250b981],
11	Inc.	NNP	ORGANIZATION	Inc.	appos	9	SENT_153	[p12l271t931r367b974],
12	.	.	O	.	_	0	SENT_153	[p12l271t931r367b974],

1	Neither	DT	O	neither	det	2	SENT_154	[p12l388t926r588b974],
2	company	NN	O	company	nsubj	3	SENT_154	[p12l603t943r846b989],
3	had	VBD	O	have	_	0	SENT_154	[p12l860t926r958b974],
4	other	JJ	O	other	amod	5	SENT_154	[p12l974t926r1113b974],
5	input	NN	O	input	dobj	3	SENT_154	[p12l1128t929r1272b989],
6	into	IN	O	into	_	0	SENT_154	[p12l1287t929r1390b974],
7	trial	NN	O	trial	nn	8	SENT_154	[p12l1406t926r1512b974],
8	design	NN	O	design	prep_into	3	SENT_154	[p12l9t1003r197b1067],
9	,	,	O	,	_	0	SENT_154	[p12l9t1003r197b1067],
10	data	NNS	O	datum	nn	11	SENT_154	[p12l218t1003r326b1052],
11	collection	NN	O	collection	prep_into	3	SENT_154	[p12l345t1003r612b1059],
12	,	,	O	,	_	0	SENT_154	[p12l345t1003r612b1059],
13	management	NN	O	management	prep_into	3	SENT_154	[p12l633t1013r999b1067],
14	,	,	O	,	_	0	SENT_154	[p12l633t1013r999b1067],
15	or	CC	O	or	_	0	SENT_154	[p12l1021t1021r1075b1052],
16	interpretation	NN	O	interpretation	prep_into	3	SENT_154	[p12l1092t1006r1473b1066],
17	.	.	O	.	_	0	SENT_154	[p12l1092t1006r1473b1066],

1	Results	NNS	O	result	_	0	SENT_155	[p12l12t1151r229b1207],

1	338	CD	NUMBER	338	num	2	SENT_156	[p12l11t1240r101b1284],
2	patients	NNS	O	patient	nsubjpass	4	SENT_156	[p12l130t1239r339b1298],
3	were	VBD	O	be	auxpass	4	SENT_156	[p12l368t1253r495b1284],
4	screened	VBN	O	screen	_	0	SENT_156	[p12l526t1235r760b1284],
5	for	IN	O	for	_	0	SENT_156	[p12l788t1235r864b1284],
6	the	DT	O	the	det	7	SENT_156	[p12l891t1235r973b1284],
7	trial	NN	O	trial	prep_for	4	SENT_156	[p12l1002t1235r1108b1284],
8	between	IN	O	between	_	0	SENT_156	[p12l1136t1235r1358b1284],
9	2000	CD	DATE	2000	prep_between	7	SENT_156	[p12l1388t1240r1511b1284],
10	and	CC	DATE	and	_	0	SENT_156	[p12l9t1313r107b1362],
11	2002	CD	DATE	2002	prep_between	7	SENT_156	[p12l133t1317r270b1369],
12	;	:	O	;	_	0	SENT_156	[p12l133t1317r270b1369],
13	78	CD	NUMBER	78	nsubjpass	15	SENT_156	[p12l300t1316r359b1363],
14	were	VBD	O	be	auxpass	15	SENT_156	[p12l383t1331r510b1362],
15	enrolled	VBN	O	enrol	parataxis	4	SENT_156	[p12l537t1313r754b1362],
16	(	NN	O	(	nn	17	SENT_156	[p12l783t1313r956b1377],
17	ﬁgure	NN	O	ﬁgure	dobj	15	SENT_156	[p12l783t1313r956b1377],
18	2	CD	NUMBER	2	num	19	SENT_156	[p12l983t1318r1044b1377],
19	)	NN	O	)	dep	17	SENT_156	[p12l983t1318r1044b1377],
20	.	.	O	.	_	0	SENT_156	[p12l983t1318r1044b1377],

1	The	DT	O	the	det	5	SENT_157	[p12l1071t1313r1173b1362],
2	clinical	JJ	O	clinical	amod	5	SENT_157	[p12l1200t1313r1388b1362],
3	and	CC	O	and	_	0	SENT_157	[p12l1414t1313r1512b1362],
4	physiological	JJ	O	physiological	amod	5	SENT_157	[p12l8t1392r355b1456],
5	characteristics	NNS	O	characteristic	nsubjpass	11	SENT_157	[p12l378t1392r755b1440],
6	of	IN	O	of	_	0	SENT_157	[p12l780t1392r839b1440],
7	the	DT	O	the	det	9	SENT_157	[p12l852t1392r934b1440],
8	enrolled	VBN	O	enrol	amod	9	SENT_157	[p12l958t1392r1176b1440],
9	patients	NNS	O	patient	prep_of	5	SENT_157	[p12l1198t1395r1407b1455],
10	are	VBP	O	be	auxpass	11	SENT_157	[p12l1432t1409r1511b1440],
11	given	VBN	O	give	_	0	SENT_157	[p12l9t1472r151b1533],
12	in	IN	O	in	_	0	SENT_157	[p12l182t1472r235b1517],
13	table	NN	O	table	prep_in	11	SENT_157	[p12l265t1469r391b1518],
14	1	CD	NUMBER	1	num	13	SENT_157	[p12l427t1474r466b1518],
15	.	.	O	.	_	0	SENT_157	[p12l427t1474r466b1518],

1	The	DT	O	the	det	3	SENT_158	[p12l499t1469r601b1518],
2	mean	NN	O	mean	nn	3	SENT_158	[p12l633t1487r783b1518],
3	FEV	NN	O	fev	nsubjpass	10	SENT_158	[p12l817t1472r942b1530],
4	,	,	O	,	_	0	SENT_158	[p12l817t1472r942b1530],
5	was	VBD	O	be	auxpass	10	SENT_158	[p12l973t1487r1071b1518],
6	almost	RB	O	almost	quantmod	7	SENT_158	[p12l1105t1469r1284b1518],
7	90	CD	PERCENT	90	num	8	SENT_158	[p12l1315t1472r1429b1520],
8	%	NN	PERCENT	%	npadvmod	9	SENT_158	[p12l1315t1472r1429b1520],
9	of	IN	O	of	advmod	10	SENT_158	[p12l1462t1469r1521b1518],
10	predicted	VBN	O	predict	_	0	SENT_158	[p12l8t1547r269b1610],
11	,	,	O	,	_	0	SENT_158	[p12l8t1547r269b1610],
12	and	CC	O	and	_	0	SENT_158	[p12l293t1547r391b1596],
13	each	DT	O	each	det	14	SENT_158	[p12l412t1547r532b1596],
14	patient	NN	O	patient	nsubj	17	SENT_158	[p12l552t1550r738b1610],
15	on	IN	O	on	_	0	SENT_158	[p12l758t1564r825b1596],
16	average	NN	O	average	prep_on	14	SENT_158	[p12l847t1564r1045b1611],
17	used	VBD	O	use	conj_and	10	SENT_158	[p12l1066t1547r1192b1596],
18	one	CD	NUMBER	one	num	19	SENT_158	[p12l1213t1565r1308b1596],
19	puff	NN	O	puff	dobj	17	SENT_158	[p12l1330t1547r1449b1610],
20	of	IN	O	of	_	0	SENT_158	[p12l1462t1547r1521b1596],
21	albuterol	NN	O	albuterol	prep_of	19	SENT_158	[p12l9t1626r243b1674],
22	per	IN	O	per	_	0	SENT_158	[p12l289t1643r375b1689],
23	day	NN	DURATION	day	prep_per	21	SENT_158	[p12l421t1626r522b1689],
24	.	.	O	.	_	0	SENT_158	[p12l421t1626r522b1689],

1	Matching	VBG	O	match	csubj	9	SENT_159	[p12l573t1626r825b1690],
2	by	IN	O	by	_	0	SENT_159	[p12l869t1626r932b1689],
3	lung	NN	O	lung	nn	4	SENT_159	[p12l975t1626r1096b1690],
4	function	NN	O	function	prep_by	1	SENT_159	[p12l1142t1626r1367b1674],
5	was	VBD	O	be	cop	9	SENT_159	[p12l1411t1643r1510b1674],
6	successful	JJ	O	successful	amod	9	SENT_159	[p12l10t1703r281b1752],
7	(	NN	O	(	nn	9	SENT_159	[p12l311t1707r549b1767],
8	Arg/Arg	NN	O	arg/arg	nn	9	SENT_159	[p12l311t1707r549b1767],
9	FEV1	NN	O	fev1	_	0	SENT_159	[p12l578t1706r703b1764],
10	89-9	CD	PERCENT	89-9	num	11	SENT_159	[p12l732t1706r908b1754],
11	%	NN	PERCENT	%	npadvmod	12	SENT_159	[p12l732t1706r908b1754],
12	of	IN	O	of	advmod	13	SENT_159	[p12l936t1703r995b1752],
13	predicted	VBN	O	predict	partmod	9	SENT_159	[p12l1012t1703r1273b1767],
14	,	,	O	,	_	0	SENT_159	[p12l1012t1703r1273b1767],
15	Gly/Gly	NNP	O	Gly/Gly	appos	9	SENT_159	[p12l1304t1703r1513b1767],
16	89	CD	NUMBER	89	num	15	SENT_159	[p12l9t1785r68b1830],
17	-	:	O	-	_	0	SENT_159	[p12l82t1809r90b1817],
18	8	CD	PERCENT	8	num	19	SENT_159	[p12l103t1784r185b1832],
19	%	NN	PERCENT	%	dep	15	SENT_159	[p12l103t1784r185b1832],
20	of	IN	O	of	_	0	SENT_159	[p12l205t1781r264b1830],
21	predicted	VBN	O	predict	amod	22	SENT_159	[p12l272t1781r553b1845],
22	)	NN	O	)	prep_of	19	SENT_159	[p12l272t1781r553b1845],
23	.	.	O	.	_	0	SENT_159	[p12l272t1781r553b1845],

1	Within	IN	O	within	_	0	SENT_160	[p12l57t1860r244b1909],
2	each	DT	O	each	det	3	SENT_160	[p12l297t1860r416b1908],
3	genotype	NN	O	genotype	prep_within	17	SENT_160	[p12l469t1869r707b1924],
4	the	DT	O	the	det	5	SENT_160	[p12l759t1860r842b1908],
5	characteristics	NNS	O	characteristic	nsubjpass	17	SENT_160	[p12l895t1860r1273b1908],
6	of	IN	O	of	_	0	SENT_160	[p12l1327t1860r1386b1908],
7	the	DT	O	the	det	8	SENT_160	[p12l1428t1860r1511b1908],
8	patients	NNS	O	patient	prep_of	5	SENT_160	[p12l8t1940r217b2000],
9	at	IN	O	at	_	0	SENT_160	[p12l236t1947r283b1986],
10	the	DT	O	the	det	11	SENT_160	[p12l298t1937r381b1986],
11	start	NN	O	start	prep_at	8	SENT_160	[p12l400t1947r516b1986],
12	of	IN	O	of	_	0	SENT_160	[p12l533t1937r591b1986],
13	each	DT	O	each	det	15	SENT_160	[p12l600t1937r720b1986],
14	treatment	NN	O	treatment	nn	15	SENT_160	[p12l736t1947r998b1986],
15	period	NN	O	period	prep_of	11	SENT_160	[p12l1014t1937r1185b2000],
16	are	VBP	O	be	auxpass	17	SENT_160	[p12l1202t1955r1281b1986],
17	given	VBN	O	give	_	0	SENT_160	[p12l1300t1940r1442b2001],
18	in	IN	O	in	_	0	SENT_160	[p12l1459t1940r1512b1985],
19	table	NN	O	table	prep_in	17	SENT_160	[p12l7t2015r133b2064],
20	2	CD	NUMBER	2	num	19	SENT_160	[p12l162t2020r204b2063],
21	.	.	O	.	_	0	SENT_160	[p12l162t2020r204b2063],

1	There	EX	O	there	expl	2	SENT_161	[p12l233t2015r388b2064],
2	were	VBD	O	be	_	0	SENT_161	[p12l415t2032r541b2064],
3	no	DT	O	no	det	5	SENT_161	[p12l569t2032r635b2064],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_161	[p12l665t2015r944b2079],
5	differences	NNS	O	difference	nsubj	2	SENT_161	[p12l970t2015r1262b2064],
6	between	IN	O	between	_	0	SENT_161	[p12l1290t2015r1512b2064],
7	the	DT	O	the	det	8	SENT_161	[p12l7t2093r90b2141],
8	starts	NNS	O	start	prep_between	5	SENT_161	[p12l130t2102r269b2141],
9	of	IN	O	of	_	0	SENT_161	[p12l309t2093r368b2141],
10	the	DT	O	the	det	11	SENT_161	[p12l396t2093r479b2141],
11	ﬁrst	NN	O	ﬁrst	prep_of	8	SENT_161	[p12l517t2093r623b2141],
12	and	CC	O	and	_	0	SENT_161	[p12l660t2093r758b2141],
13	second	JJ	ORDINAL	second	amod	15	SENT_161	[p12l797t2093r980b2141],
14	treatment	NN	O	treatment	nn	15	SENT_161	[p12l1016t2102r1278b2141],
15	periods	NNS	O	period	conj_and	11	SENT_161	[p12l1315t2093r1510b2156],
16	within	IN	O	within	_	0	SENT_161	[p12l7t2170r179b2219],
17	each	DT	O	each	det	18	SENT_161	[p12l201t2170r320b2219],
18	sequence	NN	O	sequence	prep_within	2	SENT_161	[p12l343t2187r587b2233],
19	of	IN	O	of	_	0	SENT_161	[p12l609t2170r668b2219],
20	each	DT	O	each	det	21	SENT_161	[p12l681t2170r800b2219],
21	genotype	NN	O	genotype	prep_of	18	SENT_161	[p12l822t2180r1074b2234],
22	.	.	O	.	_	0	SENT_161	[p12l822t2180r1074b2234],

1	Similarly	RB	O	similarly	advmod	4	SENT_162	[p12l1101t2170r1352b2234],
2	,	,	O	,	_	0	SENT_162	[p12l1101t2170r1352b2234],
3	there	EX	O	there	expl	4	SENT_162	[p12l1375t2170r1511b2219],
4	were	VBD	O	be	_	0	SENT_162	[p12l7t2266r133b2297],
5	no	DT	O	no	det	7	SENT_162	[p12l153t2265r220b2297],
6	signiﬁcant	JJ	O	signiﬁcant	amod	7	SENT_162	[p12l242t2248r521b2312],
7	differences	NNS	O	difference	nsubj	4	SENT_162	[p12l540t2248r832b2297],
8	between	IN	O	between	_	0	SENT_162	[p12l852t2248r1074b2297],
9	the	DT	O	the	det	10	SENT_162	[p12l1093t2248r1176b2297],
10	starts	NNS	O	start	prep_between	7	SENT_162	[p12l1198t2258r1337b2297],
11	of	IN	O	of	_	0	SENT_162	[p12l1360t2248r1418b2297],
12	the	DT	O	the	det	13	SENT_162	[p12l1428t2248r1511b2297],
13	active	JJ	O	active	prep_of	10	SENT_162	[p12l9t2329r156b2374],
14	to	TO	O	to	_	0	SENT_162	[p12l191t2335r241b2374],
15	placebo	NN	O	placebo	prep_to	13	SENT_162	[p12l277t2326r477b2389],
16	and	CC	O	and	_	0	SENT_162	[p12l514t2326r612b2374],
17	placebo	NN	O	placebo	prep_to	13	SENT_162	[p12l646t2326r847b2389],
18	to	TO	O	to	_	0	SENT_162	[p12l882t2335r931b2374],
19	active	JJ	O	active	amod	20	SENT_162	[p12l968t2329r1116b2374],
20	sequences	NNS	O	sequence	prep_to	13	SENT_162	[p12l1154t2343r1424b2389],
21	of	IN	O	of	prep	13	SENT_162	[p12l1462t2326r1521b2374],
22	either	CC	O	either	dep	21	SENT_162	[p12l9t2403r163b2452],
23	genotype	NN	O	genotype	conj	21	SENT_162	[p12l181t2413r433b2467],
24	.	.	O	.	_	0	SENT_162	[p12l181t2413r433b2467],

1	During	IN	O	during	_	0	SENT_163	[p12l61t2484r251b2545],
2	the	DT	O	the	det	5	SENT_163	[p12l275t2481r357b2530],
3	double-blind	JJ	O	double-blind	amod	5	SENT_163	[p12l383t2481r720b2530],
4	treatment	NN	O	treatment	nn	5	SENT_163	[p12l744t2491r1006b2530],
5	phase	NN	O	phase	prep_during	15	SENT_163	[p12l1029t2481r1196b2544],
6	,	,	O	,	_	0	SENT_163	[p12l1029t2481r1196b2544],
7	in	IN	O	in	_	0	SENT_163	[p12l1223t2484r1276b2529],
8	patients	NNS	O	patient	prep_in	15	SENT_163	[p12l1300t2484r1510b2544],
9	with	IN	O	with	_	0	SENT_163	[p12l7t2560r124b2608],
10	the	DT	O	the	det	12	SENT_163	[p12l160t2560r243b2608],
11	Gly/Gly	NNP	O	Gly/Gly	nn	12	SENT_163	[p12l282t2560r491b2623],
12	genotype	NN	O	genotype	prep_with	8	SENT_163	[p12l528t2569r780b2624],
13	,	,	O	,	_	0	SENT_163	[p12l528t2569r780b2624],
14	there	EX	O	there	expl	15	SENT_163	[p12l818t2560r955b2608],
15	was	VBD	O	be	_	0	SENT_163	[p12l990t2577r1089b2608],
16	no	DT	O	no	det	18	SENT_163	[p12l1128t2577r1194b2608],
17	signiﬁcant	JJ	O	signiﬁcant	amod	18	SENT_163	[p12l1233t2560r1512b2624],
18	change	NN	O	change	nsubj	15	SENT_163	[p12l9t2637r197b2701],
19	in	IN	O	in	_	0	SENT_163	[p12l246t2640r299b2685],
20	self-monitored	JJ	O	self-monitored	amod	22	SENT_163	[p12l349t2637r739b2686],
21	morning	NN	TIME	morning	nn	22	SENT_163	[p12l786t2640r1021b2701],
22	PEFR	NN	ORGANIZATION	pefr	prep_in	18	SENT_163	[p12l1072t2640r1222b2685],
23	over	IN	O	over	_	0	SENT_163	[p12l1270t2655r1382b2686],
24	the	DT	DURATION	the	det	26	SENT_163	[p12l1428t2637r1511b2686],
25	16	CD	DURATION	16	num	26	SENT_163	[p12l12t2718r68b2762],
26	weeks	NNS	NUMBER	week	prep_over	22	SENT_163	[p12l89t2714r249b2763],
27	of	IN	O	of	_	0	SENT_163	[p12l273t2714r332b2762],
28	double-blind	JJ	O	double-blind	amod	29	SENT_163	[p12l344t2714r681b2763],
29	treatment	NN	O	treatment	prep_of	26	SENT_163	[p12l700t2724r963b2763],
30	with	IN	O	with	_	0	SENT_163	[p12l981t2714r1098b2763],
31	placebo	NN	O	placebo	prep_with	29	SENT_163	[p12l1119t2714r1333b2777],
32	.	.	O	.	_	0	SENT_163	[p12l1119t2714r1333b2777],

1	There	EX	O	there	expl	2	SENT_164	[p12l1356t2714r1511b2763],
2	was	VBD	O	be	_	0	SENT_164	[p12l7t2810r105b2841],
3	a	DT	O	a	det	5	SENT_164	[p12l141t2810r167b2841],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_164	[p12l203t2793r482b2857],
5	increase	NN	O	increase	nsubj	2	SENT_164	[p12l514t2796r733b2841],
6	in	IN	O	in	_	0	SENT_164	[p12l767t2796r820b2840],
7	PEFR	NN	O	pefr	prep_in	5	SENT_164	[p12l856t2796r1005b2840],
8	during	IN	O	during	_	0	SENT_164	[p12l1039t2793r1218b2857],
9	treatment	NN	O	treatment	prep_during	2	SENT_164	[p12l1250t2802r1512b2841],
10	with	IN	O	with	_	0	SENT_164	[p12l7t2870r124b2919],
11	regularly	RB	O	regularly	advmod	2	SENT_164	[p12l162t2870r398b2934],
12	scheduled	VBN	O	schedule	amod	15	SENT_164	[p12l437t2870r704b2919],
13	albuterol	NN	O	albuterol	nn	15	SENT_164	[p12l741t2870r976b2919],
14	(	NN	O	(	nn	15	SENT_164	[p12l1018t2870r1190b2934],
15	ﬁgure	NN	O	ﬁgure	prep_with	2	SENT_164	[p12l1018t2870r1190b2934],
16	3	CD	NUMBER	3	num	17	SENT_164	[p12l1231t2875r1291b2934],
17	)	NN	O	)	dep	15	SENT_164	[p12l1231t2875r1291b2934],
18	.	.	O	.	_	0	SENT_164	[p12l1231t2875r1291b2934],

1	At	IN	O	at	_	0	SENT_165	[p12l1331t2874r1392b2918],
2	the	DT	DURATION	the	det	3	SENT_165	[p12l1428t2870r1511b2919],
3	end	NN	DURATION	end	prep_at	29	SENT_165	[p12l9t2947r107b2995],
4	of	IN	DURATION	of	_	0	SENT_165	[p12l144t2947r203b2995],
5	16	CD	DURATION	16	num	6	SENT_165	[p12l235t2951r292b2995],
6	weeks	NNS	NUMBER	week	prep_of	3	SENT_165	[p12l328t2947r488b2995],
7	of	IN	O	of	_	0	SENT_165	[p12l528t2947r587b2995],
8	active	JJ	O	active	amod	9	SENT_165	[p12l616t2950r763b2995],
9	treatment	NN	O	treatment	prep_of	6	SENT_165	[p12l800t2957r1075b3002],
10	,	,	O	,	_	0	SENT_165	[p12l800t2957r1075b3002],
11	the	DT	O	the	det	26	SENT_165	[p12l1113t2947r1196b2995],
12	treatmentattributable	JJ	O	treatmentattributable	amod	26	SENT_165	[p12l1233t2957r1510b2995, p12l9t3026r312b3074],
13	difference	NN	O	difference	dep	12	SENT_165	[p12l333t3026r600b3074],
14	(	CD	NUMBER	(	num	13	SENT_165	[p12l624t3029r698b3090],
15	ie	FW	O	ie	dep	13	SENT_165	[p12l624t3029r698b3090],
16	,	,	O	,	_	0	SENT_165	[p12l624t3029r698b3090],
17	active	JJ	O	active	amod	19	SENT_165	[p12l721t3029r868b3074],
18	treatment	NN	O	treatment	nn	19	SENT_165	[p12l888t3035r1150b3074],
19	PEFR	NN	ORGANIZATION	pefr	appos	13	SENT_165	[p12l1171t3029r1320b3073],
20	minus	CC	O	minus	advmod	19	SENT_165	[p12l1339t3029r1510b3074],
21	that	IN	O	that	nsubj	22	SENT_165	[p12l7t3103r110b3152],
22	measured	VBN	O	measure	rcmod	19	SENT_165	[p12l131t3103r395b3152],
23	during	IN	O	during	_	0	SENT_165	[p12l416t3103r594b3167],
24	placebo	NN	O	placebo	prep_during	22	SENT_165	[p12l615t3103r816b3166],
25	treatment	NN	O	treatment	nn	26	SENT_165	[p12l837t3108r1114b3167],
26	)	NN	O	)	nsubj	29	SENT_165	[p12l837t3108r1114b3167],
27	was	VBD	O	be	cop	29	SENT_165	[p12l1138t3120r1236b3152],
28	14	CD	NUMBER	14	num	29	SENT_165	[p12l1263t3108r1321b3151],
29	L/min	NN	O	l/min	_	0	SENT_165	[p12l1345t3106r1512b3166],
30	(	CD	PERCENT	(	num	33	SENT_165	[p12l12t3184r142b3245],
31	95	CD	PERCENT	95	number	32	SENT_165	[p12l12t3184r142b3245],
32	%	NN	PERCENT	%	amod	33	SENT_165	[p12l12t3184r142b3245],
33	CI	NN	O	ci	dep	29	SENT_165	[p12l162t3185r221b3230],
34	3	CD	NUMBER	3	number	36	SENT_165	[p12l244t3186r268b3230],
35	to	TO	O	to	dep	36	SENT_165	[p12l287t3191r336b3230],
36	25	CD	NUMBER	25	num	33	SENT_165	[p12l355t3184r428b3237],
37	;	:	O	;	_	0	SENT_165	[p12l355t3184r428b3237],
38	p	NN	O	p	dep	29	SENT_165	[p12l448t3184r737b3245],
39	=	JJ	O	=	amod	41	SENT_165	[p12l448t3184r737b3245],
40	O-0175	NN	O	o-0175	nn	41	SENT_165	[p12l448t3184r737b3245],
41	)	NN	O	)	dep	38	SENT_165	[p12l448t3184r737b3245],
42	.	.	O	.	_	0	SENT_165	[p12l448t3184r737b3245],

1	This	DT	O	this	det	2	SENT_166	[p12l756t3181r872b3230],
2	improvement	NN	O	improvement	nsubj	3	SENT_166	[p12l891t3184r1254b3244],
3	appeared	VBD	O	appear	_	0	SENT_166	[p12l1271t3181r1512b3244],
4	to	TO	O	to	aux	5	SENT_166	[p12l7t3269r56b3308],
5	persist	VB	O	persist	xcomp	3	SENT_166	[p12l99t3263r276b3323],
6	through	IN	O	through	_	0	SENT_166	[p12l316t3260r532b3324],
7	the	DT	O	the	det	15	SENT_166	[p12l573t3260r656b3308],
8	subsequent	JJ	O	subsequent	amod	15	SENT_166	[p12l700t3260r1005b3323],
9	8-week	JJ	DURATION	8-week	amod	15	SENT_166	[p12l1047t3260r1231b3308],
10	wash-out	JJ	O	wash-out	amod	15	SENT_166	[p12l1270t3260r1512b3308],
11	period	NN	O	period	nn	15	SENT_166	[p12l8t3337r178b3400],
12	(	NN	O	(	nn	15	SENT_166	[p12l224t3337r396b3401],
13	ﬁgure	NN	O	ﬁgure	nn	15	SENT_166	[p12l224t3337r396b3401],
14	3	CD	NUMBER	3	num	15	SENT_166	[p12l441t3342r500b3401],
15	)	NN	O	)	prep_through	5	SENT_166	[p12l441t3342r500b3401],
16	.	.	O	.	_	0	SENT_166	[p12l441t3342r500b3401],

1	By	IN	O	by	_	0	SENT_167	[p12l548t3342r613b3401],
2	contrast	NN	O	contrast	prep_by	12	SENT_167	[p12l654t3347r880b3393],
3	,	,	O	,	_	0	SENT_167	[p12l654t3347r880b3393],
4	in	IN	O	in	_	0	SENT_167	[p12l924t3340r977b3385],
5	patients	NNS	O	patient	prep_in	12	SENT_167	[p12l1018t3340r1227b3400],
6	with	IN	O	with	_	0	SENT_167	[p12l1270t3337r1387b3386],
7	the	DT	O	the	det	9	SENT_167	[p12l1428t3337r1511b3386],
8	Arg/Arg	NN	O	arg/arg	nn	9	SENT_167	[p12l7t3418r230b3479],
9	genotype	NN	O	genotype	prep_with	5	SENT_167	[p12l260t3425r512b3479],
10	,	,	O	,	_	0	SENT_167	[p12l260t3425r512b3479],
11	there	EX	O	there	expl	12	SENT_167	[p12l543t3415r679b3464],
12	was	VBD	O	be	_	0	SENT_167	[p12l707t3432r805b3464],
13	no	DT	O	no	det	15	SENT_167	[p12l836t3432r902b3464],
14	signiﬁcant	JJ	O	signiﬁcant	amod	15	SENT_167	[p12l934t3415r1213b3479],
15	change	NN	O	change	nsubj	12	SENT_167	[p12l1241t3415r1429b3479],
16	in	IN	O	in	_	0	SENT_167	[p12l1458t3418r1512b3463],
17	selﬁmonitored	JJ	O	selﬁmonitored	amod	19	SENT_167	[p12l10t3494r400b3542],
18	morning	NN	TIME	morning	nn	19	SENT_167	[p12l436t3497r671b3558],
19	PEFR	NN	ORGANIZATION	pefr	prep_in	15	SENT_167	[p12l711t3497r860b3541],
20	over	IN	O	over	_	0	SENT_167	[p12l897t3511r1009b3542],
21	the	DT	DURATION	the	det	23	SENT_167	[p12l1044t3494r1127b3542],
22	16	CD	DURATION	16	num	23	SENT_167	[p12l1169t3498r1225b3542],
23	weeks	NNS	NUMBER	week	prep_over	19	SENT_167	[p12l1262t3494r1422b3542],
24	of	IN	O	of	_	0	SENT_167	[p12l1462t3494r1521b3542],
25	treatment	NN	O	treatment	prep_of	23	SENT_167	[p12l7t3581r269b3620],
26	with	IN	O	with	_	0	SENT_167	[p12l302t3571r420b3620],
27	albuterol	NN	O	albuterol	prep_with	25	SENT_167	[p12l456t3571r704b3627],
28	,	,	O	,	_	0	SENT_167	[p12l456t3571r704b3627],
29	but	CC	O	but	_	0	SENT_167	[p12l741t3571r830b3620],
30	there	EX	O	there	expl	39	SENT_167	[p12l863t3571r999b3620],
31	was	VBD	O	be	auxpass	39	SENT_167	[p12l1034t3588r1132b3620],
32	a	DT	O	a	det	34	SENT_167	[p12l1170t3589r1196b3620],
33	signiﬁcant	JJ	O	signiﬁcant	amod	34	SENT_167	[p12l1233t3571r1513b3635],
34	increase	NN	O	increase	nsubjpass	39	SENT_167	[p12l8t3652r226b3698],
35	during	IN	O	during	_	0	SENT_167	[p12l273t3649r452b3713],
36	treatment	NN	O	treatment	prep_during	34	SENT_167	[p12l496t3659r758b3698],
37	with	IN	O	with	prep	39	SENT_167	[p12l800t3649r918b3698],
38	regularly	RB	O	regularly	pcomp	37	SENT_167	[p12l963t3649r1200b3713],
39	scheduled	VBN	O	schedule	conj_but	12	SENT_167	[p12l1245t3649r1512b3698],
40	placebo	NN	O	placebo	nn	42	SENT_167	[p12l8t3728r208b3791],
41	(	NN	O	(	nn	42	SENT_167	[p12l235t3728r407b3792],
42	ﬁgure	NN	O	ﬁgure	dobj	39	SENT_167	[p12l235t3728r407b3792],
43	3	CD	NUMBER	3	num	44	SENT_167	[p12l432t3732r492b3792],
44	)	NN	O	)	dep	42	SENT_167	[p12l432t3732r492b3792],
45	.	.	O	.	_	0	SENT_167	[p12l432t3732r492b3792],

1	Again	RB	O	again	advmod	5	SENT_168	[p12l515t3731r687b3792],
2	,	,	O	,	_	0	SENT_168	[p12l515t3731r687b3792],
3	the	DT	O	the	det	4	SENT_168	[p12l710t3728r793b3776],
4	improvement	NN	O	improvement	nsubj	5	SENT_168	[p12l816t3731r1178b3791],
5	appeared	VBD	O	appear	_	0	SENT_168	[p12l1200t3728r1442b3791],
6	to	TO	O	to	aux	7	SENT_168	[p12l1462t3737r1511b3776],
7	persist	VB	O	persist	xcomp	5	SENT_168	[p13l8t16r185b76],
8	through	IN	O	through	_	0	SENT_168	[p13l206t13r421b77],
9	the	DT	O	the	det	12	SENT_168	[p13l443t13r526b62],
10	8-week	JJ	DURATION	8-week	amod	12	SENT_168	[p13l550t13r734b62],
11	wash-out	JJ	O	wash-out	amod	12	SENT_168	[p13l753t13r996b62],
12	period	NN	O	period	prep_through	7	SENT_168	[p13l1017t13r1200b76],
13	.	.	O	.	_	0	SENT_168	[p13l1017t13r1200b76],

1	At	IN	O	at	_	0	SENT_169	[p13l1225t17r1287b61],
2	the	DT	DURATION	the	det	3	SENT_169	[p13l1307t13r1390b62],
3	end	NN	DURATION	end	prep_at	16	SENT_169	[p13l1414t13r1512b62],
4	of	IN	DURATION	of	_	0	SENT_169	[p13l9t90r68b138],
5	16	CD	DURATION	16	num	6	SENT_169	[p13l119t94r176b138],
6	weeks	NNS	NUMBER	week	prep_of	3	SENT_169	[p13l231t90r392b138],
7	of	IN	O	of	_	0	SENT_169	[p13l451t90r510b138],
8	active	JJ	O	active	amod	9	SENT_169	[p13l558t93r705b138],
9	treatment	NN	O	treatment	prep_of	6	SENT_169	[p13l762t100r1036b145],
10	,	,	O	,	_	0	SENT_169	[p13l762t100r1036b145],
11	the	DT	O	the	det	13	SENT_169	[p13l1094t90r1177b138],
12	treatmentattributable	JJ	O	treatmentattributable	amod	13	SENT_169	[p13l1233t100r1510b138, p13l9t169r312b217],
13	difference	NN	O	difference	nsubj	16	SENT_169	[p13l361t169r627b217],
14	was	VBD	O	be	cop	16	SENT_169	[p13l673t186r772b217],
15	-10	CD	NUMBER	-10	num	16	SENT_169	[p13l819t173r914b217],
16	L/min	NN	O	l/min	_	0	SENT_169	[p13l964t172r1131b232],
17	(	CD	NUMBER	(	num	18	SENT_169	[p13l1182t173r1290b233],
18	-19	CD	NUMBER	-19	dep	16	SENT_169	[p13l1182t173r1290b233],
19	to	TO	O	to	_	0	SENT_169	[p13l1337t178r1386b217],
20	-2	CD	NUMBER	-2	prep_to	18	SENT_169	[p13l1433t173r1509b225],
21	;	:	O	;	_	0	SENT_169	[p13l1433t173r1509b225],
22	p	NN	O	p	dep	16	SENT_169	[p13l8t251r297b310],
23	=	JJ	O	=	amod	25	SENT_169	[p13l8t251r297b310],
24	0-0209	CD	NUMBER	0-0209	tmod	23	SENT_169	[p13l8t251r297b310],
25	)	NN	O	)	dep	22	SENT_169	[p13l8t251r297b310],
26	.	.	O	.	_	0	SENT_169	[p13l8t251r297b310],

1	Thus	RB	O	thus	advmod	7	SENT_170	[p13l337t246r487b302],
2	,	,	O	,	_	0	SENT_170	[p13l337t246r487b302],
3	the	DT	O	the	det	6	SENT_170	[p13l527t246r610b295],
4	genotype-attributable	JJ	O	genotype-attributable	amod	6	SENT_170	[p13l649t246r1212b310],
5	treatment	NN	O	treatment	nn	6	SENT_170	[p13l1250t256r1513b295],
6	difference	NN	O	difference	nsubj	7	SENT_170	[p13l9t324r275b373],
7	(	VBD	O	(	_	0	SENT_170	[p13l307t324r405b388],
8	the	DT	O	the	det	9	SENT_170	[p13l307t324r405b388],
9	effect	NN	O	effect	dobj	7	SENT_170	[p13l433t324r578b373],
10	of	IN	O	of	_	0	SENT_170	[p13l605t324r664b373],
11	treatment	NN	O	treatment	prep_of	9	SENT_170	[p13l682t334r944b373],
12	in	IN	O	in	_	0	SENT_170	[p13l971t327r1024b372],
13	Arg/Arg	NN	O	arg/arg	nn	14	SENT_170	[p13l1050t327r1273b388],
14	patients	NNS	O	patient	prep_in	11	SENT_170	[p13l1301t327r1510b387],
15	minus	CC	O	minus	advmod	11	SENT_170	[p13l8t406r178b451],
16	that	IN	O	that	complm	24	SENT_170	[p13l197t403r300b451],
17	observed	VBN	O	observe	csubj	24	SENT_170	[p13l318t403r553b451],
18	in	IN	O	in	_	0	SENT_170	[p13l570t406r623b450],
19	Gly/Gly	JJ	O	gly/gly	amod	21	SENT_170	[p13l642t403r851b466],
20	patients	NNS	O	patient	nn	21	SENT_170	[p13l867t406r1093b467],
21	)	NN	O	)	prep_in	17	SENT_170	[p13l867t406r1093b467],
22	was	VBD	O	be	cop	24	SENT_170	[p13l1113t420r1212b451],
23	-24	CD	NUMBER	-24	num	24	SENT_170	[p13l1230t407r1325b450],
24	L/min	NN	O	l/min	ccomp	7	SENT_170	[p13l1345t406r1512b466],
25	(	CD	NUMBER	(	num	26	SENT_170	[p13l12t483r120b544],
26	-37	CD	NUMBER	-37	dep	24	SENT_170	[p13l12t483r120b544],
27	to	TO	O	to	_	0	SENT_170	[p13l138t490r187b529],
28	-12	CD	NUMBER	-12	prep_to	26	SENT_170	[p13l205t485r313b536],
29	;	:	O	;	_	0	SENT_170	[p13l205t485r313b536],
30	p	NN	O	p	dep	26	SENT_170	[p13l333t485r604b543],
31	=	JJ	O	=	amod	30	SENT_170	[p13l333t485r604b543],
32	0-0003	CD	NUMBER	0-0003	tmod	31	SENT_170	[p13l333t485r604b543],
33	;	:	O	;	_	0	SENT_170	[p13l333t485r604b543],
34	table	NN	O	table	dep	26	SENT_170	[p13l624t480r750b529],
35	3	CD	NUMBER	3	num	36	SENT_170	[p13l772t485r831b544],
36	)	NN	O	)	dep	34	SENT_170	[p13l772t485r831b544],
37	.	.	O	.	_	0	SENT_170	[p13l772t485r831b544],

1	Since	IN	O	since	mark	3	SENT_171	[p13l62t561r203b607],
2	we	PRP	O	we	nsubj	3	SENT_171	[p13l249t576r322b607],
3	observed	VBD	O	observe	_	0	SENT_171	[p13l370t558r605b607],
4	a	DT	O	a	det	6	SENT_171	[p13l651t575r678b607],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_171	[p13l726t558r1005b622],
6	improvement	NN	O	improvement	dobj	3	SENT_171	[p13l1050t561r1413b621],
7	in	IN	O	in	_	0	SENT_171	[p13l1459t561r1512b606],
8	morning	NN	TIME	morning	nn	9	SENT_171	[p13l8t640r243b701],
9	PEFR	NN	O	pefr	prep_in	3	SENT_171	[p13l270t640r419b684],
10	in	IN	O	in	_	0	SENT_171	[p13l442t640r495b684],
11	Arg/Arg	NN	O	arg/arg	nn	12	SENT_171	[p13l518t640r742b701],
12	patients	NNS	O	patient	prep_in	9	SENT_171	[p13l766t640r974b700],
13	during	IN	O	during	_	0	SENT_171	[p13l1001t637r1180b701],
14	the	DT	O	the	det	15	SENT_171	[p13l1203t637r1286b685],
15	placebo	NN	O	placebo	prep_during	3	SENT_171	[p13l1310t637r1511b700],

1	Articles	NNPS	O	Articles	_	0	SENT_172	[p13l101t1104r249b1140],

1	Variable	JJ	O	variable	amod	2	SENT_173	[p13l51t1335r137b1354],
2	Change	NNP	O	Change	dep	23	SENT_173	[p13l414t1335r492b1360],
3	in	IN	O	in	_	0	SENT_173	[p13l498t1335r516b1354],
4	Arg/Arg	NNP	O	Arg/Arg	prep_in	2	SENT_173	[p13l1704t1336r1788b1360],
5	minus	CC	O	minus	_	0	SENT_173	[p13l1796t1335r1860b1354],
6	Gly/Gly	NNP	O	Gly/Gly	conj_minus	4	SENT_173	[p13l1866t1335r1943b1360],
7	difference	NN	O	difference	nn	14	SENT_173	[p13l1948t1335r2054b1354],
8	Arg/Arg	NN	O	arg/arg	nn	14	SENT_173	[p13l413t1383r497b1407],
9	Gly/Gly	NN	O	gly/gly	nn	14	SENT_173	[p13l1035t1382r1111b1407],
10	Mean	NN	O	mean	nn	14	SENT_173	[p13l1705t1386r1759b1404],
11	(	CD	PERCENT	(	num	14	SENT_173	[p13l1766t1385r1817b1409],
12	95	CD	PERCENT	95	num	14	SENT_173	[p13l1766t1385r1817b1409],
13	%	NN	PERCENT	%	nn	14	SENT_173	[p13l1766t1385r1817b1409],
14	CI	NN	O	ci	dep	4	SENT_173	[p13l1825t1385r1850b1409],
15	)	CD	NUMBER	)	num	16	SENT_173	[p13l1825t1385r1850b1409],
16	P	NN	O	p	dep	23	SENT_173	[p13l1999t1391r2011b1410],
17	Albuterol	NNP	O	Albuterol	nn	23	SENT_173	[p13l413t1429r506b1449],
18	Placebo	NNP	O	Placebo	nn	23	SENT_173	[p13l539t1429r615b1449],
19	Difference	NNP	O	Difference	nn	23	SENT_173	[p13l647t1429r747b1449],
20	(	CD	PERCENT	(	num	23	SENT_173	[p13l754t1430r805b1454],
21	95	CD	PERCENT	95	num	23	SENT_173	[p13l754t1430r805b1454],
22	%	NN	PERCENT	%	nn	23	SENT_173	[p13l754t1430r805b1454],
23	CI	NN	O	ci	dep	34	SENT_173	[p13l812t1430r838b1454],
24	)	NN	O	)	nn	28	SENT_173	[p13l812t1430r838b1454],
25	p	NN	O	p	nn	28	SENT_173	[p13l914t1436r926b1454],
26	Albuterol	NNP	O	Albuterol	nn	28	SENT_173	[p13l1034t1429r1127b1449],
27	Placebo	NNP	O	Placebo	nn	28	SENT_173	[p13l1168t1429r1243b1449],
28	Difference	NNP	O	Difference	dep	23	SENT_173	[p13l1280t1429r1381b1449],
29	(	CD	PERCENT	(	num	32	SENT_173	[p13l1388t1430r1439b1454],
30	95	CD	PERCENT	95	number	31	SENT_173	[p13l1388t1430r1439b1454],
31	%	NN	PERCENT	%	amod	32	SENT_173	[p13l1388t1430r1439b1454],
32	CI	NN	O	ci	dep	28	SENT_173	[p13l1446t1430r1471b1454],
33	)	NN	O	)	nn	34	SENT_173	[p13l1446t1430r1471b1454],
34	p	NN	O	p	_	0	SENT_173	[p13l1541t1436r1553b1454],

1	Morning	NN	TIME	morning	dep	308	SENT_174	[p13l52t1477r136b1502],
2	PEFR	NN	O	pefr	dep	308	SENT_174	[p13l144t1478r197b1499],
3	,	,	O	,	_	0	SENT_174	[p13l144t1478r197b1499],
4	L/min	NN	O	l/min	dep	308	SENT_174	[p13l205t1477r261b1498],
5	2	CD	NUMBER	2	dep	308	SENT_174	[p13l426t1479r437b1496],
6	12	CD	NUMBER	12	dep	308	SENT_174	[p13l542t1479r566b1496],
7	-1	CD	NUMBER	-1	dep	308	SENT_174	[p13l643t1479r681b1496],
8	o	NN	O	o	dep	308	SENT_174	[p13l643t1479r681b1496],
9	(	CD	NUMBER	(	dep	308	SENT_174	[p13l689t1477r735b1501],
10	-19	CD	NUMBER	-19	dep	308	SENT_174	[p13l689t1477r735b1501],
11	to	TO	O	to	dep	308	SENT_174	[p13l741t1480r762b1496],
12	-2	CD	NUMBER	-2	dep	308	SENT_174	[p13l769t1477r801b1501],
13	)	CD	NUMBER	)	dep	308	SENT_174	[p13l769t1477r801b1501],
14	00209	CD	NUMBER	00209	dep	308	SENT_174	[p13l914t1479r986b1499],
15	13	CD	NUMBER	13	dep	308	SENT_174	[p13l1039t1479r1062b1499],
16	-1	CD	NUMBER	-1	dep	308	SENT_174	[p13l1172t1479r1196b1496],
17	14	CD	NUMBER	14	dep	308	SENT_174	[p13l1283t1479r1309b1498],
18	(	NN	O	(	dep	308	SENT_174	[p13l1315t1477r1334b1501],
19	3	CD	NUMBER	3	dep	308	SENT_174	[p13l1315t1477r1334b1501],
20	to	TO	O	to	dep	308	SENT_174	[p13l1340t1480r1362b1496],
21	25	CD	NUMBER	25	dep	308	SENT_174	[p13l1369t1478r1401b1501],
22	)	CD	NUMBER	)	dep	308	SENT_174	[p13l1369t1478r1401b1501],
23	00175	CD	NUMBER	00175	dep	308	SENT_174	[p13l1541t1479r1613b1499],
24	-24	CD	NUMBER	-24	dep	308	SENT_174	[p13l1708t1479r1747b1498],
25	(	NN	O	(	dep	308	SENT_174	[p13l1753t1477r1799b1501],
26	-37	CD	NUMBER	-37	dep	308	SENT_174	[p13l1753t1477r1799b1501],
27	to	TO	O	to	dep	308	SENT_174	[p13l1805t1480r1826b1496],
28	-12	CD	NUMBER	-12	dep	308	SENT_174	[p13l1833t1477r1879b1501],
29	)	CD	NUMBER	)	dep	308	SENT_174	[p13l1833t1477r1879b1501],
30	0-0003	CD	NUMBER	0-0003	dep	308	SENT_174	[p13l1999t1479r2070b1499],
31	Evening	NN	TIME	evening	dep	308	SENT_174	[p13l53t1513r131b1537],
32	PEFR	NN	O	pefr	dep	308	SENT_174	[p13l139t1514r192b1535],
33	,	,	O	,	_	0	SENT_174	[p13l139t1514r192b1535],
34	L/min	NN	O	l/min	dep	308	SENT_174	[p13l200t1513r256b1534],
35	8	CD	NUMBER	8	dep	308	SENT_174	[p13l426t1512r437b1531],
36	4	CD	NUMBER	4	dep	308	SENT_174	[p13l554t1515r568b1534],
37	4	CD	NUMBER	4	dep	308	SENT_174	[p13l669t1514r682b1534],
38	(	NN	O	(	dep	308	SENT_174	[p13l689t1513r721b1536],
39	-5	CD	NUMBER	-5	dep	308	SENT_174	[p13l689t1513r721b1536],
40	to	TO	O	to	dep	308	SENT_174	[p13l727t1515r749b1531],
41	13	CD	NUMBER	13	dep	308	SENT_174	[p13l756t1513r788b1536],
42	)	CD	NUMBER	)	dep	308	SENT_174	[p13l756t1513r788b1536],
43	04210	CD	NUMBER	04210	dep	308	SENT_174	[p13l914t1514r986b1534],
44	16	CD	NUMBER	16	dep	308	SENT_174	[p13l1039t1512r1063b1531],
45	-3	CD	NUMBER	-3	dep	308	SENT_174	[p13l1172t1515r1196b1534],
46	19	CD	NUMBER	19	dep	308	SENT_174	[p13l1283t1515r1307b1534],
47	(	NN	O	(	dep	308	SENT_174	[p13l1315t1512r1334b1536],
48	8	CD	NUMBER	8	dep	308	SENT_174	[p13l1315t1512r1334b1536],
49	to	TO	O	to	dep	308	SENT_174	[p13l1340t1515r1362b1531],
50	30	CD	NUMBER	30	dep	308	SENT_174	[p13l1368t1513r1401b1536],
51	)	CD	NUMBER	)	dep	308	SENT_174	[p13l1368t1513r1401b1536],
52	00014	CD	NUMBER	00014	dep	308	SENT_174	[p13l1542t1515r1614b1534],
53	-15	CD	NUMBER	-15	dep	308	SENT_174	[p13l1707t1515r1745b1534],
54	(	NN	O	(	dep	308	SENT_174	[p13l1753t1512r1799b1536],
55	-28	CD	NUMBER	-28	dep	308	SENT_174	[p13l1753t1512r1799b1536],
56	to	TO	O	to	dep	308	SENT_174	[p13l1805t1515r1826b1531],
57	-2	CD	NUMBER	-2	dep	308	SENT_174	[p13l1834t1513r1866b1536],
58	)	CD	NUMBER	)	dep	308	SENT_174	[p13l1834t1513r1866b1536],
59	00204	CD	NUMBER	00204	dep	308	SENT_174	[p13l1999t1515r2072b1534],
60	PEFR	NN	O	pefr	dep	308	SENT_174	[p13l53t1549r101b1567],
61	variability	NN	O	variability	dep	308	SENT_174	[p13l107t1548r209b1573],
62	,	,	O	,	_	0	SENT_174	[p13l107t1548r209b1573],
63	%	NN	O	%	dep	308	SENT_174	[p13l216t1551r232b1567],
64	2-3	CD	NUMBER	2-3	dep	308	SENT_174	[p13l426t1550r456b1570],
65	-0	CD	NUMBER	-0	dep	308	SENT_174	[p13l542t1550r586b1570],
66	-3	CD	NUMBER	-3	dep	308	SENT_174	[p13l542t1550r586b1570],
67	2-6	CD	NUMBER	2-6	dep	308	SENT_174	[p13l670t1547r701b1567],
68	(	NN	O	(	dep	308	SENT_174	[p13l708t1549r747b1572],
69	0-7	CD	NUMBER	0-7	dep	308	SENT_174	[p13l708t1549r747b1572],
70	to	TO	O	to	dep	308	SENT_174	[p13l753t1551r774b1567],
71	4-5	CD	NUMBER	4-5	dep	308	SENT_174	[p13l780t1549r820b1572],
72	)	CD	NUMBER	)	dep	308	SENT_174	[p13l780t1549r820b1572],
73	00091	CD	NUMBER	00091	dep	308	SENT_174	[p13l914t1550r985b1570],
74	13	CD	NUMBER	13	dep	308	SENT_174	[p13l1052t1550r1082b1570],
75	-0	CD	NUMBER	-0	dep	308	SENT_174	[p13l1172t1550r1215b1570],
76	-3	CD	NUMBER	-3	dep	308	SENT_174	[p13l1172t1550r1215b1570],
77	1-6	CD	NUMBER	1-6	dep	308	SENT_174	[p13l1297t1547r1327b1567],
78	(	NN	O	(	dep	308	SENT_174	[p13l1334t1549r1386b1572],
79	-0	CD	NUMBER	-0	dep	308	SENT_174	[p13l1334t1549r1386b1572],
80	-3	CD	NUMBER	-3	dep	308	SENT_174	[p13l1334t1549r1386b1572],
81	to	TO	O	to	dep	308	SENT_174	[p13l1392t1551r1413b1567],
82	3-5	CD	NUMBER	3-5	dep	308	SENT_174	[p13l1420t1549r1459b1572],
83	)	CD	NUMBER	)	dep	308	SENT_174	[p13l1420t1549r1459b1572],
84	00889	CD	NUMBER	00889	dep	308	SENT_174	[p13l1541t1547r1613b1570],
85	1-0	CD	NUMBER	1-0	dep	308	SENT_174	[p13l1735t1550r1765b1567],
86	(	NN	O	(	dep	308	SENT_174	[p13l1772t1547r1824b1572],
87	-1	CD	NUMBER	-1	dep	308	SENT_174	[p13l1772t1547r1824b1572],
88	-8	CD	NUMBER	-8	dep	308	SENT_174	[p13l1772t1547r1824b1572],
89	to	TO	O	to	dep	308	SENT_174	[p13l1830t1551r1852b1567],
90	3-7	CD	NUMBER	3-7	dep	308	SENT_174	[p13l1858t1549r1897b1572],
91	)	CD	NUMBER	)	dep	308	SENT_174	[p13l1858t1549r1897b1572],
92	0-4782	CD	NUMBER	0-4782	dep	308	SENT_174	[p13l1999t1547r2070b1570],
93	FEV	NN	O	fev	dep	308	SENT_174	[p13l53t1585r101b1608],
94	,	,	O	,	_	0	SENT_174	[p13l53t1585r101b1608],
95	,	,	O	,	_	0	SENT_174	[p13l53t1585r101b1608],
96	L	NN	O	l	dep	308	SENT_174	[p13l109t1585r119b1603],
97	-0	CD	NUMBER	-0	dep	308	SENT_174	[p13l413t1586r470b1606],
98	-09	CD	NUMBER	-09	dep	308	SENT_174	[p13l413t1586r470b1606],
99	0-04	CD	NUMBER	0-04	dep	308	SENT_174	[p13l555t1586r601b1605],
100	-0	CD	NUMBER	-0	dep	308	SENT_174	[p13l657t1586r714b1606],
101	-13	CD	NUMBER	-13	dep	308	SENT_174	[p13l657t1586r714b1606],
102	(	NN	O	(	dep	308	SENT_174	[p13l721t1584r786b1608],
103	-0	CD	NUMBER	-0	dep	308	SENT_174	[p13l721t1584r786b1608],
104	-22	CD	NUMBER	-22	dep	308	SENT_174	[p13l721t1584r786b1608],
105	to	TO	O	to	dep	308	SENT_174	[p13l793t1587r814b1603],
106	-0	CD	NUMBER	-0	dep	308	SENT_174	[p13l821t1584r886b1608],
107	-05	CD	NUMBER	-05	dep	308	SENT_174	[p13l821t1584r886b1608],
108	)	NN	O	)	dep	308	SENT_174	[p13l821t1584r886b1608],
109	0-0023	CD	NUMBER	0-0023	dep	308	SENT_174	[p13l914t1586r985b1606],
110	0-01	CD	NUMBER	0-01	dep	308	SENT_174	[p13l1051t1586r1095b1603],
111	—	NN	O	—	dep	308	SENT_174	[p13l1172t1586r1228b1606],
112	0-05	CD	NUMBER	0-05	dep	308	SENT_174	[p13l1172t1586r1228b1606],
113	0-06	CD	NUMBER	0-06	dep	308	SENT_174	[p13l1296t1583r1340b1603],
114	(	NN	O	(	dep	308	SENT_174	[p13l1348t1584r1413b1608],
115	-0	CD	NUMBER	-0	dep	308	SENT_174	[p13l1348t1584r1413b1608],
116	-01	CD	NUMBER	-01	dep	308	SENT_174	[p13l1348t1584r1413b1608],
117	to	TO	O	to	dep	308	SENT_174	[p13l1419t1587r1440b1603],
118	0-13	CD	NUMBER	0-13	dep	308	SENT_174	[p13l1447t1584r1499b1608],
119	)	CD	NUMBER	)	dep	308	SENT_174	[p13l1447t1584r1499b1608],
120	0-0942	CD	NUMBER	0-0942	dep	308	SENT_174	[p13l1541t1586r1613b1606],
121	-0	CD	NUMBER	-0	dep	308	SENT_174	[p13l1721t1586r1778b1606],
122	-19	CD	NUMBER	-19	dep	308	SENT_174	[p13l1721t1586r1778b1606],
123	(	NN	O	(	dep	308	SENT_174	[p13l1786t1584r1851b1608],
124	-0	CD	NUMBER	-0	dep	308	SENT_174	[p13l1786t1584r1851b1608],
125	-31	CD	NUMBER	-31	dep	308	SENT_174	[p13l1786t1584r1851b1608],
126	to	TO	O	to	dep	308	SENT_174	[p13l1857t1587r1879b1603],
127	-0	CD	NUMBER	-0	dep	308	SENT_174	[p13l1886t1583r1951b1608],
128	-03	CD	NUMBER	-03	dep	308	SENT_174	[p13l1886t1583r1951b1608],
129	)	NN	O	)	dep	308	SENT_174	[p13l1886t1583r1951b1608],
130	0-0016	CD	NUMBER	0-0016	dep	308	SENT_174	[p13l1999t1583r2071b1603],
131	FEV	NN	O	fev	dep	308	SENT_174	[p13l53t1621r101b1643],
132	,	,	O	,	_	0	SENT_174	[p13l53t1621r101b1643],
133	,	,	O	,	_	0	SENT_174	[p13l53t1621r101b1643],
134	%	NN	O	%	dep	308	SENT_174	[p13l108t1623r124b1638],
135	predicted	VBD	O	predict	dep	308	SENT_174	[p13l131t1619r224b1644],
136	-2	CD	NUMBER	-2	dep	308	SENT_174	[p13l413t1621r457b1641],
137	-7	CD	NUMBER	-7	dep	308	SENT_174	[p13l413t1621r457b1641],
138	1-6	CD	NUMBER	1-6	dep	308	SENT_174	[p13l556t1619r586b1638],
139	-4	CD	NUMBER	-4	dep	308	SENT_174	[p13l657t1621r700b1641],
140	-3	CD	NUMBER	-3	dep	308	SENT_174	[p13l657t1621r700b1641],
141	(	NN	O	(	dep	308	SENT_174	[p13l708t1619r760b1643],
142	-6	CD	NUMBER	-6	dep	308	SENT_174	[p13l708t1619r760b1643],
143	-8	CD	NUMBER	-8	dep	308	SENT_174	[p13l708t1619r760b1643],
144	to	TO	O	to	dep	308	SENT_174	[p13l766t1622r787b1638],
145	-1.7	CD	NUMBER	-1.7	dep	308	SENT_174	[p13l794t1620r846b1643],
146	)	CD	NUMBER	)	dep	308	SENT_174	[p13l794t1620r846b1643],
147	0-0016	CD	NUMBER	0-0016	dep	308	SENT_174	[p13l914t1619r986b1638],
148	0-3	CD	NUMBER	0-3	dep	308	SENT_174	[p13l1051t1621r1082b1641],
149	-1	CD	NUMBER	-1	dep	308	SENT_174	[p13l1172t1622r1215b1641],
150	-7	CD	NUMBER	-7	dep	308	SENT_174	[p13l1172t1622r1215b1641],
151	2.0	CD	NUMBER	2.0	dep	308	SENT_174	[p13l1296t1621r1327b1638],
152	(	NN	O	(	dep	308	SENT_174	[p13l1334t1620r1354b1643],
153	o	NN	O	o	dep	308	SENT_174	[p13l1334t1620r1354b1643],
154	to	TO	O	to	dep	308	SENT_174	[p13l1359t1622r1381b1638],
155	4.0	CD	NUMBER	4.0	dep	308	SENT_174	[p13l1387t1620r1426b1643],
156	)	CD	NUMBER	)	dep	308	SENT_174	[p13l1387t1620r1426b1643],
157	00531	CD	NUMBER	00531	dep	308	SENT_174	[p13l1541t1621r1613b1641],
158	-62	CD	NUMBER	-62	dep	308	SENT_174	[p13l1721t1619r1764b1638],
159	(	NN	O	(	dep	308	SENT_174	[p13l1772t1620r1824b1643],
160	-9.7	CD	NUMBER	-9.7	dep	308	SENT_174	[p13l1772t1620r1824b1643],
161	to	TO	O	to	dep	308	SENT_174	[p13l1830t1622r1852b1638],
162	-2	CD	NUMBER	-2	dep	308	SENT_174	[p13l1859t1619r1910b1643],
163	-8	CD	NUMBER	-8	dep	308	SENT_174	[p13l1859t1619r1910b1643],
164	)	NN	O	)	dep	308	SENT_174	[p13l1859t1619r1910b1643],
165	00007	CD	NUMBER	00007	dep	308	SENT_174	[p13l1999t1621r2071b1641],
166	FVC	NN	O	fvc	dep	308	SENT_174	[p13l53t1656r96b1678],
167	,	,	O	,	_	0	SENT_174	[p13l53t1656r96b1678],
168	L	NN	O	l	dep	308	SENT_174	[p13l104t1656r113b1674],
169	-0	CD	NUMBER	-0	dep	308	SENT_174	[p13l413t1657r470b1676],
170	-07	CD	NUMBER	-07	dep	308	SENT_174	[p13l413t1657r470b1676],
171	0-03	CD	NUMBER	0-03	dep	308	SENT_174	[p13l555t1657r599b1677],
172	—	NN	O	—	dep	308	SENT_174	[p13l657t1657r714b1674],
173	0-10	CD	NUMBER	0-10	dep	308	SENT_174	[p13l657t1657r714b1674],
174	(	CD	NUMBER	(	dep	308	SENT_174	[p13l721t1654r787b1679],
175	-016	CD	NUMBER	-016	dep	308	SENT_174	[p13l721t1654r787b1679],
176	to	TO	O	to	dep	308	SENT_174	[p13l793t1658r814b1674],
177	-004	CD	NUMBER	-004	dep	308	SENT_174	[p13l821t1656r886b1679],
178	)	CD	NUMBER	)	dep	308	SENT_174	[p13l821t1656r886b1679],
179	0-0017	CD	NUMBER	0-0017	dep	308	SENT_174	[p13l914t1657r986b1676],
180	0-01	CD	NUMBER	0-01	dep	308	SENT_174	[p13l1051t1657r1095b1674],
181	-0	CD	NUMBER	-0	dep	308	SENT_174	[p13l1172t1657r1229b1676],
182	-07	CD	NUMBER	-07	dep	308	SENT_174	[p13l1172t1657r1229b1676],
183	0-07	CD	NUMBER	0-07	dep	308	SENT_174	[p13l1296t1657r1340b1677],
184	(	NN	O	(	dep	308	SENT_174	[p13l1348t1656r1399b1679],
185	0-02	CD	NUMBER	0-02	dep	308	SENT_174	[p13l1348t1656r1399b1679],
186	to	TO	O	to	dep	308	SENT_174	[p13l1406t1658r1427b1674],
187	013	CD	NUMBER	013	dep	308	SENT_174	[p13l1434t1656r1486b1679],
188	)	CD	NUMBER	)	dep	308	SENT_174	[p13l1434t1656r1486b1679],
189	0-0069	CD	NUMBER	0-0069	dep	308	SENT_174	[p13l1541t1654r1613b1677],
190	—	NN	O	—	dep	308	SENT_174	[p13l1721t1654r1778b1674],
191	0-18	CD	NUMBER	0-18	dep	308	SENT_174	[p13l1721t1654r1778b1674],
192	(	CD	NUMBER	(	dep	308	SENT_174	[p13l1786t1654r1851b1679],
193	-0	CD	NUMBER	-0	dep	308	SENT_174	[p13l1786t1654r1851b1679],
194	-26	CD	NUMBER	-26	dep	308	SENT_174	[p13l1786t1654r1851b1679],
195	to	TO	O	to	dep	308	SENT_174	[p13l1857t1658r1879b1674],
196	-009	CD	NUMBER	-009	dep	308	SENT_174	[p13l1886t1656r1951b1679],
197	)	CD	NUMBER	)	dep	308	SENT_174	[p13l1886t1656r1951b1679],
198	00001	CD	NUMBER	00001	dep	308	SENT_174	[p13l1999t1657r2070b1674],
199	Morning	NN	TIME	morning	dep	308	SENT_174	[p13l52t1691r136b1716],
200	symptom	NN	O	symptom	dep	308	SENT_174	[p13l143t1694r238b1715],
201	score	NN	NUMBER	score	dep	308	SENT_174	[p13l245t1697r296b1710],
202	0-1	CD	NUMBER	0-1	dep	308	SENT_174	[p13l426t1693r456b1710],
203	o	NN	O	o	dep	308	SENT_174	[p13l555t1693r567b1710],
204	o-1	NN	O	o-1	dep	308	SENT_174	[p13l670t1691r727b1715],
205	(	CD	NUMBER	(	dep	308	SENT_174	[p13l670t1691r727b1715],
206	o	NN	O	o	dep	308	SENT_174	[p13l670t1691r727b1715],
207	to	TO	O	to	dep	308	SENT_174	[p13l733t1694r755b1710],
208	0.1	CD	NUMBER	0.1	dep	308	SENT_174	[p13l761t1691r800b1715],
209	)	CD	NUMBER	)	dep	308	SENT_174	[p13l761t1691r800b1715],
210	00011	CD	NUMBER	00011	dep	308	SENT_174	[p13l914t1693r985b1710],
211	-0.1	CD	NUMBER	-0.1	dep	308	SENT_174	[p13l1039t1693r1082b1710],
212	o	NN	O	o	dep	308	SENT_174	[p13l1184t1693r1196b1710],
213	-	:	O	-	_	0	SENT_174	[p13l1283t1691r1385b1715],
214	o-1	NN	O	o-1	dep	308	SENT_174	[p13l1283t1691r1385b1715],
215	(	CD	NUMBER	(	dep	308	SENT_174	[p13l1283t1691r1385b1715],
216	-0.2	CD	NUMBER	-0.2	dep	308	SENT_174	[p13l1283t1691r1385b1715],
217	to	TO	O	to	dep	308	SENT_174	[p13l1392t1694r1414b1710],
218	-0	CD	NUMBER	-0	dep	308	SENT_174	[p13l1421t1691r1472b1715],
219	-1	CD	NUMBER	-1	dep	308	SENT_174	[p13l1421t1691r1472b1715],
220	)	NN	O	)	dep	308	SENT_174	[p13l1421t1691r1472b1715],
221	<	JJR	O	<	dep	308	SENT_174	[p13l1542t1693r1626b1710],
222	0-0001	CD	NUMBER	0-0001	dep	308	SENT_174	[p13l1542t1693r1626b1710],
223	0-2	CD	NUMBER	0-2	dep	308	SENT_174	[p13l1734t1693r1764b1710],
224	(	NN	O	(	dep	308	SENT_174	[p13l1772t1691r1811b1715],
225	0-1	CD	NUMBER	0-1	dep	308	SENT_174	[p13l1772t1691r1811b1715],
226	to	TO	O	to	dep	308	SENT_174	[p13l1817t1694r1838b1710],
227	0-3	CD	NUMBER	0-3	dep	308	SENT_174	[p13l1845t1691r1884b1715],
228	)	CD	NUMBER	)	dep	308	SENT_174	[p13l1845t1691r1884b1715],
229	<	JJR	O	<	dep	308	SENT_174	[p13l2000t1693r2084b1710],
230	0-0001	CD	NUMBER	0-0001	dep	308	SENT_174	[p13l2000t1693r2084b1710],
231	Rescue	NN	O	rescue	dep	308	SENT_174	[p13l53t1728r120b1745],
232	ipratropium	NN	O	ipratropium	dep	308	SENT_174	[p13l127t1727r251b1751],
233	,	,	O	,	_	0	SENT_174	[p13l127t1727r251b1751],
234	puffs	NNS	O	puff	dep	308	SENT_174	[p13l258t1726r309b1751],
235	per	IN	O	per	dep	308	SENT_174	[p13l315t1732r347b1751],
236	day	NN	DURATION	day	dep	308	SENT_174	[p13l352t1726r387b1751],
237	-0	CD	NUMBER	-0	dep	308	SENT_174	[p13l413t1728r456b1745],
238	-1	CD	NUMBER	-1	dep	308	SENT_174	[p13l413t1728r456b1745],
239	-03	CD	NUMBER	-03	dep	308	SENT_174	[p13l542t1728r586b1748],
240	0-2	CD	NUMBER	0-2	dep	308	SENT_174	[p13l670t1728r700b1745],
241	(	NN	O	(	dep	308	SENT_174	[p13l708t1727r727b1750],
242	o	NN	O	o	dep	308	SENT_174	[p13l708t1727r727b1750],
243	to	TO	O	to	dep	308	SENT_174	[p13l733t1729r755b1745],
244	0-4	CD	NUMBER	0-4	dep	308	SENT_174	[p13l761t1727r800b1750],
245	)	CD	NUMBER	)	dep	308	SENT_174	[p13l761t1727r800b1750],
246	0-0430	CD	NUMBER	0-0430	dep	308	SENT_174	[p13l914t1728r986b1748],
247	-0	CD	NUMBER	-0	dep	308	SENT_174	[p13l1039t1728r1082b1748],
248	-3	CD	NUMBER	-3	dep	308	SENT_174	[p13l1039t1728r1082b1748],
249	o	NN	O	o	dep	308	SENT_174	[p13l1184t1728r1196b1745],
250	-03	CD	NUMBER	-03	dep	308	SENT_174	[p13l1283t1728r1326b1748],
251	(	CD	NUMBER	(	dep	308	SENT_174	[p13l1334t1727r1385b1750],
252	-0	CD	NUMBER	-0	dep	308	SENT_174	[p13l1334t1727r1385b1750],
253	-5	CD	NUMBER	-5	dep	308	SENT_174	[p13l1334t1727r1385b1750],
254	to	TO	O	to	dep	308	SENT_174	[p13l1392t1729r1414b1745],
255	—	CD	NUMBER	—	dep	308	SENT_174	[p13l1420t1727r1472b1750],
256	0-2	CD	NUMBER	0-2	dep	308	SENT_174	[p13l1420t1727r1472b1750],
257	)	NN	O	)	dep	308	SENT_174	[p13l1420t1727r1472b1750],
258	00003	CD	NUMBER	00003	dep	308	SENT_174	[p13l1541t1728r1613b1748],
259	05	CD	NUMBER	05	dep	308	SENT_174	[p13l1734t1728r1764b1748],
260	(	NN	O	(	dep	308	SENT_174	[p13l1772t1727r1811b1750],
261	0-3	CD	NUMBER	0-3	dep	308	SENT_174	[p13l1772t1727r1811b1750],
262	to	TO	O	to	dep	308	SENT_174	[p13l1817t1729r1838b1745],
263	0-8	CD	NUMBER	0-8	dep	308	SENT_174	[p13l1845t1726r1884b1750],
264	)	CD	NUMBER	)	dep	308	SENT_174	[p13l1845t1726r1884b1750],
265	0-0002	CD	NUMBER	0-0002	dep	308	SENT_174	[p13l1999t1728r2070b1745],
266	Rescue	NN	O	rescue	dep	308	SENT_174	[p13l53t1763r120b1781],
267	albuterol	NN	O	albuterol	dep	308	SENT_174	[p13l127t1761r221b1784],
268	,	,	O	,	_	0	SENT_174	[p13l127t1761r221b1784],
269	puffs	NNS	O	puff	dep	308	SENT_174	[p13l228t1761r278b1787],
270	per	IN	O	per	dep	308	SENT_174	[p13l284t1768r316b1787],
271	day	NN	DURATION	day	dep	308	SENT_174	[p13l322t1761r357b1787],
272	0-4	CD	NUMBER	0-4	dep	308	SENT_174	[p13l426t1764r458b1784],
273	0-1	CD	NUMBER	0-1	dep	308	SENT_174	[p13l555t1764r586b1781],
274	0-2	CD	NUMBER	0-2	dep	308	SENT_174	[p13l670t1764r700b1781],
275	(	NN	O	(	dep	308	SENT_174	[p13l708t1763r728b1786],
276	o	NN	O	o	dep	308	SENT_174	[p13l708t1763r728b1786],
277	to	TO	O	to	dep	308	SENT_174	[p13l733t1765r755b1781],
278	0-4	CD	NUMBER	0-4	dep	308	SENT_174	[p13l761t1763r800b1786],
279	)	CD	NUMBER	)	dep	308	SENT_174	[p13l761t1763r800b1786],
280	00186	CD	NUMBER	00186	dep	308	SENT_174	[p13l914t1761r986b1781],
281	-01	CD	NUMBER	-01	dep	308	SENT_174	[p13l1038t1764r1082b1781],
282	0-3	CD	NUMBER	0-3	dep	308	SENT_174	[p13l1184t1764r1215b1784],
283	-0	CD	NUMBER	-0	dep	308	SENT_174	[p13l1283t1764r1326b1784],
284	-3	CD	NUMBER	-3	dep	308	SENT_174	[p13l1283t1764r1326b1784],
285	(	NN	O	(	dep	308	SENT_174	[p13l1334t1763r1387b1786],
286	-0	CD	NUMBER	-0	dep	308	SENT_174	[p13l1334t1763r1387b1786],
287	-4	CD	NUMBER	-4	dep	308	SENT_174	[p13l1334t1763r1387b1786],
288	to	TO	O	to	dep	308	SENT_174	[p13l1392t1765r1414b1781],
289	-0	CD	NUMBER	-0	dep	308	SENT_174	[p13l1420t1763r1472b1786],
290	-2	CD	NUMBER	-2	dep	308	SENT_174	[p13l1420t1763r1472b1786],
291	)	NN	O	)	dep	308	SENT_174	[p13l1420t1763r1472b1786],
292	<	JJR	O	<	dep	308	SENT_174	[p13l1542t1764r1626b1781],
293	0-0001	CD	NUMBER	0-0001	dep	308	SENT_174	[p13l1542t1764r1626b1781],
294	0-5	CD	NUMBER	0-5	dep	308	SENT_174	[p13l1734t1764r1764b1784],
295	(	NN	O	(	dep	308	SENT_174	[p13l1772t1763r1811b1786],
296	0-3	CD	NUMBER	0-3	dep	308	SENT_174	[p13l1772t1763r1811b1786],
297	to	TO	O	to	dep	308	SENT_174	[p13l1817t1765r1838b1781],
298	0-8	CD	NUMBER	0-8	dep	308	SENT_174	[p13l1845t1761r1884b1786],
299	)	CD	NUMBER	)	dep	308	SENT_174	[p13l1845t1761r1884b1786],
300	<	JJR	O	<	dep	308	SENT_174	[p13l2000t1764r2084b1781],
301	0-0001	CD	NUMBER	0-0001	dep	308	SENT_174	[p13l2000t1764r2084b1781],
302	Changes	NNS	O	change	dep	308	SENT_174	[p13l41t1816r119b1839],
303	referto	JJ	O	referto	dep	308	SENT_174	[p13l125t1816r191b1834],
304	modelled	VBN	O	model	dep	308	SENT_174	[p13l197t1816r283b1834],
305	data	NNS	O	datum	dep	308	SENT_174	[p13l288t1816r329b1834],
306	in	IN	O	in	dep	308	SENT_174	[p13l335t1817r350b1834],
307	ﬁgure	NN	O	ﬁgure	dep	308	SENT_174	[p13l356t1816r410b1839],
308	3	CD	NUMBER	3	_	0	SENT_174	[p13l416t1818r432b1836],
309	.	.	O	.	_	0	SENT_174	[p13l416t1818r432b1836],

1	FVC	NN	O	fvc	_	0	SENT_175	[p13l439t1816r544b1834],
2	=	JJ	O	=	amod	5	SENT_175	[p13l439t1816r544b1834],
3	forced	JJ	O	forced	amod	5	SENT_175	[p13l439t1816r544b1834],
4	vital	JJ	O	vital	amod	5	SENT_175	[p13l550t1816r588b1834],
5	capacity	NN	O	capacity	dep	1	SENT_175	[p13l594t1817r674b1839],
6	.	.	O	.	_	0	SENT_175	[p13l594t1817r674b1839],

1	Table	NNP	O	Table	_	0	SENT_176	[p13l40t1877r99b1899],
2	3	CD	NUMBER	3	num	1	SENT_176	[p13l104t1880r124b1901],
3	:	:	O	:	_	0	SENT_176	[p13l104t1880r124b1901],
4	Change	NNP	O	Change	dep	1	SENT_176	[p13l131t1877r215b1905],
5	in	IN	O	in	_	0	SENT_176	[p13l222t1878r241b1898],
6	outcome	NN	O	outcome	nn	7	SENT_176	[p13l248t1881r350b1898],
7	variables	NNS	O	variable	conj_and	7	SENT_176	[p13l356t1877r456b1898],
8	at	IN	O	at	_	0	SENT_176	[p13l462t1881r485b1898],
9	16	CD	DURATION	16	num	10	SENT_176	[p13l492t1877r520b1898],
10	weeks	NNS	NUMBER	week	prep_at	7	SENT_176	[p13l526t1877r597b1898],
11	within	IN	O	within	_	0	SENT_176	[p13l603t1877r677b1898],
12	each	DT	O	each	det	13	SENT_176	[p13l684t1877r735b1898],
13	genotype	NN	O	genotype	prep_within	10	SENT_176	[p13l742t1881r850b1905],
14	and	CC	O	and	_	0	SENT_176	[p13l857t1877r899b1898],
15	between	IN	O	between	_	0	SENT_176	[p13l906t1877r1004b1898],
16	genotypes	NNS	O	genotype	nn	17	SENT_176	[p13l1011t1881r1131b1905],
17	phase	NN	O	phase	prep_between	7	SENT_176	[p13l644t2041r811b2104],
18	,	,	O	,	_	0	SENT_176	[p13l644t2041r811b2104],
19	in	IN	O	in	_	0	SENT_176	[p13l846t2044r899b2088],
20	a	DT	O	a	det	22	SENT_176	[p13l932t2058r958b2089],
21	secondary	JJ	O	secondary	amod	22	SENT_176	[p13l993t2041r1257b2104],
22	analysis	NN	O	analysis	prep_in	7	SENT_176	[p13l1289t2041r1496b2104],
23	We	PRP	O	we	nsubj	25	SENT_176	[p13l1529t2058r1602b2089],
24	also	RB	O	also	advmod	25	SENT_176	[p13l1636t2041r1737b2089],
25	examined	VBD	O	examine	rcmod	22	SENT_176	[p13l1771t2041r2029b2089],
26	the	DT	SET	the	det	30	SENT_176	[p13l2060t2041r2142b2089],
27	weekly	JJ	SET	weekly	amod	30	SENT_176	[p13l643t2118r825b2182],
28	morning	NN	SET	morning	nn	30	SENT_176	[p13l872t2121r1106b2182],
29	PEFR	NN	ORGANIZATION	pefr	nn	30	SENT_176	[p13l1158t2121r1307b2166],
30	measurements	NNS	O	measurement	dobj	25	SENT_176	[p13l1355t2128r1750b2167],
31	stratiﬁed	VBN	O	stratiﬁed	partmod	30	SENT_176	[p13l1803t2118r2035b2167],
32	by	IN	O	by	_	0	SENT_176	[p13l2082t2118r2144b2182],
33	genotype	NN	O	genotype	agent	31	SENT_176	[p13l646t2206r883b2261],
34	in	IN	O	in	_	0	SENT_176	[p13l915t2200r968b2244],
35	the	DT	O	the	det	42	SENT_176	[p13l998t2197r1080b2245],
36	6-week	JJ	DURATION	6-week	amod	42	SENT_176	[p13l1114t2197r1296b2245],
37	single-blind	JJ	O	single-blind	amod	42	SENT_176	[p13l1328t2197r1641b2261],
38	run-in	NN	O	run-in	nn	42	SENT_176	[p13l1672t2200r1839b2245],
39	(	NN	O	(	nn	42	SENT_176	[p13l1874t2197r2046b2261],
40	ﬁgure	NN	O	ﬁgure	nn	42	SENT_176	[p13l1874t2197r2046b2261],
41	4	CD	NUMBER	4	num	42	SENT_176	[p13l2077t2201r2140b2261],
42	)	NN	O	)	prep_in	33	SENT_176	[p13l2077t2201r2140b2261],
43	.	.	O	.	_	0	SENT_176	[p13l2077t2201r2140b2261],

1	During	IN	O	during	_	0	SENT_177	[p13l648t2277r837b2338],
2	the	DT	O	the	det	4	SENT_177	[p13l855t2274r937b2323],
3	run-in	JJ	O	run-in	amod	4	SENT_177	[p13l957t2277r1124b2323],
4	period	NN	O	period	prep_during	13	SENT_177	[p13l1143t2274r1326b2337],
5	,	,	O	,	_	0	SENT_177	[p13l1143t2274r1326b2337],
6	before	IN	O	before	_	0	SENT_177	[p13l1346t2274r1513b2323],
7	any	DT	O	any	det	9	SENT_177	[p13l1533t2292r1626b2338],
8	masked	VBN	O	mask	amod	9	SENT_177	[p13l1644t2274r1849b2323],
9	treatment	NN	O	treatment	prep_before	13	SENT_177	[p13l1867t2284r2140b2330],
10	,	,	O	,	_	0	SENT_177	[p13l1867t2284r2140b2330],
11	all	DT	O	all	det	12	SENT_177	[p13l645t2351r706b2399],
12	patients	NNS	O	patient	nsubj	13	SENT_177	[p13l748t2354r956b2414],
13	switched	VBD	O	switch	_	0	SENT_177	[p13l1003t2351r1235b2400],
14	from	IN	O	from	_	0	SENT_177	[p13l1277t2351r1408b2399],
15	albuterol	NN	O	albuterol	prep_from	13	SENT_177	[p13l1451t2351r1686b2400],
16	to	TO	O	to	_	0	SENT_177	[p13l1728t2361r1776b2399],
17	ipratropium	NN	O	ipratropium	nn	18	SENT_177	[p13l1821t2354r2143b2414],
18	bromide	NN	O	bromide	prep_to	13	SENT_177	[p13l644t2429r868b2477],
19	as	IN	O	as	_	0	SENT_177	[p13l886t2446r937b2477],
20	primary	JJ	O	primary	amod	22	SENT_177	[p13l955t2432r1168b2492],
21	rescue	NN	O	rescue	nn	22	SENT_177	[p13l1182t2446r1352b2477],
22	medication	NN	O	medication	prep_as	13	SENT_177	[p13l1369t2429r1680b2477],
23	.	.	O	.	_	0	SENT_177	[p13l1369t2429r1680b2477],

1	Patients	NNS	O	patient	nsubj	6	SENT_178	[p13l1701t2432r1911b2477],
2	with	IN	O	with	_	0	SENT_178	[p13l1927t2429r2045b2477],
3	the	DT	O	the	det	5	SENT_178	[p13l2060t2429r2142b2477],
4	Arg/Arg	NN	O	arg/arg	nn	5	SENT_178	[p13l644t2510r866b2570],
5	genotype	NN	O	genotype	prep_with	1	SENT_178	[p13l895t2516r1132b2570],
6	experienced	VBD	O	experience	_	0	SENT_178	[p13l1161t2506r1478b2569],
7	a	DT	O	a	det	10	SENT_178	[p13l1506t2524r1532b2555],
8	23	CD	NUMBER	23	num	10	SENT_178	[p13l1561t2511r1618b2555],
9	L/min	NN	O	l/min	nn	10	SENT_178	[p13l1651t2509r1817b2569],
10	increase	NN	O	increase	nn	24	SENT_178	[p13l1844t2509r2062b2555],
11	in	IN	O	in	_	0	SENT_178	[p13l2090t2509r2143b2554],
12	morning	NN	TIME	morning	nn	13	SENT_178	[p13l645t2587r879b2648],
13	PEFR	NN	O	pefr	prep_in	10	SENT_178	[p13l913t2587r1061b2632],
14	by	IN	O	by	_	0	SENT_178	[p13l1091t2584r1153b2648],
15	the	DT	DURATION	the	det	16	SENT_178	[p13l1182t2584r1265b2633],
16	end	NN	DURATION	end	prep_by	13	SENT_178	[p13l1297t2584r1395b2633],
17	of	IN	DURATION	of	_	0	SENT_178	[p13l1427t2584r1485b2633],
18	week	NN	DURATION	week	nn	21	SENT_178	[p13l1507t2584r1643b2633],
19	6	CD	NUMBER	6	num	21	SENT_178	[p13l1674t2588r1702b2633],
20	(	NN	O	(	nn	21	SENT_178	[p13l1738t2588r2042b2648],
21	p	NN	O	p	prep_of	16	SENT_178	[p13l1738t2588r2042b2648],
22	=	JJ	O	=	amod	24	SENT_178	[p13l1738t2588r2042b2648],
23	0-0162	CD	NUMBER	0-0162	tmod	22	SENT_178	[p13l1738t2588r2042b2648],
24	)	NN	O	)	dobj	6	SENT_178	[p13l1738t2588r2042b2648],
25	.	.	O	.	_	0	SENT_178	[p13l1738t2588r2042b2648],

1	By	IN	O	by	_	0	SENT_179	[p13l2079t2589r2144b2648],
2	contrast	NN	O	contrast	prep_by	9	SENT_179	[p13l645t2672r870b2719],
3	,	,	O	,	_	0	SENT_179	[p13l645t2672r870b2719],
4	those	DT	O	those	nsubj	9	SENT_179	[p13l889t2663r1030b2711],
5	with	IN	O	with	_	0	SENT_179	[p13l1046t2663r1163b2711],
6	the	DT	O	the	det	8	SENT_179	[p13l1179t2663r1262b2711],
7	Gly/Gly	NNP	O	Gly/Gly	nn	8	SENT_179	[p13l1281t2663r1489b2726],
8	genotype	NN	O	genotype	prep_with	4	SENT_179	[p13l1506t2672r1743b2727],
9	improved	VBD	O	improve	_	0	SENT_179	[p13l1761t2663r2015b2726],
10	only	RB	O	only	advmod	14	SENT_179	[p13l2032t2663r2144b2726],
11	2	CD	NUMBER	2	num	14	SENT_179	[p13l646t2745r672b2788],
12	L/min	NN	O	l/min	nn	14	SENT_179	[p13l695t2743r861b2803],
13	(	NN	O	(	nn	14	SENT_179	[p13l883t2745r1167b2804],
14	p	NN	O	p	dobj	9	SENT_179	[p13l883t2745r1167b2804],
15	=	JJ	O	=	amod	14	SENT_179	[p13l883t2745r1167b2804],
16	0-8399	CD	NUMBER	0-8399	tmod	15	SENT_179	[p13l883t2745r1167b2804],
17	;	:	O	;	_	0	SENT_179	[p13l883t2745r1167b2804],
18	ﬁgure	NN	O	ﬁgure	nn	20	SENT_179	[p13l1188t2740r1344b2804],
19	4	CD	NUMBER	4	num	20	SENT_179	[p13l1362t2745r1425b2804],
20	)	NN	O	)	dep	14	SENT_179	[p13l1362t2745r1425b2804],
21	.	.	O	.	_	0	SENT_179	[p13l1362t2745r1425b2804],

1	There	EX	O	there	expl	15	SENT_180	[p13l694t2818r849b2867],
2	were	VBD	O	be	auxpass	15	SENT_180	[p13l869t2836r995b2867],
3	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_180	[p13l1019t2818r1297b2882],
4	genotype-related	JJ	O	genotype-related	amod	5	SENT_180	[p13l1318t2818r1755b2882],
5	differences	NNS	O	difference	nsubjpass	15	SENT_180	[p13l1776t2818r2067b2867],
6	in	IN	O	in	_	0	SENT_180	[p13l2090t2821r2143b2866],
7	response	NN	O	response	prep_in	5	SENT_180	[p13l645t2913r881b2959],
8	to	TO	O	to	_	0	SENT_180	[p13l915t2905r964b2944],
9	the	DT	O	the	det	12	SENT_180	[p13l998t2896r1080b2944],
10	16-week	JJ	DURATION	16-week	amod	12	SENT_180	[p13l1119t2896r1331b2944],
11	double-blind	JJ	O	double-blind	amod	12	SENT_180	[p13l1364t2896r1701b2944],
12	treatment	NN	O	treatment	prep_to	15	SENT_180	[p13l1733t2905r1994b2944],
13	with	IN	O	with	prep	12	SENT_180	[p13l2026t2896r2143b2944],
14	regularly	RB	O	regularly	pcomp	13	SENT_180	[p13l645t2973r880b3037],
15	scheduled	VBN	O	schedule	ccomp	23	SENT_180	[p13l903t2973r1169b3022],
16	albuterol	NN	O	albuterol	dobj	15	SENT_180	[p13l1191t2973r1424b3022],
17	compared	VBN	O	compare	_	0	SENT_180	[p13l1447t2973r1710b3036],
18	with	IN	O	with	prepc_compared_with	15	SENT_180	[p13l1730t2973r1847b3022],
19	placebo	NN	O	placebo	pobj	15	SENT_180	[p13l1868t2973r2068b3036],
20	in	IN	O	in	_	0	SENT_180	[p13l2090t2976r2143b3021],
21	FEV1	NN	O	fev1	prep_in	19	SENT_180	[p13l648t3054r787b3112],
22	,	,	O	,	_	0	SENT_180	[p13l648t3054r787b3112],
23	forced	VBD	O	force	_	0	SENT_180	[p13l832t3051r997b3100],
24	vital	JJ	O	vital	amod	25	SENT_180	[p13l1037t3051r1148b3100],
25	capacity	NN	O	capacity	nsubj	23	SENT_180	[p13l1191t3054r1413b3115],
26	,	,	O	,	_	0	SENT_180	[p13l1191t3054r1413b3115],
27	patient-recorded	JJ	O	patient-recorded	amod	29	SENT_180	[p13l1458t3051r1893b3114],
28	evening	NN	TIME	evening	nn	29	SENT_180	[p13l1935t3054r2143b3115],
29	PEFR	NN	O	pefr	conj_and	25	SENT_180	[p13l648t3132r809b3184],
30	,	,	O	,	_	0	SENT_180	[p13l648t3132r809b3184],
31	rescue	NN	O	rescue	nn	33	SENT_180	[p13l861t3146r1031b3177],
32	inhaler	NN	O	inhaler	nn	33	SENT_180	[p13l1081t3129r1271b3177],
33	use	NN	O	use	nsubj	23	SENT_180	[p13l1318t3146r1423b3184],
34	,	,	O	,	_	0	SENT_180	[p13l1318t3146r1423b3184],
35	and	CC	O	and	_	0	SENT_180	[p13l1476t3129r1573b3177],
36	asthma	NN	O	asthma	nn	37	SENT_180	[p13l1623t3129r1816b3177],
37	symptoms	NNS	O	symptom	nsubj	23	SENT_180	[p13l1868t3138r2141b3192],
38	(	RB	O	(	advmod	39	SENT_180	[p13l649t3206r789b3270],
39	table	NN	O	table	rcmod	37	SENT_180	[p13l649t3206r789b3270],
40	3	CD	NUMBER	3	num	41	SENT_180	[p13l816t3211r875b3270],
41	)	NN	O	)	dep	39	SENT_180	[p13l816t3211r875b3270],
42	.	.	O	.	_	0	SENT_180	[p13l816t3211r875b3270],

1	Arg/Arg	NN	O	arg/arg	nn	2	SENT_181	[p13l901t3210r1124b3270],
2	individuals	NNS	O	individual	nsubj	3	SENT_181	[p13l1147t3206r1438b3255],
3	improved	VBN	O	improve	_	0	SENT_181	[p13l1463t3206r1718b3269],
4	during	IN	O	during	_	0	SENT_181	[p13l1741t3206r1919b3270],
5	placebo	NN	O	placebo	nn	6	SENT_181	[p13l1943t3206r2142b3269],
6	use	NN	O	use	prep_during	3	SENT_181	[p13l644t3301r734b3333],
7	when	WRB	O	when	advmod	11	SENT_181	[p13l762t3284r909b3333],
8	albuterol	NN	O	albuterol	nn	9	SENT_181	[p13l938t3284r1172b3333],
9	use	NN	O	use	nsubjpass	11	SENT_181	[p13l1201t3301r1291b3333],
10	was	VBD	O	be	auxpass	11	SENT_181	[p13l1319t3301r1417b3333],
11	limited	VBN	O	limit	dep	6	SENT_181	[p13l1447t3284r1637b3333],
12	(	RB	O	(	advmod	11	SENT_181	[p13l1670t3284r1810b3348],
13	table	NN	O	table	nn	15	SENT_181	[p13l1670t3284r1810b3348],
14	3	CD	NUMBER	3	num	15	SENT_181	[p13l1843t3289r1902b3348],
15	)	NN	O	)	dobj	11	SENT_181	[p13l1843t3289r1902b3348],
16	.	.	O	.	_	0	SENT_181	[p13l1843t3289r1902b3348],

1	Gly/Gly	RB	O	gly/gly	dep	2	SENT_182	[p13l1936t3284r2144b3348],
2	individuals	NNS	O	individual	_	0	SENT_182	[p13l645t3363r936b3411],
3	compared	VBN	O	compare	_	0	SENT_182	[p13l645t3440r909b3503],
4	with	IN	O	with	prepc_compared_with	2	SENT_182	[p13l925t3440r1042b3489],
5	placebo	NN	O	placebo	nn	7	SENT_182	[p13l1060t3440r1259b3503],
6	(	CD	NUMBER	(	num	7	SENT_182	[p13l1282t3440r1422b3504],
7	table	NN	O	table	pobj	2	SENT_182	[p13l1282t3440r1422b3504],
8	3	CD	NUMBER	3	num	9	SENT_182	[p13l1444t3445r1503b3504],
9	)	NN	O	)	dep	7	SENT_182	[p13l1444t3445r1503b3504],
10	.	.	O	.	_	0	SENT_182	[p13l1444t3445r1503b3504],

1	improved	VBN	O	improve	_	0	SENT_183	[p13l1002t3363r1256b3426],
2	with	IN	O	with	_	0	SENT_183	[p13l1318t3363r1436b3411],
3	regular	JJ	O	regular	amod	5	SENT_183	[p13l1500t3363r1690b3427],
4	albuterol	NN	O	albuterol	nn	5	SENT_183	[p13l1754t3363r1989b3411],
5	use	NN	O	use	prep_with	1	SENT_183	[p13l2052t3380r2142b3411],

1	There	EX	O	there	expl	2	SENT_184	[p13l694t3518r849b3567],
2	were	VBD	O	be	_	0	SENT_184	[p13l892t3536r1017b3567],
3	no	DT	O	no	det	5	SENT_184	[p13l1062t3536r1128b3567],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_184	[p13l1175t3518r1453b3582],
5	differences	NNS	O	difference	nsubj	2	SENT_184	[p13l1496t3518r1787b3567],
6	among	IN	O	among	_	0	SENT_184	[p13l1833t3536r2017b3582],
7	the	DT	O	the	det	11	SENT_184	[p13l2060t3518r2142b3567],
8	treatment	NN	O	treatment	nn	11	SENT_184	[p13l644t3606r905b3645],
9	or	CC	O	or	_	0	SENT_184	[p13l950t3614r1004b3645],
10	genotype	NN	O	genotype	nn	11	SENT_184	[p13l1049t3606r1286b3661],
11	groups	NNS	O	group	prep_among	5	SENT_184	[p13l1333t3614r1513b3661],
12	in	IN	O	in	_	0	SENT_184	[p13l1560t3600r1613b3644],
13	the	DT	O	the	det	14	SENT_184	[p13l1657t3597r1739b3645],
14	frequency	NN	O	frequency	prep_in	2	SENT_184	[p13l1785t3597r2049b3660],
15	of	IN	O	of	_	0	SENT_184	[p13l2093t3597r2152b3645],
16	signiﬁcant	JJ	O	signiﬁcant	amod	18	SENT_184	[p13l647t3674r924b3738],
17	asthma	NN	O	asthma	nn	18	SENT_184	[p13l952t3674r1145b3723],
18	exacerbations	NNS	O	exacerbation	prep_of	14	SENT_184	[p13l1173t3674r1530b3723],
19	or	CC	O	or	_	0	SENT_184	[p13l1561t3692r1615b3723],
20	treatment	NN	O	treatment	nn	21	SENT_184	[p13l1640t3684r1902b3723],
21	failures	NNS	O	failure	conj_or	18	SENT_184	[p13l1928t3674r2140b3723],
22	.	.	O	.	_	0	SENT_184	[p13l1928t3674r2140b3723],

1	:	:	O	:	_	0	SENT_185	[p14l873t155r975b163],
2	Arg/Arg	NN	O	arg/arg	nsubj	3	SENT_185	[p14l998t141r1134b184],
3	modelled	VBD	O	model	_	0	SENT_185	[p14l1148t140r1308b173],

1	Arg/Arg	NN	O	arg/arg	_	0	SENT_186	[p14l998t188r1134b231],
2	raw	JJ	O	raw	amod	3	SENT_186	[p14l1148t198r1209b220],
3	means	NNS	O	means	dep	1	SENT_186	[p14l1220t198r1332b220],
4	J	NN	O	j	dep	1	SENT_186	[p14l1957t208r2089b248],

1	20	CD	NUMBER	20	_	0	SENT_187	[p14l746t259r788b288],
2	—	SYM	O	—	dep	5	SENT_187	[p14l873t249r975b257],
3	-	:	O	-	_	0	SENT_187	[p14l873t249r975b257],
4	Gly/Gly	NN	O	gly/gly	nsubj	5	SENT_187	[p14l998t234r1122b278],
5	modelled	VBD	O	model	dep	1	SENT_187	[p14l1133t234r1293b267],
6	—	CD	NUMBER	—	num	9	SENT_187	[p14l873t297r975b303],
7	Gly/Gly	NNP	O	Gly/Gly	nn	9	SENT_187	[p14l998t281r1122b325],
8	raw	JJ	O	raw	amod	9	SENT_187	[p14l1133t292r1195b315],
9	means	NNS	O	means	dobj	5	SENT_187	[p14l1206t292r1318b315],

1	Morning	NN	TIME	morning	nn	2	SENT_188	[p14l663t622r706b766],
2	PEFR	NN	O	pefr	_	0	SENT_188	[p14l665t524r695b607],
3	(	CD	NUMBER	(	num	5	SENT_188	[p14l663t386r704b512],
4	L/min	NN	O	l/min	nn	5	SENT_188	[p14l663t386r704b512],
5	)	NN	O	)	dep	2	SENT_188	[p14l663t386r704b512],
6	.	.	O	.	_	0	SENT_188	[p14l723t763r764b791],

1	L	NN	ORGANIZATION	l	nn	3	SENT_189	[p14l723t763r764b791],
2	O	NN	ORGANIZATION	o	nn	3	SENT_189	[p14l768t763r788b791],
3	O	NN	ORGANIZATION	o	_	0	SENT_189	[p14l768t595r788b624],
4	1	CD	NUMBER	1	number	5	SENT_189	[p14l817t986r835b1014],
5	2	CD	NUMBER	2	num	7	SENT_189	[p14l1069t986r1087b1014],
6	3	CD	NUMBER	3	number	7	SENT_189	[p14l1323t986r1341b1019],
7	4	CD	NUMBER	4	dep	3	SENT_189	[p14l1569t986r1592b1019],
8	5	CD	NUMBER	5	number	9	SENT_189	[p14l1825t986r1843b1019],
9	6	CD	NUMBER	6	amod	7	SENT_189	[p14l2077t981r2098b1014],

1	Week	NN	DURATION	week	_	0	SENT_190	[p14l1330t1044r1426b1078],
2	of	IN	O	of	dep	1	SENT_190	[p14l1436t1044r1474b1078],
3	run	NN	O	run	nn	4	SENT_190	[p14l1483t1046r1586b1078],
4	—	NN	O	—	pobj	2	SENT_190	[p14l1483t1046r1586b1078],
5	in	IN	O	in	dep	1	SENT_190	[p14l1483t1046r1586b1078],

1	Figure	NNP	O	Figure	_	0	SENT_191	[p14l645t1171r759b1217],
2	4	CD	NUMBER	4	num	1	SENT_191	[p14l767t1175r802b1211],
3	:	:	O	:	_	0	SENT_191	[p14l767t1175r802b1211],
4	Change	NNP	O	Change	dep	1	SENT_191	[p14l814t1170r960b1217],
5	in	IN	O	in	_	0	SENT_191	[p14l972t1170r1005b1205],
6	morning	NN	TIME	morning	nn	7	SENT_191	[p14l1019t1171r1185b1217],
7	PEFR	NN	ORGANIZATION	pefr	prep_in	4	SENT_191	[p14l1200t1173r1294b1205],
8	after	IN	O	after	mark	18	SENT_191	[p14l1305t1169r1400b1206],
9	the	DT	O	the	det	11	SENT_191	[p14l1408t1170r1474b1206],
10	ﬁrst	NN	O	ﬁrst	nn	11	SENT_191	[p14l1484t1169r1564b1206],
11	week	NN	DURATION	week	nsubj	18	SENT_191	[p14l1574t1170r1678b1206],
12	of	IN	O	of	_	0	SENT_191	[p14l1689t1169r1731b1206],
13	the	DT	O	the	det	17	SENT_191	[p14l1739t1170r1805b1206],
14	6-week	JJ	DURATION	6-week	amod	17	SENT_191	[p14l1816t1169r1962b1206],
15	single-blind	JJ	O	single-blind	amod	17	SENT_191	[p14l645t1231r876b1278],
16	run-in	NN	O	run-in	nn	17	SENT_191	[p14l889t1232r1005b1267],
17	Data	NNS	O	datum	prep_of	11	SENT_191	[p14l647t1296r731b1329],
18	show	VBP	O	show	dep	4	SENT_191	[p14l743t1293r842b1329],
19	weekly	JJ	SET	weekly	amod	20	SENT_191	[p14l852t1293r980b1339],
20	changes	NNS	O	change	dobj	18	SENT_191	[p14l991t1293r1151b1340],
21	.	.	O	.	_	0	SENT_191	[p14l991t1293r1151b1340],

1	Patients	NNS	O	patient	nsubj	2	SENT_192	[p14l1167t1295r1315b1329],
2	discontinued	VBN	O	discontinue	_	0	SENT_192	[p14l1327t1293r1569b1329],
3	albuterol	NN	O	albuterol	dobj	2	SENT_192	[p14l1581t1293r1745b1329],
4	and	CC	O	and	_	0	SENT_192	[p14l1758t1293r1827b1329],
5	were	VBD	O	be	auxpass	6	SENT_192	[p14l1837t1305r1927b1329],
6	given	VBN	O	give	conj_and	2	SENT_192	[p14l1939t1295r2037b1340],
7	ipratropium	NN	O	ipratropium	nn	8	SENT_192	[p14l646t1357r866b1402],
8	bromide	NN	O	bromide	dobj	6	SENT_192	[p14l880t1355r1035b1391],
9	as	IN	O	as	_	0	SENT_192	[p14l1047t1367r1084b1391],
10	needed	VBN	O	need	prep_as	6	SENT_192	[p14l1097t1355r1241b1391],
11	.	.	O	.	_	0	SENT_192	[p14l1097t1355r1241b1391],

1	Compared	VBN	O	compare	_	0	SENT_193	[p14l1255t1355r1448b1402],
2	with	IN	O	with	prepc_compared_with	8	SENT_193	[p14l1458t1355r1540b1391],
3	the	DT	O	the	det	5	SENT_193	[p14l1552t1355r1614b1391],
4	ﬁrst	NN	O	ﬁrst	nn	5	SENT_193	[p14l1624t1355r1696b1391],
5	week	NN	DURATION	week	pobj	8	SENT_193	[p14l1707t1355r1813b1398],
6	,	,	O	,	_	0	SENT_193	[p14l1707t1355r1813b1398],
7	PEFR	NN	ORGANIZATION	pefr	nsubj	8	SENT_193	[p14l1828t1358r1917b1391],
8	improved	VBD	O	improve	_	0	SENT_193	[p14l1930t1355r2107b1402],
9	23	CD	NUMBER	23	num	10	SENT_193	[p14l646t1423r691b1459],
10	L/min	NN	O	l/min	nsubj	14	SENT_193	[p14l707t1419r811b1458],
11	in	IN	O	in	_	0	SENT_193	[p14l826t1419r856b1453],
12	Arg/Arg	NN	O	arg/arg	nn	13	SENT_193	[p14l869t1419r1016b1465],
13	participants	NNS	O	participant	prep_in	10	SENT_193	[p14l1029t1419r1248b1464],
14	(	VBP	O	(	ccomp	8	SENT_193	[p14l1261t1417r1472b1464],
15	p	NN	O	p	nsubj	25	SENT_193	[p14l1261t1417r1472b1464],
16	=	JJ	O	=	amod	18	SENT_193	[p14l1261t1417r1472b1464],
17	O-0162	NN	O	o-0162	nn	18	SENT_193	[p14l1261t1417r1472b1464],
18	)	NN	O	)	dep	15	SENT_193	[p14l1261t1417r1472b1464],
19	and	CC	O	and	_	0	SENT_193	[p14l1486t1418r1554b1453],
20	2	CD	NUMBER	2	num	21	SENT_193	[p14l1567t1423r1587b1453],
21	L/min	NN	O	l/min	nsubj	25	SENT_193	[p14l1602t1419r1707b1458],
22	in	IN	O	in	_	0	SENT_193	[p14l1722t1419r1751b1453],
23	Gly/Gly	NN	O	gly/gly	nn	24	SENT_193	[p14l1766t1418r1899b1464],
24	participants	NNS	O	participant	prep_in	21	SENT_193	[p14l1909t1419r2128b1464],
25	(	VBP	O	(	ccomp	14	SENT_193	[p14l646t1478r868b1525],
26	p	NN	O	p	nsubj	27	SENT_193	[p14l646t1478r868b1525],
27	=	JJ	O	=	ccomp	25	SENT_193	[p14l646t1478r868b1525],
28	0	CD	NUMBER	0	num	29	SENT_193	[p14l646t1478r868b1525],
29	«	CD	NUMBER	«	iobj	27	SENT_193	[p14l646t1478r868b1525],
30	8399	CD	NUMBER	8399	num	31	SENT_193	[p14l646t1478r868b1525],
31	)	NN	O	)	dobj	27	SENT_193	[p14l646t1478r868b1525],
32	.	.	O	.	_	0	SENT_193	[p14l646t1478r868b1525],

1	Among	IN	O	among	_	0	SENT_194	[p14l6t1875r291b1960],
2	patients	NNS	O	patient	prep_among	8	SENT_194	[p14l347t1874r645b1959],
3	with	IN	O	with	_	0	SENT_194	[p14l702t1869r870b1938],
4	Arg/Arg	NN	O	arg/arg	nn	5	SENT_194	[p14l925t1875r1243b1960],
5	genotype	NN	O	genotype	prep_with	2	SENT_194	[p14l1301t1883r1661b1960],
6	,	,	O	,	_	0	SENT_194	[p14l1301t1883r1661b1960],
7	there	EX	O	there	expl	8	SENT_194	[p14l1720t1869r1914b1938],
8	were	VBD	O	be	_	0	SENT_194	[p14l1970t1894r2150b1938],
9	asthma	NN	O	asthma	nn	10	SENT_194	[p14l9t1980r285b2049],
10	exacerbations	NNS	O	exacerbation	nsubj	8	SENT_194	[p14l311t1980r821b2049],
11	during	IN	O	during	_	0	SENT_194	[p14l849t1980r1105b2071],
12	treatment	NN	O	treatment	prep_during	10	SENT_194	[p14l1128t1994r1501b2049],
13	with	IN	O	with	_	0	SENT_194	[p14l1523t1980r1690b2049],
14	albuterol	NN	O	albuterol	prep_with	12	SENT_194	[p14l1716t1980r2051b2049],
15	in	IN	O	in	_	0	SENT_194	[p14l2075t1985r2151b2048],
16	two	CD	NUMBER	two	num	17	SENT_194	[p14l6t2105r140b2160],
17	individuals	NNS	O	individual	prep_in	14	SENT_194	[p14l184t2092r601b2160],
18	and	CC	O	and	_	0	SENT_194	[p14l647t2092r786b2160],
19	during	IN	O	during	_	0	SENT_194	[p14l828t2092r1083b2183],
20	the	DT	O	the	det	22	SENT_194	[p14l1124t2092r1242b2160],
21	placebo	NN	O	placebo	nn	22	SENT_194	[p14l1285t2092r1570b2182],
22	phase	NN	O	phase	conj_and	12	SENT_194	[p14l1614t2092r1832b2182],
23	in	IN	O	in	_	0	SENT_194	[p14l1875t2096r1951b2159],
24	four	CD	NUMBER	four	number	25	SENT_194	[p14l1993t2092r2152b2160],
25	(	CD	NUMBER	(	num	26	SENT_194	[p14l13t2208r358b2293],
26	p	NN	O	p	prep_in	22	SENT_194	[p14l13t2208r358b2293],
27	=	JJ	O	=	amod	29	SENT_194	[p14l13t2208r358b2293],
28	O-32	NN	O	o-32	nn	29	SENT_194	[p14l13t2208r358b2293],
29	)	NN	O	)	dep	10	SENT_194	[p14l13t2208r358b2293],
30	.	.	O	.	_	0	SENT_194	[p14l13t2208r358b2293],

1	Similarly	RB	O	similarly	advmod	11	SENT_195	[p14l413t2202r771b2293],
2	,	,	O	,	_	0	SENT_195	[p14l413t2202r771b2293],
3	among	IN	O	among	_	0	SENT_195	[p14l821t2227r1084b2293],
4	the	DT	O	the	det	5	SENT_195	[p14l1129t2202r1247b2271],
5	patients	NNS	O	patient	prep_among	11	SENT_195	[p14l1294t2207r1592b2292],
6	with	IN	O	with	_	0	SENT_195	[p14l1639t2202r1806b2271],
7	Gly/Gly	JJ	O	gly/gly	amod	8	SENT_195	[p14l1855t2202r2153b2293],
8	genotype	NN	O	genotype	prep_with	5	SENT_195	[p14l9t2328r368b2405],
9	,	,	O	,	_	0	SENT_195	[p14l9t2328r368b2405],
10	there	EX	O	there	expl	11	SENT_195	[p14l443t2314r636b2383],
11	were	VBD	O	be	_	0	SENT_195	[p14l707t2339r887b2383],
12	asthma	NN	O	asthma	nn	13	SENT_195	[p14l962t2314r1237b2383],
13	exacerbations	NNS	O	exacerbation	nsubj	11	SENT_195	[p14l1310t2314r1821b2383],
14	during	IN	O	during	_	0	SENT_195	[p14l1896t2314r2151b2405],
15	treatment	NN	O	treatment	prep_during	13	SENT_195	[p14l6t2439r380b2494],
16	with	IN	O	with	_	0	SENT_195	[p14l412t2426r579b2494],
17	albuterol	NN	O	albuterol	prep_with	15	SENT_195	[p14l615t2426r950b2494],
18	in	IN	O	in	_	0	SENT_195	[p14l986t2430r1061b2493],
19	two	CD	NUMBER	two	num	20	SENT_195	[p14l1095t2439r1229b2494],
20	individuals	NNS	O	individual	prep_in	17	SENT_195	[p14l1266t2426r1682b2494],
21	and	CC	O	and	_	0	SENT_195	[p14l1721t2426r1861b2494],
22	during	IN	O	during	_	0	SENT_195	[p14l1896t2426r2151b2517],
23	the	DT	O	the	det	25	SENT_195	[p14l6t2536r124b2605],
24	placebo	NN	O	placebo	nn	25	SENT_195	[p14l190t2536r475b2626],
25	phase	NN	O	phase	conj_and	15	SENT_195	[p14l540t2536r759b2626],
26	in	IN	O	in	_	0	SENT_195	[p14l825t2541r900b2604],
27	four	CD	NUMBER	four	number	28	SENT_195	[p14l965t2536r1125b2605],
28	(	CD	NUMBER	(	num	29	SENT_195	[p14l1193t2542r1538b2627],
29	p	NN	O	p	prep_in	25	SENT_195	[p14l1193t2542r1538b2627],
30	=	JJ	O	=	amod	32	SENT_195	[p14l1193t2542r1538b2627],
31	O-32	NN	O	o-32	nn	32	SENT_195	[p14l1193t2542r1538b2627],
32	)	NN	O	)	dep	13	SENT_195	[p14l1193t2542r1538b2627],
33	.	.	O	.	_	0	SENT_195	[p14l1193t2542r1538b2627],

1	Analyses	NNS	O	analysis	_	0	SENT_196	[p14l1605t2536r1939b2627],
2	that	WDT	O	that	nsubj	3	SENT_196	[p14l2005t2536r2152b2605],
3	excluded	VBD	O	exclude	rcmod	1	SENT_196	[p14l8t2647r341b2716],
4	data	NNS	O	datum	dobj	3	SENT_196	[p14l387t2647r542b2716],
5	after	IN	O	after	mark	9	SENT_196	[p14l589t2647r760b2716],
6	occurrences	NNS	O	occurrence	nsubj	9	SENT_196	[p14l806t2671r1257b2716],
7	of	IN	O	of	_	0	SENT_196	[p14l1307t2647r1391b2716],
8	exacerbations	NNS	O	exacerbation	prep_of	6	SENT_196	[p14l1425t2647r1936b2716],
9	gave	VBD	O	give	advcl	3	SENT_196	[p14l1986t2672r2150b2738],
10	essentially	RB	O	essentially	advmod	13	SENT_196	[p14l8t2759r402b2849],
11	the	DT	O	the	det	13	SENT_196	[p14l425t2759r543b2827],
12	same	JJ	O	same	amod	13	SENT_196	[p14l573t2783r767b2827],
13	results	NNS	O	result	nsubj	14	SENT_196	[p14l795t2759r1045b2827],
14	(	VBP	O	(	ccomp	9	SENT_196	[p14l1079t2766r1225b2850],
15	not	RB	O	not	neg	14	SENT_196	[p14l1079t2766r1225b2850],
16	shown	VBN	O	show	partmod	1	SENT_196	[p14l1253t2759r1546b2850],
17	)	NN	O	)	dobj	16	SENT_196	[p14l1253t2759r1546b2850],
18	.	.	O	.	_	0	SENT_196	[p14l1253t2759r1546b2850],

1	Discussion	NN	O	discussion	nn	4	SENT_197	[p14l13t2971r467b3050],
2	Retrospective	JJ	O	retrospective	amod	4	SENT_197	[p14l12t3097r502b3183],
3	genotype-stratiﬁed	JJ	O	genotype-stratiﬁed	amod	4	SENT_197	[p14l556t3093r1240b3184],
4	analyses	NNS	O	analysis	nsubj	10	SENT_197	[p14l1292t3093r1596b3183],
5	of	IN	O	of	_	0	SENT_197	[p14l1651t3093r1734b3161],
6	previously	RB	DATE	previously	advmod	7	SENT_197	[p14l1772t3093r2153b3183],
7	published	VBN	O	publish	amod	8	SENT_197	[p14l7t3204r375b3293],
8	studies	NNS	O	study	prep_of	4	SENT_197	[p14l414t3204r670b3272],
9	have	VBP	O	have	aux	10	SENT_197	[p14l709t3204r878b3272],
10	suggested	VBN	O	suggest	_	0	SENT_197	[p14l919t3204r1285b3294],
11	that	IN	O	that	complm	24	SENT_197	[p14l1320t3204r1464b3272],
12	polymorphism	NN	O	polymorphism	nsubjpass	24	SENT_197	[p14l1500t3204r2049b3294],
13	at	IN	O	at	_	0	SENT_197	[p14l2087t3217r2152b3272],
14	the	DT	O	the	det	17	SENT_197	[p14l6t3314r121b3383],
15	16th	JJ	ORDINAL	16th	amod	17	SENT_197	[p14l149t3314r307b3383],
16	aminoacid	JJ	O	aminoacid	amod	17	SENT_197	[p14l328t3314r716b3383],
17	residue	NN	O	residue	prep_at	12	SENT_197	[p14l735t3314r1007b3383],
18	of	IN	O	of	_	0	SENT_197	[p14l1029t3314r1112b3383],
19	the	DT	O	the	det	22	SENT_197	[p14l1118t3314r1234b3383],
20	[	CD	NUMBER	[	num	22	SENT_197	[p14l1260t3314r1749b3405],
21	3,-adrenergic	JJ	O	3,-adrenergic	amod	22	SENT_197	[p14l1260t3314r1749b3405],
22	receptor	NN	O	receptor	prep_of	17	SENT_197	[p14l1769t3328r2072b3404],
23	is	VBZ	O	be	auxpass	24	SENT_197	[p14l2091t3319r2148b3383],
24	associated	VBN	O	associate	ccomp	10	SENT_197	[p14l8t3426r383b3494],
25	with	IN	O	with	_	0	SENT_197	[p14l448t3426r612b3494],
26	adverse	JJ	O	adverse	amod	27	SENT_197	[p14l681t3426r955b3494],
27	effects	NNS	O	effect	prep_with	24	SENT_197	[p14l1025t3426r1259b3494],
28	of	IN	O	of	_	0	SENT_197	[p14l1330t3426r1413b3494],
29	B-agonist	JJ	O	b-agonist	amod	30	SENT_197	[p14l1473t3430r1815b3517],
30	use	NN	O	use	prep_of	27	SENT_197	[p14l1881t3450r2008b3494],
31	in	IN	O	in	_	0	SENT_197	[p14l2077t3430r2151b3493],
32	asthmatic	JJ	O	asthmatic	amod	33	SENT_197	[p14l8t3536r368b3605],
33	patients	NNS	O	patient	prep_in	30	SENT_197	[p14l404t3541r817b3626],
34	.	.	O	.	_	0	SENT_197	[p14l404t3541r817b3626],

1	“‘	NN	O	“‘	npadvmod	12	SENT_198	[p14l404t3541r817b3626],
2	2	CD	NUMBER	2	num	1	SENT_198	[p14l404t3541r817b3626],
3	In	IN	O	in	_	0	SENT_198	[p14l859t3543r937b3604],
4	our	PRP$	O	we	poss	6	SENT_198	[p14l975t3561r1101b3605],
5	prospective	JJ	O	prospective	amod	6	SENT_198	[p14l1136t3541r1553b3626],
6	study	NN	O	study	prep_in	12	SENT_198	[p14l1593t3537r1791b3627],
7	stratiﬁed	VBN	O	stratiﬁed	partmod	6	SENT_198	[p14l1828t3536r2152b3605],
8	by	IN	O	by	_	0	SENT_198	[p14l6t3647r93b3738],
9	genotype	NN	O	genotype	agent	7	SENT_198	[p14l138t3661r488b3738],
10	,	,	O	,	_	0	SENT_198	[p14l138t3661r488b3738],
11	we	PRP	O	we	nsubj	12	SENT_198	[p14l535t3672r638b3716],
12	found	VBD	O	find	_	0	SENT_198	[p14l684t3647r905b3716],
13	that	IN	O	that	complm	19	SENT_198	[p14l948t3647r1092b3716],
14	patients	NNS	O	patient	nsubj	19	SENT_198	[p14l1135t3652r1425b3737],
15	with	IN	O	with	_	0	SENT_198	[p14l1471t3647r1636b3716],
16	the	DT	O	the	det	18	SENT_198	[p14l1679t3647r1795b3716],
17	Arg/Arg	NN	O	arg/arg	nn	18	SENT_198	[p14l1839t3652r2151b3738],
18	genotype	NN	O	genotype	prep_with	14	SENT_198	[p15l9t30r341b108],
19	improved	VBN	O	improve	ccomp	12	SENT_198	[p15l440t17r795b107],
20	when	WRB	O	when	advmod	24	SENT_198	[p15l890t17r1096b85],
21	B-agonist	JJ	MISC	b-agonist	amod	22	SENT_198	[p15l1199t21r1541b108],
22	therapy	NN	O	therapy	nsubjpass	26	SENT_198	[p15l1637t17r1916b107],
23	was	VBD	O	be	auxpass	24	SENT_198	[p15l2010t41r2148b85],
24	withdrawn	VBN	O	withdraw	advcl	19	SENT_198	[p15l6t127r405b196],
25	and	CC	O	and	_	0	SENT_198	[p15l451t127r588b196],
26	replaced	VBN	O	replace	conj_and	24	SENT_198	[p15l632t127r942b217],
27	with	IN	O	with	_	0	SENT_198	[p15l984t127r1148b196],
28	ipratropium	NN	O	ipratropium	nn	29	SENT_198	[p15l1193t132r1643b217],
29	bromide	NN	O	bromide	prep_with	24	SENT_198	[p15l1686t127r2019b196],
30	.	.	O	.	_	0	SENT_198	[p15l1686t127r2019b196],

1	In	IN	O	in	_	0	SENT_199	[p15l2073t134r2151b195],
2	patients	NNS	O	patient	prep_in	11	SENT_199	[p15l7t243r297b328],
3	who	WP	O	who	nsubj	4	SENT_199	[p15l351t238r508b307],
4	had	VBD	O	have	rcmod	2	SENT_199	[p15l561t238r699b307],
5	the	DT	O	the	det	7	SENT_199	[p15l750t238r865b307],
6	Gly/Gly	NNP	O	Gly/Gly	nn	7	SENT_199	[p15l922t238r1212b329],
7	genotype	NN	O	genotype	dobj	4	SENT_199	[p15l1265t252r1615b329],
8	,	,	O	,	_	0	SENT_199	[p15l1265t252r1615b329],
9	the	DT	O	the	det	10	SENT_199	[p15l1670t238r1786b307],
10	opposite	JJ	O	opposite	nsubj	11	SENT_199	[p15l1840t243r2150b328],
11	occurred	VBD	O	occur	_	0	SENT_199	[p15l8t350r578b440],
12	—	RB	O	—	advmod	11	SENT_199	[p15l8t350r578b440],
13	they	PRP	O	they	nsubj	14	SENT_199	[p15l8t350r578b440],
14	were	VBD	O	be	ccomp	11	SENT_199	[p15l598t374r774b418],
15	better	RB	O	better	advmod	14	SENT_199	[p15l797t350r1012b418],
16	with	IN	O	with	_	0	SENT_199	[p15l1032t350r1196b418],
17	regular	JJ	O	regular	amod	19	SENT_199	[p15l1219t350r1484b441],
18	B-agonist	JJ	MISC	b-agonist	amod	19	SENT_199	[p15l1512t354r1854b441],
19	therapy	NN	O	therapy	prep_with	14	SENT_199	[p15l1874t350r2153b440],
20	than	IN	O	than	_	0	SENT_199	[p15l6t460r174b529],
21	when	WRB	O	when	advmod	24	SENT_199	[p15l205t460r411b529],
22	it	PRP	O	it	nsubjpass	24	SENT_199	[p15l443t465r493b529],
23	was	VBD	O	be	auxpass	24	SENT_199	[p15l523t485r660b530],
24	withdrawn	VBN	O	withdraw	prepc_than	14	SENT_199	[p15l694t460r1111b530],
25	.	.	O	.	_	0	SENT_199	[p15l694t460r1111b530],

1	These	DT	O	these	det	2	SENT_200	[p15l1146t460r1367b529],
2	improvements	NNS	O	improvement	nsubj	5	SENT_200	[p15l1401t465r1940b550],
3	were	VBD	O	be	cop	5	SENT_200	[p15l1973t485r2150b530],
4	not	RB	O	not	neg	5	SENT_200	[p15l8t585r130b640],
5	restricted	JJ	O	restricted	_	0	SENT_200	[p15l161t571r507b640],
6	to	TO	O	to	_	0	SENT_200	[p15l538t585r606b640],
7	our	PRP$	O	we	poss	10	SENT_200	[p15l641t596r768b640],
8	primary	JJ	O	primary	amod	10	SENT_200	[p15l799t576r1097b662],
9	outcome	NN	O	outcome	nn	10	SENT_200	[p15l1129t585r1449b640],
10	variable	NN	O	variable	prep_to	5	SENT_200	[p15l1480t571r1787b650],
11	,	,	O	,	_	0	SENT_200	[p15l1480t571r1787b650],
12	morning	NN	TIME	morning	nn	13	SENT_200	[p15l1823t576r2151b662],
13	PEFR	NN	O	pefr	appos	10	SENT_200	[p15l12t687r237b751],
14	.	.	O	.	_	0	SENT_200	[p15l12t687r237b751],

1	They	PRP	O	they	nsubj	2	SENT_201	[p15l302t683r487b773],
2	extended	VBD	O	extend	_	0	SENT_201	[p15l548t683r879b751],
3	to	TO	O	to	_	0	SENT_201	[p15l939t696r1007b751],
4	other	JJ	O	other	amod	6	SENT_201	[p15l1071t683r1265b751],
5	physiological	JJ	O	physiological	amod	6	SENT_201	[p15l1325t683r1805b774],
6	indices	NNS	O	index	prep_to	2	SENT_201	[p15l1868t683r2147b762],
7	,	,	O	,	_	0	SENT_201	[p15l1868t683r2147b762],
8	symptoms	NNS	O	symptom	prep_to	2	SENT_201	[p15l11t807r413b884],
9	,	,	O	,	_	0	SENT_201	[p15l11t807r413b884],
10	and	CC	O	and	_	0	SENT_201	[p15l442t793r579b862],
11	rescue	NN	O	rescue	nn	13	SENT_201	[p15l602t818r839b862],
12	medication	NN	O	medication	nn	13	SENT_201	[p15l864t793r1278b862],
13	use	NN	O	use	conj_and	6	SENT_201	[p15l1301t818r1446b862],
14	.	.	O	.	_	0	SENT_201	[p15l1301t818r1446b862],

1	A	DT	O	a	det	2	SENT_202	[p15l78t909r138b972],
2	sixth	NN	ORDINAL	sixth	nsubj	7	SENT_202	[p15l186t904r362b973],
3	of	IN	O	of	_	0	SENT_202	[p15l409t904r493b973],
4	US	NNP	LOCATION	US	nn	6	SENT_202	[p15l530t909r640b973],
5	asthmatic	JJ	O	asthmatic	amod	6	SENT_202	[p15l693t904r1060b973],
6	patients	NNS	O	patient	prep_of	2	SENT_202	[p15l1106t909r1404b994],
7	have	VBP	O	have	_	0	SENT_202	[p15l1451t904r1624b973],
8	the	DT	O	the	det	10	SENT_202	[p15l1669t904r1787b973],
9	Arg/Arg	NN	O	arg/arg	nn	10	SENT_202	[p15l1833t909r2151b995],
10	genotype	NN	O	genotype	dobj	7	SENT_202	[p15l9t1029r368b1107],
11	,	,	O	,	_	0	SENT_202	[p15l9t1029r368b1107],
12	and	CC	O	and	_	0	SENT_202	[p15l420t1016r560b1084],
13	the	DT	O	the	det	15	SENT_202	[p15l605t1016r722b1084],
14	allele	NN	O	allele	nn	15	SENT_202	[p15l772t1016r965b1084],
15	frequency	NN	O	frequency	nsubj	18	SENT_202	[p15l1013t1016r1390b1106],
16	is	VBZ	O	be	cop	18	SENT_202	[p15l1436t1020r1494b1084],
17	even	RB	O	even	advmod	18	SENT_202	[p15l1545t1040r1717b1084],
18	greater	JJR	O	greater	conj_and	7	SENT_202	[p15l1766t1029r2030b1107],
19	in	IN	O	in	_	0	SENT_202	[p15l2075t1020r2151b1083],
20	individuals	NNS	O	individual	prep_in	18	SENT_202	[p15l7t1126r424b1195],
21	of	IN	O	of	_	0	SENT_202	[p15l472t1126r556b1195],
22	African	JJ	LOCATION	african	amod	23	SENT_202	[p15l586t1126r869b1195],
23	descent	NN	O	descent	prep_of	20	SENT_202	[p15l914t1126r1267b1195],
24	.	.	O	.	_	0	SENT_202	[p15l914t1126r1267b1195],

1	“	NN	O	“	nsubj	4	SENT_203	[p15l914t1126r1267b1195],
2	Our	PRP$	O	we	poss	3	SENT_203	[p15l1314t1132r1464b1195],
3	ﬁndings	NNS	O	ﬁndings	dep	1	SENT_203	[p15l1506t1126r1818b1217],
4	suggest	VBP	O	suggest	_	0	SENT_203	[p15l1867t1140r2153b1217],
5	that	IN	O	that	complm	12	SENT_203	[p15l6t1237r154b1306],
6	patients	NNS	O	patient	nsubj	12	SENT_203	[p15l190t1242r487b1327],
7	with	IN	O	with	_	0	SENT_203	[p15l527t1237r694b1306],
8	the	DT	O	the	det	10	SENT_203	[p15l731t1237r849b1306],
9	Arg/Arg	NN	O	arg/arg	nn	10	SENT_203	[p15l887t1242r1206b1328],
10	genotype	NN	O	genotype	prep_with	6	SENT_203	[p15l1245t1251r1584b1328],
11	might	MD	O	might	aux	12	SENT_203	[p15l1623t1237r1853b1328],
12	beneﬁt	VB	O	beneﬁt	ccomp	4	SENT_203	[p15l1888t1237r2152b1306],
13	from	IN	O	from	_	0	SENT_203	[p15l8t1349r194b1417],
14	discontinuing	VBG	O	discontinue	prepc_from	12	SENT_203	[p15l247t1349r774b1440],
15	the	DT	O	the	det	16	SENT_203	[p15l825t1349r943b1417],
16	use	NN	O	use	dobj	14	SENT_203	[p15l995t1373r1124b1417],
17	of	IN	O	of	_	0	SENT_203	[p15l1178t1349r1262b1417],
18	albuterol	NN	O	albuterol	prep_of	16	SENT_203	[p15l1302t1349r1636b1417],
19	as	IN	O	as	_	0	SENT_203	[p15l1689t1373r1762b1417],
20	a	DT	O	a	det	22	SENT_203	[p15l1818t1373r1855b1417],
21	rescue	NN	O	rescue	nn	22	SENT_203	[p15l1907t1373r2150b1417],
22	inhaler	NN	O	inhaler	prep_as	14	SENT_203	[p15l7t1459r278b1528],
23	and	CC	O	and	_	0	SENT_203	[p15l350t1459r490b1528],
24	using	VBG	O	use	conj_and	14	SENT_203	[p15l561t1464r773b1550],
25	as-needed	JJ	O	as-needed	amod	27	SENT_203	[p15l848t1459r1224b1528],
26	ipratropium	NN	O	ipratropium	nn	27	SENT_203	[p15l1296t1464r1757b1549],
27	bromide	NN	O	bromide	dobj	24	SENT_203	[p15l1829t1459r2150b1528],
28	instead	RB	O	instead	advmod	24	SENT_203	[p15l8t1570r298b1639],
29	.	.	O	.	_	0	SENT_203	[p15l8t1570r298b1639],

1	Our	PRP$	O	we	poss	4	SENT_204	[p15l329t1576r479b1639],
2	primary	JJ	O	primary	amod	4	SENT_204	[p15l500t1575r804b1661],
3	outcome	NN	O	outcome	nn	4	SENT_204	[p15l827t1584r1154b1639],
4	variable	NN	O	variable	nsubj	6	SENT_204	[p15l1176t1570r1471b1639],
5	was	VBD	O	be	cop	6	SENT_204	[p15l1494t1594r1634b1639],
6	PEFR	NNP	O	PEFR	_	0	SENT_204	[p15l1664t1575r1895b1649],
7	,	,	O	,	_	0	SENT_204	[p15l1664t1575r1895b1649],
8	which	WDT	O	which	nsubjpass	14	SENT_204	[p15l1920t1570r2151b1639],
9	shows	VBZ	O	show	rcmod	6	SENT_204	[p15l11t1682r240b1750],
10	wide	JJ	O	wide	amod	11	SENT_204	[p15l273t1682r451b1750],
11	variability	NN	O	variability	dobj	9	SENT_204	[p15l482t1682r857b1772],
12	but	CC	O	but	_	0	SENT_204	[p15l887t1682r1013b1750],
13	is	VBZ	O	be	auxpass	14	SENT_204	[p15l1044t1686r1102b1750],
14	recognised	VBN	O	recognise	conj_but	9	SENT_204	[p15l1137t1682r1550b1773],
15	as	IN	O	as	_	0	SENT_204	[p15l1582t1706r1655b1750],
16	an	DT	O	a	det	17	SENT_204	[p15l1691t1706r1781b1750],
17	indicator	NN	O	indicator	prep_as	14	SENT_204	[p15l1814t1682r2152b1750],
18	that	WDT	O	that	nsubj	19	SENT_204	[p15l6t1791r154b1860],
19	correlates	VBZ	O	correlate	rcmod	17	SENT_204	[p15l196t1791r558b1860],
20	well	RB	O	well	advmod	19	SENT_204	[p15l602t1791r756b1860],
21	with	IN	O	with	_	0	SENT_204	[p15l797t1791r965b1860],
22	clinical	JJ	O	clinical	amod	23	SENT_204	[p15l1009t1791r1277b1860],
23	outcomes	NNS	O	outcome	prep_with	19	SENT_204	[p15l1323t1805r1686b1860],
24	in	IN	O	in	_	0	SENT_204	[p15l1732t1796r1808b1859],
25	asthma	NN	O	asthma	prep_in	23	SENT_204	[p15l1852t1791r2147b1860],
26	.	.	O	.	_	0	SENT_204	[p15l1852t1791r2147b1860],

1	Changes	NNS	O	change	nsubjpass	22	SENT_205	[p15l10t1902r356b1993],
2	,	,	O	,	_	0	SENT_205	[p15l10t1902r356b1993],
3	both	DT	O	both	preconj	4	SENT_205	[p15l387t1902r559b1971],
4	declines	NNS	O	decline	appos	1	SENT_205	[p15l589t1902r894b1971],
5	and	CC	O	and	_	0	SENT_205	[p15l927t1902r1066b1971],
6	improvements	NNS	O	improvement	appos	1	SENT_205	[p15l1094t1907r1667b1992],
7	,	,	O	,	_	0	SENT_205	[p15l1094t1907r1667b1992],
8	of	IN	O	of	_	0	SENT_205	[p15l1702t1902r1786b1971],
9	a	DT	O	a	det	11	SENT_205	[p15l1803t1927r1840b1971],
10	smaller	JJR	O	smaller	amod	11	SENT_205	[p15l1872t1902r2152b1971],
11	magnitude	NN	O	magnitude	prep_of	1	SENT_205	[p15l8t2014r419b2105],
12	than	IN	O	than	_	0	SENT_205	[p15l442t2014r613b2082],
13	the	DT	O	the	det	14	SENT_205	[p15l636t2014r754b2082],
14	difference	NN	O	difference	prep_than	11	SENT_205	[p15l779t2014r1158b2082],
15	in	IN	O	in	_	0	SENT_205	[p15l1183t2018r1259b2081],
16	PEFR	NN	O	pefr	prep_in	1	SENT_205	[p15l1286t2018r1499b2081],
17	that	IN	O	that	dep	19	SENT_205	[p15l1520t2014r1667b2082],
18	we	PRP	O	we	nsubj	19	SENT_205	[p15l1687t2038r1791b2082],
19	observed	VBD	O	observe	dep	1	SENT_205	[p15l1817t2014r2152b2082],
20	have	VBP	O	have	aux	22	SENT_205	[p15l6t2123r178b2192],
21	been	VBN	O	be	auxpass	22	SENT_205	[p15l203t2123r386b2192],
22	associated	VBN	O	associate	_	0	SENT_205	[p15l413t2123r797b2192],
23	with	IN	O	with	_	0	SENT_205	[p15l819t2123r986b2192],
24	clinical	JJ	O	clinical	amod	25	SENT_205	[p15l1013t2123r1281b2192],
25	deterioration	NN	O	deterioration	prep_with	22	SENT_205	[p15l1307t2123r1796b2192],
26	and	CC	O	and	_	0	SENT_205	[p15l1822t2123r1961b2192],
27	with	IN	O	with	_	0	SENT_205	[p15l1983t2123r2151b2192],
28	the	DT	O	the	det	30	SENT_205	[p15l6t2234r124b2303],
29	beneﬁcial	JJ	O	beneﬁcial	amod	30	SENT_205	[p15l159t2234r525b2303],
30	effects	NNS	O	effect	prep_with	22	SENT_205	[p15l562t2234r802b2303],
31	of	IN	O	of	_	0	SENT_205	[p15l841t2234r925b2303],
32	withdrawing	VBG	O	withdraw	prepc_of	30	SENT_205	[p15l945t2234r1425b2325],
33	or	CC	O	or	_	0	SENT_205	[p15l1462t2259r1539b2303],
34	adding	VBG	O	add	prepc_of	30	SENT_205	[p15l1574t2234r1833b2325],
35	inhaled	VBN	O	inhale	partmod	45	SENT_205	[p15l1868t2234r2152b2303],
36	corticosteroid	NN	O	corticosteroid	nn	37	SENT_205	[p15l8t2346r524b2414],
37	therapy	NN	O	therapy	dobj	35	SENT_205	[p15l603t2346r905b2436],
38	,	,	O	,	_	0	SENT_205	[p15l603t2346r905b2436],
39	respectively	RB	O	respectively	advmod	41	SENT_205	[p15l990t2346r1556b2436],
40	.17	CD	NUMBER	.17	number	41	SENT_205	[p15l990t2346r1556b2436],
41	'18	CD	NUMBER	'18	rcmod	37	SENT_205	[p15l990t2346r1556b2436],
42	Furthermore	RB	O	furthermore	advmod	35	SENT_205	[p15l1640t2346r2147b2425],
43	,	,	O	,	_	0	SENT_205	[p15l1640t2346r2147b2425],
44	there	EX	O	there	expl	45	SENT_205	[p15l6t2457r200b2525],
45	were	VBD	O	be	ccomp	34	SENT_205	[p15l235t2481r415b2525],
46	parallel	JJ	O	parallel	amod	47	SENT_205	[p15l452t2457r730b2546],
47	changes	NNS	O	change	nsubj	45	SENT_205	[p15l767t2457r1071b2547],
48	in	IN	O	in	_	0	SENT_205	[p15l1110t2461r1185b2524],
49	other	JJ	O	other	amod	51	SENT_205	[p15l1222t2457r1420b2525],
50	outcome	NN	O	outcome	nn	51	SENT_205	[p15l1455t2470r1782b2525],
51	variables	NNS	O	variable	prep_in	47	SENT_205	[p15l1817t2457r2148b2525],
52	such	JJ	O	such	_	0	SENT_205	[p15l11t2567r185b2636],
53	as	IN	O	as	_	0	SENT_205	[p15l219t2591r292b2636],
54	FEV1	NN	O	fev1	prep_such_as	51	SENT_205	[p15l332t2572r531b2653],
55	,	,	O	,	_	0	SENT_205	[p15l332t2572r531b2653],
56	symptom	NN	O	symptom	nn	57	SENT_205	[p15l570t2581r926b2658],
57	scores	NNS	O	score	prep_such_as	51	SENT_205	[p15l961t2591r1212b2646],
58	,	,	O	,	_	0	SENT_205	[p15l961t2591r1212b2646],
59	and	CC	O	and	_	0	SENT_205	[p15l1249t2567r1389b2636],
60	rescue	NN	O	rescue	nn	62	SENT_205	[p15l1421t2591r1664b2636],
61	inhaler	NN	O	inhaler	nn	62	SENT_205	[p15l1698t2567r1968b2636],
62	use	NN	O	use	conj_and	54	SENT_205	[p15l1998t2591r2147b2646],
63	,	,	O	,	_	0	SENT_205	[p15l1998t2591r2147b2646],
64	all	DT	O	all	nsubj	65	SENT_205	[p15l8t2679r95b2747],
65	suggesting	VBG	O	suggest	partmod	45	SENT_205	[p15l161t2683r570b2770],
66	a	DT	O	a	det	69	SENT_205	[p15l635t2703r672b2747],
67	clinically	RB	O	clinically	advmod	68	SENT_205	[p15l737t2679r1071b2769],
68	relevant	JJ	O	relevant	amod	69	SENT_205	[p15l1134t2679r1436b2747],
69	genotype-speciﬁc	NN	O	genotype-speciﬁc	dobj	65	SENT_205	[p15l1500t2679r2151b2770],

1	Articles	NNPS	O	Articles	_	0	SENT_206	[p15l6t3252r154b3288],
2	I	PRP	O	I	dep	1	SENT_206	[p15l202t3089r250b3287],

1	response	NN	O	response	_	0	SENT_207	[p15l8t3573r364b3637],
2	.	.	O	.	_	0	SENT_207	[p15l8t3573r364b3637],

1	We	PRP	O	we	nsubj	4	SENT_208	[p15l390t3555r514b3617],
2	did	VBD	O	do	aux	4	SENT_208	[p15l539t3548r658b3617],
3	not	RB	O	not	neg	4	SENT_208	[p15l680t3562r804b3617],
4	observe	VB	O	observe	_	0	SENT_208	[p15l826t3548r1110b3617],
5	a	DT	O	a	det	6	SENT_208	[p15l1135t3573r1172b3617],
6	difference	NN	O	difference	dobj	4	SENT_208	[p15l1196t3548r1574b3617],
7	in	IN	O	in	_	0	SENT_208	[p15l1598t3553r1673b3616],
8	the	DT	O	the	det	9	SENT_208	[p15l1695t3548r1812b3617],
9	number	NN	O	number	prep_in	4	SENT_208	[p15l1836t3549r2141b3617],
10	of	IN	O	of	_	0	SENT_208	[p15l9t3658r93b3727],
11	asthma	NN	O	asthma	nn	12	SENT_208	[p15l143t3658r418b3727],
12	exacerbations	NNS	O	exacerbation	prep_of	9	SENT_208	[p15l480t3658r1009b3727],
13	.	.	O	.	_	0	SENT_208	[p15l480t3658r1009b3727],

1	However	RB	O	however	advmod	6	SENT_209	[p15l1079t3665r1433b3737],
2	,	,	O	,	_	0	SENT_209	[p15l1079t3665r1433b3737],
3	the	DT	O	the	det	4	SENT_209	[p15l1497t3658r1615b3727],
4	patients	NNS	O	patient	nsubj	6	SENT_209	[p15l1677t3663r1973b3747],
5	we	PRP	O	we	nsubj	6	SENT_209	[p15l2036t3683r2139b3727],
6	wvvw	VBP	O	wvvw	_	0	SENT_209	[p15l808t2953r1346b3004],
7	.	.	O	.	_	0	SENT_209	[p15l808t2953r1346b3004],

1	the	DT	O	the	det	2	SENT_210	[p15l808t2953r1346b3004],
2	|	NN	O	|	_	0	SENT_210	[p15l808t2953r1346b3004],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_210	[p15l808t2953r1346b3004],
4	Vol	NNP	O	Vol	dep	2	SENT_210	[p15l1389t2953r1479b3004],
5	364	CD	NUMBER	364	num	4	SENT_210	[p15l1500t2952r1610b3012],
6	October	NNP	DATE	October	tmod	4	SENT_210	[p15l1655t2953r1881b3004],
7	23	CD	DATE	23	num	6	SENT_210	[p15l1899t2960r1985b3013],
8	,	,	DATE	,	_	0	SENT_210	[p15l1899t2960r1985b3013],
9	2004	CD	DATE	2004	num	6	SENT_210	[p15l2006t2960r2152b3011],

1	studied	VBN	O	study	csubj	2	SENT_211	[p16l11t18r286b86],
2	had	VBD	O	have	_	0	SENT_211	[p16l332t18r471b86],
3	mild	JJ	O	mild	amod	4	SENT_211	[p16l518t18r694b86],
4	disease	NN	O	disease	dobj	2	SENT_211	[p16l742t18r1031b96],
5	,	,	O	,	_	0	SENT_211	[p16l742t18r1031b96],
6	and	CC	O	and	cc	2	SENT_211	[p16l1084t18r1222b86],
7	thus	RB	O	thus	advmod	2	SENT_211	[p16l1268t18r1431b86],
8	the	DT	O	the	det	9	SENT_211	[p16l1481t18r1598b86],
9	frequency	NN	O	frequency	nsubj	14	SENT_211	[p16l1647t18r2022b107],
10	of	IN	O	of	_	0	SENT_211	[p16l2069t18r2153b86],
11	asthma	NN	O	asthma	nn	12	SENT_211	[p16l9t126r284b195],
12	exacerbations	NNS	O	exacerbation	prep_of	9	SENT_211	[p16l338t126r846b195],
13	was	VBD	O	be	cop	14	SENT_211	[p16l900t151r1039b195],
14	low	JJ	O	low	ccomp	2	SENT_211	[p16l1093t126r1243b195],
15	.	.	O	.	_	0	SENT_211	[p16l1093t126r1243b195],

1	A	DT	O	a	det	2	SENT_212	[p16l1299t131r1359b194],
2	trial	NN	O	trial	nsubjpass	17	SENT_212	[p16l1410t126r1559b195],
3	with	IN	O	with	_	0	SENT_212	[p16l1611t126r1777b195],
4	a	DT	O	a	det	8	SENT_212	[p16l1831t151r1869b195],
5	much	RB	O	much	advmod	6	SENT_212	[p16l1921t126r2140b195],
6	longer	JJR	O	longer	amod	8	SENT_212	[p16l7t236r251b326],
7	treatment	NN	O	treatment	nn	8	SENT_212	[p16l314t250r686b304],
8	period	NN	O	period	prep_with	2	SENT_212	[p16l751t236r993b325],
9	and	CC	O	and	_	0	SENT_212	[p16l1059t236r1198b304],
10	a	DT	O	a	det	12	SENT_212	[p16l1265t261r1302b304],
11	greater	JJR	O	greater	amod	12	SENT_212	[p16l1370t250r1633b326],
12	number	NN	O	number	prep_with	2	SENT_212	[p16l1697t236r2003b304],
13	of	IN	O	of	_	0	SENT_212	[p16l2069t236r2153b304],
14	patients	NNS	O	patient	prep_of	12	SENT_212	[p16l8t350r304b435],
15	would	MD	O	would	aux	17	SENT_212	[p16l340t346r572b414],
16	be	VB	O	be	auxpass	17	SENT_212	[p16l605t346r692b413],
17	needed	VBN	O	need	_	0	SENT_212	[p16l727t346r999b414],
18	to	TO	O	to	aux	19	SENT_212	[p16l1031t359r1100b413],
19	show	VB	O	show	xcomp	17	SENT_212	[p16l1139t346r1334b414],
20	a	DT	O	a	det	22	SENT_212	[p16l1368t370r1405b413],
21	genotype-stratiﬁed	JJ	O	genotype-stratiﬁed	amod	22	SENT_212	[p16l1441t346r2141b436],
22	effect	NN	O	effect	dobj	19	SENT_212	[p16l9t454r215b523],
23	on	IN	O	on	_	0	SENT_212	[p16l240t479r334b523],
24	asthma	NN	O	asthma	nn	25	SENT_212	[p16l360t454r635b523],
25	exacerbations	NNS	O	exacerbation	prep_on	19	SENT_212	[p16l661t454r1190b523],
26	.	.	O	.	_	0	SENT_212	[p16l661t454r1190b523],

1	Previous	JJ	O	previous	amod	3	SENT_213	[p16l84t569r404b632],
2	retrospective	NN	O	retrospective	nn	3	SENT_213	[p16l437t569r917b653],
3	analyses	NNS	O	analysis	nsubj	5	SENT_213	[p16l949t564r1259b654],
4	had	VBD	O	have	aux	5	SENT_213	[p16l1290t564r1430b632],
5	suggested	VBN	O	suggest	_	0	SENT_213	[p16l1462t564r1835b654],
6	that	IN	O	that	complm	9	SENT_213	[p16l1862t564r2009b632],
7	we	PRP	O	we	nsubj	9	SENT_213	[p16l2036t589r2139b632],
8	would	MD	O	would	aux	9	SENT_213	[p16l6t674r240b742],
9	observe	VB	O	observe	ccomp	5	SENT_213	[p16l320t674r604b742],
10	an	DT	O	a	det	12	SENT_213	[p16l686t698r776b741],
11	adverse	JJ	O	adverse	amod	12	SENT_213	[p16l857t674r1136b742],
12	outcome	NN	O	outcome	dobj	9	SENT_213	[p16l1219t687r1544b742],
13	with	IN	O	with	_	0	SENT_213	[p16l1624t674r1790b742],
14	regular	JJ	O	regular	amod	16	SENT_213	[p16l1871t674r2141b764],
15	albuterol	NN	O	albuterol	nn	16	SENT_213	[p16l9t782r342b851],
16	use	NN	O	use	prep_with	9	SENT_213	[p16l393t807r522b851],
17	in	IN	O	in	_	0	SENT_213	[p16l575t787r650b849],
18	Arg/Arg	NN	O	arg/arg	nn	19	SENT_213	[p16l701t788r1017b872],
19	patients	NNS	O	patient	prep_in	16	SENT_213	[p16l1069t787r1365b871],
20	as	IN	O	as	mark	30	SENT_213	[p16l1421t807r1493b851],
21	compared	VBN	O	compare	_	0	SENT_213	[p16l1549t782r1924b871],
22	with	IN	O	with	prepc_compared_with	30	SENT_213	[p16l1973t782r2140b851],
23	Gly/Gly	NN	O	gly/gly	nn	24	SENT_213	[p16l11t891r307b981],
24	patients	NNS	O	patient	pobj	30	SENT_213	[p16l327t896r750b980],
25	.1	CD	NUMBER	.1	num	26	SENT_213	[p16l327t896r750b980],
26	“	NN	O	“	dep	24	SENT_213	[p16l327t896r750b980],
27	2	CD	NUMBER	2	dep	26	SENT_213	[p16l327t896r750b980],
28	Those	DT	O	those	det	29	SENT_213	[p16l772t891r1000b959],
29	studies	NNS	O	study	nsubj	30	SENT_213	[p16l1026t891r1287b959],
30	examined	VBD	O	examine	advcl	9	SENT_213	[p16l1313t891r1680b959],
31	the	DT	O	the	det	32	SENT_213	[p16l1701t891r1818b959],
32	effect	NN	O	effect	dobj	30	SENT_213	[p16l1842t891r2047b959],
33	of	IN	O	of	_	0	SENT_213	[p16l2069t891r2153b959],
34	regular	JJ	O	regular	amod	36	SENT_213	[p16l8t1001r279b1091],
35	albuterol	NN	O	albuterol	nn	36	SENT_213	[p16l301t1001r634b1069],
36	use	NN	O	use	prep_of	32	SENT_213	[p16l655t1025r783b1069],
37	but	CC	O	but	_	0	SENT_213	[p16l806t1001r931b1068],
38	did	VBD	O	do	aux	41	SENT_213	[p16l953t1001r1071b1069],
39	not	RB	O	not	neg	41	SENT_213	[p16l1093t1014r1217b1068],
40	simultaneously	RB	O	simultaneously	advmod	41	SENT_213	[p16l1240t1001r1817b1090],
41	limit	VB	O	limit	conj_but	30	SENT_213	[p16l1836t1001r2018b1068],
42	asneeded	JJ	O	asneeded	amod	44	SENT_213	[p16l2040t1025r2138b1069, p16l8t1109r280b1178],
43	albuterol	NN	O	albuterol	nn	44	SENT_213	[p16l342t1109r675b1178],
44	use	NN	O	use	dobj	41	SENT_213	[p16l735t1134r883b1187],
45	,	,	O	,	_	0	SENT_213	[p16l735t1134r883b1187],
46	as	IN	O	as	mark	48	SENT_213	[p16l950t1134r1023b1178],
47	we	PRP	O	we	nsubj	48	SENT_213	[p16l1085t1134r1188b1178],
48	did	VBD	O	do	advcl	5	SENT_213	[p16l1253t1109r1371b1178],
49	in	IN	O	in	_	0	SENT_213	[p16l1432t1114r1507b1176],
50	this	DT	O	this	det	51	SENT_213	[p16l1567t1109r1705b1178],
51	study	NN	O	study	prep_in	48	SENT_213	[p16l1772t1109r1990b1199],
52	,	,	O	,	_	0	SENT_213	[p16l1772t1109r1990b1199],
53	by	IN	O	by	_	0	SENT_213	[p16l2054t1109r2141b1199],
54	providing	VBG	O	provide	prepc_by	48	SENT_213	[p16l8t1218r371b1308],
55	ipratropium	NN	O	ipratropium	nn	56	SENT_213	[p16l412t1223r871b1307],
56	bromide	NN	O	bromide	dobj	54	SENT_213	[p16l911t1218r1230b1286],
57	to	TO	O	to	aux	59	SENT_213	[p16l1272t1232r1341b1286],
58	be	VB	O	be	auxpass	59	SENT_213	[p16l1383t1218r1469b1286],
59	used	VBN	O	use	xcomp	54	SENT_213	[p16l1510t1218r1688b1286],
60	as	IN	O	as	_	0	SENT_213	[p16l1730t1242r1803b1286],
61	needed	VBN	O	need	prep_as	59	SENT_213	[p16l1847t1218r2136b1286],
62	.	.	O	.	_	0	SENT_213	[p16l1847t1218r2136b1286],

1	Thus	RB	O	thus	advmod	8	SENT_214	[p16l7t1329r219b1407],
2	,	,	O	,	_	0	SENT_214	[p16l7t1329r219b1407],
3	those	DT	O	those	det	4	SENT_214	[p16l283t1329r484b1397],
4	studies	NNS	O	study	nsubj	8	SENT_214	[p16l550t1329r811b1397],
5	would	MD	O	would	aux	8	SENT_214	[p16l873t1329r1106b1397],
6	not	RB	O	not	neg	8	SENT_214	[p16l1167t1342r1291b1397],
7	have	VB	O	have	aux	8	SENT_214	[p16l1350t1329r1522b1397],
8	predicted	VBN	O	predict	_	0	SENT_214	[p16l1584t1329r1935b1418],
9	that	IN	O	that	complm	16	SENT_214	[p16l1995t1329r2141b1397],
10	withdrawal	NN	O	withdrawal	nsubj	16	SENT_214	[p16l6t1438r425b1507],
11	of	IN	O	of	_	0	SENT_214	[p16l496t1438r580b1507],
12	albuterol	NN	O	albuterol	prep_of	10	SENT_214	[p16l637t1438r970b1507],
13	per	FW	O	per	nn	14	SENT_214	[p16l1038t1463r1162b1527],
14	se	FW	O	se	advmod	16	SENT_214	[p16l1232t1463r1305b1507],
15	would	MD	O	would	aux	16	SENT_214	[p16l1373t1438r1606b1507],
16	produce	VB	O	produce	ccomp	8	SENT_214	[p16l1674t1438r1979b1527],
17	an	DT	O	a	det	18	SENT_214	[p16l2050t1463r2140b1507],
18	improvement	NN	O	improvement	dobj	16	SENT_214	[p16l8t1552r523b1636],
19	in	IN	O	in	_	0	SENT_214	[p16l552t1552r627b1614],
20	airway	NN	O	airway	nn	21	SENT_214	[p16l659t1552r903b1637],
21	obstruction	NN	O	obstruction	prep_in	18	SENT_214	[p16l933t1547r1362b1615],
22	in	IN	O	in	_	0	SENT_214	[p16l1393t1552r1468b1614],
23	patients	NNS	O	patient	prep_in	16	SENT_214	[p16l1498t1552r1794b1636],
24	with	IN	O	with	_	0	SENT_214	[p16l1825t1547r1992b1615],
25	the	DT	O	the	det	27	SENT_214	[p16l2022t1547r2139b1615],
26	Arg/Arg	NN	O	arg/arg	nn	27	SENT_214	[p16l7t1662r323b1747],
27	genotype	NN	O	genotype	prep_with	23	SENT_214	[p16l391t1670r748b1747],
28	.	.	O	.	_	0	SENT_214	[p16l391t1670r748b1747],

1	We	PRP	O	we	nsubj	2	SENT_215	[p16l817t1663r941b1725],
2	noted	VBD	O	note	_	0	SENT_215	[p16l1008t1657r1221b1725],
3	this	DT	O	this	det	5	SENT_215	[p16l1285t1657r1422b1725],
4	genotype-speciﬁc	JJ	O	genotype-speciﬁc	amod	5	SENT_215	[p16l1492t1657r2140b1747],
5	effect	NN	O	effect	dobj	2	SENT_215	[p16l9t1765r214b1834],
6	in	IN	O	in	_	0	SENT_215	[p16l242t1770r317b1832],
7	Arg/Arg	NN	O	arg/arg	nn	8	SENT_215	[p16l346t1770r662b1855],
8	patients	NNS	O	patient	prep_in	2	SENT_215	[p16l691t1770r1009b1854],
9	,	,	O	,	_	0	SENT_215	[p16l691t1770r1009b1854],
10	both	CC	O	both	dep	2	SENT_215	[p16l1041t1765r1211b1834],
11	in	IN	O	in	conj	2	SENT_215	[p16l1241t1770r1316b1832],
12	our	PRP$	O	we	poss	16	SENT_215	[p16l1346t1790r1475b1834],
13	initial	JJ	O	initial	amod	16	SENT_215	[p16l1503t1765r1721b1834],
14	open-label	JJ	O	open-label	amod	16	SENT_215	[p16l1752t1765r2140b1854],
15	run-in	NN	O	run-in	nn	16	SENT_215	[p16l8t1879r246b1942],
16	(	NN	O	(	pobj	11	SENT_215	[p16l324t1874r553b1964],
17	when	WRB	O	when	advmod	19	SENT_215	[p16l324t1874r553b1964],
18	patients	NNS	O	patient	nsubj	19	SENT_215	[p16l625t1879r921b1963],
19	discontinued	VBN	O	discontinue	advcl	2	SENT_215	[p16l997t1874r1488b1942],
20	most	JJS	O	most	dobj	19	SENT_215	[p16l1560t1888r1748b1942],
21	of	IN	O	of	_	0	SENT_215	[p16l1820t1874r1904b1942],
22	their	PRP$	O	they	poss	24	SENT_215	[p16l1962t1874r2141b1942],
23	albuterol	NN	O	albuterol	nn	24	SENT_215	[p16l9t1985r342b2053],
24	use	NN	O	use	prep_of	20	SENT_215	[p16l384t2009r512b2053],
25	and	CC	O	and	_	0	SENT_215	[p16l557t1985r696b2053],
26	substituted	VBN	O	substitute	advcl	2	SENT_215	[p16l741t1985r1158b2053],
27	ipratropium	NN	O	ipratropium	nn	28	SENT_215	[p16l1200t1989r1659b2074],
28	bromide	NN	O	bromide	dobj	26	SENT_215	[p16l1700t1985r2020b2053],
29	as	IN	O	as	_	0	SENT_215	[p16l2065t2009r2137b2053],
30	needed	VBN	O	need	amod	31	SENT_215	[p16l8t2093r301b2183],
31	)	NN	O	)	prep_as	26	SENT_215	[p16l8t2093r301b2183],
32	and	CC	O	and	_	0	SENT_215	[p16l338t2093r477b2162],
33	during	IN	O	during	_	0	SENT_215	[p16l507t2093r760b2183],
34	the	DT	O	the	det	37	SENT_215	[p16l789t2093r906b2162],
35	masked	VBN	O	mask	amod	37	SENT_215	[p16l937t2093r1230b2162],
36	treatment	NN	O	treatment	nn	37	SENT_215	[p16l1258t2107r1629b2162],
37	phase	NN	O	phase	prep_during	26	SENT_215	[p16l1658t2093r1875b2182],
38	(	CD	NUMBER	(	dobj	2	SENT_215	[p16l1912t2093r2140b2183],
39	when	WRB	O	when	advmod	46	SENT_215	[p16l1912t2093r2140b2183],
40	the	DT	O	the	det	42	SENT_215	[p16l7t2202r124b2270],
41	placebo	NN	O	placebo	nn	42	SENT_215	[p16l167t2202r451b2291],
42	group	NN	O	group	dep	46	SENT_215	[p16l496t2227r716b2292],
43	also	RB	O	also	advmod	42	SENT_215	[p16l760t2202r904b2270],
44	limited	JJ	O	limited	amod	46	SENT_215	[p16l947t2202r1217b2270],
45	albuterol	NN	O	albuterol	nn	46	SENT_215	[p16l1259t2202r1592b2270],
46	use	NN	O	use	dep	38	SENT_215	[p16l1633t2209r1809b2292],
47	)	CD	NUMBER	)	dep	46	SENT_215	[p16l1633t2209r1809b2292],
48	.	.	O	.	_	0	SENT_215	[p16l1633t2209r1809b2292],

1	We	PRP	O	we	nsubj	4	SENT_216	[p16l1854t2209r1978b2271],
2	did	VBD	O	do	aux	4	SENT_216	[p16l2023t2202r2141b2270],
3	not	RB	O	not	neg	4	SENT_216	[p16l8t2326r132b2381],
4	observe	VB	O	observe	_	0	SENT_216	[p16l183t2313r466b2381],
5	such	PDT	O	such	predet	7	SENT_216	[p16l521t2313r695b2381],
6	an	DT	O	a	det	7	SENT_216	[p16l748t2337r837b2381],
7	improvement	NN	O	improvement	dobj	4	SENT_216	[p16l889t2317r1403b2402],
8	on	IN	O	on	_	0	SENT_216	[p16l1454t2337r1548b2381],
9	withdrawal	NN	O	withdrawal	prep_on	4	SENT_216	[p16l1598t2313r2017b2381],
10	of	IN	O	of	_	0	SENT_216	[p16l2069t2313r2153b2381],
11	albuterol	NN	O	albuterol	prep_of	9	SENT_216	[p16l9t2421r342b2490],
12	in	IN	O	in	_	0	SENT_216	[p16l368t2426r443b2488],
13	the	DT	O	the	det	15	SENT_216	[p16l468t2421r586b2490],
14	Gly/Gly	JJ	O	gly/gly	amod	15	SENT_216	[p16l615t2421r911b2511],
15	patients	NNS	O	patient	prep_in	11	SENT_216	[p16l935t2426r1252b2510],
16	.	.	O	.	_	0	SENT_216	[p16l935t2426r1252b2510],

1	Although	IN	O	although	mark	8	SENT_217	[p16l1282t2421r1637b2511],
2	the	DT	O	the	det	4	SENT_217	[p16l1662t2421r1779b2490],
3	observed	VBN	O	observe	amod	4	SENT_217	[p16l1807t2421r2141b2490],
4	effect	NN	O	effect	nsubj	8	SENT_217	[p16l9t2531r214b2600],
5	could	MD	O	could	aux	8	SENT_217	[p16l247t2531r452b2600],
6	have	VB	O	have	aux	8	SENT_217	[p16l483t2531r654b2600],
7	been	VBN	O	be	cop	8	SENT_217	[p16l688t2531r869b2600],
8	due	JJ	O	due	advcl	35	SENT_217	[p16l903t2531r1040b2600],
9	to	TO	O	to	_	0	SENT_217	[p16l1072t2545r1142b2600],
10	a	DT	O	a	det	12	SENT_217	[p16l1178t2556r1215b2600],
11	differential	JJ	O	differential	amod	12	SENT_217	[p16l1249t2531r1664b2600],
12	response	NN	O	response	prep_to	8	SENT_217	[p16l1697t2555r2034b2620],
13	of	IN	O	of	_	0	SENT_217	[p16l2069t2531r2153b2600],
14	these	DT	O	these	det	15	SENT_217	[p16l7t2641r204b2709],
15	genotypes	NNS	O	genotype	prep_of	12	SENT_217	[p16l258t2654r632b2731],
16	to	TO	O	to	_	0	SENT_217	[p16l685t2654r755b2709],
17	ipratropium	NN	O	ipratropium	nn	18	SENT_217	[p16l808t2645r1267b2730],
18	bromide	NN	O	bromide	prep_to	8	SENT_217	[p16l1318t2641r1637b2708],
19	(	CD	NUMBER	(	num	18	SENT_217	[p16l1696t2647r1822b2731],
20	eg	FW	O	eg	npadvmod	8	SENT_217	[p16l1696t2647r1822b2731],
21	,	,	O	,	_	0	SENT_217	[p16l1696t2647r1822b2731],
22	greater	JJR	O	greater	amod	24	SENT_217	[p16l1878t2654r2141b2731],
23	protective	JJ	O	protective	amod	24	SENT_217	[p16l8t2754r375b2838],
24	effect	NN	O	effect	appos	20	SENT_217	[p16l401t2749r606b2818],
25	of	IN	O	of	_	0	SENT_217	[p16l630t2749r714b2818],
26	ipratropium	NN	O	ipratropium	prep_of	24	SENT_217	[p16l726t2754r1185b2838],
27	in	IN	O	in	_	0	SENT_217	[p16l1209t2754r1284b2816],
28	Arg/Arg	NN	O	arg/arg	nn	29	SENT_217	[p16l1308t2755r1624b2839],
29	patients	NNS	O	patient	prep_in	8	SENT_217	[p16l1649t2754r1994b2839],
30	)	RB	O	)	advmod	29	SENT_217	[p16l1649t2754r1994b2839],
31	,	,	O	,	_	0	SENT_217	[p16l1649t2754r1994b2839],
32	the	DT	O	the	det	33	SENT_217	[p16l2021t2749r2139b2818],
33	data	NNS	O	datum	nsubj	35	SENT_217	[p16l9t2858r163b2926],
34	still	RB	O	still	advmod	35	SENT_217	[p16l210t2858r343b2926],
35	suggest	VBP	O	suggest	_	0	SENT_217	[p16l390t2872r674b2948],
36	that	IN	O	that	complm	40	SENT_217	[p16l717t2858r863b2926],
37	Arg/Arg	NN	O	arg/arg	nn	38	SENT_217	[p16l905t2863r1221b2948],
38	patients	NNS	O	patient	nsubj	40	SENT_217	[p16l1265t2863r1561b2947],
39	might	MD	O	might	aux	40	SENT_217	[p16l1609t2858r1836b2948],
40	beneﬁt	VB	O	beneﬁt	ccomp	35	SENT_217	[p16l1878t2858r2141b2926],
41	from	IN	O	from	_	0	SENT_217	[p16l8t2968r194b3035],
42	a	DT	O	a	det	45	SENT_217	[p16l229t2992r266b3036],
43	reliever	NN	O	reliever	nn	45	SENT_217	[p16l300t2968r581b3036],
44	treatment	NN	O	treatment	nn	45	SENT_217	[p16l612t2981r984b3036],
45	strategy	NN	O	strategy	prep_from	40	SENT_217	[p16l1019t2981r1310b3058],
46	much	RB	O	much	advmod	47	SENT_217	[p16l1342t2968r1561b3036],
47	different	JJ	O	different	amod	45	SENT_217	[p16l1596t2968r1922b3036],
48	from	IN	O	from	_	0	SENT_217	[p16l1954t2968r2140b3035],
49	the	DT	O	the	det	50	SENT_217	[p16l7t3076r124b3145],
50	one	CD	NUMBER	one	prep_from	40	SENT_217	[p16l189t3101r324b3145],
51	currently	RB	DATE	currently	advmod	52	SENT_217	[p16l389t3076r730b3166],
52	recommended	VBN	O	recommend	partmod	50	SENT_217	[p16l791t3076r1359b3155],
53	,	,	O	,	_	0	SENT_217	[p16l791t3076r1359b3155],
54	namely	RB	O	namely	advmod	50	SENT_217	[p16l1426t3076r1704b3166],
55	as-needed	JJ	O	as-needed	amod	57	SENT_217	[p16l1766t3076r2141b3145],
56	B2-agonist	NN	O	b2-agonist	nn	57	SENT_217	[p16l13t3190r386b3276],
57	use	NN	O	use	dep	50	SENT_217	[p16l408t3209r556b3254],
58	.	.	O	.	_	0	SENT_217	[p16l408t3209r556b3254],

1	The	DT	O	the	det	2	SENT_218	[p16l78t3297r220b3365],
2	pattem	NN	O	pattem	nsubj	10	SENT_218	[p16l258t3310r520b3386],
3	of	IN	O	of	_	0	SENT_218	[p16l558t3297r640b3365],
4	response	NN	O	response	prep_of	2	SENT_218	[p16l665t3321r992b3386],
5	seen	VBN	O	see	partmod	4	SENT_218	[p16l1033t3321r1197b3365],
6	with	IN	O	with	_	0	SENT_218	[p16l1232t3297r1395b3365],
7	our	PRP$	O	we	poss	8	SENT_218	[p16l1434t3321r1559b3365],
8	intervention	NN	O	intervention	prep_with	5	SENT_218	[p16l1595t3301r2044b3365],
9	is	VBZ	O	be	cop	10	SENT_218	[p16l2081t3301r2137b3365],
10	interesting	JJ	O	interesting	_	0	SENT_218	[p16l8t3410r421b3495],
11	.	.	O	.	_	0	SENT_218	[p16l8t3410r421b3495],

1	Although	IN	O	although	mark	3	SENT_219	[p16l460t3405r807b3495],
2	we	PRP	O	we	nsubj	3	SENT_219	[p16l842t3430r944b3474],
3	saw	VBD	O	see	advcl	19	SENT_219	[p16l984t3430r1121b3474],
4	an	DT	O	a	det	5	SENT_219	[p16l1157t3430r1245b3474],
5	improvement	NN	O	improvement	dobj	3	SENT_219	[p16l1282t3410r1783b3494],
6	in	IN	O	in	_	0	SENT_219	[p16l1819t3410r1893b3472],
7	PEFR	NN	O	pefr	prep_in	3	SENT_219	[p16l1934t3410r2141b3472],
8	in	IN	O	in	_	0	SENT_219	[p16l8t3519r82b3581],
9	Arg/Arg	NN	O	arg/arg	nn	10	SENT_219	[p16l101t3519r410b3604],
10	patients	NNS	O	patient	prep_in	7	SENT_219	[p16l430t3519r717b3603],
11	when	WRB	O	when	advmod	14	SENT_219	[p16l739t3514r943b3582],
12	albuterol	NN	O	albuterol	nsubjpass	14	SENT_219	[p16l965t3514r1287b3582],
13	was	VBD	O	be	auxpass	14	SENT_219	[p16l1306t3538r1443b3582],
14	withdrawn	VBN	O	withdraw	advcl	3	SENT_219	[p16l1464t3514r1877b3592],
15	,	,	O	,	_	0	SENT_219	[p16l1464t3514r1877b3592],
16	we	PRP	O	we	nsubj	19	SENT_219	[p16l1900t3539r2002b3582],
17	did	VBD	O	do	aux	19	SENT_219	[p16l2025t3514r2141b3582],
18	not	RB	O	not	neg	19	SENT_219	[p16l8t3637r129b3691],
19	see	VB	O	see	_	0	SENT_219	[p16l196t3648r308b3691],
20	a	DT	O	a	det	21	SENT_219	[p16l376t3648r413b3691],
21	decline	NN	O	decline	dobj	19	SENT_219	[p16l480t3624r739b3692],
22	in	IN	O	in	_	0	SENT_219	[p16l806t3628r880b3690],
23	PEFR	NN	O	pefr	prep_in	19	SENT_219	[p16l949t3628r1157b3690],
24	when	WRB	O	when	advmod	28	SENT_219	[p16l1219t3624r1424b3692],
25	regular	JJ	O	regular	amod	26	SENT_219	[p16l1489t3624r1752b3714],
26	albuterol	NN	O	albuterol	nsubjpass	28	SENT_219	[p16l1818t3624r2140b3692],
27	was	VBD	O	be	auxpass	28	SENT_219	[p16l6t3758r143b3802],
28	initiated	VBN	O	initiate	advcl	19	SENT_219	[p16l187t3733r505b3802],
29	.	.	O	.	_	0	SENT_219	[p16l187t3733r505b3802],

1	The	DT	O	the	det	2	SENT_220	[p16l549t3733r691b3802],
2	short-terrn	NN	O	short-terrn	nsubj	14	SENT_220	[p16l736t3733r1140b3813],
3	,	,	O	,	_	0	SENT_220	[p16l736t3733r1140b3813],
4	direct	JJ	O	direct	amod	6	SENT_220	[p16l1185t3733r1392b3802],
5	relaxation	NN	O	relaxation	nn	6	SENT_220	[p16l1431t3733r1789b3802],
6	effect	NN	O	effect	appos	2	SENT_220	[p16l1831t3733r2030b3802],
7	of	IN	O	of	_	0	SENT_220	[p16l2071t3733r2153b3802],
8	albuterol	NN	O	albuterol	prep_of	6	SENT_220	[p17l9t26r332b94],
9	on	IN	O	on	_	0	SENT_220	[p17l390t51r483b94],
10	airway	NN	O	airway	nn	12	SENT_220	[p17l542t31r779b116],
11	smooth	JJ	O	smooth	amod	12	SENT_220	[p17l837t26r1112b94],
12	muscle	NN	O	muscle	prep_on	8	SENT_220	[p17l1170t26r1433b94],
13	might	MD	O	might	aux	14	SENT_220	[p17l1491t26r1714b116],
14	mask	NN	O	mask	_	0	SENT_220	[p17l1770t26r1970b94],
15	the	DT	O	the	det	18	SENT_220	[p17l2024t26r2139b94],
16	adverse	JJ	O	adverse	amod	18	SENT_220	[p17l9t136r281b204],
17	long-term	JJ	O	long-term	amod	18	SENT_220	[p17l336t136r699b226],
18	effect	NN	O	effect	dobj	14	SENT_220	[p17l754t136r953b204],
19	in	IN	O	in	_	0	SENT_220	[p17l1006t140r1080b202],
20	Arg/Arg	NN	O	arg/arg	nn	21	SENT_220	[p17l1133t141r1441b226],
21	patients	NNS	O	patient	prep_in	14	SENT_220	[p17l1496t140r1803b225],
22	.	.	O	.	_	0	SENT_220	[p17l1496t140r1803b225],

1	Such	PDT	O	such	predet	3	SENT_221	[p17l1867t136r2047b204],
2	a	DT	O	a	det	3	SENT_221	[p17l2102t160r2140b203],
3	hypothesis	NN	O	hypothesis	nsubj	6	SENT_221	[p17l7t244r398b334],
4	would	MD	O	would	aux	6	SENT_221	[p17l489t244r717b313],
5	be	VB	O	be	cop	6	SENT_221	[p17l804t244r889b313],
6	consistent	JJ	O	consistent	_	0	SENT_221	[p17l982t249r1353b313],
7	with	IN	O	with	_	0	SENT_221	[p17l1441t244r1603b312],
8	our	PRP$	O	we	poss	10	SENT_221	[p17l1694t269r1820b313],
9	earlier	JJR	O	earlier	amod	10	SENT_221	[p17l1909t244r2141b313],
10	observation	NN	O	observation	prep_with	6	SENT_221	[p17l9t353r431b421],
11	that	IN	O	that	complm	21	SENT_221	[p17l460t353r603b421],
12	most	JJS	O	most	nsubj	21	SENT_221	[p17l631t367r817b421],
13	of	IN	O	of	_	0	SENT_221	[p17l847t353r929b421],
14	the	DT	O	the	det	15	SENT_221	[p17l946t353r1060b421],
15	decline	NN	O	decline	prep_of	12	SENT_221	[p17l1093t353r1352b421],
16	in	IN	O	in	_	0	SENT_221	[p17l1383t358r1457b420],
17	PEFR	NN	ORGANIZATION	pefr	prep_in	15	SENT_221	[p17l1491t358r1699b420],
18	in	IN	O	in	_	0	SENT_221	[p17l1729t358r1802b420],
19	Arg/Arg	NN	O	arg/arg	nn	20	SENT_221	[p17l1831t358r2140b443],
20	patients	NNS	O	patient	prep_in	17	SENT_221	[p17l8t467r295b552],
21	occurred	VBD	O	occur	ccomp	6	SENT_221	[p17l426t463r746b531],
22	after	IN	O	after	mark	26	SENT_221	[p17l873t463r1038b531],
23	regular	JJ	O	regular	amod	24	SENT_221	[p17l1164t463r1427b553],
24	albuterol	NN	O	albuterol	nsubjpass	26	SENT_221	[p17l1553t463r1876b531],
25	was	VBD	O	be	auxpass	26	SENT_221	[p17l2000t487r2137b531],
26	discontinued	VBN	O	discontinue	advcl	21	SENT_221	[p17l9t571r548b640],
27	.	.	O	.	_	0	SENT_221	[p17l9t571r548b640],

1	“	RB	O	“	advmod	5	SENT_222	[p17l9t571r548b640],
2	It	PRP	O	it	nsubj	5	SENT_222	[p17l595t578r649b640],
3	is	VBZ	O	be	cop	5	SENT_222	[p17l688t576r744b640],
4	also	RB	O	also	advmod	5	SENT_222	[p17l788t571r928b640],
5	consistent	JJ	O	consistent	dep	10	SENT_222	[p17l971t576r1343b640],
6	with	IN	O	with	_	0	SENT_222	[p17l1379t571r1542b640],
7	the	DT	O	the	det	8	SENT_222	[p17l1582t572r1696b640],
8	decline	NN	O	decline	prep_with	5	SENT_222	[p17l1738t572r1998b640],
9	we	PRP	O	we	dep	8	SENT_222	[p17l2037t596r2139b640],
10	observed	VBD	O	observe	_	0	SENT_222	[p17l9t681r334b749],
11	in	IN	O	in	_	0	SENT_222	[p17l436t686r509b748],
12	Arg/Arg	NN	O	arg/arg	nn	13	SENT_222	[p17l611t686r919b771],
13	patients	NNS	O	patient	prep_in	10	SENT_222	[p17l1021t686r1309b770],
14	immediately	RB	O	immediately	advmod	10	SENT_222	[p17l1414t681r1874b771],
15	after	IN	O	after	_	0	SENT_222	[p17l1976t681r2141b749],
16	withdrawal	NN	O	withdrawal	prep_after	10	SENT_222	[p17l6t791r414b859],
17	of	IN	O	of	_	0	SENT_222	[p17l445t791r528b859],
18	regular	JJ	O	regular	amod	19	SENT_222	[p17l546t791r808b881],
19	albuterol	NN	O	albuterol	prep_of	16	SENT_222	[p17l838t791r1178b869],
20	,	,	O	,	_	0	SENT_222	[p17l838t791r1178b869],
21	which	WDT	O	which	nsubjpass	24	SENT_222	[p17l1211t791r1435b859],
22	was	VBD	O	be	auxpass	24	SENT_222	[p17l1464t815r1600b859],
23	then	RB	O	then	advmod	24	SENT_222	[p17l1632t791r1799b858],
24	followed	VBN	O	follow	rcmod	19	SENT_222	[p17l1830t791r2141b859],
25	by	IN	O	by	_	0	SENT_222	[p17l7t899r93b989],
26	an	DT	O	a	det	28	SENT_222	[p17l135t924r223b968],
27	improvement	NN	O	improvement	nn	28	SENT_222	[p17l266t904r768b988],
28	(	NN	O	(	agent	24	SENT_222	[p17l814t899r1023b989],
29	week	NN	DURATION	week	tmod	24	SENT_222	[p17l814t899r1023b989],
30	20	CD	NUMBER	20	nsubj	10	SENT_222	[p17l1066t905r1168b978],
31	,	,	O	,	_	0	SENT_222	[p17l1066t905r1168b978],
32	ﬁgure	NN	O	ﬁgure	appos	30	SENT_222	[p17l1214t899r1430b989],
33	3	CD	NUMBER	3	num	32	SENT_222	[p17l1478t906r1534b978],
34	,	,	O	,	_	0	SENT_222	[p17l1478t906r1534b978],
35	Arg/Arg	NN	O	arg/arg	nn	36	SENT_222	[p17l1578t905r1931b989],
36	)	NN	O	)	appos	32	SENT_222	[p17l1578t905r1931b989],
37	.	.	O	.	_	0	SENT_222	[p17l1578t905r1931b989],

1	This	DT	O	this	det	2	SENT_223	[p17l1977t899r2137b968],
2	decline	NN	O	decline	nsubj	4	SENT_223	[p17l9t1008r269b1076],
3	also	RB	O	also	advmod	4	SENT_223	[p17l299t1008r438b1076],
4	suggests	VBZ	O	suggest	_	0	SENT_223	[p17l470t1022r778b1098],
5	the	DT	O	the	det	6	SENT_223	[p17l807t1008r922b1076],
6	possibility	NN	O	possibility	dobj	4	SENT_223	[p17l950t1008r1322b1098],
7	that	IN	O	that	complm	16	SENT_223	[p17l1347t1008r1489b1076],
8	Arg/Arg	NN	O	arg/arg	nn	9	SENT_223	[p17l1514t1013r1823b1098],
9	patients	NNS	O	patient	nsubj	16	SENT_223	[p17l1850t1013r2137b1097],
10	using	VBG	O	use	partmod	9	SENT_223	[p17l7t1122r213b1208],
11	large	JJ	O	large	amod	12	SENT_223	[p17l265t1118r444b1208],
12	amounts	NNS	O	amount	dobj	10	SENT_223	[p17l500t1131r821b1186],
13	of	IN	O	of	_	0	SENT_223	[p17l878t1118r960b1185],
14	albuterol	NN	O	albuterol	prep_of	12	SENT_223	[p17l1001t1118r1324b1186],
15	might	MD	O	might	aux	16	SENT_223	[p17l1377t1118r1600b1208],
16	beneﬁt	VB	O	beneﬁt	ccomp	4	SENT_223	[p17l1650t1118r1906b1186],
17	from	IN	O	from	_	0	SENT_223	[p17l1958t1118r2140b1185],
18	gradual	JJ	O	gradual	amod	19	SENT_223	[p17l9t1226r284b1316],
19	withdrawal	NN	O	withdrawal	prep_from	16	SENT_223	[p17l305t1226r712b1295],
20	as	IN	O	as	mark	21	SENT_223	[p17l737t1251r808b1295],
21	opposed	VBN	O	oppose	advcl	16	SENT_223	[p17l835t1226r1140b1315],
22	to	TO	O	to	_	0	SENT_223	[p17l1161t1240r1229b1295],
23	abrupt	JJ	O	abrupt	amod	24	SENT_223	[p17l1254t1226r1495b1315],
24	cessation	NN	O	cessation	prep_to	21	SENT_223	[p17l1518t1231r1852b1295],
25	of	IN	O	of	_	0	SENT_223	[p17l1876t1226r1959b1295],
26	their	PRP$	O	they	poss	28	SENT_223	[p17l1967t1226r2141b1295],
27	B-agonist	JJ	MISC	b-agonist	amod	28	SENT_223	[p17l13t1340r352b1425],
28	therapy	NN	O	therapy	prep_of	24	SENT_223	[p17l373t1335r664b1425],
29	.	.	O	.	_	0	SENT_223	[p17l373t1335r664b1425],

1	Our	PRP$	O	we	poss	2	SENT_224	[p17l82t1451r230b1513],
2	groups	NNS	O	group	nsubjpass	4	SENT_224	[p17l270t1469r527b1535],
3	were	VBD	O	be	auxpass	4	SENT_224	[p17l567t1469r746b1513],
4	stratiﬁed	VBN	O	stratiﬁed	_	0	SENT_224	[p17l790t1445r1121b1513],
5	entirely	RB	O	entirely	advmod	4	SENT_224	[p17l1160t1445r1445b1534],
6	on	IN	O	on	_	0	SENT_224	[p17l1483t1469r1577b1512],
7	genotype	NN	O	genotype	prep_on	4	SENT_224	[p17l1618t1458r1956b1535],
8	at	IN	O	at	_	0	SENT_224	[p17l1997t1458r2063b1512],
9	a	DT	O	a	det	13	SENT_224	[p17l2102t1469r2140b1513],
10	single	JJ	O	single	amod	13	SENT_224	[p17l11t1553r232b1643],
11	locus	NN	O	locus	nn	13	SENT_224	[p17l266t1553r861b1642],
12	—	NN	O	—	nn	13	SENT_224	[p17l266t1553r861b1642],
13	position	NN	O	position	prep_at	4	SENT_224	[p17l266t1553r861b1642],
14	16	CD	NUMBER	16	dep	13	SENT_224	[p17l900t1559r981b1621],
15	of	IN	O	of	_	0	SENT_224	[p17l1017t1553r1100b1622],
16	the	DT	O	the	det	19	SENT_224	[p17l1120t1553r1237b1622],
17	[	CD	NUMBER	[	num	19	SENT_224	[p17l1277t1553r1775b1643],
18	32-adrenergic	JJ	O	32-adrenergic	amod	19	SENT_224	[p17l1277t1553r1775b1643],
19	receptor	NN	O	receptor	prep_of	14	SENT_224	[p17l1809t1567r2135b1642],
20	.	.	O	.	_	0	SENT_224	[p17l1809t1567r2135b1642],

1	However	RB	O	however	advmod	4	SENT_225	[p17l12t1669r366b1740],
2	,	,	O	,	_	0	SENT_225	[p17l12t1669r366b1740],
3	there	EX	O	there	expl	4	SENT_225	[p17l393t1662r586b1730],
4	are	VBP	O	be	_	0	SENT_225	[p17l612t1687r724b1730],
5	several	JJ	O	several	amod	9	SENT_225	[p17l752t1662r1007b1731],
6	other	JJ	O	other	amod	9	SENT_225	[p17l1032t1662r1229b1730],
7	functional	JJ	O	functional	amod	8	SENT_225	[p17l1252t1662r1636b1730],
8	polymorphic	JJ	O	polymorphic	amod	9	SENT_225	[p17l1660t1662r2140b1752],
9	loci	NNS	O	locus	nsubj	4	SENT_225	[p17l7t1772r139b1840],
10	in	IN	O	in	_	0	SENT_225	[p17l167t1776r242b1838],
11	the	DT	O	the	det	12	SENT_225	[p17l268t1772r386b1840],
12	gene	NN	O	gene	prep_in	9	SENT_225	[p17l416t1796r592b1862],
13	encoding	VBG	O	encode	partmod	12	SENT_225	[p17l622t1772r968b1862],
14	this	DT	O	this	det	15	SENT_225	[p17l995t1772r1132b1840],
15	receptor	NN	O	receptor	dobj	13	SENT_225	[p17l1162t1777r1539b1861],
16	.	.	O	.	_	0	SENT_225	[p17l1162t1777r1539b1861],

1	”	NN	O	”	dep	7	SENT_226	[p17l1162t1777r1539b1861],
2	Since	IN	O	since	dep	7	SENT_226	[p17l1572t1776r1771b1840],
3	the	DT	O	the	det	4	SENT_226	[p17l1799t1772r1916b1840],
4	locus	NN	O	locus	nsubj	7	SENT_226	[p17l1943t1772r2137b1840],
5	we	PRP	O	we	nsubj	6	SENT_226	[p17l6t1905r110b1949],
6	studied	VBD	O	study	rcmod	4	SENT_226	[p17l173t1881r448b1949],
7	is	VBZ	O	be	advcl	23	SENT_226	[p17l507t1885r565b1949],
8	in	IN	O	in	_	0	SENT_226	[p17l628t1885r703b1947],
9	linkage	NN	O	linkage	nn	10	SENT_226	[p17l761t1880r1035b1970],
10	disequilibrium	NN	O	disequilibrium	prep_in	7	SENT_226	[p17l1097t1881r1659b1969],
11	with	IN	O	with	_	0	SENT_226	[p17l1717t1880r1883b1949],
12	other	JJ	O	other	amod	14	SENT_226	[p17l1944t1881r2141b1949],
13	polymorphic	JJ	O	polymorphic	amod	14	SENT_226	[p17l8t1989r488b2079],
14	loci	NNS	O	locus	prep_with	10	SENT_226	[p17l552t1989r684b2057],
15	in	IN	O	in	_	0	SENT_226	[p17l749t1994r824b2056],
16	the	DT	O	the	det	18	SENT_226	[p17l889t1989r1006b2057],
17	B2-adrenergic	JJ	O	b2-adrenergic	amod	18	SENT_226	[p17l1078t1989r1576b2079],
18	receptor	NN	O	receptor	prep_in	14	SENT_226	[p17l1641t2003r1968b2078],
19	,	,	O	,	_	0	SENT_226	[p17l1641t2003r1968b2078],
20	we	PRP	O	we	nsubj	23	SENT_226	[p17l2036t2014r2139b2057],
21	can	MD	O	can	aux	23	SENT_226	[p17l9t2113r265b2168],
22	not	RB	O	not	neg	23	SENT_226	[p17l9t2113r265b2168],
23	say	VB	O	say	_	0	SENT_226	[p17l292t2124r407b2189],
24	whether	IN	O	whether	complm	33	SENT_226	[p17l430t2100r741b2168],
25	the	DT	O	the	det	26	SENT_226	[p17l764t2100r881b2168],
26	variant	NN	O	variant	nsubj	33	SENT_226	[p17l906t2104r1169b2168],
27	at	IN	O	at	_	0	SENT_226	[p17l1194t2113r1259b2168],
28	the	DT	O	the	det	29	SENT_226	[p17l1283t2100r1400b2168],
29	locus	NN	O	locus	prep_at	26	SENT_226	[p17l1425t2100r1619b2168],
30	we	PRP	O	we	nsubj	31	SENT_226	[p17l1646t2124r1750b2168],
31	studied	VBD	O	study	rcmod	29	SENT_226	[p17l1779t2100r2054b2168],
32	is	VBZ	O	be	cop	33	SENT_226	[p17l2079t2104r2137b2168],
33	wvvw	NN	O	wvvw	ccomp	23	SENT_226	[p17l7t2371r542b2422],
34	.	.	O	.	_	0	SENT_226	[p17l7t2371r542b2422],

1	the	DT	O	the	det	2	SENT_227	[p17l7t2371r542b2422],
2	|	NN	O	|	_	0	SENT_227	[p17l7t2371r542b2422],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_227	[p17l7t2371r542b2422],
4	Vol	NNP	O	Vol	dep	2	SENT_227	[p17l585t2371r675b2422],
5	364	CD	NUMBER	364	num	4	SENT_227	[p17l696t2370r805b2429],
6	October	NNP	DATE	October	tmod	4	SENT_227	[p17l850t2371r1074b2422],
7	23	CD	DATE	23	num	6	SENT_227	[p17l1092t2377r1177b2431],
8	,	,	DATE	,	_	0	SENT_227	[p17l1092t2377r1177b2431],
9	2004	CD	DATE	2004	num	6	SENT_227	[p17l1199t2377r1345b2429],

1	the	DT	O	the	det	2	SENT_228	[p17l7t2558r90b2607],
2	active	JJ	O	active	_	0	SENT_228	[p17l133t2562r281b2607],
3	one	CD	NUMBER	one	dep	2	SENT_228	[p17l324t2576r433b2607],
4	.	.	O	.	_	0	SENT_228	[p17l324t2576r433b2607],

1	Others	NNS	O	other	nsubj	3	SENT_229	[p17l480t2558r657b2607],
2	have	VBP	O	have	aux	3	SENT_229	[p17l700t2558r821b2607],
3	suggested	VBN	O	suggest	_	0	SENT_229	[p17l865t2558r1128b2622],
4	that	IN	O	that	complm	9	SENT_229	[p17l1169t2558r1272b2607],
5	speciﬁc	NN	O	speciﬁc	nn	7	SENT_229	[p17l1315t2558r1512b2622],
6	haplotype	NN	O	haplotype	nn	7	SENT_229	[p17l7t2636r265b2700],
7	combinations	NNS	O	combination	nsubjpass	9	SENT_229	[p17l313t2636r675b2685],
8	are	VBP	O	be	auxpass	9	SENT_229	[p17l725t2653r804b2685],
9	associated	VBN	O	associate	ccomp	3	SENT_229	[p17l852t2636r1122b2685],
10	with	IN	O	with	_	0	SENT_229	[p17l1167t2636r1285b2685],
11	altered	JJ	O	altered	amod	13	SENT_229	[p17l1332t2636r1512b2685],
12	bronchodilator	NN	O	bronchodilator	nn	13	SENT_229	[p17l7t2714r403b2762],
13	responses	NNS	O	response	prep_with	9	SENT_229	[p17l419t2717r732b2777],
14	.	.	O	.	_	0	SENT_229	[p17l419t2717r732b2777],

1	”	NN	O	”	nn	2	SENT_230	[p17l419t2717r732b2777],
2	Analysis	NN	O	analysis	nsubj	10	SENT_230	[p17l748t2714r971b2777],
3	of	IN	O	of	_	0	SENT_230	[p17l991t2714r1050b2762],
4	the	DT	O	the	det	5	SENT_230	[p17l1058t2714r1141b2762],
5	haplotypes	NNS	O	haplotype	prep_of	2	SENT_230	[p17l1158t2714r1441b2777],
6	of	IN	O	of	_	0	SENT_230	[p17l1462t2714r1521b2762],
7	our	PRP$	O	we	poss	9	SENT_230	[p17l9t2809r99b2840],
8	enrolled	VBN	O	enrol	amod	9	SENT_230	[p17l127t2791r345b2840],
9	patients	NNS	O	patient	prep_of	5	SENT_230	[p17l372t2795r581b2855],
10	showed	VBD	O	show	_	0	SENT_230	[p17l613t2791r814b2840],
11	that	IN	O	that	complm	23	SENT_230	[p17l840t2791r943b2840],
12	the	DT	O	the	det	14	SENT_230	[p17l970t2791r1052b2840],
13	vast	JJ	O	vast	amod	14	SENT_230	[p17l1080t2801r1183b2840],
14	majority	NN	O	majority	nsubj	23	SENT_230	[p17l1210t2794r1434b2855],
15	of	IN	O	of	_	0	SENT_230	[p17l1462t2791r1520b2840],
16	those	DT	O	those	prep_of	14	SENT_230	[p17l7t2869r149b2918],
17	with	IN	O	with	_	0	SENT_230	[p17l167t2869r284b2918],
18	the	DT	O	the	det	20	SENT_230	[p17l303t2869r385b2918],
19	Arg/Arg	NN	O	arg/arg	nn	20	SENT_230	[p17l404t2872r627b2933],
20	genotype	NN	O	genotype	prep_with	16	SENT_230	[p17l647t2879r885b2933],
21	were	VBD	O	be	cop	23	SENT_230	[p17l903t2886r1030b2918],
22	also	RB	O	also	advmod	23	SENT_230	[p17l1050t2869r1151b2918],
23	homozygous	JJ	O	homozygous	ccomp	10	SENT_230	[p17l1170t2869r1510b2933],
24	for	IN	O	for	_	0	SENT_230	[p17l8t2947r84b2995],
25	the	DT	O	the	det	27	SENT_230	[p17l109t2947r191b2995],
26	Gln	NN	MISC	gln	nn	27	SENT_230	[p17l221t2947r318b2995],
27	allele	NN	O	allele	prep_for	23	SENT_230	[p17l346t2947r481b2995],
28	at	IN	O	at	_	0	SENT_230	[p17l509t2956r556b2995],
29	the	DT	O	the	det	30	SENT_230	[p17l581t2947r663b2995],
30	codon	NN	O	codon	prep_at	23	SENT_230	[p17l691t2947r851b2995],
31	for	IN	O	for	_	0	SENT_230	[p17l878t2947r954b2995],
32	the	DT	O	the	det	35	SENT_230	[p17l979t2947r1062b2995],
33	27th	JJ	ORDINAL	27th	amod	35	SENT_230	[p17l1090t2947r1206b2997],
34	aminoacid	JJ	O	aminoacid	amod	35	SENT_230	[p17l1233t2947r1512b2995],
35	residue	NN	O	residue	prep_for	30	SENT_230	[p17l8t3024r203b3073],
36	in	IN	O	in	_	0	SENT_230	[p17l251t3027r304b3072],
37	the	DT	O	the	det	40	SENT_230	[p17l350t3024r433b3073],
38	B2-adrenergic	JJ	O	b2-adrenergic	amod	40	SENT_230	[p17l484t3024r836b3088],
39	receptor	NN	O	receptor	nn	40	SENT_230	[p17l883t3034r1101b3088],
40	(	NN	O	(	prep_in	35	SENT_230	[p17l1152t3029r1254b3088],
41	not	RB	O	not	neg	40	SENT_230	[p17l1152t3029r1254b3088],
42	shown	VBN	O	show	partmod	40	SENT_230	[p17l1303t3024r1509b3088],
43	)	NN	O	)	dobj	42	SENT_230	[p17l1303t3024r1509b3088],
44	.	.	O	.	_	0	SENT_230	[p17l1303t3024r1509b3088],

1	Because	IN	O	because	mark	6	SENT_231	[p17l11t3107r224b3151],
2	our	PRP$	O	we	poss	3	SENT_231	[p17l260t3120r351b3151],
3	study	NN	O	study	nsubjpass	9	SENT_231	[p17l387t3102r529b3166],
4	was	VBD	O	be	auxpass	6	SENT_231	[p17l561t3119r659b3151],
5	not	RB	O	not	neg	6	SENT_231	[p17l696t3112r783b3151],
6	powered	VBN	O	power	advcl	18	SENT_231	[p17l817t3102r1057b3165],
7	,	,	O	,	_	0	SENT_231	[p17l817t3102r1057b3165],
8	or	CC	O	or	_	0	SENT_231	[p17l1095t3120r1149b3151],
9	enrolled	VBN	O	enrol	advcl	18	SENT_231	[p17l1184t3102r1414b3158],
10	,	,	O	,	_	0	SENT_231	[p17l1184t3102r1414b3158],
11	by	IN	O	by	advcl	18	SENT_231	[p17l1451t3102r1513b3166],
12	haplotypes	NNS	O	haplotype	pobj	11	SENT_231	[p17l7t3180r306b3243],
13	,	,	O	,	_	0	SENT_231	[p17l7t3180r306b3243],
14	we	PRP	O	we	nsubj	18	SENT_231	[p17l326t3197r399b3228],
15	can	MD	O	can	aux	18	SENT_231	[p17l419t3189r600b3228],
16	not	RB	O	not	neg	18	SENT_231	[p17l419t3189r600b3228],
17	further	RB	O	further	advmod	18	SENT_231	[p17l618t3180r806b3228],
18	dissect	VB	O	dissect	_	0	SENT_231	[p17l825t3180r1004b3228],
19	the	DT	O	the	det	20	SENT_231	[p17l1022t3180r1104b3228],
20	role	NN	O	role	dobj	18	SENT_231	[p17l1124t3180r1224b3228],
21	of	IN	O	of	_	0	SENT_231	[p17l1244t3180r1303b3228],
22	speciﬁc	JJ	O	speciﬁc	amod	23	SENT_231	[p17l1315t3180r1512b3243],
23	haplotypes	NNS	O	haplotype	prep_of	20	SENT_231	[p17l7t3257r290b3321],
24	on	IN	O	on	_	0	SENT_231	[p17l311t3275r378b3306],
25	treatment	NN	O	treatment	nn	26	SENT_231	[p17l395t3267r657b3306],
26	response	NN	O	response	prep_on	18	SENT_231	[p17l674t3274r925b3320],
27	.	.	O	.	_	0	SENT_231	[p17l674t3274r925b3320],

1	We	PRP	O	we	nsubj	4	SENT_232	[p17l57t3340r144b3384],
2	can	MD	O	can	aux	4	SENT_232	[p17l178t3352r268b3384],
3	only	RB	O	only	advmod	4	SENT_232	[p17l302t3335r413b3399],
4	speculate	VB	O	speculate	_	0	SENT_232	[p17l446t3335r688b3398],
5	as	IN	O	as	_	0	SENT_232	[p17l722t3352r773b3384],
6	to	TO	O	to	prepc_as_to	4	SENT_232	[p17l806t3345r855b3384],
7	the	DT	O	the	det	8	SENT_232	[p17l887t3335r969b3384],
8	mechanism	NN	O	mechanism	pobj	4	SENT_232	[p17l1003t3335r1314b3384],
9	of	IN	O	of	_	0	SENT_232	[p17l1348t3335r1406b3384],
10	the	DT	O	the	det	13	SENT_232	[p17l1429t3335r1511b3384],
11	genotype-speciﬁc	JJ	O	genotype-speciﬁc	amod	13	SENT_232	[p17l9t3414r461b3478],
12	long-term	JJ	O	long-term	amod	13	SENT_232	[p17l498t3414r759b3478],
13	effect	NN	O	effect	prep_of	8	SENT_232	[p17l797t3414r940b3462],
14	on	IN	O	on	_	0	SENT_232	[p17l978t3431r1044b3462],
15	airﬂow	NN	O	airﬂow	prep_on	13	SENT_232	[p17l1083t3414r1265b3462],
16	that	IN	O	that	complm	18	SENT_232	[p17l1300t3414r1403b3462],
17	we	PRP	O	we	nsubj	18	SENT_232	[p17l1438t3431r1511b3462],
18	observed	VBD	O	observe	ccomp	4	SENT_232	[p17l9t3491r242b3540],
19	in	IN	O	in	_	0	SENT_232	[p17l285t3494r337b3539],
20	relation	NN	O	relation	prep_in	18	SENT_232	[p17l381t3491r582b3540],
21	to	TO	O	to	_	0	SENT_232	[p17l625t3501r674b3540],
22	B-agonist	JJ	O	b-agonist	amod	23	SENT_232	[p17l722t3494r966b3555],
23	therapy	NN	O	therapy	prep_to	18	SENT_232	[p17l1007t3491r1217b3555],
24	.	.	O	.	_	0	SENT_232	[p17l1007t3491r1217b3555],

1	Although	IN	O	although	mark	8	SENT_233	[p17l1263t3491r1511b3555],
2	the	DT	O	the	det	3	SENT_233	[p17l7t3569r89b3618],
3	polymorphisms	NNS	O	polymorphism	nsubjpass	8	SENT_233	[p17l117t3569r532b3633],
4	we	PRP	O	we	nsubj	5	SENT_233	[p17l559t3587r632b3618],
5	examined	VBD	O	examine	rcmod	3	SENT_233	[p17l661t3569r917b3618],
6	have	VBP	O	have	aux	8	SENT_233	[p17l943t3569r1063b3618],
7	been	VBN	O	be	auxpass	8	SENT_233	[p17l1090t3569r1217b3618],
8	associated	VBN	O	associate	advcl	29	SENT_233	[p17l1245t3569r1512b3618],
9	with	IN	O	with	_	0	SENT_233	[p17l7t3648r123b3696],
10	changes	NNS	O	change	prep_with	8	SENT_233	[p17l163t3648r375b3712],
11	in	IN	O	in	_	0	SENT_233	[p17l416t3651r469b3695],
12	receptor	NN	O	receptor	nn	13	SENT_233	[p17l508t3657r725b3711],
13	regulation	NN	O	regulation	prep_in	10	SENT_233	[p17l763t3648r1033b3712],
14	or	CC	O	or	_	0	SENT_233	[p17l1073t3665r1127b3696],
15	signal	NN	O	signal	nn	16	SENT_233	[p17l1167t3648r1322b3712],
16	transduction	NN	O	transduction	conj_or	13	SENT_233	[p17l1361t3657r1510b3696, p17l9t3724r332b3780],
17	,1	CD	NUMBER	,1	number	18	SENT_233	[p17l1361t3657r1510b3696, p17l9t3724r332b3780],
18	°	CD	NUMBER	°	dep	13	SENT_233	[p17l1361t3657r1510b3696, p17l9t3724r332b3780],
19	’	NN	O	’	dep	18	SENT_233	[p17l1361t3657r1510b3696, p17l9t3724r332b3780],
20	2	CD	NUMBER	2	num	19	SENT_233	[p17l1361t3657r1510b3696, p17l9t3724r332b3780],
21	°	CD	NUMBER	°	number	22	SENT_233	[p17l1361t3657r1510b3696, p17l9t3724r332b3780],
22	’“	CD	NUMBER	’“	num	24	SENT_233	[p17l1361t3657r1510b3696, p17l9t3724r332b3780],
23	their	PRP$	O	they	poss	24	SENT_233	[p17l362t3724r487b3773],
24	relation	NN	O	relation	nsubj	29	SENT_233	[p17l515t3724r717b3773],
25	to	TO	O	to	_	0	SENT_233	[p17l745t3734r794b3773],
26	our	PRP$	O	we	poss	27	SENT_233	[p17l825t3742r915b3773],
27	outcomes	NNS	O	outcome	prep_to	24	SENT_233	[p17l944t3734r1197b3773],
28	is	VBZ	O	be	cop	29	SENT_233	[p17l1228t3728r1268b3773],
29	unclear	JJ	O	unclear	_	0	SENT_233	[p17l1299t3724r1509b3773],
30	.	.	O	.	_	0	SENT_233	[p17l1299t3724r1509b3773],

1	Rather	RB	O	rather	advmod	2	SENT_234	[p18l11t18r185b67],
2	than	IN	O	than	advcl	18	SENT_234	[p18l202t18r321b67],
3	being	VBG	O	be	cop	5	SENT_234	[p18l339t18r487b82],
4	directly	RB	O	directly	advmod	5	SENT_234	[p18l507t18r701b82],
5	due	JJ	O	due	pcomp	2	SENT_234	[p18l719t18r815b67],
6	to	TO	O	to	_	0	SENT_234	[p18l834t28r882b67],
7	the	DT	O	the	det	8	SENT_234	[p18l902t18r984b67],
8	polymorphisms	NNS	O	polymorphism	prep_to	5	SENT_234	[p18l1003t18r1418b82],
9	we	PRP	O	we	nsubj	10	SENT_234	[p18l1438t36r1511b67],
10	examined	VBD	O	examine	rcmod	8	SENT_234	[p18l9t97r277b152],
11	,	,	O	,	_	0	SENT_234	[p18l9t97r277b152],
12	the	DT	O	the	det	13	SENT_234	[p18l311t97r393b145],
13	effect	NN	O	effect	nsubjpass	18	SENT_234	[p18l427t97r570b145],
14	we	PRP	O	we	nsubj	15	SENT_234	[p18l599t114r672b145],
15	observed	VBD	O	observe	rcmod	13	SENT_234	[p18l705t97r939b145],
16	might	MD	O	might	aux	18	SENT_234	[p18l970t97r1129b161],
17	be	VB	O	be	auxpass	18	SENT_234	[p18l1159t97r1220b145],
18	related	VBN	O	relate	_	0	SENT_234	[p18l1253t97r1431b145],
19	to	TO	O	to	_	0	SENT_234	[p18l1462t106r1511b145],
20	changes	NNS	O	change	prep_to	18	SENT_234	[p18l9t174r220b238],
21	in	IN	O	in	_	0	SENT_234	[p18l241t177r294b222],
22	a	DT	O	a	det	23	SENT_234	[p18l314t192r340b223],
23	locus	NN	O	locus	prep_in	20	SENT_234	[p18l358t174r493b223],
24	in	IN	O	in	_	0	SENT_234	[p18l514t177r567b222],
25	linkage	NN	O	linkage	prep_in	23	SENT_234	[p18l585t174r776b238],
26	with	IN	O	with	_	0	SENT_234	[p18l794t174r911b223],
27	the	DT	O	the	det	28	SENT_234	[p18l929t174r1011b223],
28	alleles	NNS	O	allele	prep_with	18	SENT_234	[p18l1032t174r1191b223],
29	we	PRP	O	we	nsubj	30	SENT_234	[p18l1210t192r1283b223],
30	studied	VBD	O	study	rcmod	28	SENT_234	[p18l1304t174r1508b223],
31	.	.	O	.	_	0	SENT_234	[p18l1304t174r1508b223],

1	Nevertheless	RB	O	nevertheless	advmod	42	SENT_235	[p18l10t251r358b306],
2	,	,	O	,	_	0	SENT_235	[p18l10t251r358b306],
3	the	DT	O	the	det	4	SENT_235	[p18l391t251r473b299],
4	nature	NN	O	nature	nsubj	42	SENT_235	[p18l505t261r675b299],
5	of	IN	O	of	_	0	SENT_235	[p18l708t251r766b299],
6	the	DT	O	the	det	7	SENT_235	[p18l788t251r870b299],
7	effect	NN	O	effect	prep_of	4	SENT_235	[p18l902t251r1045b299],
8	we	PRP	O	we	nsubj	9	SENT_235	[p18l1074t268r1146b299],
9	observed	VBD	O	observe	rcmod	7	SENT_235	[p18l1179t251r1424b306],
10	,	,	O	,	_	0	SENT_235	[p18l1179t251r1424b306],
11	as	IN	O	as	mark	12	SENT_235	[p18l1459t268r1510b299],
12	judged	VBN	O	judge	dep	4	SENT_235	[p18l8t330r188b394],
13	temporally	RB	O	temporally	advmod	12	SENT_235	[p18l226t330r509b393],
14	(	CD	NUMBER	(	dobj	12	SENT_235	[p18l551t335r639b394],
15	eg	FW	O	eg	nsubj	22	SENT_235	[p18l551t335r639b394],
16	,	,	O	,	_	0	SENT_235	[p18l551t335r639b394],
17	the	DT	O	the	det	18	SENT_235	[p18l680t330r762b378],
18	effect	NN	O	effect	appos	15	SENT_235	[p18l802t330r945b378],
19	on	IN	O	on	_	0	SENT_235	[p18l984t347r1050b378],
20	morning	NN	TIME	morning	nn	21	SENT_235	[p18l1089t333r1322b394],
21	PEFR	NN	ORGANIZATION	pefr	prep_on	18	SENT_235	[p18l1364t333r1512b377],
22	measured	VBD	O	measure	rcmod	14	SENT_235	[p18l8t406r270b454],
23	more	JJR	O	more	mwe	24	SENT_235	[p18l290t424r428b454],
24	than	IN	O	than	quantmod	25	SENT_235	[p18l448t406r568b454],
25	10	CD	NUMBER	10	num	26	SENT_235	[p18l592t411r649b454],
26	h	NN	O	h	dobj	22	SENT_235	[p18l669t406r704b454],
27	after	IN	O	after	_	0	SENT_235	[p18l726t406r845b454],
28	albuterol	NN	O	albuterol	prep_after	26	SENT_235	[p18l865t406r1111b462],
29	,	,	O	,	_	0	SENT_235	[p18l865t406r1111b462],
30	and	CC	O	and	_	0	SENT_235	[p18l1135t406r1232b454],
31	onset	NN	O	onset	conj_and	26	SENT_235	[p18l1253t416r1395b454],
32	and	CC	O	and	_	0	SENT_235	[p18l1415t406r1512b454],
33	development	NN	O	development	conj_and	26	SENT_235	[p18l9t484r350b547],
34	of	IN	O	of	_	0	SENT_235	[p18l375t484r433b533],
35	the	DT	O	the	det	36	SENT_235	[p18l449t484r531b533],
36	effect	NN	O	effect	prep_of	31	SENT_235	[p18l558t484r701b533],
37	over	IN	O	over	_	0	SENT_235	[p18l726t501r836b533],
38	several	JJ	DURATION	several	amod	39	SENT_235	[p18l863t484r1041b533],
39	weeks	NNS	DURATION	week	prep_over	36	SENT_235	[p18l1065t484r1258b548],
40	)	RB	O	)	advmod	22	SENT_235	[p18l1065t484r1258b548],
41	,	,	O	,	_	0	SENT_235	[p18l1065t484r1258b548],
42	suggests	VBZ	O	suggest	_	0	SENT_235	[p18l1288t494r1510b548],
43	that	IN	O	that	complm	46	SENT_235	[p18l7t563r109b611],
44	it	PRP	O	it	nsubjpass	46	SENT_235	[p18l159t566r194b611],
45	is	VBZ	O	be	auxpass	46	SENT_235	[p18l244t566r284b611],
46	mediated	VBN	O	mediate	ccomp	42	SENT_235	[p18l337t563r583b611],
47	through	IN	O	through	_	0	SENT_235	[p18l631t563r845b627],
48	mechanisms	NNS	O	mechanism	prep_through	46	SENT_235	[p18l895t563r1232b611],
49	different	JJ	O	different	amod	48	SENT_235	[p18l1285t563r1512b611],
50	from	IN	O	from	_	0	SENT_235	[p18l8t640r138b689],
51	those	DT	O	those	prep_from	49	SENT_235	[p18l170t640r310b689],
52	we	PRP	O	we	nsubj	54	SENT_235	[p18l342t658r414b689],
53	normally	RB	O	normally	advmod	54	SENT_235	[p18l447t640r685b704],
54	associate	VBP	O	associate	rcmod	51	SENT_235	[p18l717t643r949b689],
55	with	IN	O	with	_	0	SENT_235	[p18l981t640r1097b689],
56	activation	NN	O	activation	prep_with	54	SENT_235	[p18l1130t643r1382b689],
57	and	CC	O	and	_	0	SENT_235	[p18l1415t640r1512b689],
58	signalling	NN	O	signalling	conj_and	56	SENT_235	[p18l10t718r268b782],
59	at	IN	O	at	_	0	SENT_235	[p18l287t728r333b767],
60	the	DT	O	the	det	62	SENT_235	[p18l350t718r432b767],
61	B-adrenergic	JJ	MISC	b-adrenergic	amod	62	SENT_235	[p18l455t718r787b782],
62	receptor	NN	O	receptor	prep_at	54	SENT_235	[p18l805t728r1034b781],
63	.	.	O	.	_	0	SENT_235	[p18l805t728r1034b781],

1	Recent	JJ	O	recent	amod	2	SENT_236	[p18l1058t723r1236b767],
2	studies	NNS	O	study	nsubj	5	SENT_236	[p18l1256t718r1438b767],
3	in	IN	O	in	_	0	SENT_236	[p18l1459t721r1512b766],
4	mice	NNS	O	mouse	prep_in	2	SENT_236	[p18l8t800r135b845],
5	support	VBP	O	support	_	0	SENT_236	[p18l170t806r372b860],
6	this	DT	O	this	det	7	SENT_236	[p18l402t797r498b845],
7	idea	NN	O	idea	dobj	5	SENT_236	[p18l532t797r652b853],
8	;	:	O	;	_	0	SENT_236	[p18l532t797r652b853],
9	altering	VBG	O	alter	csubj	16	SENT_236	[p18l688t797r889b861],
10	the	DT	O	the	det	11	SENT_236	[p18l920t797r1002b845],
11	expression	NN	O	expression	dobj	9	SENT_236	[p18l1035t800r1315b860],
12	of	IN	O	of	_	0	SENT_236	[p18l1348t797r1407b845],
13	the	DT	O	the	det	15	SENT_236	[p18l1429t797r1511b845],
14	B-adrenergic	JJ	MISC	b-adrenergic	amod	15	SENT_236	[p18l12t874r344b938],
15	receptor	NN	O	receptor	prep_of	11	SENT_236	[p18l392t884r608b937],
16	affects	VBZ	O	affect	parataxis	5	SENT_236	[p18l657t874r823b923],
17	the	DT	O	the	det	18	SENT_236	[p18l872t874r954b923],
18	function	NN	O	function	dobj	16	SENT_236	[p18l1003t874r1227b923],
19	of	IN	O	of	_	0	SENT_236	[p18l1276t874r1334b923],
20	other	JJ	O	other	amod	21	SENT_236	[p18l1375t874r1512b923],
21	receptors	NNS	O	receptor	prep_of	18	SENT_236	[p18l8t962r263b1015],
22	,	,	O	,	_	0	SENT_236	[p18l8t962r263b1015],
23	such	JJ	O	such	_	0	SENT_236	[p18l306t952r428b1001],
24	as	IN	O	as	_	0	SENT_236	[p18l467t969r518b1001],
25	cholinergic	JJ	O	cholinergic	amod	26	SENT_236	[p18l559t952r853b1016],
26	receptors	NNS	O	receptor	prep_such_as	16	SENT_236	[p18l891t962r1146b1015],
27	,	,	O	,	_	0	SENT_236	[p18l891t962r1146b1015],
28	that	WDT	O	that	nsubj	29	SENT_236	[p18l1187t952r1289b1001],
29	control	VBP	O	control	rcmod	26	SENT_236	[p18l1327t952r1511b1001],
30	airway	NN	O	airway	nn	31	SENT_236	[p18l9t1034r179b1094],
31	contractility	NN	O	contractility	dobj	29	SENT_236	[p18l235t1031r557b1094],
32	,	,	O	,	_	0	SENT_236	[p18l235t1031r557b1094],
33	apparently	RB	O	apparently	advmod	16	SENT_236	[p18l617t1031r894b1094],
34	through	IN	O	through	_	0	SENT_236	[p18l949t1031r1162b1095],
35	effects	NNS	O	effect	prep_through	16	SENT_236	[p18l1219t1031r1386b1079],
36	on	IN	O	on	_	0	SENT_236	[p18l1445t1048r1511b1079],
37	phospholipase	NN	O	phospholipase	nn	38	SENT_236	[p18l8t1108r388b1171],
38	GB	NN	O	gb	prep_on	35	SENT_236	[p18l412t1112r553b1169],
39	.	.	O	.	_	0	SENT_236	[p18l412t1112r553b1169],

1	“	NN	O	“	nn	3	SENT_237	[p18l412t1112r553b1169],
2	The	DT	O	the	det	3	SENT_237	[p18l574t1108r675b1157],
3	effect	NN	O	effect	nsubj	8	SENT_237	[p18l697t1108r840b1157],
4	we	PRP	O	we	nsubj	5	SENT_237	[p18l859t1126r932b1157],
5	saw	VBD	O	see	rcmod	3	SENT_237	[p18l955t1126r1053b1157],
6	might	MD	O	might	aux	8	SENT_237	[p18l1073t1108r1232b1172],
7	be	VB	O	be	cop	8	SENT_237	[p18l1251t1108r1312b1157],
8	related	VBN	O	relate	_	0	SENT_237	[p18l1333t1108r1512b1157],
9	to	TO	O	to	_	0	SENT_237	[p18l7t1196r56b1235],
10	increased	VBN	O	increase	amod	11	SENT_237	[p18l84t1186r335b1235],
11	sensitivity	NN	O	sensitivity	prep_to	8	SENT_237	[p18l364t1189r626b1250],
12	to	TO	O	to	_	0	SENT_237	[p18l651t1196r700b1235],
13	the	DT	O	the	det	14	SENT_237	[p18l727t1186r809b1235],
14	effects	NNS	O	effect	prep_to	8	SENT_237	[p18l838t1186r1005b1235],
15	of	IN	O	of	_	0	SENT_237	[p18l1035t1186r1093b1235],
16	ipratropium	NN	O	ipratropium	prep_of	14	SENT_237	[p18l1111t1189r1432b1249],
17	in	IN	O	in	_	0	SENT_237	[p18l1459t1189r1511b1234],
18	Arg/Arg	NN	O	arg/arg	nn	19	SENT_237	[p18l7t1268r228b1329],
19	patients	NNS	O	patient	prep_in	8	SENT_237	[p18l254t1268r461b1328],
20	as	IN	O	as	mark	24	SENT_237	[p18l490t1282r541b1313],
21	B	NN	O	b	nn	22	SENT_237	[p18l573t1269r604b1326],
22	agonists	NNS	O	agonist	nsubjpass	24	SENT_237	[p18l633t1268r848b1329],
23	were	VBD	O	be	auxpass	24	SENT_237	[p18l874t1282r1000b1313],
24	withdrawn	VBN	O	withdraw	ccomp	8	SENT_237	[p18l1025t1265r1309b1313],
25	in	IN	O	in	_	0	SENT_237	[p18l1336t1268r1388b1312],
26	this	DT	O	this	det	27	SENT_237	[p18l1414t1265r1510b1313],
27	population	NN	O	population	prep_in	24	SENT_237	[p18l8t1342r305b1405],
28	.	.	O	.	_	0	SENT_237	[p18l8t1342r305b1405],

1	Altered	JJ	O	altered	amod	3	SENT_238	[p18l340t1342r533b1391],
2	B-adrenergic-receptor	NN	O	b-adrenergic-receptor	nn	3	SENT_238	[p18l569t1342r1136b1406],
3	signalling	NN	O	signalling	nsubj	9	SENT_238	[p18l1170t1342r1428b1406],
4	of	IN	O	of	_	0	SENT_238	[p18l1462t1342r1520b1391],
5	these	DT	O	these	det	7	SENT_238	[p18l7t1420r145b1469],
6	polymorphic	JJ	O	polymorphic	amod	7	SENT_238	[p18l171t1420r506b1484],
7	variants	NNS	O	variant	prep_of	3	SENT_238	[p18l529t1423r736b1469],
8	could	MD	O	could	aux	9	SENT_238	[p18l764t1420r907b1469],
9	affect	VB	O	affect	_	0	SENT_238	[p18l933t1420r1076b1469],
10	airway	NN	O	airway	nn	12	SENT_238	[p18l1101t1423r1271b1484],
11	smoothmuscle	NN	O	smoothmuscle	nn	12	SENT_238	[p18l1297t1420r1510b1469, p18l8t1499r197b1547],
12	mitogenesis	NN	O	mitogenesis	dobj	9	SENT_238	[p18l222t1502r540b1563],
13	and	CC	O	and	_	0	SENT_238	[p18l567t1499r665b1547],
14	production	NN	O	production	conj_and	12	SENT_238	[p18l688t1499r978b1562],
15	of	IN	O	of	_	0	SENT_238	[p18l1003t1499r1062b1547],
16	cytokines	NNS	O	cytokine	prep_of	14	SENT_238	[p18l1078t1499r1369b1562],
17	.	.	O	.	_	0	SENT_238	[p18l1078t1499r1369b1562],

1	“	NN	O	“	nsubj	5	SENT_239	[p18l1078t1499r1369b1562],
2	This	DT	O	this	det	3	SENT_239	[p18l1394t1499r1510b1547],
3	hypothesis	NN	O	hypothesis	dep	1	SENT_239	[p18l7t1576r288b1640],
4	could	MD	O	could	aux	5	SENT_239	[p18l348t1576r491b1625],
5	explain	VB	O	explain	_	0	SENT_239	[p18l548t1576r736b1640],
6	the	DT	O	the	det	10	SENT_239	[p18l791t1576r873b1625],
7	apparent	JJ	O	apparent	amod	10	SENT_239	[p18l932t1586r1164b1640],
8	long	JJ	O	long	amod	10	SENT_239	[p18l1219t1576r1335b1640],
9	time	NN	O	time	nn	10	SENT_239	[p18l1391t1580r1511b1625],
10	constants	NNS	O	constant	dobj	5	SENT_239	[p18l9t1663r256b1701],
11	of	IN	O	of	_	0	SENT_239	[p18l276t1653r335b1701],
12	the	DT	O	the	det	13	SENT_239	[p18l342t1653r424b1701],
13	effects	NNS	O	effect	prep_of	10	SENT_239	[p18l443t1653r610b1701],
14	that	IN	O	that	complm	16	SENT_239	[p18l628t1653r730b1701],
15	we	PRP	O	we	nsubj	16	SENT_239	[p18l745t1670r818b1701],
16	observed	VBD	O	observe	ccomp	5	SENT_239	[p18l837t1653r1082b1701],
17	.	.	O	.	_	0	SENT_239	[p18l837t1653r1082b1701],

1	The	DT	O	the	det	2	SENT_240	[p18l57t1730r159b1778],
2	implications	NNS	O	implication	nsubj	8	SENT_240	[p18l196t1730r525b1793],
3	of	IN	O	of	_	0	SENT_240	[p18l564t1730r623b1778],
4	our	PRP$	O	we	poss	5	SENT_240	[p18l651t1747r742b1778],
5	results	NNS	O	result	prep_of	2	SENT_240	[p18l777t1730r953b1778],
6	are	VBP	O	be	cop	8	SENT_240	[p18l992t1747r1071b1778],
7	potentially	RB	O	potentially	advmod	8	SENT_240	[p18l1107t1730r1387b1793],
8	farreaching	JJ	O	farreaching	_	0	SENT_240	[p18l1422t1730r1510b1778, p18l8t1807r252b1871],
9	.	.	O	.	_	0	SENT_240	[p18l1422t1730r1510b1778, p18l8t1807r252b1871],

1	Previous	JJ	O	previous	amod	3	SENT_241	[p18l285t1810r511b1856],
2	retrospective	JJ	O	retrospective	amod	3	SENT_241	[p18l539t1810r877b1870],
3	studies	NNS	O	study	nsubj	4	SENT_241	[p18l907t1807r1091b1856],
4	suggested	VBD	O	suggest	_	0	SENT_241	[p18l1121t1807r1384b1871],
5	that	IN	O	that	complm	9	SENT_241	[p18l1409t1807r1512b1856],
6	regular	JJ	O	regular	amod	8	SENT_241	[p18l8t1885r199b1949],
7	albuterol	NN	O	albuterol	nn	8	SENT_241	[p18l253t1885r487b1934],
8	use	NN	O	use	nsubj	9	SENT_241	[p18l540t1902r631b1934],
9	produces	VBZ	O	produce	ccomp	4	SENT_241	[p18l685t1885r926b1948],
10	adverse	JJ	O	adverse	amod	11	SENT_241	[p18l982t1885r1179b1934],
11	effects	NNS	O	effect	dobj	9	SENT_241	[p18l1235t1885r1403b1934],
12	in	IN	O	in	_	0	SENT_241	[p18l1459t1888r1512b1933],
13	Arg/Arg	NN	O	arg/arg	nn	14	SENT_241	[p18l7t1967r230b2028],
14	patients	NNS	O	patient	prep_in	11	SENT_241	[p18l262t1967r486b2027],
15	;	:	O	;	_	0	SENT_241	[p18l262t1967r486b2027],
16	our	PRP$	O	we	poss	18	SENT_241	[p18l522t1981r612b2012],
17	prospective	JJ	O	prospective	amod	18	SENT_241	[p18l643t1967r943b2027],
18	study	NN	O	study	nsubj	19	SENT_241	[p18l978t1964r1120b2027],
19	suggests	VBZ	O	suggest	parataxis	4	SENT_241	[p18l1152t1973r1376b2028],
20	that	IN	O	that	complm	31	SENT_241	[p18l1409t1964r1512b2012],
21	even	RB	O	even	advmod	23	SENT_241	[p18l9t2059r130b2090],
22	as-needed	JJ	O	as-needed	amod	23	SENT_241	[p18l163t2041r427b2090],
23	use	NN	O	use	nsubj	31	SENT_241	[p18l458t2059r549b2090],
24	of	IN	O	of	_	0	SENT_241	[p18l583t2041r642b2090],
25	albuterol	NN	O	albuterol	prep_of	23	SENT_241	[p18l666t2041r901b2090],
26	may	MD	O	may	aux	31	SENT_241	[p18l933t2059r1046b2105],
27	not	RB	O	not	neg	31	SENT_241	[p18l1078t2051r1165b2090],
28	be	VB	O	be	cop	31	SENT_241	[p18l1195t2041r1256b2090],
29	the	DT	O	the	det	31	SENT_241	[p18l1289t2041r1371b2090],
30	best	JJS	O	best	amod	31	SENT_241	[p18l1404t2041r1512b2090],
31	strategy	NN	O	strategy	ccomp	19	SENT_241	[p18l10t2129r215b2183],
32	for	IN	O	for	_	0	SENT_241	[p18l233t2119r308b2168],
33	these	DT	O	these	det	34	SENT_241	[p18l325t2119r464b2168],
34	patients	NNS	O	patient	prep_for	31	SENT_241	[p18l484t2122r707b2182],
35	.	.	O	.	_	0	SENT_241	[p18l484t2122r707b2182],

1	An	DT	O	a	det	3	SENT_242	[p18l728t2122r807b2167],
2	adverse	JJ	O	adverse	amod	3	SENT_242	[p18l827t2119r1024b2168],
3	effect	NN	O	effect	nsubj	24	SENT_242	[p18l1044t2119r1189b2168],
4	of	IN	O	of	_	0	SENT_242	[p18l1207t2119r1266b2168],
5	albuterol	NN	O	albuterol	prep_of	3	SENT_242	[p18l1277t2119r1511b2168],
6	was	VBD	O	be	cop	7	SENT_242	[p18l7t2214r105b2245],
7	appreciable	JJ	O	appreciable	_	0	SENT_242	[p18l126t2197r428b2260],
8	only	RB	O	only	advmod	12	SENT_242	[p18l448t2197r561b2260],
9	because	IN	O	because	dep	12	SENT_242	[p18l577t2197r787b2245],
10	patients	NNS	O	patient	nsubjpass	12	SENT_242	[p18l806t2200r1015b2260],
11	were	VBD	O	be	auxpass	12	SENT_242	[p18l1034t2214r1160b2245],
12	identiﬁed	VBN	O	identiﬁed	ccomp	7	SENT_242	[p18l1180t2197r1434b2245],
13	by	IN	O	by	_	0	SENT_242	[p18l1451t2197r1513b2260],
14	their	PRP$	O	they	poss	15	SENT_242	[p18l7t2274r133b2323],
15	genotype	NN	O	genotype	agent	12	SENT_242	[p18l164t2284r402b2338],
16	at	IN	O	at	_	0	SENT_242	[p18l434t2284r481b2323],
17	the	DT	O	the	det	19	SENT_242	[p18l509t2274r592b2323],
18	B2-adrenergic	JJ	O	b2-adrenergic	amod	19	SENT_242	[p18l627t2274r979b2338],
19	receptor	NN	O	receptor	prep_at	12	SENT_242	[p18l1009t2284r1228b2338],
20	and	CC	O	and	_	0	SENT_242	[p18l1258t2274r1356b2323],
21	were	VBD	O	be	cop	24	SENT_242	[p18l1384t2292r1511b2323],
22	nearly	RB	O	nearly	advmod	24	SENT_242	[p18l8t2352r172b2416],
23	completely	RB	O	completely	advmod	24	SENT_242	[p18l197t2352r486b2416],
24	withdrawn	VBN	O	withdraw	conj_and	7	SENT_242	[p18l510t2352r796b2401],
25	from	IN	O	from	_	0	SENT_242	[p18l822t2352r953b2401],
26	albuterol	NN	O	albuterol	prep_from	24	SENT_242	[p18l980t2352r1215b2401],
27	for	IN	O	for	_	0	SENT_242	[p18l1241t2352r1317b2401],
28	a	DT	O	a	det	30	SENT_242	[p18l1343t2369r1369b2401],
29	long	JJ	O	long	amod	30	SENT_242	[p18l1394t2352r1511b2416],
30	period	NN	O	period	prep_for	24	SENT_242	[p18l8t2431r191b2494],
31	.	.	O	.	_	0	SENT_242	[p18l8t2431r191b2494],

1	The	DT	O	the	det	2	SENT_243	[p18l210t2431r312b2479],
2	effect	NN	O	effect	nsubj	3	SENT_243	[p18l331t2431r475b2479],
3	occurred	VBD	O	occur	_	0	SENT_243	[p18l492t2431r725b2479],
4	gradually	RB	O	gradually	advmod	3	SENT_243	[p18l742t2431r988b2495],
5	and	CC	O	and	_	0	SENT_243	[p18l1004t2431r1103b2479],
6	was	VBD	O	be	cop	7	SENT_243	[p18l1118t2448r1216b2479],
7	long-lived	JJ	O	long-lived	conj_and	3	SENT_243	[p18l1234t2431r1509b2495],
8	.	.	O	.	_	0	SENT_243	[p18l1234t2431r1509b2495],

1	The	DT	O	the	det	2	SENT_244	[p18l7t2507r109b2555],
2	mechanism	NN	O	mechanism	nsubj	6	SENT_244	[p18l132t2507r446b2555],
3	of	IN	O	of	_	0	SENT_244	[p18l469t2507r528b2555],
4	this	DT	O	this	det	5	SENT_244	[p18l541t2507r638b2555],
5	effect	NN	O	effect	prep_of	2	SENT_244	[p18l663t2507r807b2555],
6	remains	VBZ	O	remain	_	0	SENT_244	[p18l829t2510r1045b2555],
7	to	TO	O	to	aux	9	SENT_244	[p18l1069t2517r1118b2555],
8	be	VB	O	be	auxpass	9	SENT_244	[p18l1140t2507r1201b2555],
9	elucidated	VBN	O	elucidate	xcomp	6	SENT_244	[p18l1225t2507r1509b2555],
10	.	.	O	.	_	0	SENT_244	[p18l1225t2507r1509b2555],

1	We	PRP	O	we	nsubj	3	SENT_245	[p18l7t2589r95b2633],
2	only	RB	O	only	advmod	3	SENT_245	[p18l141t2584r254b2648],
3	studied	VBD	O	study	_	0	SENT_245	[p18l299t2584r493b2633],
4	albuterol	NN	O	albuterol	nsubj	24	SENT_245	[p18l538t2584r786b2640],
5	;	:	O	;	_	0	SENT_245	[p18l538t2584r786b2640],
6	whether	IN	O	whether	dep	11	SENT_245	[p18l832t2584r1052b2633],
7	the	DT	O	the	det	8	SENT_245	[p18l1095t2584r1178b2633],
8	effects	NNS	O	effect	nsubj	11	SENT_245	[p18l1224t2584r1392b2633],
9	we	PRP	O	we	nsubj	10	SENT_245	[p18l1438t2602r1511b2633],
10	observed	VBD	O	observe	rcmod	8	SENT_245	[p18l9t2663r244b2711],
11	occur	VBP	O	occur	dep	4	SENT_245	[p18l276t2680r422b2711],
12	with	IN	O	with	_	0	SENT_245	[p18l451t2663r569b2711],
13	other	JJ	O	other	amod	16	SENT_245	[p18l602t2663r741b2711],
14	short-acting	JJ	O	short-acting	amod	16	SENT_245	[p18l774t2663r1089b2727],
15	B	NN	O	b	nn	16	SENT_245	[p18l1125t2667r1155b2724],
16	agonists	NNS	O	agonist	prep_with	11	SENT_245	[p18l1191t2666r1423b2727],
17	,	,	O	,	_	0	SENT_245	[p18l1191t2666r1423b2727],
18	or	CC	O	or	_	0	SENT_245	[p18l1458t2680r1512b2711],
19	long-acting	JJ	O	long-acting	amod	21	SENT_245	[p18l7t2740r305b2804],
20	B	NN	O	b	nn	21	SENT_245	[p18l349t2744r380b2801],
21	agonists	NNS	O	agonist	prep_with	11	SENT_245	[p18l424t2743r656b2804],
22	,	,	O	,	_	0	SENT_245	[p18l424t2743r656b2804],
23	is	VBZ	O	be	cop	24	SENT_245	[p18l699t2743r740b2789],
24	unclear	JJ	O	unclear	ccomp	3	SENT_245	[p18l782t2740r994b2789],
25	.	.	O	.	_	0	SENT_245	[p18l782t2740r994b2789],

1	Furthermore	RB	O	furthermore	advmod	4	SENT_246	[p18l1040t2740r1396b2796],
2	,	,	O	,	_	0	SENT_246	[p18l1040t2740r1396b2796],
3	we	PRP	O	we	nsubj	4	SENT_246	[p18l1438t2758r1511b2789],
4	studied	VBD	O	study	_	0	SENT_246	[p18l10t2818r204b2867],
5	only	RB	O	only	advmod	6	SENT_246	[p18l220t2818r333b2882],
6	patients	NNS	O	patient	dobj	4	SENT_246	[p18l348t2821r557b2881],
7	with	IN	O	with	_	0	SENT_246	[p18l574t2818r692b2867],
8	mild	JJ	O	mild	amod	9	SENT_246	[p18l708t2818r832b2867],
9	disease	NN	O	disease	prep_with	6	SENT_246	[p18l849t2818r1053b2874],
10	,	,	O	,	_	0	SENT_246	[p18l849t2818r1053b2874],
11	who	WP	O	who	nsubj	12	SENT_246	[p18l1070t2818r1182b2867],
12	were	VBD	O	be	rcmod	9	SENT_246	[p18l1198t2835r1324b2867],
13	not	RB	O	not	neg	12	SENT_246	[p18l1342t2828r1429b2867],
14	on	IN	O	on	_	0	SENT_246	[p18l1445t2835r1511b2867],
15	controller	NN	O	controller	nn	16	SENT_246	[p18l9t2897r266b2945],
16	medications	NNS	O	medication	prep_on	12	SENT_246	[p18l293t2897r616b2945],
17	such	JJ	O	such	_	0	SENT_246	[p18l648t2897r771b2945],
18	as	IN	O	as	_	0	SENT_246	[p18l800t2914r851b2945],
19	inhaled	VBN	O	inhale	prepc_such_as	16	SENT_246	[p18l881t2897r1080b2945],
20	corticosteroids	NNS	O	corticosteroid	dobj	19	SENT_246	[p18l1108t2897r1509b2945],
21	.	.	O	.	_	0	SENT_246	[p18l1108t2897r1509b2945],

1	We	PRP	O	we	nsubj	4	SENT_247	[p18l7t2978r95b3021],
2	do	VBP	O	do	aux	4	SENT_247	[p18l112t2973r175b3021],
3	not	RB	O	not	neg	4	SENT_247	[p18l191t2983r278b3021],
4	know	VB	O	know	_	0	SENT_247	[p18l293t2973r439b3021],
5	whether	IN	O	whether	complm	15	SENT_247	[p18l453t2973r672b3021],
6	the	DT	O	the	det	8	SENT_247	[p18l687t2973r769b3021],
7	adverse	JJ	O	adverse	amod	8	SENT_247	[p18l787t2973r984b3021],
8	effects	NNS	O	effect	nsubj	15	SENT_247	[p18l1001t2973r1170b3021],
9	we	PRP	O	we	nsubj	10	SENT_247	[p18l1186t2990r1260b3021],
10	observed	VBD	O	observe	rcmod	8	SENT_247	[p18l1277t2973r1512b3021],
11	in	IN	O	in	_	0	SENT_247	[p18l8t3053r61b3098],
12	Arg/Arg	NN	O	arg/arg	nn	13	SENT_247	[p18l80t3053r303b3114],
13	patients	NNS	O	patient	prep_in	10	SENT_247	[p18l322t3053r531b3113],
14	would	MD	O	would	aux	15	SENT_247	[p18l552t3050r716b3099],
15	occur	VB	O	occur	ccomp	4	SENT_247	[p18l736t3067r881b3099],
16	in	IN	O	in	_	0	SENT_247	[p18l900t3053r953b3098],
17	more	RBR	O	more	advmod	18	SENT_247	[p18l973t3067r1112b3099],
18	severe	JJ	O	severe	amod	19	SENT_247	[p18l1134t3067r1296b3099],
19	asthma	NN	O	asthma	prep_in	15	SENT_247	[p18l1318t3050r1511b3099],
20	or	CC	O	or	_	0	SENT_247	[p18l9t3146r63b3177],
21	during	IN	O	during	_	0	SENT_247	[p18l121t3129r300b3193],
22	treatment	NN	O	treatment	prep_during	15	SENT_247	[p18l357t3138r619b3177],
23	with	IN	O	with	_	0	SENT_247	[p18l675t3129r792b3177],
24	inhaled	VBN	O	inhale	prepc_with	15	SENT_247	[p18l851t3129r1050b3177],
25	corticosteroids	NNS	O	corticosteroid	dobj	24	SENT_247	[p18l1108t3129r1509b3177],
26	.	.	O	.	_	0	SENT_247	[p18l1108t3129r1509b3177],

1	I	PRP	O	I	_	0	SENT_248	[p18l6t3432r53b3630],
2	Articles	NNPS	O	Articles	dep	1	SENT_248	[p18l101t3595r249b3631],

1	Nonetheless	RB	O	nonetheless	advmod	7	SENT_249	[p19l649t73r989b129],
2	,	,	O	,	_	0	SENT_249	[p19l649t73r989b129],
3	a	DT	O	a	det	5	SENT_249	[p19l1016t91r1042b122],
4	reasonable	JJ	O	reasonable	amod	5	SENT_249	[p19l1066t73r1351b122],
5	approach	NN	O	approach	nsubj	7	SENT_249	[p19l1376t73r1620b136],
6	would	MD	O	would	aux	7	SENT_249	[p19l1643t73r1807b122],
7	be	VB	O	be	_	0	SENT_249	[p19l1829t73r1890b122],
8	to	TO	O	to	aux	9	SENT_249	[p19l1914t83r1963b122],
9	devise	VB	O	devise	xcomp	7	SENT_249	[p19l1989t73r2151b122],
10	and	CC	O	and	_	0	SENT_249	[p19l648t151r746b200],
11	test	VB	O	test	conj_and	9	SENT_249	[p19l767t161r861b200],
12	alternative	JJ	O	alternative	amod	15	SENT_249	[p19l883t151r1159b200],
13	asthma	NN	O	asthma	nn	15	SENT_249	[p19l1183t151r1377b200],
14	management	NN	O	management	nn	15	SENT_249	[p19l1400t161r1754b215],
15	strategies	NNS	O	strategy	dobj	9	SENT_249	[p19l1777t154r2025b215],
16	that	WDT	O	that	nsubj	17	SENT_249	[p19l2049t151r2152b200],
17	limit	VBP	O	limit	rcmod	15	SENT_249	[p19l646t231r774b279],
18	B-agonist	JJ	MISC	b-agonist	amod	19	SENT_249	[p19l828t234r1074b295],
19	use	NN	O	use	dobj	17	SENT_249	[p19l1123t248r1213b279],
20	in	IN	O	in	_	0	SENT_249	[p19l1264t234r1317b278],
21	patients	NNS	O	patient	prep_in	19	SENT_249	[p19l1368t234r1577b294],
22	with	IN	O	with	_	0	SENT_249	[p19l1628t231r1745b279],
23	the	DT	O	the	det	26	SENT_249	[p19l1795t231r1878b279],
24	Arg/Arg	NN	O	arg/arg	nn	26	SENT_249	[p19l1928t234r2151b295],
25	g	NN	O	g	nn	26	SENT_249	[p19l648t320r900b374],
26	€	NN	MONEY	€	prep_with	17	SENT_249	[p19l648t320r900b374],
27	1	CD	MONEY	1	number	28	SENT_249	[p19l648t320r900b374],
28	’	CD	MONEY	’	num	30	SENT_249	[p19l648t320r900b374],
29	lOtVp	NN	O	lotvp	nn	30	SENT_249	[p19l648t320r900b374],
30	€	NN	O	€	dep	17	SENT_249	[p19l648t320r900b374],
31	.	.	O	.	_	0	SENT_249	[p19l648t320r900b374],

1	Contributors	NNS	O	contributor	_	0	SENT_250	[p19l648t415r899b451],

1	E	NN	O	e	nn	2	SENT_251	[p19l649t477r672b512],
2	Israel	NNP	LOCATION	Israel	dep	10	SENT_251	[p19l690t475r813b518],
3	,	,	O	,	_	0	SENT_251	[p19l690t475r813b518],
4	V	NNP	O	V	nn	6	SENT_251	[p19l829t479r861b513],
5	M	NNP	O	M	nn	6	SENT_251	[p19l876t479r916b512],
6	Chinchilli	NNP	PERSON	Chinchilli	appos	2	SENT_251	[p19l933t475r1148b518],
7	,	,	O	,	_	0	SENT_251	[p19l933t475r1148b518],
8	I	PRP	O	I	appos	2	SENT_251	[p19l1165t479r1178b523],
9	G	NN	O	g	dep	10	SENT_251	[p19l1196t478r1229b512],
10	Ford	NNP	ORGANIZATION	Ford	dep	55	SENT_251	[p19l1246t475r1351b518],
11	,	,	O	,	_	0	SENT_251	[p19l1246t475r1351b518],
12	H	NNP	O	H	nn	14	SENT_251	[p19l1369t479r1405b512],
13	A	NNP	O	A	nn	14	SENT_251	[p19l1421t478r1454b512],
14	Boushey	NNP	PERSON	Boushey	appos	10	SENT_251	[p19l1469t475r1654b524],
15	,	,	O	,	_	0	SENT_251	[p19l1469t475r1654b524],
16	R	NNP	O	R	nn	17	SENT_251	[p19l1672t479r1702b512],
17	Cherniack	NNP	O	Cherniack	appos	10	SENT_251	[p19l1717t475r1939b518],
18	,	,	O	,	_	0	SENT_251	[p19l1717t475r1939b518],
19	I	PRP	O	I	appos	10	SENT_251	[p19l1956t479r1969b523],
20	V	NN	O	v	prep	19	SENT_251	[p19l1984t479r2017b513],
21	Fahy	NNP	PERSON	Fahy	dep	20	SENT_251	[p19l2033t475r2140b524],
22	,	,	O	,	_	0	SENT_251	[p19l2033t475r2140b524],
23	I	PRP	O	I	appos	10	SENT_251	[p19l648t539r661b584],
24	Fish	NN	O	fish	dep	31	SENT_251	[p19l679t536r777b580],
25	,	,	O	,	_	0	SENT_251	[p19l679t536r777b580],
26	M	NN	O	m	nn	27	SENT_251	[p19l795t539r834b573],
27	Kraft	NNP	PERSON	Kraft	appos	24	SENT_251	[p19l852t536r964b579],
28	,	,	O	,	_	0	SENT_251	[p19l852t536r964b579],
29	S	NN	O	s	appos	24	SENT_251	[p19l983t538r1003b574],
30	I	PRP	O	I	dep	31	SENT_251	[p19l1021t539r1034b584],
31	Kunselman	NNP	O	Kunselman	dep	55	SENT_251	[p19l1052t536r1301b579],
32	,	,	O	,	_	0	SENT_251	[p19l1052t536r1301b579],
33	S	NN	O	s	nn	35	SENT_251	[p19l1320t538r1340b574],
34	C	NN	O	c	nn	35	SENT_251	[p19l1358t538r1387b574],
35	Lazarus	NNP	PERSON	Lazarus	appos	31	SENT_251	[p19l1405t539r1574b579],
36	,	,	O	,	_	0	SENT_251	[p19l1405t539r1574b579],
37	R	NNP	O	R	nn	39	SENT_251	[p19l1592t539r1621b573],
38	F	NN	PERSON	f	nn	39	SENT_251	[p19l1637t538r1660b573],
39	Lemanske	NN	PERSON	lemanske	appos	31	SENT_251	[p19l1678t536r1897b579],
40	,	,	O	,	_	0	SENT_251	[p19l1678t536r1897b579],
41	R	NN	O	r	nn	43	SENT_251	[p19l1916t539r1973b584],
42	]	CD	NUMBER	]	num	43	SENT_251	[p19l1916t539r1973b584],
43	Martin	NNP	PERSON	Martin	appos	31	SENT_251	[p19l1990t538r2141b580],
44	,	,	PERSON	,	_	0	SENT_251	[p19l1990t538r2141b580],
45	S	NNP	PERSON	S	nn	47	SENT_251	[p19l650t600r670b635],
46	P	NN	PERSON	p	nn	47	SENT_251	[p19l689t601r714b635],
47	Peters	NNP	PERSON	Peters	appos	31	SENT_251	[p19l731t601r868b641],
48	,	,	O	,	_	0	SENT_251	[p19l731t601r868b641],
49	C	NNP	O	C	nn	51	SENT_251	[p19l885t600r914b635],
50	A	NNP	O	A	nn	51	SENT_251	[p19l928t600r962b635],
51	Sorkness	NNP	MISC	Sorkness	appos	31	SENT_251	[p19l978t598r1174b641],
52	,	,	O	,	_	0	SENT_251	[p19l978t598r1174b641],
53	S	NN	O	s	appos	31	SENT_251	[p19l1193t600r1213b635],
54	I	PRP	O	I	nsubj	55	SENT_251	[p19l1231t601r1244b646],
55	Szeﬂer	VBP	O	szeﬂer	_	0	SENT_251	[p19l1264t598r1414b641],
56	,	,	O	,	_	0	SENT_251	[p19l1264t598r1414b641],
57	and	CC	O	and	_	0	SENT_251	[p19l1430t598r1506b635],
58	I	PRP	O	I	nsubj	59	SENT_251	[p19l1521t601r1534b646],
59	M	NN	O	m	conj_and	55	SENT_251	[p19l1552t601r1591b635],
60	Drazen	NN	PERSON	drazen	dobj	59	SENT_251	[p19l1610t601r1759b635],
61	designed	VBN	O	design	partmod	60	SENT_251	[p19l1773t598r1959b647],
62	the	DT	O	the	det	63	SENT_251	[p19l1972t598r2036b635],
63	study	NN	O	study	dobj	61	SENT_251	[p19l648t659r767b708],
64	.	.	O	.	_	0	SENT_251	[p19l648t659r767b708],

1	E	NN	O	e	dep	6	SENT_252	[p19l786t661r809b696],
2	Israel	NNP	LOCATION	Israel	dep	1	SENT_252	[p19l827t659r950b702],
3	,	,	O	,	_	0	SENT_252	[p19l827t659r950b702],
4	I	PRP	O	I	appos	2	SENT_252	[p19l968t662r981b707],
5	G	NN	O	g	dep	6	SENT_252	[p19l998t661r1031b696],
6	Ford	NNP	ORGANIZATION	Ford	dep	62	SENT_252	[p19l1049t659r1154b702],
7	,	,	O	,	_	0	SENT_252	[p19l1049t659r1154b702],
8	H	NNP	O	H	nn	10	SENT_252	[p19l1172t662r1207b696],
9	A	NNP	O	A	nn	10	SENT_252	[p19l1223t661r1256b696],
10	Boushey	NNP	PERSON	Boushey	appos	6	SENT_252	[p19l1271t659r1456b708],
11	,	,	O	,	_	0	SENT_252	[p19l1271t659r1456b708],
12	A	NNP	O	A	nn	13	SENT_252	[p19l1472t661r1505b696],
13	Deykin	NNP	O	Deykin	appos	6	SENT_252	[p19l1520t659r1676b708],
14	,	,	O	,	_	0	SENT_252	[p19l1520t659r1676b708],
15	I	PRP	O	I	appos	6	SENT_252	[p19l1694t662r1707b707],
16	K	NNP	O	K	nn	17	SENT_252	[p19l1725t662r1755b696],
17	Fagan	NNP	PERSON	Fagan	dep	15	SENT_252	[p19l1770t661r1904b708],
18	,	,	O	,	_	0	SENT_252	[p19l1770t661r1904b708],
19	I	PRP	O	I	dep	20	SENT_252	[p19l1921t662r1934b707],
20	V	NN	O	v	appos	6	SENT_252	[p19l1950t662r1982b696],
21	Fahy	NNP	PERSON	Fahy	dep	31	SENT_252	[p19l1998t659r2105b708],
22	,	,	O	,	_	0	SENT_252	[p19l1998t659r2105b708],
23	I	PRP	O	I	dep	24	SENT_252	[p19l648t722r661b766],
24	Fish	NN	O	fish	appos	21	SENT_252	[p19l679t718r777b761],
25	,	,	O	,	_	0	SENT_252	[p19l679t718r777b761],
26	M	NN	O	m	appos	21	SENT_252	[p19l795t722r834b755],
27	Kraft	NNP	PERSON	Kraft	dep	26	SENT_252	[p19l852t718r964b761],
28	,	,	O	,	_	0	SENT_252	[p19l852t718r964b761],
29	S	NN	O	s	appos	21	SENT_252	[p19l983t721r1003b756],
30	I	PRP	O	I	dep	31	SENT_252	[p19l1021t722r1034b766],
31	Kunselman	NNP	O	Kunselman	dep	46	SENT_252	[p19l1052t718r1301b761],
32	,	,	O	,	_	0	SENT_252	[p19l1052t718r1301b761],
33	S	NN	O	s	nn	35	SENT_252	[p19l1320t721r1340b756],
34	C	NN	O	c	nn	35	SENT_252	[p19l1358t721r1387b756],
35	Lazarus	NNP	PERSON	Lazarus	appos	31	SENT_252	[p19l1405t722r1574b761],
36	,	,	O	,	_	0	SENT_252	[p19l1405t722r1574b761],
37	R	NNP	O	R	nn	39	SENT_252	[p19l1592t722r1621b755],
38	F	NN	O	f	nn	39	SENT_252	[p19l1637t721r1660b755],
39	Lemanske	NN	O	lemanske	appos	31	SENT_252	[p19l1678t718r1897b761],
40	,	,	O	,	_	0	SENT_252	[p19l1678t718r1897b761],
41	S	NN	O	s	nn	42	SENT_252	[p19l650t782r670b817],
42	B	NN	O	b	appos	31	SENT_252	[p19l689t783r715b816],
43	Liggett	NNP	ORGANIZATION	Liggett	dep	42	SENT_252	[p19l733t782r883b829],
44	,	,	O	,	_	0	SENT_252	[p19l733t782r883b829],
45	R	NN	O	r	appos	31	SENT_252	[p19l901t783r930b817],
46	I	PRP	O	I	dep	47	SENT_252	[p19l945t783r958b828],
47	Martin	NNP	PERSON	Martin	dep	62	SENT_252	[p19l976t782r1126b823],
48	,	,	O	,	_	0	SENT_252	[p19l976t782r1126b823],
49	S	NNP	O	S	nn	51	SENT_252	[p19l1146t782r1166b817],
50	P	NN	PERSON	p	nn	51	SENT_252	[p19l1185t783r1209b816],
51	Peters	NNP	PERSON	Peters	appos	47	SENT_252	[p19l1227t783r1363b823],
52	,	,	O	,	_	0	SENT_252	[p19l1227t783r1363b823],
53	E	NNP	O	E	nn	54	SENT_252	[p19l1382t782r1405b817],
54	Silverman	NNP	PERSON	Silverman	appos	47	SENT_252	[p19l1424t780r1643b823],
55	,	,	O	,	_	0	SENT_252	[p19l1424t780r1643b823],
56	C	NNP	O	C	nn	58	SENT_252	[p19l1661t782r1689b817],
57	A	NNP	O	A	nn	58	SENT_252	[p19l1704t782r1737b817],
58	Sorkness	NNP	MISC	Sorkness	appos	47	SENT_252	[p19l1753t780r1949b823],
59	,	,	O	,	_	0	SENT_252	[p19l1753t780r1949b823],
60	S	NN	O	s	appos	47	SENT_252	[p19l650t843r670b878],
61	I	PRP	O	I	nsubj	62	SENT_252	[p19l688t844r701b888],
62	Szeﬂer	VBP	O	szeﬂer	_	0	SENT_252	[p19l721t840r871b883],
63	,	,	O	,	_	0	SENT_252	[p19l721t840r871b883],
64	M	NN	O	m	nn	65	SENT_252	[p19l888t844r927b877],
65	E	NN	O	e	nsubj	66	SENT_252	[p19l946t842r969b877],
66	Wechsler	NNP	PERSON	Wechsler	xcomp	62	SENT_252	[p19l984t840r1188b883],
67	,	,	O	,	_	0	SENT_252	[p19l984t840r1188b883],
68	and	CC	O	and	_	0	SENT_252	[p19l1205t840r1281b878],
69	I	PRP	O	I	nsubj	70	SENT_252	[p19l1296t844r1309b888],
70	M	NN	O	m	conj_and	62	SENT_252	[p19l1327t844r1366b877],
71	Drazen	NN	PERSON	drazen	nsubj	72	SENT_252	[p19l1384t844r1533b878],
72	took	VBD	O	take	ccomp	70	SENT_252	[p19l1547t840r1637b878],
73	part	NN	O	part	dobj	72	SENT_252	[p19l1650t848r1732b889],
74	in	IN	O	in	_	0	SENT_252	[p19l1745t843r1786b877],
75	running	VBG	O	run	prepc_in	72	SENT_252	[p19l1800t843r1971b890],
76	the	DT	O	the	det	77	SENT_252	[p19l1984t840r2049b878],
77	study	NN	O	study	dobj	75	SENT_252	[p19l648t901r767b950],
78	.	.	O	.	_	0	SENT_252	[p19l648t901r767b950],

1	E	NN	O	e	nn	2	SENT_253	[p19l786t904r809b938],
2	Israel	NNP	LOCATION	Israel	dep	21	SENT_253	[p19l827t901r950b944],
3	,	,	O	,	_	0	SENT_253	[p19l827t901r950b944],
4	V	NNP	O	V	nn	6	SENT_253	[p19l966t905r998b939],
5	M	NNP	O	M	nn	6	SENT_253	[p19l1013t905r1052b938],
6	Chinchilli	NNP	PERSON	Chinchilli	appos	2	SENT_253	[p19l1070t901r1285b944],
7	,	,	O	,	_	0	SENT_253	[p19l1070t901r1285b944],
8	H	NNP	O	H	nn	10	SENT_253	[p19l1304t905r1339b938],
9	A	NNP	O	A	nn	10	SENT_253	[p19l1355t904r1388b938],
10	Boushey	NNP	PERSON	Boushey	appos	2	SENT_253	[p19l1403t901r1589b950],
11	,	,	O	,	_	0	SENT_253	[p19l1403t901r1589b950],
12	A	NNP	O	A	nn	13	SENT_253	[p19l1604t904r1637b938],
13	Deykin	NNP	O	Deykin	appos	2	SENT_253	[p19l1652t901r1808b950],
14	,	,	O	,	_	0	SENT_253	[p19l1652t901r1808b950],
15	I	PRP	O	I	appos	2	SENT_253	[p19l1826t905r1839b949],
16	V	NN	O	v	prep	15	SENT_253	[p19l1854t905r1887b939],
17	Fahy	NNP	PERSON	Fahy	dep	16	SENT_253	[p19l1902t901r2010b950],
18	,	,	O	,	_	0	SENT_253	[p19l1902t901r2010b950],
19	S	NN	O	s	appos	2	SENT_253	[p19l650t965r670b1000],
20	I	PRP	O	I	dep	21	SENT_253	[p19l688t966r701b1010],
21	Kunselman	NNP	O	Kunselman	dep	36	SENT_253	[p19l720t962r968b1005],
22	,	,	O	,	_	0	SENT_253	[p19l720t962r968b1005],
23	S	NN	O	s	nn	25	SENT_253	[p19l987t965r1007b1000],
24	C	NN	O	c	nn	25	SENT_253	[p19l1026t965r1054b1000],
25	Lazarus	NNP	PERSON	Lazarus	appos	21	SENT_253	[p19l1072t966r1241b1006],
26	,	,	O	,	_	0	SENT_253	[p19l1072t966r1241b1006],
27	R	NNP	O	R	nn	29	SENT_253	[p19l1259t966r1288b999],
28	F	NN	O	f	nn	29	SENT_253	[p19l1304t965r1327b999],
29	Lemanske	NN	O	lemanske	appos	21	SENT_253	[p19l1345t962r1565b1005],
30	,	,	O	,	_	0	SENT_253	[p19l1345t962r1565b1005],
31	S	NN	O	s	nn	32	SENT_253	[p19l1584t965r1604b1000],
32	B	NN	O	b	appos	21	SENT_253	[p19l1623t966r1648b999],
33	Liggett	NNP	ORGANIZATION	Liggett	dep	32	SENT_253	[p19l1667t965r1817b1012],
34	,	,	O	,	_	0	SENT_253	[p19l1667t965r1817b1012],
35	R	NN	O	r	appos	21	SENT_253	[p19l1835t966r1864b999],
36	I	PRP	O	I	dep	37	SENT_253	[p19l1879t966r1892b1010],
37	Martin	NNP	PERSON	Martin	dep	44	SENT_253	[p19l1910t965r2060b1005],
38	,	,	O	,	_	0	SENT_253	[p19l1910t965r2060b1005],
39	N	NNP	PERSON	N	nn	40	SENT_253	[p19l648t1027r680b1060],
40	Mitra	NNP	PERSON	Mitra	appos	37	SENT_253	[p19l697t1025r819b1066],
41	,	,	O	,	_	0	SENT_253	[p19l697t1025r819b1066],
42	S	NN	O	s	appos	37	SENT_253	[p19l838t1026r859b1060],
43	I	PRP	O	I	nsubj	44	SENT_253	[p19l877t1027r890b1071],
44	Szeﬂer	VBP	O	szeﬂer	dep	58	SENT_253	[p19l909t1023r1059b1066],
45	,	,	O	,	_	0	SENT_253	[p19l909t1023r1059b1066],
46	M	NN	O	m	nn	48	SENT_253	[p19l1077t1027r1116b1060],
47	E	NN	O	e	nn	48	SENT_253	[p19l1134t1025r1158b1060],
48	Wechsler	NNP	PERSON	Wechsler	nsubj	58	SENT_253	[p19l1173t1023r1377b1066],
49	,	,	O	,	_	0	SENT_253	[p19l1173t1023r1377b1066],
50	S	NN	PERSON	s	nn	52	SENT_253	[p19l1396t1026r1416b1060],
51	T	NN	PERSON	t	nn	52	SENT_253	[p19l1432t1025r1462b1060],
52	Weiss	NNP	PERSON	Weiss	nsubj	58	SENT_253	[p19l1474t1026r1609b1066],
53	,	,	O	,	_	0	SENT_253	[p19l1474t1026r1609b1066],
54	and	CC	O	and	_	0	SENT_253	[p19l1626t1023r1702b1060],
55	I	PRP	O	I	nsubj	58	SENT_253	[p19l1717t1027r1730b1071],
56	M	NN	O	m	nn	57	SENT_253	[p19l1747t1027r1787b1060],
57	Drazen	NN	PERSON	drazen	dep	55	SENT_253	[p19l1805t1027r1954b1060],
58	analysed	VBD	O	analyse	_	0	SENT_253	[p19l1969t1023r2147b1072],
59	the	DT	O	the	det	60	SENT_253	[p19l646t1084r711b1122],
60	data	NNS	O	datum	dobj	58	SENT_253	[p19l726t1084r820b1122],
61	.	.	O	.	_	0	SENT_253	[p19l726t1084r820b1122],

1	E	NN	O	e	nn	2	SENT_254	[p19l838t1086r862b1121],
2	Israel	NNP	LOCATION	Israel	dep	10	SENT_254	[p19l880t1084r1003b1127],
3	,	,	O	,	_	0	SENT_254	[p19l880t1084r1003b1127],
4	V	NNP	O	V	nn	6	SENT_254	[p19l1018t1088r1051b1122],
5	M	NNP	O	M	nn	6	SENT_254	[p19l1066t1088r1105b1121],
6	Chinchilli	NNP	PERSON	Chinchilli	appos	2	SENT_254	[p19l1123t1084r1338b1127],
7	,	,	O	,	_	0	SENT_254	[p19l1123t1084r1338b1127],
8	I	PRP	O	I	appos	2	SENT_254	[p19l1355t1088r1368b1132],
9	G	NN	O	g	dep	10	SENT_254	[p19l1386t1087r1418b1122],
10	Ford	NNP	ORGANIZATION	Ford	dep	61	SENT_254	[p19l1436t1084r1541b1127],
11	,	,	O	,	_	0	SENT_254	[p19l1436t1084r1541b1127],
12	H	NNP	O	H	nn	14	SENT_254	[p19l1559t1088r1594b1121],
13	A	NNP	O	A	nn	14	SENT_254	[p19l1610t1087r1643b1121],
14	Boushey	NNP	PERSON	Boushey	appos	10	SENT_254	[p19l1659t1084r1844b1133],
15	,	,	O	,	_	0	SENT_254	[p19l1659t1084r1844b1133],
16	TI	NNP	PERSON	TI	nn	17	SENT_254	[p19l1859t1086r1916b1132],
17	Craig	NNP	PERSON	Craig	appos	10	SENT_254	[p19l1934t1087r2055b1134],
18	,	,	O	,	_	0	SENT_254	[p19l1934t1087r2055b1134],
19	A	NNP	O	A	nn	20	SENT_254	[p19l646t1149r679b1183],
20	Deykin	NNP	O	Deykin	appos	10	SENT_254	[p19l694t1146r851b1195],
21	,	,	O	,	_	0	SENT_254	[p19l694t1146r851b1195],
22	I	CD	NUMBER	i	num	24	SENT_254	[p19l868t1150r881b1194],
23	M	NN	O	m	nn	24	SENT_254	[p19l898t1150r938b1183],
24	Drazen	NN	PERSON	drazen	appos	10	SENT_254	[p19l956t1150r1116b1189],
25	,	,	O	,	_	0	SENT_254	[p19l956t1150r1116b1189],
26	I	PRP	O	I	appos	10	SENT_254	[p19l1133t1150r1146b1194],
27	V	NN	O	v	prep	26	SENT_254	[p19l1162t1150r1194b1184],
28	Fahy	NNP	PERSON	Fahy	dep	27	SENT_254	[p19l1210t1146r1317b1195],
29	,	,	O	,	_	0	SENT_254	[p19l1210t1146r1317b1195],
30	M	NN	O	m	appos	10	SENT_254	[p19l1335t1150r1374b1183],
31	Kraft	NNP	PERSON	Kraft	dep	47	SENT_254	[p19l1393t1146r1504b1189],
32	,	,	O	,	_	0	SENT_254	[p19l1393t1146r1504b1189],
33	S	NN	O	s	nn	35	SENT_254	[p19l1523t1149r1543b1183],
34	C	NN	O	c	nn	35	SENT_254	[p19l1561t1149r1590b1183],
35	Lazarus	NNP	PERSON	Lazarus	appos	31	SENT_254	[p19l1608t1150r1777b1189],
36	,	,	O	,	_	0	SENT_254	[p19l1608t1150r1777b1189],
37	R	NNP	O	R	nn	39	SENT_254	[p19l1795t1150r1824b1183],
38	F	NN	O	f	nn	39	SENT_254	[p19l1840t1148r1862b1183],
39	Lemanske	NN	O	lemanske	appos	31	SENT_254	[p19l1881t1146r2100b1189],
40	,	,	O	,	_	0	SENT_254	[p19l1881t1146r2100b1189],
41	S	NN	O	s	nn	42	SENT_254	[p19l650t1210r670b1244],
42	B	NN	O	b	appos	31	SENT_254	[p19l689t1211r714b1244],
43	Liggett	NNP	ORGANIZATION	Liggett	dep	42	SENT_254	[p19l733t1209r883b1256],
44	,	,	O	,	_	0	SENT_254	[p19l733t1209r883b1256],
45	R	NN	O	r	appos	31	SENT_254	[p19l901t1211r930b1244],
46	I	PRP	O	I	dep	47	SENT_254	[p19l945t1211r958b1255],
47	Martin	NNP	PERSON	Martin	dep	61	SENT_254	[p19l976t1209r1126b1250],
48	,	,	O	,	_	0	SENT_254	[p19l976t1209r1126b1250],
49	N	NNP	PERSON	N	nn	50	SENT_254	[p19l1144t1211r1176b1244],
50	Mitra	NNP	PERSON	Mitra	appos	47	SENT_254	[p19l1193t1209r1315b1250],
51	,	,	O	,	_	0	SENT_254	[p19l1193t1209r1315b1250],
52	S	NNP	PERSON	S	nn	54	SENT_254	[p19l1334t1210r1354b1244],
53	P	NN	PERSON	p	nn	54	SENT_254	[p19l1373t1211r1398b1244],
54	Peters	NNP	PERSON	Peters	appos	47	SENT_254	[p19l1415t1211r1552b1250],
55	,	,	O	,	_	0	SENT_254	[p19l1415t1211r1552b1250],
56	E	NNP	PERSON	E	nn	57	SENT_254	[p19l1570t1209r1593b1244],
57	Silverman	NNP	PERSON	Silverman	appos	47	SENT_254	[p19l1612t1207r1832b1250],
58	,	,	O	,	_	0	SENT_254	[p19l1612t1207r1832b1250],
59	S	NN	O	s	appos	47	SENT_254	[p19l1851t1210r1871b1244],
60	I	PRP	O	I	nsubj	61	SENT_254	[p19l1889t1211r1902b1255],
61	Szeﬂer	VBP	O	szeﬂer	_	0	SENT_254	[p19l1921t1207r2071b1250],
62	,	,	O	,	_	0	SENT_254	[p19l1921t1207r2071b1250],
63	M	NN	O	m	nn	64	SENT_254	[p19l648t1270r688b1303],
64	E	NN	O	e	nsubj	65	SENT_254	[p19l706t1269r729b1303],
65	Wechsler	NNP	PERSON	Wechsler	xcomp	61	SENT_254	[p19l744t1267r948b1310],
66	,	,	O	,	_	0	SENT_254	[p19l744t1267r948b1310],
67	and	CC	O	and	_	0	SENT_254	[p19l965t1267r1041b1304],
68	S	NN	PERSON	s	nn	70	SENT_254	[p19l1058t1269r1078b1304],
69	T	NN	PERSON	t	nn	70	SENT_254	[p19l1094t1269r1124b1303],
70	Weiss	NNP	PERSON	Weiss	nsubj	71	SENT_254	[p19l1136t1269r1259b1304],
71	wrote	VBD	O	write	conj_and	61	SENT_254	[p19l1274t1274r1389b1304],
72	the	DT	O	the	det	73	SENT_254	[p19l1403t1267r1467b1304],
73	report	NN	O	report	dobj	71	SENT_254	[p19l1482t1274r1617b1315],
74	.	.	O	.	_	0	SENT_254	[p19l1482t1274r1617b1315],

1	Conﬂict	NN	O	conﬂict	_	0	SENT_255	[p19l648t1359r800b1396],
2	of	IN	O	of	_	0	SENT_255	[p19l811t1359r854b1396],
3	interest	NN	O	interest	nn	4	SENT_255	[p19l863t1361r1014b1396],
4	statement	NN	O	statement	prep_of	1	SENT_255	[p19l1026t1366r1232b1396],

1	VMC	NNP	ORGANIZATION	VMC	nn	5	SENT_256	[p19l646t1423r766b1463],
2	,	,	O	,	_	0	SENT_256	[p19l646t1423r766b1463],
3	IGF	NNP	ORGANIZATION	IGF	appos	5	SENT_256	[p19l783t1422r874b1468],
4	,	,	O	,	_	0	SENT_256	[p19l783t1422r874b1468],
5	HAB	NNP	O	HAB	nsubj	17	SENT_256	[p19l892t1423r1005b1463],
6	,	,	O	,	_	0	SENT_256	[p19l892t1423r1005b1463],
7	IF	IN	O	if	mark	9	SENT_256	[p19l1022t1422r1076b1468],
8	,	,	O	,	_	0	SENT_256	[p19l1022t1422r1076b1468],
9	RFL	NNP	ORGANIZATION	RFL	advcl	17	SENT_256	[p19l1095t1422r1188b1463],
10	,	,	O	,	_	0	SENT_256	[p19l1095t1422r1188b1463],
11	RIM	NNP	O	RIM	nsubj	17	SENT_256	[p19l1206t1424r1308b1468],
12	,	,	O	,	_	0	SENT_256	[p19l1206t1424r1308b1468],
13	SPP	NNP	O	SPP	nsubj	17	SENT_256	[p19l1327t1423r1420b1463],
14	,	,	O	,	_	0	SENT_256	[p19l1327t1423r1420b1463],
15	and	CC	O	and	_	0	SENT_256	[p19l1437t1420r1513b1457],
16	IMD	NNP	ORGANIZATION	IMD	conj_and	11	SENT_256	[p19l1528t1424r1623b1468],
17	hold	VBP	O	hold	_	0	SENT_256	[p19l1638t1420r1730b1457],
18	a	DT	O	a	det	19	SENT_256	[p19l1744t1433r1764b1457],
19	patent	NN	O	patent	dobj	17	SENT_256	[p19l1778t1427r1908b1469],
20	on	IN	O	on	_	0	SENT_256	[p19l1922t1433r1974b1457],
21	the	DT	O	the	det	22	SENT_256	[p19l1987t1420r2051b1457],
22	use	NN	O	use	prep_on	17	SENT_256	[p19l2065t1433r2136b1457],
23	of	IN	O	of	_	0	SENT_256	[p19l647t1482r693b1519],
24	genotype	NN	O	genotype	prep_of	22	SENT_256	[p19l701t1489r886b1531],
25	at	IN	O	at	_	0	SENT_256	[p19l901t1489r937b1519],
26	the	DT	O	the	det	28	SENT_256	[p19l950t1482r1014b1519],
27	B,-adrenergic	JJ	O	b,-adrenergic	amod	28	SENT_256	[p19l1032t1482r1305b1531],
28	receptor	NN	O	receptor	prep_at	24	SENT_256	[p19l1319t1489r1489b1531],
29	and	CC	O	and	_	0	SENT_256	[p19l1503t1482r1579b1519],
30	the	DT	O	the	det	31	SENT_256	[p19l1592t1482r1656b1519],
31	effects	NNS	O	effect	prep_of	22	SENT_256	[p19l1671t1482r1802b1519],
32	of	IN	O	of	_	0	SENT_256	[p19l1818t1482r1864b1519],
33	regular	JJ	O	regular	amod	35	SENT_256	[p19l1871t1482r2020b1531],
34	albuterol	NN	O	albuterol	nn	35	SENT_256	[p19l647t1543r830b1580],
35	use	NN	O	use	prep_of	31	SENT_256	[p19l843t1556r924b1580],
36	.	.	O	.	_	0	SENT_256	[p19l843t1556r924b1580],

1	Other	JJ	O	other	amod	3	SENT_257	[p19l942t1543r1061b1580],
2	potential	JJ	O	potential	amod	3	SENT_257	[p19l1074t1543r1256b1592],
3	conﬂicts	NNS	O	conﬂicts	nsubj	4	SENT_257	[p19l1270t1543r1442b1580],
4	are	VBP	O	be	_	0	SENT_257	[p19l1458t1556r1519b1580],
5	as	IN	O	as	mark	6	SENT_257	[p19l1534t1556r1574b1580],
6	follows	VBZ	O	follow	advcl	4	SENT_257	[p19l1590t1543r1747b1580],
7	.	.	O	.	_	0	SENT_257	[p19l1590t1543r1747b1580],

1	EI	NNP	O	EI	_	0	SENT_258	[p19l1765t1545r1819b1580],
2	:	:	O	:	_	0	SENT_258	[p19l1765t1545r1819b1580],
3	consultancies	NNS	O	consultancy	dep	1	SENT_258	[p19l1835t1543r2115b1580],
4	and/or	JJ	O	and/or	amod	6	SENT_258	[p19l647t1604r788b1653],
5	research	NN	O	research	nn	6	SENT_258	[p19l801t1604r975b1641],
6	support	NN	O	support	dep	3	SENT_258	[p19l991t1611r1150b1653],
7	from	IN	O	from	_	0	SENT_258	[p19l1163t1604r1265b1641],
8	G1axoSmithKline	NN	O	g1axosmithkline	prep_from	6	SENT_258	[p19l1280t1604r1647b1647],
9	,	,	O	,	_	0	SENT_258	[p19l1280t1604r1647b1647],
10	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	6	SENT_258	[p19l1662t1606r1934b1647],
11	,	,	O	,	_	0	SENT_258	[p19l1662t1606r1934b1647],
12	Aventis	NNP	ORGANIZATION	Aventis	prep_from	6	SENT_258	[p19l1949t1606r2115b1647],
13	,	,	O	,	_	0	SENT_258	[p19l1949t1606r2115b1647],
14	Schering	NNP	ORGANIZATION	Schering	nn	15	SENT_258	[p19l650t1665r832b1714],
15	Plough	NNP	ORGANIZATION	Plough	prep_from	6	SENT_258	[p19l848t1665r1004b1714],
16	,	,	O	,	_	0	SENT_258	[p19l848t1665r1004b1714],
17	Genentech	NNP	ORGANIZATION	Genentech	prep_from	6	SENT_258	[p19l1022t1665r1256b1708],
18	,	,	O	,	_	0	SENT_258	[p19l1022t1665r1256b1708],
19	Merck	NNP	PERSON	Merck	prep_from	6	SENT_258	[p19l1274t1665r1414b1708],
20	,	,	O	,	_	0	SENT_258	[p19l1274t1665r1414b1708],
21	and	CC	O	and	_	0	SENT_258	[p19l1430t1665r1507b1702],
22	Novartis	NNP	ORGANIZATION	Novartis	conj_and	8	SENT_258	[p19l1521t1667r1703b1702],
23	.	.	O	.	_	0	SENT_258	[p19l1521t1667r1703b1702],

1	VMC	NNP	O	VMC	nsubj	4	SENT_259	[p19l1719t1667r1838b1702],
2	:	:	O	:	_	0	SENT_259	[p19l1719t1667r1838b1702],
3	has	VBZ	O	have	aux	4	SENT_259	[p19l1854t1665r1923b1702],
4	consulted	VBN	O	consult	_	0	SENT_259	[p19l1939t1665r2139b1702],
5	for	IN	O	for	_	0	SENT_259	[p19l647t1726r706b1763],
6	G1axoSmithKline	NN	O	g1axosmithkline	prep_for	4	SENT_259	[p19l720t1726r1087b1769],
7	,	,	O	,	_	0	SENT_259	[p19l720t1726r1087b1769],
8	Iohnson	NN	O	iohnson	prep_for	4	SENT_259	[p19l1104t1726r1276b1774],
9	and	CC	O	and	_	0	SENT_259	[p19l1291t1726r1367b1763],
10	Iohnson	NN	O	iohnson	prep_for	4	SENT_259	[p19l1382t1726r1564b1774],
11	,	,	O	,	_	0	SENT_259	[p19l1382t1726r1564b1774],
12	Bristol-Myers	NNP	O	Bristol-Myers	nn	13	SENT_259	[p19l1582t1726r1857b1775],
13	Squibb	NNP	O	Squibb	prep_for	4	SENT_259	[p19l1876t1726r2030b1775],
14	,	,	O	,	_	0	SENT_259	[p19l1876t1726r2030b1775],
15	and	CC	O	and	_	0	SENT_259	[p19l2046t1726r2123b1763],
16	Aventis	NNP	ORGANIZATION	Aventis	conj_and	6	SENT_259	[p19l646t1788r812b1823],
17	.	.	O	.	_	0	SENT_259	[p19l646t1788r812b1823],

1	IGF	NN	O	igf	_	0	SENT_260	[p19l829t1788r920b1833],
2	:	:	O	:	_	0	SENT_260	[p19l829t1788r920b1833],
3	honoraria	NN	O	honorarium	dep	1	SENT_260	[p19l935t1786r1138b1823],
4	and	CC	O	and	_	0	SENT_260	[p19l1153t1786r1229b1823],
5	/	:	O	/	punct	6	SENT_260	[p19l1231t1789r1247b1834],
6	or	CC	O	or	dep	3	SENT_260	[p19l1251t1799r1293b1823],
7	consultancies	NNS	O	consultancy	dep	8	SENT_260	[p19l1307t1786r1586b1823],
8	with	IN	O	with	dep	6	SENT_260	[p19l1600t1786r1692b1823],
9	Glaxo	NNP	ORGANIZATION	Glaxo	pobj	8	SENT_260	[p19l1707t1786r1823b1823],
10	SmithKline	NNP	ORGANIZATION	SmithKline	conj_and	3	SENT_260	[p19l1829t1786r2074b1828],
11	,	,	O	,	_	0	SENT_260	[p19l1829t1786r2074b1828],
12	Merck	NNP	PERSON	Merck	conj_and	10	SENT_260	[p19l648t1846r779b1883],
13	and	CC	O	and	_	0	SENT_260	[p19l792t1846r869b1883],
14	Sepracor	NNP	O	Sepracor	conj_and	3	SENT_260	[p19l885t1848r1074b1894],
15	.	.	O	.	_	0	SENT_260	[p19l885t1848r1074b1894],

1	HAB	NN	O	hab	nsubj	3	SENT_261	[p19l1093t1848r1193b1882],
2	has	VBZ	O	have	aux	3	SENT_261	[p19l1209t1846r1278b1883],
3	received	VBN	O	receive	ccomp	7	SENT_261	[p19l1293t1846r1463b1883],
4	honoraria	NN	O	honorarium	dobj	3	SENT_261	[p19l1476t1846r1689b1888],
5	,	,	O	,	_	0	SENT_261	[p19l1476t1846r1689b1888],
6	consultancies	NNS	O	consultancy	nsubj	7	SENT_261	[p19l1706t1846r1985b1883],
7	and/or	VBP	O	and/or	_	0	SENT_261	[p19l2001t1846r2141b1894],
8	research	NN	O	research	nn	9	SENT_261	[p19l647t1906r821b1944],
9	support	NN	O	support	dobj	7	SENT_261	[p19l837t1914r995b1955],
10	from	IN	O	from	_	0	SENT_261	[p19l1009t1906r1110b1944],
11	G1axoSmithKline	NN	O	g1axosmithkline	prep_from	7	SENT_261	[p19l1126t1906r1493b1949],
12	,	,	O	,	_	0	SENT_261	[p19l1126t1906r1493b1949],
13	Aventis	NNP	ORGANIZATION	Aventis	nn	30	SENT_261	[p19l1508t1909r1674b1949],
14	,	,	O	,	_	0	SENT_261	[p19l1508t1909r1674b1949],
15	Becker	NNP	PERSON	Becker	appos	30	SENT_261	[p19l1692t1906r1841b1949],
16	,	,	O	,	_	0	SENT_261	[p19l1692t1906r1841b1949],
17	Dynavax	NNP	ORGANIZATION	Dynavax	appos	30	SENT_261	[p19l1859t1910r2042b1955],
18	,	,	O	,	_	0	SENT_261	[p19l1859t1910r2042b1955],
19	Novartis	NNP	ORGANIZATION	Novartis	appos	30	SENT_261	[p19l648t1970r830b2010],
20	,	,	O	,	_	0	SENT_261	[p19l648t1970r830b2010],
21	Genentech	NNP	ORGANIZATION	Genentech	appos	30	SENT_261	[p19l847t1967r1082b2010],
22	,	,	O	,	_	0	SENT_261	[p19l847t1967r1082b2010],
23	Merck	NNP	PERSON	Merck	appos	30	SENT_261	[p19l1100t1967r1240b2010],
24	,	,	O	,	_	0	SENT_261	[p19l1100t1967r1240b2010],
25	Pharmacia	NNP	LOCATION	Pharmacia	appos	30	SENT_261	[p19l1258t1967r1488b2010],
26	,	,	O	,	_	0	SENT_261	[p19l1258t1967r1488b2010],
27	Roche	NNP	PERSON	Roche	appos	30	SENT_261	[p19l1506t1967r1643b2010],
28	,	,	O	,	_	0	SENT_261	[p19l1506t1967r1643b2010],
29	Schering	NNP	ORGANIZATION	Schering	appos	30	SENT_261	[p19l1662t1967r1844b2017],
30	Plough	NNP	ORGANIZATION	Plough	prep_from	7	SENT_261	[p19l1860t1967r2016b2017],
31	,	,	O	,	_	0	SENT_261	[p19l1860t1967r2016b2017],
32	Abbott	NNP	PERSON	Abbott	prep_from	7	SENT_261	[p19l646t2028r796b2071],
33	,	,	O	,	_	0	SENT_261	[p19l646t2028r796b2071],
34	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	7	SENT_261	[p19l811t2030r1082b2071],
35	,	,	O	,	_	0	SENT_261	[p19l811t2030r1082b2071],
36	and	CC	O	and	_	0	SENT_261	[p19l1099t2028r1175b2066],
37	SynerMed	NNP	O	SynerMed	conj_and	11	SENT_261	[p19l1192t2028r1411b2077],
38	.	.	O	.	_	0	SENT_261	[p19l1192t2028r1411b2077],

1	AD	NN	O	ad	_	0	SENT_262	[p19l1427t2031r1506b2066],
2	:	:	O	:	_	0	SENT_262	[p19l1427t2031r1506b2066],
3	honoraria	NN	O	honorarium	nn	5	SENT_262	[p19l1522t2028r1724b2066],
4	and/or	NN	O	and/or	nn	5	SENT_262	[p19l1739t2028r1879b2077],
5	consultancies	NNS	O	consultancy	dep	1	SENT_262	[p19l647t2088r927b2125],
6	for	IN	O	for	_	0	SENT_262	[p19l942t2088r1001b2125],
7	Merck	NNP	ORGANIZATION	Merck	nn	11	SENT_262	[p19l1016t2088r1155b2131],
8	,	,	O	,	_	0	SENT_262	[p19l1016t2088r1155b2131],
9	Aventis	NNP	ORGANIZATION	Aventis	appos	11	SENT_262	[p19l1171t2090r1337b2131],
10	,	,	O	,	_	0	SENT_262	[p19l1171t2090r1337b2131],
11	Novartis	NNP	ORGANIZATION	Novartis	prep_for	5	SENT_262	[p19l1354t2091r1536b2131],
12	,	,	O	,	_	0	SENT_262	[p19l1354t2091r1536b2131],
13	and	CC	O	and	_	0	SENT_262	[p19l1553t2088r1629b2125],
14	Genentech	NNP	ORGANIZATION	Genentech	prep_for	5	SENT_262	[p19l1644t2088r1878b2125],
15	.	.	O	.	_	0	SENT_262	[p19l1644t2088r1878b2125],

1	IVF	NNP	O	IVF	_	0	SENT_263	[p19l1896t2090r1982b2136],
2	:	:	O	:	_	0	SENT_263	[p19l1896t2090r1982b2136],
3	honoraria	NN	O	honorarium	dep	1	SENT_263	[p19l646t2149r859b2192],
4	,	,	O	,	_	0	SENT_263	[p19l646t2149r859b2192],
5	consultancies	NNS	O	consultancy	appos	3	SENT_263	[p19l876t2149r1155b2186],
6	and	CC	O	and	_	0	SENT_263	[p19l1171t2149r1247b2186],
7	/	:	O	/	punct	9	SENT_263	[p19l1250t2153r1265b2198],
8	or	CC	O	or	dep	9	SENT_263	[p19l1269t2162r1312b2186],
9	research	NN	O	research	dep	5	SENT_263	[p19l1325t2149r1499b2186],
10	support	NN	O	support	conj_and	5	SENT_263	[p19l1514t2157r1673b2198],
11	from	IN	O	from	_	0	SENT_263	[p19l1686t2149r1788b2186],
12	G1axoSmithKline	NN	O	g1axosmithkline	prep_from	10	SENT_263	[p19l648t2211r1015b2254],
13	,	,	O	,	_	0	SENT_263	[p19l648t2211r1015b2254],
14	Merck	NNP	PERSON	Merck	nn	26	SENT_263	[p19l1032t2211r1172b2254],
15	,	,	O	,	_	0	SENT_263	[p19l1032t2211r1172b2254],
16	Genentech	NNP	ORGANIZATION	Genentech	appos	26	SENT_263	[p19l1190t2211r1425b2254],
17	,	,	O	,	_	0	SENT_263	[p19l1190t2211r1425b2254],
18	Amgen	NNP	ORGANIZATION	Amgen	appos	26	SENT_263	[p19l1440t2214r1603b2260],
19	,	,	O	,	_	0	SENT_263	[p19l1440t2214r1603b2260],
20	Bayer	NNP	ORGANIZATION	Bayer	appos	26	SENT_263	[p19l1621t2215r1745b2260],
21	,	,	O	,	_	0	SENT_263	[p19l1621t2215r1745b2260],
22	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	appos	26	SENT_263	[p19l1761t2213r2032b2254],
23	,	,	O	,	_	0	SENT_263	[p19l1761t2213r2032b2254],
24	Texas	NNP	ORGANIZATION	Texas	appos	26	SENT_263	[p19l646t2274r761b2309],
25	Biology	NNP	ORGANIZATION	Biology	nn	26	SENT_263	[p19l779t2272r932b2321],
26	Corp	NNP	ORGANIZATION	Corp	conj_and	12	SENT_263	[p19l947t2275r1057b2321],
27	,	,	O	,	_	0	SENT_263	[p19l947t2275r1057b2321],
28	Schering	NNP	ORGANIZATION	Schering	nn	29	SENT_263	[p19l1077t2272r1259b2321],
29	Plough	NNP	ORGANIZATION	Plough	conj_and	12	SENT_263	[p19l1275t2272r1431b2321],
30	,	,	O	,	_	0	SENT_263	[p19l1275t2272r1431b2321],
31	Boehringer-Ingelheim	NNP	PERSON	Boehringer-Ingelheim	conj_and	12	SENT_263	[p19l1449t2272r1922b2321],
32	,	,	O	,	_	0	SENT_263	[p19l1449t2272r1922b2321],
33	and	CC	O	and	_	0	SENT_263	[p19l1939t2272r2015b2309],
34	Roche	NNP	PERSON	Roche	prep_from	10	SENT_263	[p19l649t2333r785b2370],
35	.	.	O	.	_	0	SENT_263	[p19l649t2333r785b2370],

1	MK	NN	O	mk	_	0	SENT_264	[p19l803t2337r887b2370],
2	:	:	O	:	_	0	SENT_264	[p19l803t2337r887b2370],
3	honoraria	NN	O	honorarium	dep	1	SENT_264	[p19l902t2333r1105b2370],
4	from	IN	O	from	_	0	SENT_264	[p19l1119t2333r1221b2370],
5	Glaxo-Welcome	NNP	O	Glaxo-Welcome	nn	8	SENT_264	[p19l1237t2333r1562b2371],
6	and	CC	O	and	_	0	SENT_264	[p19l1577t2333r1653b2370],
7	Schering	NNP	O	Schering	conj_and	5	SENT_264	[p19l1670t2333r1852b2382],
8	Plough	NNP	O	Plough	prep_from	3	SENT_264	[p19l1868t2333r2024b2382],
9	.	.	O	.	_	0	SENT_264	[p19l1868t2333r2024b2382],

1	SCL	NN	O	scl	_	0	SENT_265	[p19l2043t2336r2136b2370],
2	:	:	O	:	_	0	SENT_265	[p19l2043t2336r2136b2370],
3	consultancies	NNS	O	consultancy	dep	1	SENT_265	[p19l647t2393r927b2430],
4	and/or	JJ	O	and/or	amod	6	SENT_265	[p19l943t2393r1083b2441],
5	research	NN	O	research	nn	6	SENT_265	[p19l1096t2393r1271b2430],
6	support	NN	O	support	dep	3	SENT_265	[p19l1286t2400r1445b2441],
7	from	IN	O	from	_	0	SENT_265	[p19l1458t2393r1560b2430],
8	G1axoSmithKline	NN	O	g1axosmithkline	prep_from	6	SENT_265	[p19l1575t2393r1942b2436],
9	,	,	O	,	_	0	SENT_265	[p19l1575t2393r1942b2436],
10	Merck	NNP	PERSON	Merck	nn	19	SENT_265	[p19l1960t2393r2100b2436],
11	,	,	O	,	_	0	SENT_265	[p19l1960t2393r2100b2436],
12	Aventis	NNP	ORGANIZATION	Aventis	appos	19	SENT_265	[p19l646t2456r812b2497],
13	,	,	O	,	_	0	SENT_265	[p19l646t2456r812b2497],
14	Novartis	NNP	ORGANIZATION	Novartis	appos	19	SENT_265	[p19l829t2456r1011b2497],
15	,	,	O	,	_	0	SENT_265	[p19l829t2456r1011b2497],
16	Genentech	NNP	ORGANIZATION	Genentech	appos	19	SENT_265	[p19l1029t2454r1263b2497],
17	,	,	O	,	_	0	SENT_265	[p19l1029t2454r1263b2497],
18	Schering	NNP	ORGANIZATION	Schering	appos	19	SENT_265	[p19l1283t2454r1465b2503],
19	Plough	NNP	ORGANIZATION	Plough	prep_from	6	SENT_265	[p19l1481t2454r1637b2503],
20	,	,	O	,	_	0	SENT_265	[p19l1481t2454r1637b2503],
21	and	CC	O	and	_	0	SENT_265	[p19l1654t2454r1730b2491],
22	BoehringerIngelheim	NNP	O	BoehringerIngelheim	conj_and	8	SENT_265	[p19l1745t2454r1990b2503, p19l649t2515r872b2564],
23	.	.	O	.	_	0	SENT_265	[p19l1745t2454r1990b2503, p19l649t2515r872b2564],

1	RF	NN	O	rf	nn	2	SENT_266	[p19l891t2517r946b2551],
2	L	NN	O	l	_	0	SENT_266	[p19l952t2518r984b2552],
3	:	:	O	:	_	0	SENT_266	[p19l952t2518r984b2552],
4	honoraria	NN	O	honorarium	dep	2	SENT_266	[p19l1000t2514r1203b2552],
5	and	CC	O	and	_	0	SENT_266	[p19l1217t2515r1293b2552],
6	/	:	O	/	punct	7	SENT_266	[p19l1296t2518r1312b2563],
7	or	CC	O	or	dep	4	SENT_266	[p19l1315t2528r1358b2552],
8	consultancies	NNS	O	consultancy	dep	9	SENT_266	[p19l1371t2515r1651b2552],
9	from	IN	O	from	dep	7	SENT_266	[p19l1666t2514r1768b2552],
10	G1axoSmithKline	NN	O	g1axosmithkline	conj_and	4	SENT_266	[p19l648t2575r1015b2617],
11	,	,	O	,	_	0	SENT_266	[p19l648t2575r1015b2617],
12	Merck	NNP	PERSON	Merck	nn	16	SENT_266	[p19l1032t2575r1172b2617],
13	,	,	O	,	_	0	SENT_266	[p19l1032t2575r1172b2617],
14	Aventis	NNP	ORGANIZATION	Aventis	appos	16	SENT_266	[p19l1187t2577r1354b2617],
15	,	,	O	,	_	0	SENT_266	[p19l1187t2577r1354b2617],
16	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	conj_and	4	SENT_266	[p19l1369t2577r1641b2617],
17	,	,	O	,	_	0	SENT_266	[p19l1369t2577r1641b2617],
18	and	CC	O	and	_	0	SENT_266	[p19l1657t2575r1733b2612],
19	Genentech	NNP	ORGANIZATION	Genentech	conj_and	4	SENT_266	[p19l1748t2575r1982b2612],
20	.	.	O	.	_	0	SENT_266	[p19l1748t2575r1982b2612],

1	CAS	NNP	O	CAS	_	0	SENT_267	[p19l2000t2577r2101b2612],
2	:	:	O	:	_	0	SENT_267	[p19l2000t2577r2101b2612],
3	consultancies	NNS	O	consultancy	dep	1	SENT_267	[p19l647t2634r927b2672],
4	and	CC	O	and	_	0	SENT_267	[p19l943t2634r1019b2672],
5	honoraria	NN	O	honorarium	dep	1	SENT_267	[p19l1031t2634r1234b2672],
6	from	IN	O	from	_	0	SENT_267	[p19l1248t2634r1350b2672],
7	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	prep_from	3	SENT_267	[p19l1366t2634r1732b2672],
8	.	.	O	.	_	0	SENT_267	[p19l1366t2634r1732b2672],

1	SIS	NNP	O	SIS	_	0	SENT_268	[p19l1751t2637r1830b2682],
2	:	:	O	:	_	0	SENT_268	[p19l1751t2637r1830b2682],
3	consultancies	NNS	O	consultancy	dep	1	SENT_268	[p19l1847t2634r2127b2672],
4	and/or	JJ	O	and/or	amod	6	SENT_268	[p19l647t2695r788b2744],
5	research	NN	O	research	nn	6	SENT_268	[p19l801t2695r975b2733],
6	support	NN	O	support	dep	3	SENT_268	[p19l991t2703r1150b2744],
7	from	IN	O	from	_	0	SENT_268	[p19l1163t2695r1265b2733],
8	G1axoSmithKline	NN	O	g1axosmithkline	prep_from	6	SENT_268	[p19l1280t2695r1647b2738],
9	,	,	O	,	_	0	SENT_268	[p19l1280t2695r1647b2738],
10	Schering	NNP	ORGANIZATION	Schering	nn	19	SENT_268	[p19l1666t2695r1848b2745],
11	Plough	NNP	ORGANIZATION	Plough	nn	19	SENT_268	[p19l1864t2695r2020b2745],
12	,	,	O	,	_	0	SENT_268	[p19l1864t2695r2020b2745],
13	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	appos	19	SENT_268	[p19l646t2759r917b2799],
14	,	,	O	,	_	0	SENT_268	[p19l646t2759r917b2799],
15	Merck	NNP	PERSON	Merck	appos	19	SENT_268	[p19l935t2756r1075b2799],
16	,	,	O	,	_	0	SENT_268	[p19l935t2756r1075b2799],
17	Genentech	NNP	ORGANIZATION	Genentech	appos	19	SENT_268	[p19l1092t2756r1327b2799],
18	,	,	O	,	_	0	SENT_268	[p19l1092t2756r1327b2799],
19	Novartis	NNP	ORGANIZATION	Novartis	prep_from	6	SENT_268	[p19l1344t2759r1527b2799],
20	,	,	O	,	_	0	SENT_268	[p19l1344t2759r1527b2799],
21	and	CC	O	and	_	0	SENT_268	[p19l1543t2756r1619b2794],
22	Aventis	NNP	ORGANIZATION	Aventis	conj_and	8	SENT_268	[p19l1632t2759r1798b2794],
23	.	.	O	.	_	0	SENT_268	[p19l1632t2759r1798b2794],

1	MEW	NNP	O	MEW	_	0	SENT_269	[p19l1815t2758r1942b2794],
2	:	:	O	:	_	0	SENT_269	[p19l1815t2758r1942b2794],
3	honoraria	NN	O	honorarium	dep	1	SENT_269	[p19l646t2817r859b2860],
4	,	,	O	,	_	0	SENT_269	[p19l646t2817r859b2860],
5	consultancies	NNS	O	consultancy	appos	3	SENT_269	[p19l876t2817r1167b2860],
6	,	,	O	,	_	0	SENT_269	[p19l876t2817r1167b2860],
7	and	CC	O	and	_	0	SENT_269	[p19l1183t2817r1278b2866],
8	/	:	O	/	punct	9	SENT_269	[p19l1183t2817r1278b2866],
9	or	CC	O	or	dep	3	SENT_269	[p19l1282t2830r1324b2854],
10	research	NN	O	research	nn	11	SENT_269	[p19l1337t2817r1512b2854],
11	support	NN	O	support	dep	12	SENT_269	[p19l1527t2825r1686b2866],
12	from	IN	O	from	dep	9	SENT_269	[p19l1699t2817r1801b2854],
13	Merck	NNP	ORGANIZATION	Merck	pobj	12	SENT_269	[p19l1816t2817r1956b2860],
14	,	,	O	,	_	0	SENT_269	[p19l1816t2817r1956b2860],
15	G1axoSmithKline	NN	O	g1axosmithkline	appos	13	SENT_269	[p19l648t2878r1015b2921],
16	,	,	O	,	_	0	SENT_269	[p19l648t2878r1015b2921],
17	Genentech	NNP	ORGANIZATION	Genentech	nn	21	SENT_269	[p19l1032t2878r1267b2921],
18	,	,	O	,	_	0	SENT_269	[p19l1032t2878r1267b2921],
19	Novartis	NNP	ORGANIZATION	Novartis	appos	21	SENT_269	[p19l1284t2881r1466b2921],
20	,	,	O	,	_	0	SENT_269	[p19l1284t2881r1466b2921],
21	Sepracor	NNP	O	Sepracor	dep	1	SENT_269	[p19l1485t2881r1675b2927],
22	,	,	O	,	_	0	SENT_269	[p19l1485t2881r1675b2927],
23	and	CC	O	and	_	0	SENT_269	[p19l1691t2878r1768b2915],
24	Aventis	NNP	ORGANIZATION	Aventis	dep	1	SENT_269	[p19l1780t2881r1946b2915],
25	.	.	O	.	_	0	SENT_269	[p19l1780t2881r1946b2915],

1	STW	NN	O	stw	_	0	SENT_270	[p19l1966t2880r2075b2916],
2	:	:	O	:	_	0	SENT_270	[p19l1966t2880r2075b2916],
3	consultancies	NNS	O	consultancy	dep	1	SENT_270	[p19l647t2940r927b2977],
4	and/or	JJ	O	and/or	amod	6	SENT_270	[p19l943t2940r1083b2989],
5	research	NN	O	research	nn	6	SENT_270	[p19l1096t2940r1271b2977],
6	support	NN	O	support	dep	3	SENT_270	[p19l1286t2947r1445b2989],
7	from	IN	O	from	_	0	SENT_270	[p19l1458t2940r1560b2977],
8	Glaxo-Welcome	NNP	O	Glaxo-Welcome	nn	21	SENT_270	[p19l1575t2940r1912b2983],
9	,	,	O	,	_	0	SENT_270	[p19l1575t2940r1912b2983],
10	Roche	NNP	PERSON	Roche	appos	21	SENT_270	[p19l1930t2940r2066b2983],
11	,	,	O	,	_	0	SENT_270	[p19l1930t2940r2066b2983],
12	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	appos	21	SENT_270	[p19l646t3003r917b3044],
13	,	,	O	,	_	0	SENT_270	[p19l646t3003r917b3044],
14	Millennium	NNP	O	Millennium	appos	21	SENT_270	[p19l935t3001r1194b3044],
15	,	,	O	,	_	0	SENT_270	[p19l935t3001r1194b3044],
16	Genentech	NNP	ORGANIZATION	Genentech	appos	21	SENT_270	[p19l1211t3001r1446b3044],
17	,	,	O	,	_	0	SENT_270	[p19l1211t3001r1446b3044],
18	Pﬁzer	NNP	PERSON	Pﬁzer	appos	21	SENT_270	[p19l1464t3001r1594b3044],
19	,	,	O	,	_	0	SENT_270	[p19l1464t3001r1594b3044],
20	Schering	NNP	ORGANIZATION	Schering	appos	21	SENT_270	[p19l1613t3001r1795b3050],
21	Plough	NNP	ORGANIZATION	Plough	prep_from	6	SENT_270	[p19l1811t3001r1968b3050],
22	,	,	O	,	_	0	SENT_270	[p19l1811t3001r1968b3050],
23	Boehringer-Ingelheim	NNP	PERSON	Boehringer-Ingelheim	prep_from	6	SENT_270	[p19l649t3062r1122b3111],
24	,	,	O	,	_	0	SENT_270	[p19l649t3062r1122b3111],
25	Variagenics	NNP	ORGANIZATION	Variagenics	prep_from	6	SENT_270	[p19l1137t3064r1391b3111],
26	,	,	O	,	_	0	SENT_270	[p19l1137t3064r1391b3111],
27	Genome	NNP	O	Genome	nn	28	SENT_270	[p19l1408t3065r1585b3099],
28	Therapeutics	NNPS	O	Therapeutics	conj_and	21	SENT_270	[p19l1599t3062r1879b3111],
29	,	,	O	,	_	0	SENT_270	[p19l1599t3062r1879b3111],
30	and	CC	O	and	_	0	SENT_270	[p19l1895t3062r1972b3099],
31	Merck	NNP	ORGANIZATION	Merck	nn	32	SENT_270	[p19l1987t3062r2117b3099],
32	Frost	NNP	ORGANIZATION	Frost	conj_and	21	SENT_270	[p19l649t3125r763b3160],
33	.	.	O	.	_	0	SENT_270	[p19l649t3125r763b3160],

1	IMD	NNP	O	IMD	_	0	SENT_271	[p19l780t3126r887b3171],
2	:	:	O	:	_	0	SENT_271	[p19l780t3126r887b3171],
3	ad-hoc	JJ	O	ad-hoc	amod	4	SENT_271	[p19l904t3123r1039b3160],
4	consultant	NN	O	consultant	dep	1	SENT_271	[p19l1054t3123r1271b3160],
5	for	IN	O	for	_	0	SENT_271	[p19l1284t3123r1343b3160],
6	Abbott	NNP	ORGANIZATION	Abbott	nn	7	SENT_271	[p19l1355t3123r1495b3160],
7	Laboratories	NNP	ORGANIZATION	Laboratories	prep_for	4	SENT_271	[p19l1511t3123r1763b3160],
8	when	WRB	O	when	advmod	12	SENT_271	[p19l1778t3123r1892b3160],
9	the	DT	O	the	det	10	SENT_271	[p19l1905t3123r1970b3160],
10	study	NN	O	study	nsubjpass	12	SENT_271	[p19l1986t3123r2096b3172],
11	was	VBD	O	be	auxpass	12	SENT_271	[p19l646t3197r722b3221],
12	conceived	VBN	O	conceive	dep	7	SENT_271	[p19l738t3184r941b3221],
13	and	CC	O	and	_	0	SENT_271	[p19l955t3184r1031b3221],
14	until	IN	O	until	_	0	SENT_271	[p19l1044t3184r1142b3221],
15	May	NNP	DATE	May	prep_until	17	SENT_271	[p19l1158t3187r1254b3233],
16	,	,	DATE	,	_	0	SENT_271	[p19l1158t3187r1254b3233],
17	2000	CD	DATE	2000	dep	7	SENT_271	[p19l1271t3187r1378b3221],
18	.	.	O	.	_	0	SENT_271	[p19l1271t3187r1378b3221],

1	Other	JJ	O	other	amod	2	SENT_272	[p19l1395t3184r1515b3221],
2	authors	NNS	O	author	_	0	SENT_272	[p19l1528t3184r1695b3221],
3	:	:	O	:	_	0	SENT_272	[p19l1528t3184r1695b3221],
4	none	NN	O	none	nsubj	5	SENT_272	[p19l1711t3197r1815b3221],
5	declared	VBD	O	declare	dep	2	SENT_272	[p19l1830t3184r2012b3221],
6	.	.	O	.	_	0	SENT_272	[p19l1830t3184r2012b3221],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_273	[p20l647t29r1019b76],
2	The	DT	O	the	det	3	SENT_273	[p20l646t89r725b126],
3	trial	NN	O	trial	nsubjpass	5	SENT_273	[p20l739t89r822b126],
4	was	VBD	O	be	auxpass	5	SENT_273	[p20l834t102r911b126],
5	funded	VBN	O	fund	rcmod	1	SENT_273	[p20l926t89r1074b126],
6	by	IN	O	by	_	0	SENT_273	[p20l1087t89r1135b138],
7	grants	NNS	O	grant	agent	5	SENT_273	[p20l1149t96r1276b138],
8	US	NNP	LOCATION	US	nn	9	SENT_273	[p20l1294t92r1353b126],
9	NIH/NHLBI	NNP	O	NIH/NHLBI	dep	7	SENT_273	[p20l1372t93r1650b138],
10	:	:	O	:	_	0	SENT_273	[p20l1372t93r1650b138],
11	5	CD	NUMBER	5	num	13	SENT_273	[p20l1668t91r1687b126],
12	U10	NN	O	u10	nn	13	SENT_273	[p20l1706t92r1790b126],
13	HL051810	NN	O	hl051810	dep	1	SENT_273	[p20l1806t91r2029b132],
14	,	,	O	,	_	0	SENT_273	[p20l1806t91r2029b132],
15	5	CD	NUMBER	5	num	17	SENT_273	[p20l648t152r667b187],
16	U10	NN	O	u10	nn	17	SENT_273	[p20l686t153r770b187],
17	HL051823	NN	O	hl051823	dep	1	SENT_273	[p20l787t152r1010b193],
18	,	,	O	,	_	0	SENT_273	[p20l787t152r1010b193],
19	5	CD	NUMBER	5	num	21	SENT_273	[p20l1028t152r1046b187],
20	U10	NN	O	u10	nn	21	SENT_273	[p20l1065t153r1150b187],
21	HLO51831	NN	O	hlo51831	dep	1	SENT_273	[p20l1166t152r1389b193],
22	,	,	O	,	_	0	SENT_273	[p20l1166t152r1389b193],
23	5	CD	NUMBER	5	num	25	SENT_273	[p20l1407t152r1426b187],
24	U10	NN	O	u10	nn	25	SENT_273	[p20l1444t153r1529b187],
25	HL051834	NN	O	hl051834	dep	1	SENT_273	[p20l1545t152r1768b193],
26	,	,	O	,	_	0	SENT_273	[p20l1545t152r1768b193],
27	5	CD	NUMBER	5	num	29	SENT_273	[p20l1786t152r1805b187],
28	U10	NN	O	u10	nn	29	SENT_273	[p20l1824t153r1908b187],
29	HL051843	NN	O	hl051843	dep	1	SENT_273	[p20l1924t152r2147b193],
30	,	,	O	,	_	0	SENT_273	[p20l1924t152r2147b193],
31	5	CD	NUMBER	5	num	33	SENT_273	[p20l648t213r667b248],
32	U10	NN	O	u10	nn	33	SENT_273	[p20l686t214r770b248],
33	HL051845	NN	O	hl051845	dep	1	SENT_273	[p20l787t213r1010b254],
34	,	,	O	,	_	0	SENT_273	[p20l787t213r1010b254],
35	and	CC	O	and	_	0	SENT_273	[p20l1027t211r1103b248],
36	5	CD	NUMBER	5	num	38	SENT_273	[p20l1118t213r1137b248],
37	U10	NN	O	u10	nn	38	SENT_273	[p20l1156t214r1240b248],
38	HL056443	NN	O	hl056443	dep	1	SENT_273	[p20l1256t213r1479b248],
39	.	.	O	.	_	0	SENT_273	[p20l1256t213r1479b248],

1	We	PRP	O	we	nsubj	2	SENT_274	[p20l1495t214r1563b248],
2	thank	VBP	O	thank	_	0	SENT_274	[p20l1577t211r1696b248],
3	Iames	NNS	PERSON	iame	dobj	2	SENT_274	[p20l1710t214r1834b259],
4	P	NN	PERSON	p	nn	5	SENT_274	[p20l1852t214r1876b248],
5	Kiley	NN	PERSON	kiley	dep	3	SENT_274	[p20l1894t211r1996b260],
6	and	CC	O	and	_	0	SENT_274	[p20l2009t211r2086b248],
7	Hector	NNP	PERSON	Hector	nn	9	SENT_274	[p20l649t275r790b309],
8	G	NNP	PERSON	G	nn	9	SENT_274	[p20l805t274r837b309],
9	Ortega	NNP	PERSON	Ortega	conj_and	3	SENT_274	[p20l854t275r992b321],
10	of	IN	O	of	_	0	SENT_274	[p20l1007t272r1052b309],
11	the	DT	O	the	det	12	SENT_274	[p20l1059t272r1123b309],
12	NHLBI	NNP	ORGANIZATION	NHLBI	prep_of	9	SENT_274	[p20l1139t275r1288b309],
13	for	IN	O	for	_	0	SENT_274	[p20l1305t272r1363b309],
14	guidance	NN	O	guidance	prep_for	12	SENT_274	[p20l1377t272r1564b321],
15	and	CC	O	and	_	0	SENT_274	[p20l1579t272r1655b309],
16	support	NN	O	support	prep_for	12	SENT_274	[p20l1670t279r1829b321],
17	and	CC	O	and	_	0	SENT_274	[p20l1842t272r1919b309],
18	Daniel	NNP	PERSON	Daniel	nn	20	SENT_274	[p20l649t333r783b370],
19	C	NNP	PERSON	C	nn	20	SENT_274	[p20l799t335r827b370],
20	McIntyre	NNP	PERSON	McIntyre	conj_and	12	SENT_274	[p20l844t336r1032b382],
21	for	IN	O	for	_	0	SENT_274	[p20l1047t332r1106b370],
22	help	NN	O	help	prep_for	20	SENT_274	[p20l1118t333r1208b381],
23	with	IN	O	with	_	0	SENT_274	[p20l1221t333r1313b370],
24	typing	NN	O	typing	prep_with	22	SENT_274	[p20l1326t335r1456b382],
25	and	CC	O	and	_	0	SENT_274	[p20l1471t333r1547b370],
26	editing	NN	O	editing	prep_with	22	SENT_274	[p20l1561t332r1705b382],
27	the	DT	O	the	det	28	SENT_274	[p20l1718t333r1783b370],
28	report	NN	O	report	dep	20	SENT_274	[p20l1797t340r1932b381],
29	.	.	O	.	_	0	SENT_274	[p20l1797t340r1932b381],

1	References	NNS	O	reference	_	0	SENT_275	[p20l649t397r858b434],
2	1	CD	NUMBER	1	num	4	SENT_275	[p20l650t456r667b489],
3	Pearlman	NNP	O	Pearlman	nn	4	SENT_275	[p20l749t453r948b490],
4	DS	NN	O	d	dep	1	SENT_275	[p20l964t455r1035b496],
5	,	,	O	,	_	0	SENT_275	[p20l964t455r1035b496],
6	Chervinsky	NNP	PERSON	Chervinsky	nn	7	SENT_275	[p20l1053t452r1286b502],
7	P	NN	O	p	appos	4	SENT_275	[p20l1301t456r1338b496],
8	,	,	O	,	_	0	SENT_275	[p20l1301t456r1338b496],
9	LaForce	NN	PERSON	laforce	nn	10	SENT_275	[p20l1356t455r1517b490],
10	C	NN	O	c	appos	4	SENT_275	[p20l1533t455r1573b496],
11	,	,	O	,	_	0	SENT_275	[p20l1533t455r1573b496],
12	et	FW	O	et	nn	13	SENT_275	[p20l1590t460r1626b490],
13	al.	FW	O	al.	appos	4	SENT_275	[p20l1640t453r1684b490],
14	.	.	O	.	_	0	SENT_275	[p20l1640t453r1684b490],

1	A	DT	O	a	det	2	SENT_276	[p20l1699t455r1732b489],
2	comparison	NN	O	comparison	_	0	SENT_276	[p20l1746t455r1991b501],
3	of	IN	O	of	_	0	SENT_276	[p20l2005t452r2051b490],
4	salmeterol	NN	O	salmeterol	prep_of	2	SENT_276	[p20l749t508r963b546],
5	with	IN	O	with	_	0	SENT_276	[p20l976t508r1068b546],
6	albuterol	NN	O	albuterol	prep_with	2	SENT_276	[p20l1083t508r1265b546],
7	in	IN	O	in	_	0	SENT_276	[p20l1279t511r1320b545],
8	the	DT	O	the	det	9	SENT_276	[p20l1333t508r1398b546],
9	treatment	NN	O	treatment	prep_in	2	SENT_276	[p20l1412t516r1616b546],
10	of	IN	O	of	_	0	SENT_276	[p20l1629t508r1675b546],
11	mild-to-moderate	JJ	O	mild-to-moderate	amod	12	SENT_276	[p20l1682t508r2042b546],
12	asthma	NN	O	asthma	prep_of	9	SENT_276	[p20l748t564r908b601],
13	.	.	O	.	_	0	SENT_276	[p20l748t564r908b601],

1	N	NN	O	n	nn	3	SENT_277	[p20l927t568r963b601],
2	Engl	NNP	O	Engl	nn	3	SENT_277	[p20l977t564r1094b613],
3	]	NNP	O	]	nsubj	4	SENT_277	[p20l977t564r1094b613],
4	Med	VBD	O	med	_	0	SENT_277	[p20l1107t564r1193b601],
5	1992	CD	DATE	1992	dobj	4	SENT_277	[p20l1209t567r1314b607],
6	;	:	O	;	_	0	SENT_277	[p20l1209t567r1314b607],
7	327	CD	NUMBER	327	num	9	SENT_277	[p20l1331t566r1413b602],
8	:	:	O	:	_	0	SENT_277	[p20l1331t566r1413b602],
9	1420-25	CD	NUMBER	1420-25	dep	5	SENT_277	[p20l1432t566r1611b601],
10	.	.	O	.	_	0	SENT_277	[p20l1432t566r1611b601],

1	2	CD	NUMBER	2	_	0	SENT_278	[p20l648t630r668b663],
2	National	NNP	O	National	nn	5	SENT_278	[p20l748t626r923b664],
3	Asthma	NNP	O	Asthma	nn	5	SENT_278	[p20l937t626r1099b664],
4	Education	NNP	O	Education	nn	5	SENT_278	[p20l1115t626r1322b664],
5	Program	NNP	O	Program	dep	1	SENT_278	[p20l1338t630r1528b676],
6	.	.	O	.	_	0	SENT_278	[p20l1338t630r1528b676],

1	Guidelines	NNS	O	guideline	_	0	SENT_279	[p20l1546t626r1769b664],
2	for	IN	O	for	_	0	SENT_279	[p20l1785t626r1844b664],
3	the	DT	O	the	det	4	SENT_279	[p20l1856t626r1920b664],
4	diagnosis	NN	O	diagnosis	prep_for	1	SENT_279	[p20l1935t626r2130b676],
5	and	CC	O	and	_	0	SENT_279	[p20l748t681r824b718],
6	treatment	NN	O	treatment	prep_for	1	SENT_279	[p20l836t688r1041b718],
7	of	IN	O	of	_	0	SENT_279	[p20l1054t681r1100b718],
8	asthma	NN	O	asthma	prep_of	4	SENT_279	[p20l1108t681r1259b718],
9	II	CD	NUMBER	ii	num	8	SENT_279	[p20l1275t685r1318b718],
10	.	.	O	.	_	0	SENT_279	[p20l1275t685r1318b718],

1	Bethesda	NNP	LOCATION	Bethesda	nn	3	SENT_280	[p20l1337t681r1533b724],
2	,	,	O	,	_	0	SENT_280	[p20l1337t681r1533b724],
3	MD	NNP	O	MD	_	0	SENT_280	[p20l1551t685r1639b718],
4	:	:	O	:	_	0	SENT_280	[p20l1551t685r1639b718],
5	National	NNP	ORGANIZATION	National	nn	6	SENT_280	[p20l1656t681r1831b718],
6	Institutes	NNPS	ORGANIZATION	Institutes	dep	3	SENT_280	[p20l1848t683r2041b718],
7	of	IN	ORGANIZATION	of	_	0	SENT_280	[p20l2057t681r2103b718],
8	Health	NNP	ORGANIZATION	Health	prep_of	6	SENT_280	[p20l749t737r899b780],
9	,	,	O	,	_	0	SENT_280	[p20l749t737r899b780],
10	1997	CD	DATE	1997	appos	8	SENT_280	[p20l918t739r1023b775],
11	.	.	O	.	_	0	SENT_280	[p20l918t739r1023b775],

1	3	CD	NUMBER	3	_	0	SENT_281	[p20l649t803r668b837],
2	National	NNP	ORGANIZATION	National	nn	4	SENT_281	[p20l748t799r923b837],
3	Asthma	NNP	ORGANIZATION	Asthma	nn	4	SENT_281	[p20l937t799r1099b837],
4	Education	NNP	ORGANIZATION	Education	dep	1	SENT_281	[p20l1115t799r1322b837],
5	and	CC	O	and	_	0	SENT_281	[p20l1336t799r1413b837],
6	Prevention	NNP	O	Prevention	nn	7	SENT_281	[p20l1428t802r1652b837],
7	Program	NNP	O	Program	conj_and	4	SENT_281	[p20l1668t803r1858b849],
8	,	,	O	,	_	0	SENT_281	[p20l1668t803r1858b849],
9	Expert	NNP	O	Expert	nn	11	SENT_281	[p20l1876t802r2007b848],
10	Panel	NNP	O	Panel	nn	11	SENT_281	[p20l2022t799r2136b837],
11	Report	NNP	O	Report	appos	4	SENT_281	[p20l749t859r896b904],
12	.	.	O	.	_	0	SENT_281	[p20l749t859r896b904],

1	Guidelines	NNS	O	guideline	_	0	SENT_282	[p20l914t855r1137b892],
2	for	IN	O	for	advmod	8	SENT_282	[p20l1153t855r1212b892],
3	the	DT	O	the	det	4	SENT_282	[p20l1224t855r1289b892],
4	diagnosis	NN	O	diagnosis	dobj	8	SENT_282	[p20l1304t855r1498b904],
5	and	CC	O	and	_	0	SENT_282	[p20l1514t855r1590b892],
6	management	NN	O	management	conj_and	4	SENT_282	[p20l1604t862r1879b904],
7	of	IN	O	of	prep	4	SENT_282	[p20l1893t855r1939b892],
8	asthma	NN	O	asthma	dep	1	SENT_282	[p20l1946t855r2107b898],
9	,	,	O	,	_	0	SENT_282	[p20l1946t855r2107b898],
10	update	VBP	O	update	ccomp	8	SENT_282	[p20l746t911r887b959],
11	on	IN	O	on	_	0	SENT_282	[p20l902t924r953b948],
12	selected	VBN	O	select	amod	13	SENT_282	[p20l969t911r1131b948],
13	topics	NNS	O	topic	prep_on	10	SENT_282	[p20l1144t913r1276b959],
14	,	,	O	,	_	0	SENT_282	[p20l1144t913r1276b959],
15	2002	CD	DATE	2002	dep	10	SENT_282	[p20l1294t914r1400b948],
16	.	.	O	.	_	0	SENT_282	[p20l1294t914r1400b948],
17	]	SYM	O	]	dep	1	SENT_282	[p20l1411t914r1436b960],

1	Allergy	NNP	O	Allergy	nn	3	SENT_283	[p20l1447t911r1583b960],
2	Clin	NNP	O	Clin	nn	3	SENT_283	[p20l1599t911r1681b948],
3	Immanol	NNP	O	Immanol	_	0	SENT_283	[p20l1697t911r1879b948],
4	2002	CD	DATE	2002	num	6	SENT_283	[p20l1893t914r2000b954],
5	;	:	O	;	_	0	SENT_283	[p20l1893t914r2000b954],
6	110	CD	NUMBER	110	dep	3	SENT_283	[p20l2018t914r2099b948],
7	:	:	O	:	_	0	SENT_283	[p20l2018t914r2099b948],
8	S141	NN	O	s141	dep	3	SENT_283	[p20l750t969r932b1004],
9	—	CD	NUMBER	—	number	10	SENT_283	[p20l750t969r932b1004],
10	18	CD	NUMBER	18	dep	8	SENT_283	[p20l750t969r932b1004],
11	.	.	O	.	_	0	SENT_283	[p20l750t969r932b1004],

1	National	NNP	O	National	nn	2	SENT_284	[p20l151t1350r403b1404],
2	Heart	NNP	O	Heart	_	0	SENT_284	[p20l428t1356r598b1404],
3	Lung	NN	O	lung	dep	2	SENT_284	[p20l621t1356r772b1421],
4	and	CC	O	and	_	0	SENT_284	[p20l794t1350r904b1404],
5	Blood	NN	ORGANIZATION	blood	dep	2	SENT_284	[p20l927t1350r1097b1404],
6	Institute	NNP	ORGANIZATION	Institute	dep	3	SENT_284	[p20l1121t1354r1389b1404],
7	.	.	O	.	_	0	SENT_284	[p20l1121t1354r1389b1404],

1	NHLBI/WHO	NNP	O	NHLBI/WHO	nn	3	SENT_285	[p20l1415t1355r1840b1420],
2	Workshop	NNP	O	Workshop	nn	3	SENT_285	[p20l147t1430r457b1500],
3	Report	NNP	O	Report	_	0	SENT_285	[p20l483t1436r695b1500],
4	:	:	O	:	_	0	SENT_285	[p20l483t1436r695b1500],
5	Global	NNP	O	Global	nn	6	SENT_285	[p20l722t1430r916b1483],
6	strategy	NN	O	strategy	dep	3	SENT_285	[p20l940t1441r1171b1501],
7	for	IN	O	for	_	0	SENT_285	[p20l1191t1430r1276b1483],
8	asthma	NN	O	asthma	nn	9	SENT_285	[p20l1297t1430r1515b1483],
9	management	NN	O	management	prep_for	6	SENT_285	[p20l1536t1441r1933b1501],
10	and	CC	O	and	_	0	SENT_285	[p20l149t1511r259b1564],
11	prevention	NN	O	prevention	prep_for	6	SENT_285	[p20l280t1514r617b1580],
12	.	.	O	.	_	0	SENT_285	[p20l280t1514r617b1580],

1	Global	JJ	O	global	amod	2	SENT_286	[p20l644t1511r838b1564],
2	Initiative	NNP	O	Initiative	_	0	SENT_286	[p20l862t1514r1127b1564],
3	for	IN	O	for	_	0	SENT_286	[p20l1149t1511r1234b1564],
4	Asthma	NNP	O	Asthma	prep_for	2	SENT_286	[p20l1253t1511r1503b1564],
5	.	.	O	.	_	0	SENT_286	[p20l1253t1511r1503b1564],

1	Bethesda	NNP	LOCATION	Bethesda	nn	3	SENT_287	[p20l1530t1511r1815b1572],
2	,	,	O	,	_	0	SENT_287	[p20l1530t1511r1815b1572],
3	MD	NNP	O	MD	_	0	SENT_287	[p20l1841t1516r1968b1564],
4	:	:	O	:	_	0	SENT_287	[p20l1841t1516r1968b1564],
5	National	NNP	O	National	nn	6	SENT_287	[p20l151t1590r403b1644],
6	Heart	NNP	O	Heart	dep	10	SENT_287	[p20l428t1596r598b1644],
7	Lung	NN	O	lung	amod	10	SENT_287	[p20l621t1596r772b1661],
8	and	CC	O	and	_	0	SENT_287	[p20l794t1590r904b1644],
9	Blood	NN	ORGANIZATION	blood	amod	10	SENT_287	[p20l927t1590r1097b1644],
10	Institute	NNP	ORGANIZATION	Institute	dep	3	SENT_287	[p20l1121t1594r1389b1644],
11	.	.	O	.	_	0	SENT_287	[p20l1121t1594r1389b1644],

1	Publication	NN	O	publication	_	0	SENT_288	[p20l1416t1590r1756b1644],
2	#	#	MONEY	#	dep	3	SENT_288	[p20l1776t1594r2047b1644],
3	95-3659 1995	CD	MONEY	95-3659 1995	dep	1	SENT_288	[p20l153t1673r304b1724],[p20l1776t1594r2047b1644],
4	.	.	O	.	_	0	SENT_288	[p20l153t1673r304b1724],

1	Sears	NNP	ORGANIZATION	Sears	nn	2	SENT_289	[p20l153t1765r307b1815],
2	MR	NN	ORGANIZATION	mr	_	0	SENT_289	[p20l333t1767r454b1823],
3	,	,	O	,	_	0	SENT_289	[p20l333t1767r454b1823],
4	Taylor	NNP	PERSON	Taylor	nn	5	SENT_289	[p20l477t1762r667b1832],
5	DR	NN	O	dr	appos	2	SENT_289	[p20l690t1767r799b1823],
6	,	,	O	,	_	0	SENT_289	[p20l690t1767r799b1823],
7	Print	NN	O	print	nn	8	SENT_289	[p20l826t1765r975b1814],
8	CG	NN	O	cg	appos	2	SENT_289	[p20l998t1765r1109b1823],
9	,	,	O	,	_	0	SENT_289	[p20l998t1765r1109b1823],
10	et	FW	O	et	nn	11	SENT_289	[p20l1134t1772r1186b1815],
11	al.	FW	O	al.	appos	2	SENT_289	[p20l1208t1762r1271b1815],
12	.	.	O	.	_	0	SENT_289	[p20l1208t1762r1271b1815],

1	Regular	JJ	O	regular	nsubj	2	SENT_290	[p20l1298t1762r1530b1832],
2	inhaled	VBN	O	inhale	_	0	SENT_290	[p20l1550t1762r1775b1815],
3	betaagonist	NN	O	betaagonist	nn	4	SENT_290	[p20l1794t1762r1937b1815, p20l149t1845r367b1912],
4	treatment	NN	O	treatment	dobj	2	SENT_290	[p20l386t1852r681b1894],
5	in	IN	O	in	_	0	SENT_290	[p20l701t1845r760b1894],
6	bronchial	JJ	O	bronchial	amod	7	SENT_290	[p20l781t1841r1066b1894],
7	asthma	NN	O	asthma	prep_in	4	SENT_290	[p20l1088t1841r1321b1894],
8	.	.	O	.	_	0	SENT_290	[p20l1088t1841r1321b1894],

1	Lancet	NNP	O	Lancet	_	0	SENT_291	[p20l1348t1847r1533b1894],
2	1990	CD	DATE	1990	num	1	SENT_291	[p20l1556t1846r1708b1903],
3	;	:	O	;	_	0	SENT_291	[p20l1556t1846r1708b1903],
4	336	CD	NUMBER	336	num	6	SENT_291	[p20l1734t1846r1853b1894],
5	:	:	O	:	_	0	SENT_291	[p20l1734t1846r1853b1894],
6	1391-96	CD	NUMBER	1391-96	dep	1	SENT_291	[p20l153t1926r412b1974],
7	.	.	O	.	_	0	SENT_291	[p20l153t1926r412b1974],

1	Taylor	NNP	PERSON	Taylor	nn	2	SENT_292	[p20l147t2010r338b2080],
2	DR	NN	O	dr	_	0	SENT_292	[p20l361t2016r470b2072],
3	,	,	O	,	_	0	SENT_292	[p20l361t2016r470b2072],
4	Sears	NNP	ORGANIZATION	Sears	nn	5	SENT_292	[p20l498t2015r653b2064],
5	MR	NN	ORGANIZATION	mr	appos	2	SENT_292	[p20l678t2016r799b2072],
6	,	,	O	,	_	0	SENT_292	[p20l678t2016r799b2072],
7	Herbison	NNP	PERSON	Herbison	nn	8	SENT_292	[p20l826t2010r1107b2064],
8	GP	NNP	O	GP	appos	2	SENT_292	[p20l1130t2015r1237b2072],
9	,	,	O	,	_	0	SENT_292	[p20l1130t2015r1237b2072],
10	et	FW	O	et	nn	11	SENT_292	[p20l1262t2021r1314b2064],
11	al.	FW	O	al.	appos	2	SENT_292	[p20l1335t2010r1399b2064],
12	.	.	O	.	_	0	SENT_292	[p20l1335t2010r1399b2064],

1	Regular	JJ	O	regular	_	0	SENT_293	[p20l1426t2010r1658b2081],
2	inhaled	VBN	O	inhale	partmod	1	SENT_293	[p20l1678t2010r1903b2064],
3	beta	NN	O	beta	nn	4	SENT_293	[p20l1922t2010r2046b2064],
4	agonist	NN	O	agonist	dobj	2	SENT_293	[p20l149t2094r367b2160],
5	in	IN	O	in	_	0	SENT_293	[p20l387t2094r446b2143],
6	asthma	NN	O	asthma	prep_in	4	SENT_293	[p20l468t2090r700b2143],
7	:	:	O	:	_	0	SENT_293	[p20l468t2090r700b2143],
8	effects	NNS	O	effect	dep	1	SENT_293	[p20l726t2090r916b2143],
9	on	IN	O	on	_	0	SENT_293	[p20l941t2109r1015b2143],
10	exacerbations	NNS	O	exacerbation	prep_on	8	SENT_293	[p20l1036t2090r1441b2143],
11	and	CC	O	and	_	0	SENT_293	[p20l1465t2090r1575b2143],
12	lung	NN	O	lung	nn	13	SENT_293	[p20l1594t2090r1731b2161],
13	function	NN	O	function	conj_and	10	SENT_293	[p20l1752t2090r2020b2143],
14	.	.	O	.	_	0	SENT_293	[p20l1752t2090r2020b2143],

1	Thorax	NNP	O	Thorax	_	0	SENT_294	[p20l154t2171r359b2225],
2	1993	CD	DATE	1993	num	1	SENT_294	[p20l382t2176r534b2233],
3	;	:	O	;	_	0	SENT_294	[p20l382t2176r534b2233],
4	48	CD	NUMBER	48	num	6	SENT_294	[p20l558t2176r641b2225],
5	:	:	O	:	_	0	SENT_294	[p20l558t2176r641b2225],
6	134	CD	NUMBER	134	dep	1	SENT_294	[p20l669t2176r785b2225],
7	.	.	O	.	_	0	SENT_294	[p20l669t2176r785b2225],

1	Wahedna	NNP	O	Wahedna	nn	2	SENT_295	[p20l147t2260r432b2314],
2	I	NNP	O	I	_	0	SENT_295	[p20l456t2266r493b2322],
3	,	,	O	,	_	0	SENT_295	[p20l456t2266r493b2322],
4	Wong	NNP	PERSON	Wong	nn	5	SENT_295	[p20l516t2266r695b2331],
5	CS	NNP	O	CS	appos	2	SENT_295	[p20l718t2264r817b2321],
6	,	,	O	,	_	0	SENT_295	[p20l718t2264r817b2321],
7	Wisniewski	NNP	PERSON	Wisniewski	nn	8	SENT_295	[p20l840t2260r1189b2314],
8	AFZ	NNP	O	AFZ	appos	2	SENT_295	[p20l1209t2263r1359b2321],
9	,	,	O	,	_	0	SENT_295	[p20l1209t2263r1359b2321],
10	Pavord	NNP	PERSON	Pavord	nn	11	SENT_295	[p20l1386t2260r1591b2313],
11	ID	NNP	O	ID	appos	2	SENT_295	[p20l1614t2266r1703b2321],
12	,	,	O	,	_	0	SENT_295	[p20l1614t2266r1703b2321],
13	Tattersﬁeld	NNP	O	Tattersﬁeld	nn	14	SENT_295	[p20l147t2341r489b2394],
14	AE	NNP	O	AE	appos	2	SENT_295	[p20l509t2344r611b2394],
15	.	.	O	.	_	0	SENT_295	[p20l509t2344r611b2394],

1	Asthma	NN	O	asthma	nn	2	SENT_296	[p20l635t2341r869b2394],
2	control	NN	O	control	conj_and	2	SENT_296	[p20l891t2341r1101b2394],
3	during	IN	O	during	_	0	SENT_296	[p20l1123t2341r1324b2411],
4	and	CC	O	and	_	0	SENT_296	[p20l1346t2341r1456b2394],
5	after	IN	O	after	_	0	SENT_296	[p20l1477t2341r1613b2394],
6	cessation	NN	O	cessation	prep_after	2	SENT_296	[p20l1634t2344r1908b2394],
7	of	IN	O	of	_	0	SENT_296	[p20l1930t2341r1996b2394],
8	regular	JJ	O	regular	amod	11	SENT_296	[p20l148t2421r364b2491],
9	beta	NN	O	beta	nn	11	SENT_296	[p20l383t2421r507b2474],
10	2-agonist	JJ	O	2-agonist	amod	11	SENT_296	[p20l519t2424r775b2491],
11	treatment	NN	O	treatment	prep_of	2	SENT_296	[p20l794t2431r1103b2474],
12	.	.	O	.	_	0	SENT_296	[p20l794t2431r1103b2474],

1	Am	VBP	O	be	dep	4	SENT_297	[p20l1127t2424r1231b2473],
2	Rev	NN	O	rev	nn	4	SENT_297	[p20l1255t2426r1354b2474],
3	Respir	NNP	O	Respir	nn	4	SENT_297	[p20l1378t2422r1554b2490],
4	Dis	NNP	O	Dis	_	0	SENT_297	[p20l1575t2422r1666b2473],
5	1993	CD	DATE	1993	num	4	SENT_297	[p20l1690t2425r1823b2474],
6	;	:	O	;	_	0	SENT_297	[p20l1832t2440r1842b2482],
7	148	CD	NUMBER	148	dep	4	SENT_297	[p20l1868t2425r1985b2474],
8	:	:	O	:	_	0	SENT_297	[p20l1868t2425r1985b2474],
9	707-12	CD	NUMBER	707-12	dep	7	SENT_297	[p20l151t2504r376b2556],
10	.	.	O	.	_	0	SENT_297	[p20l151t2504r376b2556],

1	Drazen	NNP	PERSON	Drazen	nn	2	SENT_298	[p20l152t2597r367b2645],
2	IM	NNP	PERSON	IM	_	0	SENT_298	[p20l390t2597r491b2660],
3	,	,	O	,	_	0	SENT_298	[p20l390t2597r491b2660],
4	Israel	NNP	LOCATION	Israel	nn	5	SENT_298	[p20l519t2592r682b2645],
5	E	NNP	O	E	appos	2	SENT_298	[p20l707t2595r758b2653],
6	,	,	O	,	_	0	SENT_298	[p20l707t2595r758b2653],
7	Boushey	NNP	LOCATION	Boushey	nn	8	SENT_298	[p20l785t2592r1039b2662],
8	HA	NNP	LOCATION	HA	appos	2	SENT_298	[p20l1062t2596r1179b2653],
9	,	,	O	,	_	0	SENT_298	[p20l1062t2596r1179b2653],
10	et	FW	O	et	nn	11	SENT_298	[p20l1204t2603r1256b2645],
11	al.	FW	O	al.	appos	2	SENT_298	[p20l1277t2592r1341b2645],
12	.	.	O	.	_	0	SENT_298	[p20l1277t2592r1341b2645],

1	Comparison	NN	O	comparison	nsubj	4	SENT_299	[p20l1367t2595r1737b2661],
2	of	IN	O	of	prep	1	SENT_299	[p20l1758t2592r1825b2645],
3	regularly	RB	O	regularly	pcomp	2	SENT_299	[p20l1835t2592r2103b2662],
4	scheduled	VBN	O	schedule	_	0	SENT_299	[p20l151t2670r451b2724],
5	with	IN	O	with	_	0	SENT_299	[p20l470t2670r602b2723],
6	as-needed	JJ	O	as-needed	amod	7	SENT_299	[p20l625t2670r922b2724],
7	use	NN	O	use	prep_with	4	SENT_299	[p20l942t2689r1043b2724],
8	of	IN	O	of	_	0	SENT_299	[p20l1066t2670r1132b2724],
9	albuterol	NN	O	albuterol	prep_of	7	SENT_299	[p20l1144t2670r1409b2724],
10	in	IN	O	in	_	0	SENT_299	[p20l1430t2674r1489b2723],
11	mild	JJ	O	mild	amod	12	SENT_299	[p20l1511t2670r1650b2724],
12	asthma	NN	O	asthma	prep_in	9	SENT_299	[p20l1671t2670r1903b2724],
13	.	.	O	.	_	0	SENT_299	[p20l1671t2670r1903b2724],

1	N	NN	O	n	nn	3	SENT_300	[p20l152t2756r203b2804],
2	Engl	NNP	O	Engl	nn	3	SENT_300	[p20l224t2751r394b2821],
3	]	NNP	O	]	nsubj	4	SENT_300	[p20l224t2751r394b2821],
4	Med	VBD	O	med	_	0	SENT_300	[p20l415t2751r537b2804],
5	1996	CD	DATE	1996	dobj	4	SENT_300	[p20l561t2756r713b2812],
6	;	:	O	;	_	0	SENT_300	[p20l561t2756r713b2812],
7	335	CD	NUMBER	335	num	9	SENT_300	[p20l739t2753r858b2804],
8	:	:	O	:	_	0	SENT_300	[p20l739t2753r858b2804],
9	841-47	CD	NUMBER	841-47	dep	5	SENT_300	[p20l882t2754r1109b2807],
10	.	.	O	.	_	0	SENT_300	[p20l882t2754r1109b2807],

1	Dennis	NNP	PERSON	Dennis	nn	2	SENT_301	[p20l152t2845r363b2895],
2	SM	NNP	PERSON	SM	_	0	SENT_301	[p20l392t2845r504b2903],
3	,	,	O	,	_	0	SENT_301	[p20l392t2845r504b2903],
4	Sharp	NNP	PERSON	Sharp	nn	6	SENT_301	[p20l532t2842r704b2911],
5	S	NNP	O	S	nn	6	SENT_301	[p20l730t2845r805b2910],
6	]	NN	O	]	appos	2	SENT_301	[p20l730t2845r805b2910],
7	,	,	O	,	_	0	SENT_301	[p20l730t2845r805b2910],
8	Vickers	NNP	PERSON	Vickers	nn	9	SENT_301	[p20l828t2842r1050b2895],
9	MR	NN	PERSON	mr	appos	2	SENT_301	[p20l1076t2847r1197b2903],
10	,	,	O	,	_	0	SENT_301	[p20l1076t2847r1197b2903],
11	et	FW	O	et	nn	12	SENT_301	[p20l1222t2852r1274b2895],
12	al.	FW	O	al.	appos	2	SENT_301	[p20l1295t2842r1359b2895],
13	.	.	O	.	_	0	SENT_301	[p20l1295t2842r1359b2895],

1	Regular	JJ	O	regular	nsubj	2	SENT_302	[p20l1386t2842r1618b2912],
2	inhaled	VBN	O	inhale	_	0	SENT_302	[p20l1638t2842r1862b2895],
3	salbutamol	NN	O	salbutamol	nn	6	SENT_302	[p20l151t2921r480b2974],
4	and	CC	O	and	_	0	SENT_302	[p20l502t2921r612b2974],
5	asthma	NN	O	asthma	nn	6	SENT_302	[p20l633t2921r851b2974],
6	control	NN	O	control	dobj	2	SENT_302	[p20l873t2921r1098b2974],
7	:	:	O	:	_	0	SENT_302	[p20l873t2921r1098b2974],
8	the	DT	O	the	det	9	SENT_302	[p20l1121t2921r1214b2974],
9	TRUST	NNP	O	TRUST	nsubj	10	SENT_302	[p20l1235t2924r1463b2974],
10	randomised	VBD	O	randomise	parataxis	2	SENT_302	[p20l1483t2921r1842b2974],
11	trial	NN	O	trial	dobj	10	SENT_302	[p20l1862t2921r1996b2974],
12	.	.	O	.	_	0	SENT_302	[p20l1862t2921r1996b2974],

1	Lancet	NNP	O	Lancet	_	0	SENT_303	[p20l152t3007r336b3056],
2	2000	CD	DATE	2000	num	1	SENT_303	[p20l357t3007r512b3064],
3	;	:	O	;	_	0	SENT_303	[p20l357t3007r512b3064],
4	355	CD	NUMBER	355	num	6	SENT_303	[p20l537t3005r656b3056],
5	:	:	O	:	_	0	SENT_303	[p20l537t3005r656b3056],
6	1675-79	CD	NUMBER	1675-79	dep	1	SENT_303	[p20l684t3006r944b3058],
7	.	.	O	.	_	0	SENT_303	[p20l684t3006r944b3058],

1	Green	NNP	ORGANIZATION	Green	nn	4	SENT_304	[p20l151t3096r334b3145],
2	SA	NNP	ORGANIZATION	SA	nn	4	SENT_304	[p20l359t3096r456b3153],
3	,	,	O	,	_	0	SENT_304	[p20l359t3096r456b3153],
4	Turl	NNP	O	Turl	_	0	SENT_304	[p20l479t3091r645b3145],
5	<	JJR	O	<	dep	4	SENT_304	[p20l479t3091r645b3145],
6	i	FW	O	i	dep	5	SENT_304	[p20l479t3091r645b3145],
7	I	PRP	O	I	dep	4	SENT_304	[p20l668t3097r705b3160],
8	,	,	O	,	_	0	SENT_304	[p20l668t3097r705b3160],
9	Innis	NNP	PERSON	Innis	nn	10	SENT_304	[p20l732t3095r886b3145],
10	M	NNP	O	M	appos	7	SENT_304	[p20l911t3097r985b3153],
11	,	,	O	,	_	0	SENT_304	[p20l911t3097r985b3153],
12	Liggett	NNP	ORGANIZATION	Liggett	nn	13	SENT_304	[p20l1012t3095r1215b3162],
13	SB	NN	O	sb	appos	4	SENT_304	[p20l1240t3096r1334b3145],
14	.	.	O	.	_	0	SENT_304	[p20l1240t3096r1334b3145],

1	Amino-terminal	JJ	O	amino-terminal	amod	2	SENT_305	[p20l1357t3091r1844b3145],
2	polymorphisms	NNS	O	polymorphism	nsubj	9	SENT_305	[p20l148t3172r619b3242],
3	of	IN	O	of	_	0	SENT_305	[p20l644t3172r710b3225],
4	the	DT	O	the	det	8	SENT_305	[p20l720t3172r813b3225],
5	human	JJ	O	human	amod	8	SENT_305	[p20l834t3172r1051b3225],
6	beta	NN	O	beta	nn	8	SENT_305	[p20l1071t3172r1195b3225],
7	2-adrenergic	JJ	O	2-adrenergic	amod	8	SENT_305	[p20l1217t3172r1590b3242],
8	receptor	NN	O	receptor	prep_of	2	SENT_305	[p20l1611t3183r1858b3242],
9	impart	VB	O	impart	_	0	SENT_305	[p20l1878t3175r2080b3242],
10	distinct	JJ	O	distinct	amod	13	SENT_305	[p20l149t3252r372b3305],
11	agonist-promoted	JJ	O	agonist-promoted	amod	13	SENT_305	[p20l393t3252r924b3322],
12	regulatory	JJ	O	regulatory	amod	13	SENT_305	[p20l945t3252r1250b3322],
13	properties	NNS	O	property	dobj	9	SENT_305	[p20l1270t3255r1589b3321],
14	.	.	O	.	_	0	SENT_305	[p20l1270t3255r1589b3321],

1	Biochemistry	NNP	O	Biochemistry	_	0	SENT_306	[p20l1618t3252r1981b3321],
2	1994	CD	DATE	1994	num	1	SENT_306	[p20l153t3337r304b3393],
3	;	:	O	;	_	0	SENT_306	[p20l153t3337r304b3393],
4	33	CD	NUMBER	33	num	6	SENT_306	[p20l330t3337r413b3386],
5	:	:	O	:	_	0	SENT_306	[p20l330t3337r413b3386],
6	9414-19	CD	NUMBER	9414-19	dep	1	SENT_306	[p20l438t3336r700b3386],
7	.	.	O	.	_	0	SENT_306	[p20l438t3336r700b3386],

1	Israel	NNP	LOCATION	Israel	nn	2	SENT_307	[p20l152t3423r316b3476],
2	E	NNP	O	E	_	0	SENT_307	[p20l340t3426r391b3484],
3	,	,	O	,	_	0	SENT_307	[p20l340t3426r391b3484],
4	Drazen	NNP	PERSON	Drazen	nn	5	SENT_307	[p20l418t3428r634b3476],
5	IM	NNP	PERSON	IM	appos	2	SENT_307	[p20l656t3428r758b3491],
6	,	,	O	,	_	0	SENT_307	[p20l656t3428r758b3491],
7	Liggett	NNP	ORGANIZATION	Liggett	nn	8	SENT_307	[p20l785t3426r988b3493],
8	SB	NN	O	sb	appos	2	SENT_307	[p20l1013t3427r1107b3484],
9	,	,	O	,	_	0	SENT_307	[p20l1013t3427r1107b3484],
10	et	FW	O	et	nn	11	SENT_307	[p20l1132t3434r1184b3476],
11	al.	FW	O	al.	appos	2	SENT_307	[p20l1204t3423r1268b3476],
12	.	.	O	.	_	0	SENT_307	[p20l1204t3423r1268b3476],

1	The	DT	O	the	det	2	SENT_308	[p20l1292t3423r1406b3476],
2	effect	NN	O	effect	_	0	SENT_308	[p20l1429t3423r1592b3476],
3	of	IN	O	of	_	0	SENT_308	[p20l1613t3423r1679b3476],
4	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_308	[p20l148t3502r619b3572],
5	of	IN	O	of	_	0	SENT_308	[p20l644t3502r710b3556],
6	the	DT	O	the	det	8	SENT_308	[p20l720t3502r813b3556],
7	beta	NN	O	beta	nn	8	SENT_308	[p20l834t3502r1380b3573],
8	(	NN	O	(	prep_of	4	SENT_308	[p20l834t3502r1380b3573],
9	2	CD	NUMBER	2	dep	8	SENT_308	[p20l834t3502r1380b3573],
10	)	SYM	O	)	dep	2	SENT_308	[p20l834t3502r1380b3573],
11	-	:	O	-	_	0	SENT_308	[p20l834t3502r1380b3573],
12	adrenergic	JJ	O	adrenergic	amod	13	SENT_308	[p20l834t3502r1380b3573],
13	receptor	NN	O	receptor	dep	2	SENT_308	[p20l1401t3513r1647b3572],
14	on	IN	O	on	_	0	SENT_308	[p20l1668t3521r1742b3556],
15	the	DT	O	the	det	16	SENT_308	[p20l1763t3502r1855b3556],
16	response	NN	O	response	prep_on	13	SENT_308	[p20l1877t3521r2144b3572],
17	to	TO	O	to	_	0	SENT_308	[p20l148t3593r203b3635],
18	regular	JJ	O	regular	amod	19	SENT_308	[p20l225t3582r441b3652],
19	use	NN	O	use	prep_to	16	SENT_308	[p20l460t3601r561b3635],
20	of	IN	O	of	_	0	SENT_308	[p20l584t3582r650b3635],
21	albuterol	NN	O	albuterol	prep_of	19	SENT_308	[p20l662t3582r927b3635],
22	in	IN	O	in	_	0	SENT_308	[p20l948t3586r1008b3635],
23	asthma	NN	O	asthma	prep_in	21	SENT_308	[p20l1029t3582r1262b3635],
24	.	.	O	.	_	0	SENT_308	[p20l1029t3582r1262b3635],

1	Am	VBP	O	be	cop	2	SENT_309	[p20l1286t3586r1390b3635],
2	]	CD	NUMBER	]	dep	6	SENT_309	[p20l1402t3588r1437b3652],
3	Respir	NNP	O	Respir	nn	5	SENT_309	[p20l1460t3584r1636b3652],
4	Crit	NNP	O	Crit	nn	5	SENT_309	[p20l1658t3584r1767b3635],
5	Care	NNP	O	Care	nsubj	6	SENT_309	[p20l1792t3586r1921b3635],
6	Med	VBD	O	med	_	0	SENT_309	[p20l1944t3582r2066b3635],
7	2000	CD	DATE	2000	dobj	6	SENT_309	[p20l150t3668r304b3725],
8	;	:	O	;	_	0	SENT_309	[p20l150t3668r304b3725],
9	162	CD	NUMBER	162	num	11	SENT_309	[p20l331t3668r449b3717],
10	:	:	O	:	_	0	SENT_309	[p20l331t3668r449b3717],
11	75-80	CD	NUMBER	75-80	dep	7	SENT_309	[p20l475t3667r665b3718],
12	.	.	O	.	_	0	SENT_309	[p20l475t3667r665b3718],

1	Taylor	NNP	PERSON	Taylor	nn	2	SENT_310	[p21l147t21r338b91],
2	DR	NN	O	dr	_	0	SENT_310	[p21l361t27r470b83],
3	,	,	O	,	_	0	SENT_310	[p21l361t27r470b83],
4	Drazen	NNP	PERSON	Drazen	nn	6	SENT_310	[p21l497t27r712b75],
5	]	CD	NUMBER	]	num	6	SENT_310	[p21l735t27r836b90],
6	M	NN	O	m	appos	2	SENT_310	[p21l735t27r836b90],
7	,	,	O	,	_	0	SENT_310	[p21l735t27r836b90],
8	Herbison	NNP	PERSON	Herbison	nn	9	SENT_310	[p21l864t21r1144b75],
9	GP	NNP	O	GP	appos	6	SENT_310	[p21l1168t26r1274b83],
10	,	,	O	,	_	0	SENT_310	[p21l1168t26r1274b83],
11	Yandava	NNP	O	Yandava	nn	12	SENT_310	[p21l1297t21r1549b75],
12	CN	NN	O	cn	appos	6	SENT_310	[p21l1572t26r1683b83],
13	,	,	O	,	_	0	SENT_310	[p21l1572t26r1683b83],
14	Hancox	NN	PERSON	hancox	nn	15	SENT_310	[p21l1710t27r1938b75],
15	R	NN	O	r	appos	6	SENT_310	[p21l1962t27r2044b90],
16	]	CD	NUMBER	]	dep	15	SENT_310	[p21l1962t27r2044b90],
17	,	,	O	,	_	0	SENT_310	[p21l1962t27r2044b90],
18	Town	NNP	ORGANIZATION	Town	nn	19	SENT_310	[p21l147t105r317b155],
19	GI	NNP	O	GI	appos	6	SENT_310	[p21l340t106r430b155],
20	.	.	O	.	_	0	SENT_310	[p21l340t106r430b155],

1	Asthma	NN	O	asthma	nn	2	SENT_311	[p21l454t102r688b155],
2	exacerbations	NNS	O	exacerbation	_	0	SENT_311	[p21l711t102r1114b155],
3	during	IN	O	during	_	0	SENT_311	[p21l1139t102r1340b172],
4	long	JJ	O	long	amod	8	SENT_311	[p21l1360t102r1492b172],
5	term	NN	O	term	nn	8	SENT_311	[p21l1512t113r1655b155],
6	beta	NN	O	beta	nn	8	SENT_311	[p21l1675t102r1799b155],
7	agonist	NN	O	agonist	nn	8	SENT_311	[p21l1821t105r2038b172],
8	use	NN	O	use	prep_during	2	SENT_311	[p21l147t200r265b235],
9	:	:	O	:	_	0	SENT_311	[p21l147t200r265b235],
10	inﬂuence	NN	O	inﬂuence	dep	2	SENT_311	[p21l289t182r570b235],
11	of	IN	O	of	_	0	SENT_311	[p21l592t181r658b235],
12	beta	NN	O	beta	prep_of	10	SENT_311	[p21l668t182r868b252],
13	(	CD	NUMBER	(	num	12	SENT_311	[p21l668t182r868b252],
14	2	CD	NUMBER	2	num	17	SENT_311	[p21l668t182r868b252],
15	)	NN	O	)	nn	17	SENT_311	[p21l668t182r868b252],
16	adrenoceptor	NN	O	adrenoceptor	nn	17	SENT_311	[p21l895t182r1289b251],
17	polymorphism	NN	O	polymorphism	dep	10	SENT_311	[p21l1309t182r1767b251],
18	.	.	O	.	_	0	SENT_311	[p21l1309t182r1767b251],

1	Thorax	NNP	O	Thorax	_	0	SENT_312	[p21l1797t182r2002b235],
2	2000	CD	DATE	2000	num	1	SENT_312	[p21l151t265r665b323],
3	;	:	O	;	_	0	SENT_312	[p21l151t265r665b323],
4	55:762	CD	NUMBER	55:762	number	5	SENT_312	[p21l151t265r665b323],
5	—	CD	NUMBER	—	dep	1	SENT_312	[p21l151t265r665b323],
6	67	CD	NUMBER	67	dep	5	SENT_312	[p21l151t265r665b323],
7	.	.	O	.	_	0	SENT_312	[p21l151t265r665b323],

1	Martin	NNP	PERSON	Martin	nn	3	SENT_313	[p21l151t356r354b406],
2	R	NNP	O	R	nn	3	SENT_313	[p21l379t358r461b421],
3	]	NN	O	]	_	0	SENT_313	[p21l379t358r461b421],
4	,	,	O	,	_	0	SENT_313	[p21l379t358r461b421],
5	Kephart	NNP	ORGANIZATION	Kephart	nn	6	SENT_313	[p21l488t353r724b422],
6	DK	NNP	ORGANIZATION	DK	appos	3	SENT_313	[p21l747t358r856b414],
7	,	,	O	,	_	0	SENT_313	[p21l747t358r856b414],
8	Dyer	NNP	PERSON	Dyer	nn	9	SENT_313	[p21l883t358r1023b423],
9	AM	NNP	O	AM	appos	3	SENT_313	[p21l1042t357r1168b414],
10	,	,	O	,	_	0	SENT_313	[p21l1042t357r1168b414],
11	Fahy	NNP	PERSON	Fahy	nn	15	SENT_313	[p21l1196t353r1337b423],
12	I	PRP	O	I	dep	15	SENT_313	[p21l1358t358r1396b421],
13	,	,	O	,	_	0	SENT_313	[p21l1358t358r1396b421],
14	Kraft	NNP	PERSON	Kraft	dep	15	SENT_313	[p21l1423t353r1570b406],
15	M.	NNP	O	M.	appos	9	SENT_313	[p21l1593t358r1666b406],
16	Quality	NNP	O	Quality	nn	17	SENT_313	[p21l1693t353r1911b423],
17	control	NN	O	control	dep	3	SENT_313	[p21l1932t353r2141b406],
18	within	IN	O	within	_	0	SENT_313	[p21l147t431r341b485],
19	the	DT	O	the	det	23	SENT_313	[p21l362t431r454b485],
20	Asthma	NNP	ORGANIZATION	Asthma	nn	23	SENT_313	[p21l475t431r710b485],
21	Clinical	JJ	ORGANIZATION	clinical	amod	23	SENT_313	[p21l733t431r962b485],
22	Research	NNP	ORGANIZATION	Research	nn	23	SENT_313	[p21l986t431r1255b485],
23	Network	NNP	ORGANIZATION	Network	prep_within	17	SENT_313	[p21l1278t431r1546b485],
24	.	.	O	.	_	0	SENT_313	[p21l1278t431r1546b485],

1	Controlled	VBN	O	control	_	0	SENT_314	[p21l154t511r443b565],
2	Clin	NN	O	clin	nn	3	SENT_314	[p21l468t511r585b565],
3	Trials	NNS	O	trial	dobj	1	SENT_314	[p21l611t511r770b565],
4	2001	CD	DATE	2001	num	6	SENT_314	[p21l792t516r946b573],
5	;	:	O	;	_	0	SENT_314	[p21l792t516r946b573],
6	22	CD	NUMBER	22	dep	3	SENT_314	[p21l972t516r1055b565],
7	:	:	O	:	_	0	SENT_314	[p21l972t516r1055b565],
8	S207-21	NN	O	s207-21	dep	3	SENT_314	[p21l1083t515r1347b567],
9	.	.	O	.	_	0	SENT_314	[p21l1083t515r1347b567],

1	Martinez	NNP	PERSON	Martinez	_	0	SENT_315	[p21l151t606r420b656],
2	FD	NNP	O	FD	dobj	24	SENT_315	[p21l445t606r548b663],
3	,	,	O	,	_	0	SENT_315	[p21l445t606r548b663],
4	Graves	NNP	ORGANIZATION	Graves	nn	5	SENT_315	[p21l574t606r776b656],
5	PE	NNP	ORGANIZATION	PE	appos	2	SENT_315	[p21l802t606r896b663],
6	,	,	O	,	_	0	SENT_315	[p21l802t606r896b663],
7	Baldini	NNP	PERSON	Baldini	nn	8	SENT_315	[p21l923t603r1136b656],
8	M	NNP	O	M	appos	2	SENT_315	[p21l1159t608r1234b663],
9	,	,	O	,	_	0	SENT_315	[p21l1159t608r1234b663],
10	Solomon	NNP	ORGANIZATION	Solomon	nn	11	SENT_315	[p21l1262t603r1528b656],
11	S	NNP	ORGANIZATION	S	appos	2	SENT_315	[p21l1554t606r1602b663],
12	,	,	O	,	_	0	SENT_315	[p21l1554t606r1602b663],
13	Erickson	NNP	ORGANIZATION	Erickson	nn	15	SENT_315	[p21l1629t603r1888b656],
14	R.	NNP	ORGANIZATION	R.	nn	15	SENT_315	[p21l1913t608r1968b655],
15	Association	NNP	ORGANIZATION	Association	appos	2	SENT_315	[p21l148t685r495b734],
16	between	IN	O	between	_	0	SENT_315	[p21l515t681r765b734],
17	genetic	JJ	O	genetic	amod	18	SENT_315	[p21l787t685r1000b752],
18	polymorphisms	NNS	O	polymorphism	prep_between	15	SENT_315	[p21l1021t681r1492b751],
19	of	IN	O	of	_	0	SENT_315	[p21l1517t681r1582b734],
20	the	DT	O	the	det	22	SENT_315	[p21l1593t681r1686b734],
21	beta	NN	O	beta	nn	22	SENT_315	[p21l1706t681r1830b734],
22	2adrenoceptor	NN	O	2adrenoceptor	prep_of	2	SENT_315	[p21l1853t686r1903b734, p21l149t762r544b832],
23	and	CC	O	and	advmod	2	SENT_315	[p21l565t762r675b815],
24	response	NN	O	response	dep	1	SENT_315	[p21l695t781r962b832],
25	to	TO	O	to	_	0	SENT_315	[p21l983t773r1038b815],
26	albuterol	NN	O	albuterol	prep_to	24	SENT_315	[p21l1061t762r1326b815],
27	in	IN	O	in	_	0	SENT_315	[p21l1348t765r1407b814],
28	children	NNS	O	child	prep_in	26	SENT_315	[p21l1429t762r1677b815],
29	with	IN	O	with	prep	24	SENT_315	[p21l1696t762r1829b815],
30	and	CC	O	and	_	0	SENT_315	[p21l1851t762r1960b815],
31	without	IN	O	without	prep	24	SENT_315	[p21l147t842r379b895],
32	a	DT	O	a	det	33	SENT_315	[p21l400t861r429b895],
33	history	NN	O	history	dep	31	SENT_315	[p21l449t842r658b912],
34	of	IN	O	of	_	0	SENT_315	[p21l678t841r744b895],
35	wheezing	VBG	O	wheeze	prepc_of	33	SENT_315	[p21l754t842r1057b912],
36	.	.	O	.	_	0	SENT_315	[p21l754t842r1057b912],
37	]	SYM	O	]	dep	1	SENT_315	[p21l1074t847r1109b912],

1	Clin	NNP	O	Clin	nn	2	SENT_316	[p21l1133t842r1250b895],
2	Invest	NNP	O	Invest	_	0	SENT_316	[p21l1275t847r1439b894],
3	1997	CD	DATE	1997	num	2	SENT_316	[p21l1463t845r1614b903],
4	;	:	O	;	_	0	SENT_316	[p21l1463t845r1614b903],
5	100	CD	NUMBER	100	num	7	SENT_316	[p21l1641t847r1759b895],
6	:	:	O	:	_	0	SENT_316	[p21l1641t847r1759b895],
7	3184-88	CD	NUMBER	3184-88	dep	2	SENT_316	[p21l1786t847r2046b895],
8	.	.	O	.	_	0	SENT_316	[p21l1786t847r2046b895],

1	Ross	NNP	PERSON	Ross	nn	2	SENT_317	[p21l152t938r287b986],
2	P	NN	O	p	_	0	SENT_317	[p21l314t938r366b995],
3	,	,	O	,	_	0	SENT_317	[p21l314t938r366b995],
4	Hall	NNP	PERSON	Hall	nn	5	SENT_317	[p21l393t933r519b986],
5	L	NNP	PERSON	L	appos	2	SENT_317	[p21l543t938r590b994],
6	,	,	O	,	_	0	SENT_317	[p21l543t938r590b994],
7	Smirnov	NNP	PERSON	Smirnov	nn	11	SENT_317	[p21l619t936r874b986],
8	I	PRP	O	I	dep	11	SENT_317	[p21l897t938r933b994],
9	,	,	O	,	_	0	SENT_317	[p21l897t938r933b994],
10	Haff	NNP	PERSON	Haff	dep	11	SENT_317	[p21l960t933r1104b986],
11	L.	NNP	O	L.	appos	2	SENT_317	[p21l1118t938r1165b986],
12	High	NNP	O	High	dep	11	SENT_317	[p21l1193t933r1344b1003],
13	level	NN	O	level	nn	15	SENT_317	[p21l1364t933r1499b986],
14	multiplex	JJ	O	multiplex	amod	15	SENT_317	[p21l1520t933r1808b1003],
15	genotyping	NN	O	genotyping	dep	2	SENT_317	[p21l150t1016r484b1083],
16	by	IN	O	by	_	0	SENT_317	[p21l504t1013r573b1083],
17	MALDI-TOF	NN	O	maldi-tof	nn	19	SENT_317	[p21l596t1016r974b1066],
18	mass	NN	O	mass	nn	19	SENT_317	[p21l998t1032r1150b1066],
19	spectrometry	NN	O	spectrometry	prep_by	15	SENT_317	[p21l1175t1024r1580b1083],
20	.	.	O	.	_	0	SENT_317	[p21l1175t1024r1580b1083],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_318	[p21l1608t1018r1713b1066],
2	Biotechnol	NNP	PERSON	Biotechnol	_	0	SENT_318	[p21l1737t1013r2031b1066],
3	1998	CD	DATE	1998	num	2	SENT_318	[p21l153t1096r700b1154],
4	;	:	O	;	_	0	SENT_318	[p21l153t1096r700b1154],
5	16:1347	CD	NUMBER	16:1347	number	6	SENT_318	[p21l153t1096r700b1154],
6	—	CD	NUMBER	—	dep	2	SENT_318	[p21l153t1096r700b1154],
7	51	CD	NUMBER	51	dep	6	SENT_318	[p21l153t1096r700b1154],
8	.	.	O	.	_	0	SENT_318	[p21l153t1096r700b1154],

1	Weir	NNP	O	Weir	nn	2	SENT_319	[p21l147t1187r295b1237],
2	TD	NNP	O	TD	_	0	SENT_319	[p21l314t1187r423b1246],
3	,	,	O	,	_	0	SENT_319	[p21l314t1187r423b1246],
4	Mallek	NNP	PERSON	Mallek	nn	5	SENT_319	[p21l450t1184r652b1237],
5	N	NNP	PERSON	N	appos	2	SENT_319	[p21l673t1189r736b1246],
6	,	,	O	,	_	0	SENT_319	[p21l673t1189r736b1246],
7	Sandford	NNP	PERSON	Sandford	nn	9	SENT_319	[p21l765t1184r1036b1237],
8	A	NNP	O	A	nn	9	SENT_319	[p21l1056t1188r1144b1253],
9	]	NN	O	]	appos	2	SENT_319	[p21l1056t1188r1144b1253],
10	,	,	O	,	_	0	SENT_319	[p21l1056t1188r1144b1253],
11	et	FW	O	et	nn	12	SENT_319	[p21l1168t1195r1221b1237],
12	al.	FW	O	al.	appos	2	SENT_319	[p21l1242t1184r1306b1237],
13	.	.	O	.	_	0	SENT_319	[p21l1242t1184r1306b1237],

1	Beta	NN	O	beta	_	0	SENT_320	[p21l1333t1189r1460b1237],
2	2-adrenergic	JJ	O	2-adrenergic	amod	4	SENT_320	[p21l1483t1184r1856b1254],
3	receptor	NN	O	receptor	nn	4	SENT_320	[p21l1877t1195r2123b1254],
4	haplotypes	NNS	O	haplotype	dep	1	SENT_320	[p21l147t1264r467b1334],
5	in	IN	O	in	_	0	SENT_320	[p21l491t1267r550b1316],
6	mild	JJ	O	mild	amod	12	SENT_320	[p21l571t1264r724b1325],
7	,	,	O	,	_	0	SENT_320	[p21l571t1264r724b1325],
8	moderate	JJ	O	moderate	conj_and	6	SENT_320	[p21l749t1264r1031b1317],
9	and	CC	O	and	_	0	SENT_320	[p21l1053t1264r1163b1317],
10	fatal/near	JJ	O	fatal/near	amod	12	SENT_320	[p21l1184t1264r1476b1333],
11	fatal	JJ	O	fatal	amod	12	SENT_320	[p21l1496t1263r1624b1317],
12	asthma	NN	O	asthma	prep_in	4	SENT_320	[p21l1646t1264r1879b1317],
13	.	.	O	.	_	0	SENT_320	[p21l1646t1264r1879b1317],

1	Am	VBP	O	be	cop	2	SENT_321	[p21l147t1347r300b1413],
2	]	CD	NUMBER	]	dep	6	SENT_321	[p21l147t1347r300b1413],
3	Respir	NNP	O	Respir	nn	5	SENT_321	[p21l322t1345r498b1413],
4	Crit	NNP	O	Crit	nn	5	SENT_321	[p21l520t1345r629b1396],
5	Care	NNP	O	Care	nsubj	6	SENT_321	[p21l654t1347r783b1396],
6	Med	VBD	O	med	_	0	SENT_321	[p21l806t1343r928b1396],
7	1998	CD	DATE	1998	dobj	6	SENT_321	[p21l952t1348r1103b1405],
8	;	:	O	;	_	0	SENT_321	[p21l952t1348r1103b1405],
9	158	CD	NUMBER	158	num	11	SENT_321	[p21l1130t1346r1247b1396],
10	:	:	O	:	_	0	SENT_321	[p21l1130t1346r1247b1396],
11	787-91	CD	NUMBER	787-91	dep	7	SENT_321	[p21l1273t1346r1498b1399],
12	.	.	O	.	_	0	SENT_321	[p21l1273t1346r1498b1399],

1	Chervinsky	NNP	PERSON	Chervinsky	nn	2	SENT_322	[p21l151t1435r489b1505],
2	P	NN	PERSON	p	_	0	SENT_322	[p21l511t1440r564b1496],
3	,	,	O	,	_	0	SENT_322	[p21l511t1440r564b1496],
4	van	NN	O	van	appos	2	SENT_322	[p21l586t1454r691b1488],
5	As	IN	O	as	rcmod	4	SENT_322	[p21l712t1438r786b1488],
6	A	DT	O	a	det	9	SENT_322	[p21l808t1438r870b1496],
7	,	,	O	,	_	0	SENT_322	[p21l808t1438r870b1496],
8	Bronsky	NNP	PERSON	Bronsky	nn	9	SENT_322	[p21l897t1435r1142b1505],
9	EA	NN	PERSON	ea	pobj	5	SENT_322	[p21l1164t1438r1263b1497],
10	,	,	O	,	_	0	SENT_322	[p21l1164t1438r1263b1497],
11	et	FW	O	et	nn	12	SENT_322	[p21l1289t1446r1341b1488],
12	al.	FW	O	al.	dep	4	SENT_322	[p21l1361t1435r1425b1488],
13	.	.	O	.	_	0	SENT_322	[p21l1361t1435r1425b1488],

1	Fluticasone	NN	O	fluticasone	_	0	SENT_323	[p21l1453t1435r1795b1488],
2	propionate	NN	O	propionate	dep	1	SENT_323	[p21l1816t1438r2140b1504],
3	aerosol	NN	O	aerosol	dep	2	SENT_323	[p21l149t1513r361b1567],
4	for	IN	O	for	_	0	SENT_323	[p21l382t1513r467b1567],
5	the	DT	O	the	det	6	SENT_323	[p21l487t1513r579b1567],
6	treatment	NN	O	treatment	prep_for	3	SENT_323	[p21l601t1524r896b1567],
7	of	IN	O	of	_	0	SENT_323	[p21l917t1513r983b1567],
8	adults	NNS	O	adult	prep_of	6	SENT_323	[p21l995t1513r1173b1567],
9	with	IN	O	with	prep	8	SENT_323	[p21l1194t1513r1326b1567],
10	mild	JJ	O	mild	dep	9	SENT_323	[p21l1348t1513r1487b1567],
11	to	TO	O	to	_	0	SENT_323	[p21l1506t1524r1561b1567],
12	moderate	JJ	O	moderate	amod	13	SENT_323	[p21l1583t1513r1865b1567],
13	asthma	NN	O	asthma	prep_to	10	SENT_323	[p21l1888t1513r2120b1567],
14	.	.	O	.	_	0	SENT_323	[p21l1888t1513r2120b1567],
15	]	SYM	O	]	dep	3	SENT_323	[p21l141t1599r176b1664],

1	Allergy	NN	O	allergy	nn	2	SENT_324	[p21l194t1594r391b1664],
2	Clin	NN	O	clin	_	0	SENT_324	[p21l416t1594r533b1647],
3	Immunol	NNP	O	Immunol	dep	2	SENT_324	[p21l557t1594r821b1647],
4	1994	CD	DATE	1994	num	3	SENT_324	[p21l845t1599r997b1655],
5	;	:	O	;	_	0	SENT_324	[p21l845t1599r997b1655],
6	94	CD	NUMBER	94	num	8	SENT_324	[p21l1022t1599r1105b1647],
7	:	:	O	:	_	0	SENT_324	[p21l1022t1599r1105b1647],
8	676-83	CD	NUMBER	676-83	dep	2	SENT_324	[p21l1131t1597r1357b1650],
9	.	.	O	.	_	0	SENT_324	[p21l1131t1597r1357b1650],

1	Haahtela	NN	ORGANIZATION	haahtelum	nn	2	SENT_325	[p21l152t1685r419b1738],
2	T	NN	ORGANIZATION	t	_	0	SENT_325	[p21l439t1688r496b1746],
3	,	,	O	,	_	0	SENT_325	[p21l439t1688r496b1746],
4	Iarvinen	NN	ORGANIZATION	iarvinen	nn	5	SENT_325	[p21l521t1688r772b1753],
5	M	NN	ORGANIZATION	m	appos	2	SENT_325	[p21l796t1690r870b1746],
6	,	,	O	,	_	0	SENT_325	[p21l796t1690r870b1746],
7	Kava	NN	PERSON	kava	nn	8	SENT_325	[p21l897t1690r1036b1738],
8	T	NN	O	t	appos	2	SENT_325	[p21l1056t1688r1112b1746],
9	,	,	O	,	_	0	SENT_325	[p21l1056t1688r1112b1746],
10	et	FW	O	et	nn	11	SENT_325	[p21l1137t1695r1189b1738],
11	al.	FW	O	al.	appos	2	SENT_325	[p21l1210t1685r1274b1738],
12	.	.	O	.	_	0	SENT_325	[p21l1210t1685r1274b1738],

1	Comparison	NN	O	comparison	_	0	SENT_326	[p21l1301t1688r1670b1754],
2	of	IN	O	of	_	0	SENT_326	[p21l1692t1685r1757b1738],
3	a	DT	O	a	det	4	SENT_326	[p21l1770t1704r1799b1738],
4	beta	NN	O	beta	prep_of	1	SENT_326	[p21l1819t1685r1943b1738],
5	2agonist	CD	NUMBER	2agonist	num	4	SENT_326	[p21l1966t1690r2015b1737, p21l149t1768r381b1834],
6	,	,	O	,	_	0	SENT_326	[p21l1966t1690r2015b1737, p21l149t1768r381b1834],
7	terbutaline	NN	O	terbutaline	appos	1	SENT_326	[p21l404t1764r748b1825],
8	,	,	O	,	_	0	SENT_326	[p21l404t1764r748b1825],
9	with	IN	O	with	_	0	SENT_326	[p21l770t1764r902b1817],
10	an	DT	O	a	prep_with	1	SENT_326	[p21l924t1783r995b1817],
11	inhaled	VBN	O	inhale	partmod	10	SENT_326	[p21l1016t1764r1241b1817],
12	corticosteroid	NN	O	corticosteroid	dobj	11	SENT_326	[p21l1262t1764r1685b1826],
13	,	,	O	,	_	0	SENT_326	[p21l1262t1764r1685b1826],
14	budesonide	NN	O	budesonide	appos	12	SENT_326	[p21l1708t1764r2072b1825],
15	,	,	O	,	_	0	SENT_326	[p21l1708t1764r2072b1825],
16	in	IN	O	in	_	0	SENT_326	[p21l148t1848r208b1897],
17	newly	RB	O	newly	advmod	18	SENT_326	[p21l229t1845r404b1915],
18	detected	VBN	O	detect	amod	19	SENT_326	[p21l425t1845r672b1898],
19	asthma	NN	O	asthma	prep_in	12	SENT_326	[p21l694t1845r926b1898],
20	.	.	O	.	_	0	SENT_326	[p21l694t1845r926b1898],

1	N	NN	O	n	nn	3	SENT_327	[p21l954t1850r1005b1898],
2	Engl	NNP	O	Engl	nn	3	SENT_327	[p21l1026t1845r1148b1915],
3	]	NNP	O	]	nsubj	4	SENT_327	[p21l1161t1850r1196b1915],
4	Med	VBD	O	med	_	0	SENT_327	[p21l1216t1845r1340b1898],
5	1991	CD	DATE	1991	dobj	4	SENT_327	[p21l1363t1850r1515b1906],
6	;	:	O	;	_	0	SENT_327	[p21l1363t1850r1515b1906],
7	325	CD	NUMBER	325	num	9	SENT_327	[p21l1541t1847r1659b1898],
8	:	:	O	:	_	0	SENT_327	[p21l1541t1847r1659b1898],
9	388-92	CD	NUMBER	388-92	dep	5	SENT_327	[p21l1687t1850r1911b1898],
10	.	.	O	.	_	0	SENT_327	[p21l1687t1850r1911b1898],

1	Drysdale	NNP	PERSON	Drysdale	nn	2	SENT_328	[p21l152t1935r411b2005],
2	CM	NN	O	cm	_	0	SENT_328	[p21l435t1940r557b1997],
3	,	,	O	,	_	0	SENT_328	[p21l435t1940r557b1997],
4	McGraw	NNP	PERSON	McGraw	nn	5	SENT_328	[p21l584t1940r839b1989],
5	DW	NNP	O	DW	appos	2	SENT_328	[p21l861t1941r991b1997],
6	,	,	O	,	_	0	SENT_328	[p21l861t1941r991b1997],
7	Stack	NNP	O	Stack	nn	8	SENT_328	[p21l1019t1935r1176b1989],
8	CB	NNP	O	CB	appos	2	SENT_328	[p21l1197t1940r1301b1997],
9	,	,	O	,	_	0	SENT_328	[p21l1197t1940r1301b1997],
10	et	FW	O	et	nn	11	SENT_328	[p21l1326t1946r1378b1989],
11	al.	FW	O	al.	appos	2	SENT_328	[p21l1399t1935r1463b1989],
12	.	.	O	.	_	0	SENT_328	[p21l1399t1935r1463b1989],

1	Complex	NN	O	complex	nn	2	SENT_329	[p21l1489t1935r1755b2005],
2	promoter	NN	O	promoter	nsubj	10	SENT_329	[p21l1775t1946r2056b2005],
3	and	CC	O	and	_	0	SENT_329	[p21l149t2016r259b2069],
4	coding	VBG	O	code	amod	6	SENT_329	[p21l280t2016r480b2086],
5	region	NN	O	region	nn	6	SENT_329	[p21l502t2019r694b2086],
6	beta	NN	O	beta	nsubj	10	SENT_329	[p21l714t2016r838b2069],
7	2-adrenergic	JJ	O	2-adrenergic	amod	9	SENT_329	[p21l861t2016r1233b2086],
8	receptor	NN	O	receptor	nn	9	SENT_329	[p21l1255t2027r1501b2086],
9	haplotypes	NNS	O	haplotype	dep	2	SENT_329	[p21l1520t2016r1840b2086],
10	alter	VBP	O	alter	_	0	SENT_329	[p21l1864t2016r1996b2069],
11	receptor	NN	O	receptor	nn	12	SENT_329	[p21l148t2107r395b2166],
12	expression	NN	O	expression	dobj	10	SENT_329	[p21l416t2100r735b2166],
13	and	CC	O	and	_	0	SENT_329	[p21l757t2097r867b2150],
14	predict	VB	O	predict	conj_and	10	SENT_329	[p21l887t2097r1096b2166],
15	in	FW	O	in	nn	16	SENT_329	[p21l1116t2100r1175b2149],
16	vivo	FW	O	vivo	advmod	14	SENT_329	[p21l1195t2100r1313b2150],
17	responsiveness	NN	O	responsiveness	dobj	14	SENT_329	[p21l1335t2100r1805b2166],
18	.	.	O	.	_	0	SENT_329	[p21l1335t2100r1805b2166],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_330	[p21l153t2183r276b2231],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_330	[p21l299t2177r421b2231],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_330	[p21l439t2177r585b2231],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_330	[p21l610t2179r691b2231],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_330	[p21l723t2182r853b2231],
6	2000	CD	DATE	2000	num	5	SENT_330	[p21l875t2182r1029b2239],
7	;	:	O	;	_	0	SENT_330	[p21l875t2182r1029b2239],
8	97	CD	NUMBER	97	num	10	SENT_330	[p21l1055t2181r1138b2232],
9	:	:	O	:	_	0	SENT_330	[p21l1055t2181r1138b2232],
10	10483-88	CD	NUMBER	10483-88	dep	5	SENT_330	[p21l1167t2182r1461b2231],
11	.	.	O	.	_	0	SENT_330	[p21l1167t2182r1461b2231],

1	Green	NNP	ORGANIZATION	Green	nn	2	SENT_331	[p21l151t2273r334b2322],
2	SA	NNP	ORGANIZATION	SA	_	0	SENT_331	[p21l359t2273r456b2330],
3	,	,	O	,	_	0	SENT_331	[p21l359t2273r456b2330],
4	Cole	NNP	O	Cole	nn	5	SENT_331	[p21l482t2269r613b2322],
5	G	NNP	O	G	appos	2	SENT_331	[p21l637t2273r701b2330],
6	,	,	O	,	_	0	SENT_331	[p21l637t2273r701b2330],
7	Iacinto	NNP	O	Iacinto	nn	8	SENT_331	[p21l726t2272r931b2337],
8	M	NNP	O	M	appos	2	SENT_331	[p21l956t2274r1030b2330],
9	,	,	O	,	_	0	SENT_331	[p21l956t2274r1030b2330],
10	Innis	NNP	PERSON	Innis	nn	11	SENT_331	[p21l1057t2272r1210b2322],
11	M	NNP	O	M	appos	2	SENT_331	[p21l1236t2274r1310b2330],
12	,	,	O	,	_	0	SENT_331	[p21l1236t2274r1310b2330],
13	Liggett	NNP	ORGANIZATION	Liggett	nn	14	SENT_331	[p21l1337t2272r1540b2339],
14	SB	NN	O	sb	appos	2	SENT_331	[p21l1565t2273r1658b2322],
15	.	.	O	.	_	0	SENT_331	[p21l1565t2273r1658b2322],

1	A	DT	O	a	det	2	SENT_332	[p21l1682t2272r1728b2321],
2	polymorphism	NN	O	polymorphism	nsubj	14	SENT_332	[p21l148t2349r591b2419],
3	of	IN	O	of	_	0	SENT_332	[p21l614t2349r679b2402],
4	the	DT	O	the	det	8	SENT_332	[p21l690t2349r782b2402],
5	human	JJ	O	human	amod	8	SENT_332	[p21l803t2349r1021b2402],
6	beta	NN	O	beta	nn	8	SENT_332	[p21l1040t2349r1164b2402],
7	2-adrenergic	JJ	O	2-adrenergic	amod	8	SENT_332	[p21l1187t2349r1560b2419],
8	receptor	NN	O	receptor	prep_of	2	SENT_332	[p21l1581t2359r1827b2418],
9	within	IN	O	within	_	0	SENT_332	[p21l1846t2349r2041b2402],
10	the	DT	O	the	det	13	SENT_332	[p21l148t2428r240b2481],
11	fourth	JJ	ORDINAL	fourth	amod	13	SENT_332	[p21l263t2428r450b2481],
12	transmembrane	NN	O	transmembrane	nn	13	SENT_332	[p21l470t2428r952b2481],
13	domain	NN	O	domain	prep_within	8	SENT_332	[p21l976t2428r1204b2481],
14	alters	VBZ	O	alter	_	0	SENT_332	[p21l1226t2428r1385b2481],
15	ligand	NN	O	ligand	nn	16	SENT_332	[p21l1407t2428r1595b2499],
16	binding	NN	O	binding	nn	19	SENT_332	[p21l1615t2428r1850b2499],
17	and	CC	O	and	_	0	SENT_332	[p21l1871t2428r1981b2481],
18	functional	JJ	O	functional	nn	19	SENT_332	[p21l148t2509r455b2562],
19	properties	NNS	O	property	dobj	14	SENT_332	[p21l476t2512r778b2578],
20	of	IN	O	of	prep	19	SENT_332	[p21l802t2509r868b2562],
21	the	DT	O	the	det	22	SENT_332	[p21l879t2509r971b2562],
22	receptor	NN	O	receptor	dep	20	SENT_332	[p21l993t2520r1254b2578],
23	.	.	O	.	_	0	SENT_332	[p21l993t2520r1254b2578],
24	]	SYM	O	]	dep	19	SENT_332	[p21l1271t2514r1306b2579],

1	Biol	NNP	ORGANIZATION	Biol	nn	2	SENT_333	[p21l1328t2509r1439b2562],
2	Chem	NNP	ORGANIZATION	Chem	_	0	SENT_333	[p21l1464t2509r1626b2562],
3	1993	CD	DATE	1993	num	2	SENT_333	[p21l1650t2514r1802b2570],
4	;	:	O	;	_	0	SENT_333	[p21l1650t2514r1802b2570],
5	268	CD	NUMBER	268	num	7	SENT_333	[p21l1828t2514r1945b2562],
6	:	:	O	:	_	0	SENT_333	[p21l1828t2514r1945b2562],
7	23116-21	CD	NUMBER	23116-21	dep	2	SENT_333	[p21l151t2593r448b2641],
8	.	.	O	.	_	0	SENT_333	[p21l151t2593r448b2641],

1	Green	NNP	ORGANIZATION	Green	nn	4	SENT_334	[p21l151t2683r334b2732],
2	SA	NNP	ORGANIZATION	SA	nn	4	SENT_334	[p21l359t2683r456b2741],
3	,	,	O	,	_	0	SENT_334	[p21l359t2683r456b2741],
4	Turl	NNP	O	Turl	_	0	SENT_334	[p21l479t2679r645b2732],
5	<	JJR	O	<	dep	4	SENT_334	[p21l479t2679r645b2732],
6	i	FW	O	i	dep	5	SENT_334	[p21l479t2679r645b2732],
7	I	PRP	O	I	dep	4	SENT_334	[p21l668t2684r705b2748],
8	,	,	O	,	_	0	SENT_334	[p21l668t2684r705b2748],
9	Bejarano	NNP	PERSON	Bejarano	nn	10	SENT_334	[p21l732t2682r995b2749],
10	P	NN	O	p	appos	7	SENT_334	[p21l1021t2684r1073b2740],
11	,	,	O	,	_	0	SENT_334	[p21l1021t2684r1073b2740],
12	I-Iall	NNP	O	I-Iall	nn	13	SENT_334	[p21l1100t2679r1225b2732],
13	IP	NNP	O	IP	appos	4	SENT_334	[p21l1250t2684r1329b2741],
14	,	,	O	,	_	0	SENT_334	[p21l1250t2684r1329b2741],
15	Liggett	NNP	ORGANIZATION	Liggett	nn	16	SENT_334	[p21l1356t2682r1559b2749],
16	SB	NN	O	sb	appos	4	SENT_334	[p21l1584t2683r1677b2732],
17	.	.	O	.	_	0	SENT_334	[p21l1584t2683r1677b2732],

1	Inﬂuence	NN	O	inﬂuence	_	0	SENT_335	[p21l1705t2679r1988b2732],
2	of	IN	O	of	_	0	SENT_335	[p21l2011t2679r2077b2732],
3	beta	NN	O	beta	prep_of	1	SENT_335	[p21l147t2779r694b2849],
4	(	CD	NUMBER	(	number	5	SENT_335	[p21l147t2779r694b2849],
5	2	CD	NUMBER	2	num	3	SENT_335	[p21l147t2779r694b2849],
6	)	SYM	O	)	dep	1	SENT_335	[p21l147t2779r694b2849],
7	-	:	O	-	_	0	SENT_335	[p21l147t2779r694b2849],
8	adrenergic	JJ	O	adrenergic	amod	10	SENT_335	[p21l147t2779r694b2849],
9	receptor	NN	O	receptor	nn	10	SENT_335	[p21l715t2789r961b2848],
10	genotypes	NNS	O	genotype	dep	1	SENT_335	[p21l982t2789r1279b2849],
11	on	IN	O	on	_	0	SENT_335	[p21l1303t2798r1378b2832],
12	signal	NN	O	signal	nn	13	SENT_335	[p21l1401t2779r1577b2849],
13	transduction	NN	O	transduction	prep_on	10	SENT_335	[p21l1598t2779r1979b2832],
14	in	IN	O	in	_	0	SENT_335	[p21l2001t2782r2060b2831],
15	human	JJ	O	human	amod	19	SENT_335	[p21l147t2858r365b2912],
16	airway	NN	O	airway	nn	19	SENT_335	[p21l387t2862r580b2928],
17	smooth	JJ	O	smooth	amod	19	SENT_335	[p21l602t2858r825b2912],
18	muscle	NN	O	muscle	nn	19	SENT_335	[p21l846t2858r1061b2912],
19	cells	NNS	O	cell	prep_in	13	SENT_335	[p21l1083t2858r1228b2912],
20	.	.	O	.	_	0	SENT_335	[p21l1083t2858r1228b2912],

1	Am	VBP	O	be	dep	5	SENT_336	[p21l1251t2863r1404b2928],
2	]	CD	NUMBER	]	num	5	SENT_336	[p21l1251t2863r1404b2928],
3	Respir	NNP	O	Respir	nn	5	SENT_336	[p21l1426t2860r1602b2928],
4	Cell	NN	O	cell	nn	5	SENT_336	[p21l1624t2858r1728b2912],
5	M	NN	O	m	_	0	SENT_336	[p21l1750t2864r1812b2911],
6	ol	NN	O	ol	dep	5	SENT_336	[p21l1814t2858r1860b2911],
7	Biol	NNP	O	Biol	dep	6	SENT_336	[p21l1884t2858r1994b2911],
8	1995	CD	DATE	1995	num	7	SENT_336	[p21l153t2943r304b3001],
9	;	:	O	;	_	0	SENT_336	[p21l153t2943r304b3001],
10	13	CD	NUMBER	13	dep	7	SENT_336	[p21l331t2944r413b2993],
11	:	:	O	:	_	0	SENT_336	[p21l331t2944r413b2993],
12	25-33	CD	NUMBER	25-33	dep	10	SENT_336	[p21l439t2943r629b2993],
13	.	.	O	.	_	0	SENT_336	[p21l439t2943r629b2993],

1	McGraw	NNP	ORGANIZATION	McGraw	nn	2	SENT_337	[p21l151t3033r406b3082],
2	DW	NNP	ORGANIZATION	DW	_	0	SENT_337	[p21l429t3034r558b3090],
3	,	,	O	,	_	0	SENT_337	[p21l429t3034r558b3090],
4	Almoosa	NNP	ORGANIZATION	Almoosa	nn	5	SENT_337	[p21l581t3028r845b3082],
5	KF	NNP	ORGANIZATION	KF	appos	2	SENT_337	[p21l870t3032r967b3090],
6	,	,	O	,	_	0	SENT_337	[p21l870t3032r967b3090],
7	Paul	NNP	PERSON	Paul	nn	9	SENT_337	[p21l994t3028r1124b3082],
8	R	NN	PERSON	r	nn	9	SENT_337	[p21l1148t3034r1231b3097],
9	]	NN	O	]	appos	2	SENT_337	[p21l1148t3034r1231b3097],
10	,	,	O	,	_	0	SENT_337	[p21l1148t3034r1231b3097],
11	Kobilka	FW	LOCATION	kobilka	dep	2	SENT_337	[p21l1258t3028r1482b3082],
12	BK	NN	LOCATION	bk	dep	2	SENT_337	[p21l1506t3034r1608b3090],
13	,	,	O	,	_	0	SENT_337	[p21l1506t3034r1608b3090],
14	Liggett	NNP	ORGANIZATION	Liggett	nn	15	SENT_337	[p21l1635t3032r1838b3099],
15	SB	NN	O	sb	appos	12	SENT_337	[p21l1863t3033r1956b3082],
16	.	.	O	.	_	0	SENT_337	[p21l1863t3033r1956b3082],

1	Antithetic	JJ	MISC	antithetic	_	0	SENT_338	[p21l147t3108r447b3161],
2	regulation	NN	O	regulation	dobj	8	SENT_338	[p21l468t3108r775b3179],
3	by	IN	O	by	_	0	SENT_338	[p21l795t3108r864b3178],
4	beta-adrenergic	JJ	O	beta-adrenergic	amod	5	SENT_338	[p21l883t3108r1348b3178],
5	receptors	NNS	O	receptor	prep_by	2	SENT_338	[p21l1369t3119r1643b3178],
6	of	IN	O	of	_	0	SENT_338	[p21l1667t3108r1733b3161],
7	Gq-receptor	NN	MISC	gq-receptor	prep_of	5	SENT_338	[p21l1746t3112r2101b3178],
8	signaling	NN	O	signaling	dep	1	SENT_338	[p21l151t3189r426b3259],
9	via	IN	O	via	_	0	SENT_338	[p21l445t3192r529b3242],
10	phospholipase-C	NN	O	phospholipase-c	prep_via	11	SENT_338	[p21l550t3189r1050b3258],
11	underlies	VBZ	O	underlie	dep	8	SENT_338	[p21l1072t3189r1352b3242],
12	the	DT	O	the	det	13	SENT_338	[p21l1375t3189r1468b3242],
13	airway	NN	O	airway	dobj	11	SENT_338	[p21l1490t3192r1684b3259],
14	beta-agonist	JJ	O	beta-agonist	amod	15	SENT_338	[p21l1703t3189r2067b3259],
15	paradox	NN	O	paradox	nsubj	11	SENT_338	[p21l148t3268r398b3338],
16	.	.	O	.	_	0	SENT_338	[p21l148t3268r398b3338],
17	]	SYM	O	]	dep	1	SENT_338	[p21l415t3274r451b3338],

1	Clin	NNP	O	Clin	nn	2	SENT_339	[p21l474t3268r592b3322],
2	Invest	NNP	O	Invest	_	0	SENT_339	[p21l616t3274r780b3321],
3	2003	CD	DATE	2003	num	2	SENT_339	[p21l801t3273r955b3330],
4	;	:	O	;	_	0	SENT_339	[p21l801t3273r955b3330],
5	112	CD	NUMBER	112	num	7	SENT_339	[p21l982t3273r1100b3321],
6	:	:	O	:	_	0	SENT_339	[p21l982t3273r1100b3321],
7	619-26	CD	NUMBER	619-26	dep	2	SENT_339	[p21l1126t3273r1352b3322],
8	.	.	O	.	_	0	SENT_339	[p21l1126t3273r1352b3322],

1	Shore	NNP	O	Shore	nn	2	SENT_340	[p21l153t3360r322b3413],
2	SA	NNP	O	SA	_	0	SENT_340	[p21l349t3364r445b3422],
3	,	,	O	,	_	0	SENT_340	[p21l349t3364r445b3422],
4	Drazen	NNP	PERSON	Drazen	nn	5	SENT_340	[p21l473t3365r688b3413],
5	IM	NNP	PERSON	IM	appos	2	SENT_340	[p21l711t3365r812b3428],
6	.	.	O	.	_	0	SENT_340	[p21l711t3365r812b3428],

1	Beta-agonists	NNS	O	beta-agonist	_	0	SENT_341	[p21l840t3363r1235b3430],
2	and	CC	O	and	_	0	SENT_341	[p21l1259t3360r1368b3413],
3	asthma	NN	O	asthma	conj_and	1	SENT_341	[p21l1390t3360r1622b3413],
4	:	:	O	:	_	0	SENT_341	[p21l1390t3360r1622b3413],
5	too	RB	O	too	advmod	6	SENT_341	[p21l1646t3371r1737b3413],
6	much	JJ	O	much	dep	1	SENT_341	[p21l1759t3360r1932b3413],
7	of	IN	O	of	prep	6	SENT_341	[p21l1954t3360r2020b3413],
8	a	DT	O	a	det	10	SENT_341	[p21l2032t3379r2061b3413],
9	good	JJ	O	good	amod	10	SENT_341	[p21l150t3440r293b3510],
10	thing	NN	O	thing	dep	7	SENT_341	[p21l313t3440r499b3510],
11	?	.	O	?	_	0	SENT_341	[p21l313t3440r499b3510],
12	]	SYM	O	]	dep	1	SENT_341	[p21l515t3445r551b3510],

1	Clin	NNP	O	Clin	nn	2	SENT_342	[p21l574t3440r692b3493],
2	Invest	NNP	O	Invest	_	0	SENT_342	[p21l716t3445r880b3492],
3	2003	CD	DATE	2003	num	2	SENT_342	[p21l901t3444r1055b3501],
4	;	:	O	;	_	0	SENT_342	[p21l901t3444r1055b3501],
5	112	CD	NUMBER	112	num	7	SENT_342	[p21l1082t3445r1200b3493],
6	:	:	O	:	_	0	SENT_342	[p21l1082t3445r1200b3493],
7	495-97	CD	NUMBER	495-97	dep	2	SENT_342	[p21l1224t3443r1452b3495],
8	.	.	O	.	_	0	SENT_342	[p21l1224t3443r1452b3495],

1	wvvw	NN	O	wvvw	_	0	SENT_343	[p21l815t3692r1352b3743],
2	.	.	O	.	_	0	SENT_343	[p21l815t3692r1352b3743],

1	the	DT	O	the	det	2	SENT_344	[p21l815t3692r1352b3743],
2	|	NN	O	|	_	0	SENT_344	[p21l815t3692r1352b3743],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_344	[p21l815t3692r1352b3743],
4	Vol	NNP	O	Vol	dep	2	SENT_344	[p21l1395t3692r1484b3743],
5	364	CD	NUMBER	364	num	4	SENT_344	[p21l1505t3691r1614b3751],
6	October	NNP	DATE	October	tmod	4	SENT_344	[p21l1659t3692r1884b3743],
7	23	CD	DATE	23	num	6	SENT_344	[p21l1902t3699r1988b3753],
8	,	,	DATE	,	_	0	SENT_344	[p21l1902t3699r1988b3753],
9	2004	CD	DATE	2004	num	6	SENT_344	[p21l2009t3699r2154b3750],

